data_1wi5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wi5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -134.01 146.37 59.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.547 0.689 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 115.17 3.97 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.683 2.256 . . . . 0.0 112.361 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 139.76 -11.04 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 19.1 mtt -73.77 132.7 42.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.0 mp -93.14 113.59 25.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 203' ' ' LEU . 2.0 mp -130.88 134.13 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.0 m -83.12 118.12 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -114.73 160.55 13.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.0 p -122.53 137.07 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.21 120.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.0 t -86.27 -45.53 11.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.1 m -156.99 156.01 32.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 210' ' ' LEU . 1.2 mm? -91.5 124.31 35.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -107.89 164.83 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -22.78 35.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.471 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 4.0 p80 -98.09 -20.68 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -179.95 -149.28 8.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.476 ' CE2' HD13 ' A' ' 210' ' ' LEU . 27.0 m-85 -133.99 138.4 45.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.973 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 132.85 33.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.95 129.45 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.97 126.89 31.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.8 pt -119.95 -20.06 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 221' ' ' VAL . . . 82.51 51.99 4.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.478 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 220' ' ' GLY . 93.2 t -141.75 141.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.01 116.59 28.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 104.05 -42.85 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.518 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.5 m -74.44 125.42 28.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -114.74 132.09 56.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.93 124.54 51.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 5.5 t80 -123.27 143.39 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 14.2 tp -113.29 134.55 21.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.943 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 144.45 53.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.303 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 17.4 mt -63.03 -26.44 68.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.6 -44.18 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -82.19 -42.09 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.57 -48.95 73.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 36.0 tt0 -62.85 -33.99 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.68 -42.65 91.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.555 ' CE1' HD11 ' A' ' 252' ' ' LEU . 3.9 t80 -72.29 -37.36 69.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 241' ' ' ASN . 30.6 mt -69.66 -47.27 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.465 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.3 ptp180 -59.45 -40.52 87.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -79.98 -21.55 43.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 236' ' ' TYR . 37.4 mmtm -99.14 -72.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 237' ' ' ILE . 22.0 t-20 -83.69 35.85 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 241' ' ' ASN . 20.2 mtpp 34.44 33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 81.47 70.64 1.33 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -148.25 137.69 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -44.52 147.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 69.1 mt -86.34 -175.09 5.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -122.55 176.75 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 147.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.26 24.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -72.07 148.01 46.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -81.0 126.97 32.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CE1' ' A' ' 236' ' ' TYR . 15.4 tp -136.66 135.97 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -76.07 134.43 40.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 73.9 m -152.64 144.85 23.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.417 ' CD1' ' HA3' ' A' ' 271' ' ' GLY . 65.2 mt -133.77 138.9 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.96 119.44 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -106.48 -30.49 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -151.78 149.85 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.05 133.09 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -84.35 150.99 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -60.39 -67.61 2.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -88.13 41.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 44.15 42.74 6.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.63 -73.12 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.447 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.23 136.87 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 42.3 t -104.28 139.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 114.03 26.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 17.1 mt -111.76 149.45 31.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.6 m -149.12 150.43 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.12 118.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.842 0.353 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -108.21 147.65 36.0 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.894 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 140.87 43.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 103.76 7.22 42.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 47.4 mtt -80.66 139.26 36.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.84 108.62 19.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 203' ' ' LEU . 4.4 mp -124.28 150.98 44.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.3 m -117.48 117.06 28.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -119.65 -172.63 15.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.45 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.546 HG23 ' CD1' ' A' ' 251' ' ' TYR . 7.6 p -129.02 139.62 51.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 111.138 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.18 120.41 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.9 t -86.41 -38.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.5 p -157.0 155.75 31.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.64 123.96 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.76 168.28 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.99 -24.19 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -92.02 -14.56 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . 175.82 -167.44 39.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.09 137.07 53.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 128.59 36.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.5 135.55 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -86.55 135.71 33.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.74 -13.49 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.81 50.71 23.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.49 155.97 39.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.127 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.14 122.26 43.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.73 36.95 17.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 42.5 m -151.65 123.59 8.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -114.17 131.37 56.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.04 135.32 53.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.541 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 9.1 t80 -129.76 142.74 50.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.462 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 10.3 tp -113.99 133.44 22.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.71 143.22 50.35 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 25.6 mt -62.67 -22.92 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.34 -44.23 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -83.25 -33.21 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.0 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.23 -42.2 99.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.69 -41.45 96.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.49 ' CE1' HD12 ' A' ' 252' ' ' LEU . 2.4 t80 -72.41 -40.05 67.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 241' ' ' ASN . 43.5 mt -68.09 -43.01 85.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 8.1 ptm180 -66.61 -40.3 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 37.8 mm-40 -79.96 -20.15 46.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 21.4 mmtm -101.31 -69.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 243' ' ' GLY . 12.3 t-20 -84.37 32.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.8 OUTLIER 37.32 28.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.58 64.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.448 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.428 ' HB3' ' ND2' ' A' ' 241' ' ' ASN . . . -143.49 130.94 21.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 111.054 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -46.77 155.14 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.38 175.54 6.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -129.38 134.46 47.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.78 141.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.16 -27.0 16.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.67 148.36 52.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.546 ' CD1' HG23 ' A' ' 206' ' ' THR . 11.1 m-85 -81.99 130.27 35.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.49 HD12 ' CE1' ' A' ' 236' ' ' TYR . 38.1 tp -123.64 138.35 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -81.24 134.9 35.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 58.0 m -157.5 150.6 23.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.5 mt -127.13 139.56 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.89 123.09 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.39 -46.17 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -144.74 152.09 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.79 122.01 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 55.0 mttt -79.3 133.11 36.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -36.43 -45.48 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -109.09 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -78.33 61.51 3.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -93.95 -81.13 1.5 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 266' ' ' VAL . 90.4 t -132.24 143.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.435 ' N ' HG11 ' A' ' 265' ' ' VAL . 34.8 t -113.02 139.96 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 266' ' ' VAL . 17.9 t -99.69 131.32 45.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.5 mt -126.69 157.63 38.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 97.3 p -157.08 143.54 18.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.01 131.46 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.459 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -129.45 153.66 80.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 109.45 2.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.7 28.97 1.01 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.6 mtt -96.4 136.74 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.89 111.99 23.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.9 mp -131.09 149.14 52.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -102.1 120.22 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.91 177.71 17.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.2 p -126.68 136.83 52.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.468 HG21 ' CG ' ' A' ' 250' ' ' GLN . 94.5 t -60.95 122.74 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.1 t -86.07 -46.02 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.6 p -157.07 156.03 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 210' ' ' LEU . 7.1 mp -100.13 127.8 46.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -113.3 144.79 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . 0.461 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -64.57 -23.61 67.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -94.9 -39.44 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -153.47 -159.48 9.14 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.438 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.44 ' CE2' ' CD2' ' A' ' 230' ' ' LEU . 58.9 m-85 -133.66 132.77 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.93 125.28 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.09 137.03 34.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.97 -30.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.48 47.6 5.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 138.48 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.14 109.61 20.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.86 36.86 3.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 63.5 m -150.06 128.67 12.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.314 . . . . 0.0 111.128 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -114.66 126.33 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.82 127.66 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.567 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 18.2 t80 -132.26 126.44 33.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.6 tp -104.94 130.27 23.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.19 49.9 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 212' ' ' ASP . 31.1 mt -63.29 -29.26 70.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.61 -45.21 93.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -80.27 -42.1 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.0 98.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.85 -30.38 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.41 -43.88 84.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.563 ' CE1' HD12 ' A' ' 252' ' ' LEU . 0.8 OUTLIER -73.29 -37.81 66.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 241' ' ' ASN . 17.3 mt -68.25 -50.89 53.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.461 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 26.2 ptt85 -57.03 -40.08 76.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -80.04 -31.47 39.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 26.3 mmtt -88.28 -69.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 15.9 t-20 -83.58 35.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASN . 60.9 mttp 34.21 33.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.3 58.59 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.453 ' HB3' ' ND2' ' A' ' 241' ' ' ASN . . . -136.55 128.0 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -40.32 130.59 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 237' ' ' ILE . 21.2 mt -70.04 -175.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -127.75 178.52 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 249' ' ' GLY . 59.2 t -92.09 153.43 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.427 ' N ' HG12 ' A' ' 248' ' ' VAL . . . 63.27 12.57 45.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.485 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.468 ' CG ' HG21 ' A' ' 207' ' ' VAL . 4.6 pt20 -82.4 147.98 28.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.94 126.81 31.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -135.04 142.25 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -96.47 133.06 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 92.0 m -146.76 159.69 43.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 269' ' ' SER . 86.1 mt -136.74 137.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.12 131.24 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.24 -41.53 5.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -150.68 153.06 34.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.8 t -123.76 121.28 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 261' ' ' GLY . 24.7 tptt -127.6 143.25 51.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 260' ' ' LYS . . . 54.77 165.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.452 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 262' ' ' ASN . 38.3 p30 -95.6 40.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 142.1 40.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.443 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -108.25 -95.0 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.6 137.43 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.61 139.89 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.161 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.6 t -99.12 125.2 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.0 mt -121.02 152.09 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 255' ' ' ILE . 93.8 p -159.77 143.23 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.9 122.39 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.154 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.94 150.77 63.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.721 . . . . 0.0 110.891 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.354 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.43 11.79 3.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.4 mtt -99.14 130.95 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.42 107.94 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.26 130.72 53.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.975 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -93.55 129.4 39.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -136.01 -173.04 12.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.531 HG22 ' CD1' ' A' ' 251' ' ' TYR . 5.6 p -130.89 140.07 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 111.114 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.99 119.94 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.1 t -86.36 -39.74 16.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.3 m -157.01 156.02 32.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.413 ' CD1' HG23 ' A' ' 248' ' ' VAL . 8.4 mp -106.76 125.41 50.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -117.24 144.62 44.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . 0.431 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 2.6 m-20 -66.36 -17.76 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -95.23 -27.39 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -170.02 -159.05 14.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -133.34 129.44 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 126.17 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.95 135.31 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.78 133.65 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 pt -123.09 -22.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.06 50.03 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -143.53 147.79 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.41 124.32 35.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.4 -51.72 1.83 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.535 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -59.92 124.95 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -115.8 132.01 56.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.25 125.83 53.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 14.1 t80 -123.32 137.13 54.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.79 132.34 22.32 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.58 0.705 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 140.59 43.0 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.345 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 212' ' ' ASP . 28.9 mt -63.08 -19.88 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.77 -44.53 66.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.64 -35.54 39.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.47 -43.05 64.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 11.3 tt0 -58.46 -36.81 74.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.75 -43.18 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 236' ' ' TYR . 0.2 OUTLIER -72.1 -38.52 69.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.461 HG12 ' CD2' ' A' ' 246' ' ' LEU . 22.0 mt -66.3 -39.01 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.113 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -69.18 -41.98 76.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -79.83 -21.65 43.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.546 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 24.1 mmtt -100.17 -67.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 243' ' ' GLY . 22.3 t-20 -84.3 32.81 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' ASN . 76.2 mttt 37.94 27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 85.94 61.58 1.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.405 ' HB2' ' ND2' ' A' ' 241' ' ' ASN . . . -142.65 134.12 26.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.86 148.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.461 ' CD2' HG12 ' A' ' 237' ' ' ILE . 94.5 mt -78.58 -177.66 5.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.6 145.89 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 210' ' ' LEU . 78.1 t -72.2 128.53 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.56 -27.13 20.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.93 147.96 48.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.531 ' CD1' HG22 ' A' ' 206' ' ' THR . 12.6 m-85 -80.97 132.01 35.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.73 141.45 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.74 133.86 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.1 m -155.28 151.13 27.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.02 147.0 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 200' ' ' GLY . 2.9 t -72.72 120.28 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -107.07 -48.47 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -137.77 135.37 36.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.35 122.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -126.05 134.34 51.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 65.75 -157.77 47.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.99 -42.5 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.93 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -130.72 32.2 3.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -90.53 -101.37 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.72 134.78 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.25 139.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.7 m -99.1 117.12 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.9 mt -110.9 157.66 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -148.63 142.0 25.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 36.1 t -75.21 141.61 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -127.55 143.91 49.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.55 0.691 . . . . 0.0 110.897 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 109.1 2.23 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 146.98 -11.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.7 mtm -79.1 141.27 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.833 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.1 108.08 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 203' ' ' LEU . 3.6 mm? -117.3 128.44 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -94.3 130.87 40.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.11 -163.64 9.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.5 p -131.11 146.03 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.194 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.43 121.67 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.3 t -85.83 -43.05 13.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.467 ' HA ' ' CG2' ' A' ' 248' ' ' VAL . 5.2 m -157.05 156.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.859 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.49 125.1 50.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -116.95 162.17 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -22.93 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -96.15 -9.82 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 177.3 -161.4 28.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.627 ' CD1' ' CB ' ' A' ' 233' ' ' ALA . 84.4 m-85 -132.86 137.55 46.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.961 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.95 129.91 36.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.71 143.1 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.46 133.78 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.8 pt -125.1 -18.96 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.94 51.7 17.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 150.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.834 0.349 . . . . 0.0 111.116 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -93.84 119.2 32.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.96 43.68 13.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.1 m -155.22 123.71 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -113.43 131.42 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.79 48.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 13.0 t80 -122.92 140.48 52.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.475 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 23.5 tp -113.81 133.69 22.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.78 146.76 61.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.316 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.07 -22.76 67.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.4 -45.01 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -81.96 -37.7 26.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.627 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.32 -46.1 85.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.058 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -65.21 -39.26 92.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.7 -43.24 89.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.567 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 2.2 t80 -72.64 -42.26 64.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 233' ' ' ALA . 18.7 mt -65.23 -38.94 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.146 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.452 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 1.2 ttt85 -68.79 -43.72 75.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -79.0 -21.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.567 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 39.2 mmtt -99.31 -68.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.06 34.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 241' ' ' ASN . 79.5 mttt 34.73 34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 78.1 74.63 1.01 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -152.24 118.73 5.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -35.61 135.76 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' A' ' 215' ' ' TYR . 51.7 mt -69.22 -175.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.416 ' HG3' ' C ' ' A' ' 246' ' ' LEU . 3.4 mtpm? -144.7 130.06 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 209' ' ' SER . 23.9 t -50.62 126.05 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 109.83 -31.37 7.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.462 ' NE2' HD23 ' A' ' 246' ' ' LEU . 9.1 pt20 -62.99 148.17 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.909 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -80.73 130.82 35.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -124.3 145.32 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.18 127.48 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 35.0 m -147.2 155.19 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 269' ' ' SER . 95.3 mt -133.03 139.43 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.29 119.39 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -103.9 -48.07 4.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -138.6 140.28 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.8 t -122.16 129.11 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -85.41 176.29 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -87.97 -54.51 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -85.85 30.64 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 45.5 32.03 3.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.01 -74.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.8 t -132.68 134.24 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.33 139.6 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.7 t -99.97 118.4 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.3 mt -113.64 149.88 33.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 255' ' ' ILE . 52.3 p -145.94 142.01 28.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.93 134.65 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.853 0.358 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -100.4 148.93 35.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.567 0.698 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 129.91 8.04 3.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.9 mtt -76.16 140.36 41.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.5 108.62 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 26.4 mt -130.39 141.1 50.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.4 m -119.57 122.23 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.3 -177.61 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -124.16 138.08 54.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.47 122.88 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -88.23 -40.68 13.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.97 156.07 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.8 mm? -99.86 115.42 29.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.25 137.21 37.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -57.2 -20.55 27.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -94.5 -38.3 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -161.24 -161.94 12.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.531 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.552 ' CE1' HD23 ' A' ' 230' ' ' LEU . 41.3 m-85 -117.63 132.14 56.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.01 133.54 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.76 142.66 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.4 123.07 33.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.7 -33.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.03 37.35 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.443 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.4 t -113.11 146.29 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -97.13 98.75 10.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.03 46.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 91.2 m -158.3 124.1 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -116.7 123.92 48.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.01 129.33 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.094 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 18.9 t80 -130.48 137.65 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.46 ' C ' ' CD1' ' A' ' 228' ' ' LEU . 1.7 tm? -107.87 126.81 28.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.455 ' N ' HD11 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.78 131.66 21.66 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.688 2.259 . . . . 0.0 112.372 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.552 HD23 ' CE1' ' A' ' 215' ' ' TYR . 30.5 mt -62.4 -24.75 67.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.6 mt -65.6 -41.27 92.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -42.51 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 228' ' ' LEU . . . -59.3 -34.14 71.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.45 -34.01 70.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.41 -43.66 76.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.86 -37.79 67.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 242' ' ' LYS . 32.4 mt -68.42 -42.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 28.3 ptt180 -68.73 -35.98 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.448 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 12.1 mm100 -78.38 -39.9 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -98.1 -74.93 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 237' ' ' ILE . 4.4 m120 -52.47 -16.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 237' ' ' ILE . 32.5 mttp 59.54 36.53 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.41 46.88 5.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -136.57 117.42 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -49.57 135.54 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 215' ' ' TYR . 28.3 mt -62.6 179.2 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -131.27 170.8 14.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 210' ' ' LEU . 19.3 t -87.73 128.66 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.55 -21.93 37.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.36 148.0 51.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -81.0 127.17 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.96 135.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -93.28 125.31 37.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 13.3 m -140.28 157.64 45.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.84 140.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 200' ' ' GLY . 39.0 t -61.04 119.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -99.87 -46.89 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -140.1 152.89 46.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.417 ' C ' ' HE2' ' A' ' 260' ' ' LYS . 71.9 t -124.0 127.29 73.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 259' ' ' VAL . 0.3 OUTLIER -97.72 167.72 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -88.92 171.1 38.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.514 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 261' ' ' GLY . 3.0 p-10 45.52 40.67 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 40.47 47.34 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.54 -98.56 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 266' ' ' VAL . 13.6 t -120.59 146.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 265' ' ' VAL . 53.1 t -113.02 139.99 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 266' ' ' VAL . 2.3 m -98.97 115.44 28.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.0 mt -113.23 148.77 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 46.3 m -158.78 142.07 14.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.97 142.86 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.482 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -153.26 155.25 31.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.561 0.696 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 113.56 3.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.398 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.47 4.11 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.3 mtt -90.62 130.89 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.93 109.02 20.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -123.63 127.99 49.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m -97.78 119.45 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.42 -172.31 14.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.469 HG22 ' CD1' ' A' ' 251' ' ' TYR . 1.2 p -128.55 139.32 52.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.29 122.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -92.62 -40.43 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.98 156.09 32.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 210' ' ' LEU . 8.0 mp -109.28 125.15 51.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.87 150.97 34.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -70.17 -17.05 63.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -98.06 -25.77 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -172.27 -169.74 35.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.08 131.23 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.945 0.403 . . . . 0.0 110.929 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.04 124.44 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.92 130.16 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.09 137.07 36.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 pt -123.44 -31.84 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.58 44.43 6.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.05 140.43 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.71 111.56 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.15 37.83 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 93.1 m -154.87 123.36 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 111.162 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.34 123.03 47.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.41 127.68 53.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.558 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 23.5 t80 -131.07 137.34 49.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.474 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 20.1 tp -109.29 128.61 25.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.73 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.76 143.42 50.77 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -26.81 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.4 -40.46 95.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.408 ' HD2' ' CG2' ' A' ' 270' ' ' VAL . 0.5 OUTLIER -83.13 -35.72 25.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.456 ' CB ' HD21 ' A' ' 228' ' ' LEU . . . -68.57 -48.54 63.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -58.23 -35.32 71.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.7 -46.02 76.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.5 OUTLIER -71.3 -36.93 71.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.983 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 246' ' ' LEU . 21.7 mt -68.89 -38.92 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.47 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 2.7 ttm-85 -69.02 -41.18 78.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.5 -19.98 48.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 7.5 mmtp -101.82 -69.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 244' ' ' ALA . 17.1 t-20 -84.16 33.52 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 241' ' ' ASN . 53.8 mttt 34.63 34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.47 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 77.75 73.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.484 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.457 ' HB2' ' ND2' ' A' ' 241' ' ' ASN . . . -151.3 124.4 8.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 244' ' ' ALA . 20.4 mmtm -37.22 144.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.441 ' CD2' HG12 ' A' ' 237' ' ' ILE . 13.8 mt -80.95 178.9 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.76 127.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 108.18 -27.24 14.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -63.44 148.0 49.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.469 ' CD1' HG22 ' A' ' 206' ' ' THR . 15.5 m-85 -81.03 127.28 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.3 tp -121.04 139.36 53.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -88.87 132.47 34.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 43.3 m -153.04 153.74 33.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 256' ' ' VAL . 72.9 mt -136.8 143.75 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.41 ' N ' HG23 ' A' ' 255' ' ' ILE . 2.8 t -68.48 121.45 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -101.62 -41.97 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -150.67 155.98 40.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.19 119.2 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 261' ' ' GLY . 35.6 tttp -86.42 135.03 33.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . 35.92 -149.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -120.35 72.5 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.81 24.04 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -95.46 -87.39 1.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.19 148.98 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 267' ' ' SER . 47.2 t -119.46 139.97 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 266' ' ' VAL . 3.0 t -100.01 118.08 35.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.4 mt -111.97 150.16 30.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 255' ' ' ILE . 1.4 t -146.28 146.98 30.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.432 HG13 ' CG ' ' A' ' 236' ' ' TYR . 28.9 m -74.7 136.16 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.882 0.373 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -153.22 148.16 19.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.85 10.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.05 6.19 6.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.0 mtt -89.78 127.71 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.4 mp -89.61 109.87 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 26.4 mt -131.49 127.05 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m -84.13 119.66 25.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.94 163.84 12.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -113.5 135.47 53.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.812 0.339 . . . . 0.0 111.146 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.99 121.06 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 41.8 t -86.17 -45.09 11.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 85.1 p -157.02 155.97 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.63 129.22 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -116.31 151.88 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.05 -21.78 62.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -96.74 -17.19 20.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 179.55 -158.88 23.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.29 135.8 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.921 0.391 . . . . 0.0 110.897 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.44 129.55 35.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.1 128.4 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.01 132.82 36.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.48 -19.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 221' ' ' VAL . . . 73.18 57.68 5.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 220' ' ' GLY . 45.7 t -139.86 139.79 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.79 94.23 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.26 39.38 0.87 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 85.5 m -156.98 131.59 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.63 123.76 48.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.02 122.99 47.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -124.84 142.42 51.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.471 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 19.7 tp -113.75 134.6 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.609 0.718 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.471 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.83 142.55 47.95 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.1 -22.2 66.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.91 -43.26 79.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HD2' ' CG2' ' A' ' 270' ' ' VAL . 0.9 OUTLIER -81.76 -33.22 31.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -75.15 -51.87 12.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -60.26 -36.92 78.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.49 -41.57 98.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.564 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 4.9 t80 -73.25 -41.83 63.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 241' ' ' ASN . 47.0 mt -63.02 -39.85 86.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.6 ptm180 -69.77 -35.68 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.415 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 6.5 mm100 -81.4 -29.22 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.564 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 14.1 mmmt -107.99 -63.39 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 237' ' ' ILE . 2.7 m-20 -80.73 21.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.9 mmtm 35.82 30.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.15 40.33 8.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -104.81 113.37 26.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -40.39 126.3 2.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.412 ' CD1' HD12 ' A' ' 237' ' ' ILE . 15.4 mt -64.23 -175.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -137.31 -175.91 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 98.4 t -97.53 145.79 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.79 81.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -82.86 148.01 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -80.95 128.66 33.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 12.5 tp -131.4 142.89 50.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -98.89 131.59 44.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 97.1 m -154.03 163.05 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.63 150.37 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.51 121.57 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 269' ' ' SER . 3.9 mp0 -104.75 -40.56 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -142.99 148.83 37.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.08 126.03 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.3 144.57 36.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.34 -65.52 3.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -86.71 37.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 46.98 36.39 8.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.04 -82.48 0.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.79 134.31 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 38.1 t -108.86 139.98 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 t -99.07 121.48 41.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.42 154.13 32.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.406 ' N ' ' OE1' ' A' ' 257' ' ' GLU . 36.4 t -154.05 152.41 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.84 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.405 ' CG2' ' HD2' ' A' ' 232' ' ' LYS . 20.2 m -80.09 139.99 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -134.39 151.48 76.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 121.2 7.89 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.368 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.25 5.28 3.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.1 mtt -96.42 133.59 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.324 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -85.43 116.28 23.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.0 mp -120.92 130.22 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.3 m -97.99 126.15 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -138.46 -177.12 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.531 HG23 ' CD1' ' A' ' 251' ' ' TYR . 12.5 p -121.69 141.29 51.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.93 120.04 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.8 t -86.18 -39.29 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.1 m -157.02 156.01 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.53 122.9 48.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.08 156.96 20.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.35 -23.52 57.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -94.53 -22.17 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.5 -164.89 27.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.491 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.403 ' CE1' HD12 ' A' ' 246' ' ' LEU . 75.0 m-85 -127.55 133.21 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.91 128.28 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.01 132.64 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.97 136.67 36.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 pt -127.4 -26.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.78 56.29 2.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.503 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 89.5 t -139.88 132.82 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.36 46.45 1.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 167.48 42.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.414 HG22 ' CG2' ' A' ' 266' ' ' VAL . 54.5 m -160.43 124.42 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -107.32 125.13 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.99 125.66 53.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.559 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.417 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 20.2 tp -104.3 132.06 21.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.3 Cg_endo -69.75 146.62 60.82 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.312 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 23.7 mt -63.03 -26.58 68.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.41 -44.39 89.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -82.39 -41.89 19.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.76 -46.3 84.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -62.7 -38.82 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -65.44 -44.67 86.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.55 ' CD1' ' HG3' ' A' ' 240' ' ' LYS . 83.5 t80 -70.13 -38.66 75.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 41.3 mt -69.21 -44.28 80.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.469 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.5 ptm180 -69.65 -37.44 76.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -81.52 -27.14 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 236' ' ' TYR . 7.2 mmpt? -107.75 -64.91 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.1 m120 -81.62 25.5 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ASN . 1.2 pmtp? 32.74 34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 102.31 -45.27 1.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -34.42 120.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -53.61 152.7 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.464 HD22 ' NE2' ' A' ' 250' ' ' GLN . 17.7 mt -76.3 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -132.12 129.82 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.8 t -46.67 131.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 105.73 -30.22 10.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.464 ' NE2' HD22 ' A' ' 246' ' ' LEU . 10.2 pt20 -62.93 147.97 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.942 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.531 ' CD1' HG23 ' A' ' 206' ' ' THR . 10.6 m-85 -81.02 130.21 34.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.468 HD13 ' CE2' ' A' ' 236' ' ' TYR . 15.4 tp -123.93 145.06 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -94.28 129.05 41.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.964 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 63.7 m -148.43 151.99 36.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 256' ' ' VAL . 38.5 mt -130.79 145.95 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 255' ' ' ILE . 6.2 t -70.29 122.58 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -105.5 -45.23 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -138.78 136.53 35.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 36.1 t -122.67 125.74 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 261' ' ' GLY . 34.7 ttpt -90.14 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -37.25 -60.06 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -93.44 174.34 7.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -80.66 51.76 4.3 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -77.18 -80.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.97 133.89 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 111.133 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.414 ' CG2' HG22 ' A' ' 224' ' ' THR . 22.1 t -106.34 139.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.1 t -101.43 125.72 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -116.51 157.16 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 60.1 p -151.45 156.76 41.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 41.7 t -78.19 131.85 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -160.8 154.22 18.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 126.37 13.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.676 2.25 . . . . 0.0 112.377 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 127.74 0.84 6.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.8 mtt -90.05 128.7 36.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.36 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.6 mp -89.46 117.33 28.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.79 128.96 41.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 31.6 m -85.02 124.33 31.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.86 169.25 20.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.44 HG22 ' CD1' ' A' ' 251' ' ' TYR . 2.7 p -119.24 138.12 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.83 121.99 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.8 t -86.49 -42.01 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -157.04 156.3 32.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -106.75 125.13 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.91 154.89 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.81 -18.99 61.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -97.52 -30.41 12.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.563 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -165.13 -165.6 22.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -127.94 131.74 49.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.78 125.9 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.1 t -112.22 132.87 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -79.96 131.79 35.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 224' ' ' THR . 31.1 pt -124.05 -18.77 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.78 40.06 89.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.95 138.04 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.23 127.93 34.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.82 56.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.46 HG21 ' CD1' ' A' ' 219' ' ' ILE . 56.4 m -149.97 123.87 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -109.37 130.73 55.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.563 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -131.72 140.25 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 268' ' ' LEU . 22.6 tp -114.99 133.17 22.69 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.76 145.24 56.59 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.3 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 30.7 mt -63.38 -21.63 66.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.11 -44.7 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.25 -30.69 48.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -77.01 -44.32 31.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -58.34 -33.4 69.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.58 -43.9 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.557 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 0.8 OUTLIER -72.89 -35.49 67.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 241' ' ' ASN . 39.8 mt -70.64 -40.9 77.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.182 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.475 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 16.2 ptt85 -69.52 -37.44 77.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -80.76 -39.14 27.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.557 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 63.3 mmtt -94.05 -57.58 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 243' ' ' GLY . 2.5 m120 -81.99 23.26 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.1 OUTLIER 34.09 32.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.79 45.4 7.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -122.92 112.29 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.13 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -34.19 132.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 237' ' ' ILE . 31.2 mt -65.44 -176.56 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.91 141.89 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.68 151.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.29 -21.49 6.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.36 148.53 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.44 ' CD1' HG22 ' A' ' 206' ' ' THR . 11.3 m-85 -85.01 128.31 34.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -126.08 135.73 52.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -92.75 131.49 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 82.6 m -152.74 162.98 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 256' ' ' VAL . 44.6 mt -137.19 144.44 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 255' ' ' ILE . 9.3 t -66.43 119.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -106.65 -46.91 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -132.26 136.02 46.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.15 132.84 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -84.37 158.0 21.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -51.59 -94.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 263' ' ' GLY . 20.0 p-10 -73.67 64.13 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 36.57 42.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -66.47 -73.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 75.5 t -133.87 133.44 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.364 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 137.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.429 ' C ' ' CD2' ' A' ' 268' ' ' LEU . 2.5 m -99.66 138.71 36.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.493 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 1.0 OUTLIER -121.05 148.35 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.3 p -151.75 141.87 22.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.45 141.82 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.432 ' N ' ' HE2' ' A' ' 201' ' ' MET . 49.7 mtmt -158.61 154.01 22.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.718 . . . . 0.0 110.84 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 107.26 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.722 2.282 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.69 7.01 3.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.432 ' HE2' ' N ' ' A' ' 198' ' ' LYS . 8.6 mtt -92.8 132.66 36.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.41 112.22 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mp -131.16 129.44 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.892 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.7 m -76.99 117.84 18.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -121.06 152.08 16.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -107.58 141.54 38.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.09 121.06 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.1 t -86.45 -46.13 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -157.07 156.42 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.437 HD13 ' N ' ' A' ' 210' ' ' LEU . 9.0 mp -103.23 126.9 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -115.21 156.41 25.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.82 -24.04 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -87.96 -32.44 18.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.6 -159.55 18.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 233' ' ' ALA . 96.3 m-85 -125.19 139.92 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.32 130.83 44.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.97 146.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.55 129.68 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.468 HD13 ' CG2' ' A' ' 224' ' ' THR . 31.8 pt -121.76 -27.58 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.03 34.64 6.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.84 127.54 64.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.33 94.55 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.37 -33.47 0.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.468 ' CG2' HD13 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -92.66 151.04 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 111.163 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.78 121.09 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.14 127.62 54.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.541 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 6.2 t80 -132.09 137.03 47.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 tp -105.96 131.76 21.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 139.42 39.97 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.672 2.248 . . . . 0.0 112.321 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.436 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 26.3 mt -63.11 -21.0 65.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 12.4 mt -70.79 -45.02 65.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.87 -28.03 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 215' ' ' TYR . . . -79.9 -49.13 12.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 33.3 tt0 -58.02 -44.38 87.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 236' ' ' TYR . 6.8 pt-20 -60.9 -40.43 93.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.5 ' CE1' HD13 ' A' ' 252' ' ' LEU . 1.2 t80 -73.12 -36.82 66.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 241' ' ' ASN . 31.1 mt -70.02 -40.95 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.472 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 4.8 ptm180 -69.1 -39.55 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -80.19 -19.93 45.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 19.0 mmmt -105.88 -67.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.11 29.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.0 pttm 37.44 28.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.41 50.46 4.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -125.58 122.27 36.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.67 138.44 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.425 HD12 ' CE2' ' A' ' 215' ' ' TYR . 18.4 mt -71.99 -174.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -127.79 -174.93 3.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.91 144.16 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.98 3.52 11.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 251' ' ' TYR . 0.8 OUTLIER -66.66 144.87 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.883 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.481 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 23.7 m-85 -80.8 126.66 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.5 HD13 ' CE1' ' A' ' 236' ' ' TYR . 6.0 tp -136.75 137.15 39.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.58 132.42 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 89.9 m -149.64 152.05 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.8 mt -137.08 146.44 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.4 t -74.24 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.33 -44.02 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -143.57 144.23 31.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.95 123.69 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -88.57 121.73 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 38.37 -143.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.468 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.26 63.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.92 0.391 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 138.53 35.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.83 -109.65 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.14 148.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.128 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.16 139.32 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.8 m -98.95 120.73 39.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 25.7 mt -115.57 151.95 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.5 t -155.81 151.89 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.26 128.79 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.122 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.91 0.386 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.441 ' HG2' ' CE ' ' A' ' 201' ' ' MET . 14.1 ptmt -170.26 142.4 1.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 115.79 4.26 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 2.248 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 129.6 9.78 3.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.441 ' CE ' ' HG2' ' A' ' 198' ' ' LYS . 64.5 mtm -98.1 135.73 39.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.16 119.94 32.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 203' ' ' LEU . 5.7 mp -131.87 135.07 46.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 m -99.84 121.52 41.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.66 174.17 19.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 p -118.37 136.29 53.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.193 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.57 127.83 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.176 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.7 t -92.27 -46.11 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.9 p -157.03 155.28 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 215' ' ' TYR . 7.4 mt -100.35 133.39 44.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.84 152.31 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -64.88 -23.02 67.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.66 -47.22 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -160.63 -165.07 16.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.543 ' CD1' HD23 ' A' ' 210' ' ' LEU . 45.0 m-85 -118.15 132.96 56.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -91.58 132.96 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.06 145.31 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -89.4 124.52 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 pt -121.88 -25.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.23 47.58 10.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.81 141.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -93.9 114.19 26.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 92.13 36.34 6.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.54 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.6 m -147.48 123.96 11.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -111.35 130.87 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.54 135.49 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 59.0 t80 -131.76 141.85 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.474 ' CD2' ' HE3' ' A' ' 232' ' ' LYS . 1.7 tm? -120.59 126.58 26.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CD2' ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.77 131.04 20.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.2 -21.64 66.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.91 -45.11 87.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 233' ' ' ALA . 0.0 OUTLIER -70.45 -37.84 74.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.48 ' N ' ' HG3' ' A' ' 232' ' ' LYS . . . -75.34 -26.62 58.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -64.98 -31.67 73.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.11 -44.69 52.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.51 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.4 t80 -73.05 -37.65 66.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 241' ' ' ASN . 51.7 mt -70.02 -41.87 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.462 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.2 ptm180 -67.12 -40.2 86.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.445 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 74.9 mm-40 -80.15 -19.95 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.51 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 64.9 mmtt -103.94 -68.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 237' ' ' ILE . 11.7 t-20 -84.17 33.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 241' ' ' ASN . 74.3 mttt 34.48 32.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.94 69.16 1.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.425 ' O ' ' CG2' ' A' ' 237' ' ' ILE . . . -137.55 -177.25 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -92.66 154.04 18.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.95 152.55 21.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.0 140.18 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.7 135.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 93.97 -18.34 56.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -63.06 148.07 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.89 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -80.85 127.05 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.25 138.24 53.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.7 136.56 32.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 88.8 m -151.18 163.02 39.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.1 mt -136.17 145.5 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 5.9 t -68.02 122.31 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.22 -43.92 5.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -144.77 145.08 31.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.9 129.14 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -103.86 127.24 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -43.74 167.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 263' ' ' GLY . 7.2 p-10 45.43 37.27 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 37.34 47.58 1.53 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.54 -85.11 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 48.9 t -121.94 136.84 57.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 111.149 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.2 137.76 38.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.408 ' C ' HD22 ' A' ' 268' ' ' LEU . 1.8 t -102.11 122.41 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 268' ' ' LEU . 0.3 OUTLIER -114.33 142.87 45.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.3 m -156.97 145.76 19.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.51 123.53 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.512 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.404 ' N ' HG12 ' A' ' 259' ' ' VAL . 48.5 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.824 0.345 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -123.49 145.16 46.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 136.28 32.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.649 2.233 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 121.59 -29.28 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.5 mtt -61.45 132.15 52.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.57 108.0 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.55 132.76 54.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.4 m -89.0 120.01 30.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.95 166.22 12.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.36 56.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.18 121.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -89.23 -44.69 10.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.5 m -156.99 151.09 24.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.72 123.51 40.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -112.0 158.6 19.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.81 -21.55 57.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -92.86 -20.11 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 175.3 -171.64 44.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.558 ' CE1' HD13 ' A' ' 246' ' ' LEU . 89.0 m-85 -112.23 131.6 55.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.907 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.01 129.35 34.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.45 138.53 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.81 134.79 34.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.07 -21.14 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.22 54.87 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -148.38 138.53 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.22 125.66 36.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.87 -49.9 0.94 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 47.1 m -76.37 124.25 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 225' ' ' ARG . 4.3 ptp180 -116.53 127.99 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.01 128.75 56.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 8.0 t80 -124.75 136.35 53.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.74 130.83 22.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.0 110.943 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 145.14 56.29 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.299 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 22.4 mt -63.03 -19.2 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -44.77 88.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -81.16 -28.91 34.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 215' ' ' TYR . . . -73.12 -47.17 46.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -62.89 -38.36 90.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.35 -44.54 87.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 11.3 t80 -72.04 -41.23 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 40.9 mt -69.26 -41.03 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.482 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 21.8 ptt180 -70.05 -35.96 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.07 -36.17 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 27.4 mmtp -98.92 -58.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.4 m-20 -80.51 19.82 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm 38.25 26.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.53 44.36 5.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.509 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 -179.01 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -104.02 119.45 38.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.558 HD13 ' CE1' ' A' ' 215' ' ' TYR . 21.8 mt -62.14 -179.9 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -136.07 -175.53 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.87 149.43 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 67.16 14.98 64.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -87.52 148.06 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -81.05 128.54 33.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.07 145.13 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.62 136.08 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.5 m -153.99 163.02 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.3 mt -136.92 150.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.6 t -70.43 125.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -103.14 -46.73 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -145.42 146.61 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 197' ' ' LEU . 14.6 t -123.96 132.4 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 3.1 tppp? -78.73 150.51 32.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -35.96 -38.81 0.24 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.449 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -125.85 -176.54 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -76.07 48.21 2.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -80.31 -84.87 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.2 134.35 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 139.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.5 t -98.96 120.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 40.8 mt -111.71 154.46 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 23.2 p -152.68 141.97 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.852 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 21.1 m -73.12 134.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.502 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -146.1 144.72 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 129.66 18.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.6 -1.34 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.75 140.5 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.6 mp -102.44 113.29 26.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.66 133.07 53.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -95.63 120.47 35.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.54 -169.93 12.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.0 p -131.96 137.91 48.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.354 . . . . 0.0 111.16 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.46 127.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.5 t -96.03 -40.59 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.6 m -154.93 156.02 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.555 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.8 mm? -100.33 110.22 22.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.32 139.1 31.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -16.41 59.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -97.76 -36.74 10.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -159.58 -150.64 5.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.602 ' CE2' ' CD1' ' A' ' 246' ' ' LEU . 84.4 m-85 -133.13 132.14 41.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.911 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.9 131.4 37.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.82 145.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -92.52 128.97 38.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.56 -31.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.8 50.84 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.492 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.79 151.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.106 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 222' ' ' ASP . 3.1 t0 -92.65 110.64 22.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.73 55.59 2.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 87.7 m -156.03 122.97 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 0.0 111.191 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 266' ' ' VAL . 68.8 mtt180 -116.13 129.47 56.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.448 ' CB ' HD23 ' A' ' 268' ' ' LEU . . . -119.77 128.98 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 16.0 t80 -131.97 135.01 46.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.514 ' C ' ' CD1' ' A' ' 228' ' ' LEU . 1.4 tm? -107.76 127.03 28.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 53.5 Cg_endo -69.79 128.99 16.8 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.67 2.246 . . . . 0.0 112.346 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.05 -22.05 48.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.6 mt -64.83 -45.03 87.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -83.44 -30.52 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.464 ' CB ' HD12 ' A' ' 228' ' ' LEU . . . -68.07 -36.21 79.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.94 -39.29 94.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -62.41 -43.81 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.561 ' CE2' ' HE3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -73.14 -47.07 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 241' ' ' ASN . 34.8 mt -61.15 -49.4 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.47 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.6 ptm180 -58.1 -43.17 86.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.465 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 8.4 mm100 -80.36 -19.89 45.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 2.0 mmmp? -100.9 -75.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.2 t-20 -80.66 41.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER 33.28 34.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 75.45 54.16 5.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -131.66 120.27 22.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -33.85 146.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.602 ' CD1' ' CE2' ' A' ' 215' ' ' TYR . 11.8 mt -78.14 179.63 6.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -123.33 171.05 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 210' ' ' LEU . 75.3 t -92.54 139.83 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.33 -20.58 36.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -63.07 148.06 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.97 127.17 32.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.12 140.27 52.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.71 136.18 45.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 96.9 m -151.51 162.89 40.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.18 140.62 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.5 t -69.1 120.89 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.27 -39.7 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -144.81 141.64 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.1 t -120.66 130.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -82.25 145.7 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.33 -69.62 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.512 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.26 39.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 38.58 34.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.517 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.11 -53.53 25.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.66 143.52 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 225' ' ' ARG . 43.2 t -126.95 140.07 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.414 ' C ' HD22 ' A' ' 268' ' ' LEU . 4.3 t -98.98 142.08 30.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 268' ' ' LEU . 1.2 mm? -123.82 143.64 50.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 p -143.07 152.69 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.16 141.51 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.493 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -119.59 149.24 47.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 0.0 110.895 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 116.87 4.76 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.43 -9.83 3.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' MET . . . . . 0.452 ' O ' ' CG2' ' A' ' 255' ' ' ILE . 11.8 mtt -79.74 140.6 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.763 0.316 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.51 122.17 36.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 203' ' ' LEU . 4.5 mp -131.25 125.23 32.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 m -92.51 119.09 31.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.63 16.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 p -118.23 139.8 50.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 134.59 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.9 t -109.91 -33.88 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -157.03 156.12 32.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.83 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 10.0 mt -113.86 137.6 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.01 164.95 19.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.69 -26.49 40.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.448 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 3.6 p80 -93.59 -17.7 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.75 -162.1 27.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.456 ' CE1' HD11 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.94 139.93 46.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.926 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.85 130.5 34.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.32 131.59 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.59 134.69 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.2 pt -125.1 -21.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.92 7.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.36 135.7 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -88.68 107.24 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.92 36.93 4.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.5 m -153.01 125.31 8.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.103 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -114.08 131.75 56.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.22 134.89 54.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.475 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 24.3 t80 -127.17 140.4 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.47 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 24.9 tp -113.76 130.35 23.88 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.68 146.59 61.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.268 . . . . 0.0 112.364 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 31.3 mt -62.14 -19.9 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.77 -44.71 95.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -41.47 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.4 ' HB1' ' CD2' ' A' ' 228' ' ' LEU . . . -65.11 -48.51 73.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 12.4 tt0 -62.96 -37.73 88.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.91 -42.4 90.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.538 ' CD2' ' HD3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -72.91 -38.92 66.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 241' ' ' ASN . 66.0 mt -69.28 -40.5 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.466 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 14.3 ptm180 -70.23 -35.33 73.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -79.98 -40.43 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.538 ' HD3' ' CD2' ' A' ' 236' ' ' TYR . 0.0 OUTLIER -93.91 -55.39 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 237' ' ' ILE . 10.5 t-20 -81.43 19.12 1.03 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 241' ' ' ASN . 51.5 mttt 38.06 27.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.99 67.5 1.44 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -146.35 151.47 37.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 111.152 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.47 154.91 2.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.456 HD11 ' CE1' ' A' ' 215' ' ' TYR . 66.8 mt -95.72 171.37 8.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.89 133.05 47.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.09 136.06 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.48 -23.19 34.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.451 ' NE2' HD23 ' A' ' 246' ' ' LEU . 6.7 pt20 -63.19 148.0 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.915 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.11 127.05 32.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.8 tp -127.61 137.1 52.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -84.42 131.58 34.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 32.3 m -145.99 153.54 40.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 256' ' ' VAL . 15.2 mt -135.45 147.01 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.465 ' N ' HG21 ' A' ' 255' ' ' ILE . 40.0 t -66.93 124.52 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -105.65 -44.42 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -146.79 161.22 41.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.3 130.08 75.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -108.54 117.48 34.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -46.39 157.04 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.518 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 m120 58.87 25.46 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.912 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.47 45.75 4.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -74.57 -72.27 1.04 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 266' ' ' VAL . 94.8 t -129.04 134.43 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.402 ' N ' HG11 ' A' ' 265' ' ' VAL . 23.8 t -112.46 136.2 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.2 t -100.82 116.02 31.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.69 156.68 25.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 255' ' ' ILE . 82.3 p -152.53 142.1 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 p -82.58 143.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -158.88 152.4 19.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 132.83 24.09 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 120.52 -10.7 10.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.483 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.4 mtt -73.94 127.58 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -88.74 113.52 24.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 18.5 mt -129.69 134.92 47.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.46 117.03 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -120.12 154.85 16.33 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.9 p -104.85 132.86 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.03 120.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.2 t -86.0 -46.01 10.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.1 p -156.76 155.85 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.92 139.0 39.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.1 161.65 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -72.54 -19.05 61.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -93.35 -39.51 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -166.39 -162.04 16.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.47 ' CZ ' HD13 ' A' ' 246' ' ' LEU . 92.8 m-85 -120.58 130.34 54.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.929 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.42 133.94 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.2 t -115.95 139.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 -8.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.45 52.78 24.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.506 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.8 t -146.82 134.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -87.18 109.76 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.92 -49.17 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.452 HG21 ' CG2' ' A' ' 266' ' ' VAL . 48.6 m -68.21 124.1 22.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -111.3 131.17 55.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.22 134.79 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.567 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 36.7 t80 -131.81 143.41 50.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 229' ' ' PRO . 0.3 OUTLIER -113.7 126.22 28.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.955 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.489 ' N ' HD12 ' A' ' 228' ' ' LEU . 53.9 Cg_endo -69.73 129.13 17.09 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.94 -14.91 52.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.79 -45.06 53.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -83.17 -36.84 24.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 228' ' ' LEU . . . -64.78 -31.49 72.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -64.39 -41.19 96.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -63.64 -43.43 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.511 ' CZ ' ' HG3' ' A' ' 240' ' ' LYS . 18.3 t80 -72.1 -37.56 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 241' ' ' ASN . 76.5 mt -69.43 -45.82 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.2 ptp180 -61.47 -40.94 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -80.06 -21.17 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.511 ' HG3' ' CZ ' ' A' ' 236' ' ' TYR . 29.0 mmtm -99.44 -71.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 237' ' ' ILE . 17.2 t-20 -83.75 35.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' ASN . 25.5 mtpp 36.41 30.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.52 73.95 1.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -158.3 153.95 26.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.085 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 162.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.47 HD13 ' CZ ' ' A' ' 215' ' ' TYR . 59.0 mt -95.31 -178.1 4.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 247' ' ' LYS . 3.4 mppt? -116.77 174.9 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.5 t -102.04 144.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.82 -6.09 20.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.79 147.94 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -80.99 127.24 32.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.7 tp -128.64 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -97.67 124.25 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -142.64 163.06 33.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 269' ' ' SER . 91.6 mt -137.07 138.44 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.409 ' N ' HG22 ' A' ' 255' ' ' ILE . 15.7 t -65.25 120.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -105.81 -33.5 7.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -144.0 133.45 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.98 132.08 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -87.41 157.64 19.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -68.1 -65.21 2.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.68 41.33 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.3 37.24 1.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -62.22 -74.74 0.37 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.77 135.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 224' ' ' THR . 8.4 t -105.97 139.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.424 ' C ' ' CD2' ' A' ' 268' ' ' LEU . 7.5 m -100.39 139.54 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 268' ' ' LEU . 1.1 mm? -121.19 153.0 38.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 255' ' ' ILE . 45.8 p -159.9 141.97 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.93 133.9 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -161.21 149.65 12.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.867 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 108.84 2.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.72 -5.82 3.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.3 mtm -86.83 142.69 27.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.05 125.34 44.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.01 125.95 32.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -98.04 119.5 36.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.16 -165.18 11.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.1 p -129.92 138.75 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 128.54 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.1 t -87.8 -45.99 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.1 m -156.91 155.95 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.67 112.89 25.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . 0.403 ' CG ' HD23 ' A' ' 216' ' ' LEU . 14.3 mm-40 -94.28 143.25 26.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.74 -19.13 65.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.49 -29.96 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.545 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -166.64 -155.68 9.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.557 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 246' ' ' LEU . 89.8 m-85 -125.49 125.85 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 110.897 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 211' ' ' GLU . 2.0 mm? -86.39 133.94 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.936 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.01 141.56 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.79 131.44 34.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.1 pt -127.28 -29.42 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.44 41.09 21.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.443 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.4 t -121.78 144.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 111.074 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.75 108.09 20.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.35 33.79 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 95.8 m -143.6 123.13 13.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -116.07 120.49 39.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.95 134.36 55.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.545 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.8 t80 -132.0 144.0 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 229' ' ' PRO . 1.7 tm? -113.67 126.9 27.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 110.926 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.503 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 136.15 32.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 31.9 mt -62.9 -24.35 67.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.79 -42.24 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.57 -39.25 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 228' ' ' LEU . . . -61.0 -48.66 80.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -58.58 -37.97 76.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -64.25 -42.52 96.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 3.0 t80 -73.03 -40.02 65.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 241' ' ' ASN . 24.3 mt -68.1 -40.03 82.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.472 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.3 ptm180 -69.92 -37.98 76.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -81.38 -27.36 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 66.9 mmtt -107.38 -63.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 237' ' ' ILE . 2.4 m120 -81.37 24.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.0 mtpt 34.77 31.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.79 44.54 7.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -112.91 113.48 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -41.51 125.74 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 215' ' ' TYR . 16.2 mt -58.94 -175.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -144.17 152.12 40.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.7 t -67.08 143.56 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.95 -21.06 16.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 252' ' ' LEU . 0.9 OUTLIER -65.49 148.32 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.954 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -80.97 133.04 35.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 250' ' ' GLN . 24.2 tp -134.48 135.09 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.31 136.5 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 37.8 m -148.55 151.35 34.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 256' ' ' VAL . 90.3 mt -131.52 138.69 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 255' ' ' ILE . 17.2 t -62.73 123.71 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -106.82 -45.62 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -134.37 148.86 50.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 63.1 t -119.27 126.74 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.25 118.53 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -40.79 -56.88 2.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 263' ' ' GLY . 28.1 t30 -85.69 35.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.59 42.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -76.14 -74.21 0.95 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.6 130.99 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.19 139.95 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.1 t -99.38 120.75 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.9 mt -116.3 152.14 34.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 58.2 m -146.8 147.71 31.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.79 127.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -110.14 148.51 38.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.711 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 116.93 4.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.84 -2.92 7.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 34.3 mtt -68.07 141.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.23 111.04 20.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -124.74 137.86 54.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.4 m -112.64 125.38 54.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.32 161.01 25.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.426 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 251' ' ' TYR . 4.0 p -103.57 140.08 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.5 122.38 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.5 t -87.56 -43.36 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.1 m -156.81 155.77 32.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.58 123.73 44.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.56 147.57 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -65.09 -27.42 68.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -90.6 -32.41 16.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -164.62 -159.19 10.9 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.554 ' CE1' HD11 ' A' ' 246' ' ' LEU . 94.6 m-85 -125.71 129.51 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.01 134.05 33.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.98 142.2 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.45 124.11 33.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.94 -27.39 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.03 40.69 10.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 64.9 t -128.59 142.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.127 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.51 126.63 38.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 98.99 -48.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.6 m -69.13 123.23 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -114.97 129.69 56.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.11 128.98 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 27.4 t80 -131.85 134.34 45.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 229' ' ' PRO . 1.7 tm? -109.21 126.4 29.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.451 ' N ' HD11 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.74 133.77 26.42 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.495 ' CD2' ' CE2' ' A' ' 215' ' ' TYR . 48.9 mt -61.2 -21.86 64.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 -44.99 85.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.455 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 1.6 tmtp? -77.5 -31.54 53.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.9 -39.77 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -59.43 -33.87 71.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.33 -45.85 75.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.9 t80 -72.3 -38.04 68.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 241' ' ' ASN . 51.6 mt -69.79 -42.45 80.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.47 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 17.9 ptt180 -69.77 -36.56 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -81.39 -34.74 31.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.536 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 1.2 mmmp? -99.66 -60.03 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 237' ' ' ILE . 8.6 m-20 -80.81 21.32 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm 36.99 28.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.97 46.88 4.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.46 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.25 177.56 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -100.12 137.59 38.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.554 HD11 ' CE1' ' A' ' 215' ' ' TYR . 23.5 mt -73.43 162.37 29.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -128.38 149.68 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.19 150.57 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.82 3.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.53 148.32 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.449 ' CD1' HG23 ' A' ' 206' ' ' THR . 11.8 m-85 -80.94 129.87 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.85 140.77 52.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -87.62 128.33 35.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.9 m -147.14 149.8 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 256' ' ' VAL . 79.8 mt -134.54 139.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 255' ' ' ILE . 30.7 t -62.71 119.05 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -97.05 -40.04 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -153.62 152.94 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -123.22 127.96 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.41 178.01 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.69 -74.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 263' ' ' GLY . 1.4 m120 -80.12 45.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.72 37.98 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.97 5.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 266' ' ' VAL . 57.5 t -132.78 146.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.461 ' N ' HG11 ' A' ' 265' ' ' VAL . 27.8 t -113.33 139.33 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.9 t -99.3 118.57 36.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.88 146.98 46.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 5.6 p -147.09 145.47 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.415 HG21 ' NZ ' ' A' ' 232' ' ' LYS . 27.3 m -76.87 122.57 31.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.096 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.9 0.381 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -140.05 151.47 65.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.2 20.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 113.29 -6.12 25.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.85 138.83 56.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.9 mp -94.44 110.13 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.13 141.65 50.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -111.56 124.63 52.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.24 -174.75 13.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.7 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.03 120.69 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 t -86.47 -41.87 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 56.4 p -156.4 156.0 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 210' ' ' LEU . 9.5 mp -105.01 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -115.34 145.21 42.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -67.48 -17.87 64.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -97.24 -20.05 18.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.95 -166.78 34.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 246' ' ' LEU . 85.0 m-85 -125.79 132.95 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.417 ' CD1' ' NH2' ' A' ' 225' ' ' ARG . 1.5 mm? -88.85 132.17 34.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.897 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.15 135.17 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.1 126.97 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 pt -119.01 -18.56 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.02 43.13 8.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.55 127.29 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.107 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.91 130.33 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.64 -43.41 1.76 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.8 m -73.92 132.0 42.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.787 0.327 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.417 ' NH2' ' CD1' ' A' ' 216' ' ' LEU . 6.9 tpm_? -109.33 123.18 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.96 126.92 55.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 9.0 t80 -132.01 139.21 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 268' ' ' LEU . 15.3 tp -112.73 133.41 21.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 54.0 Cg_endo -69.72 139.49 40.48 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.11 -25.08 68.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.57 -45.05 73.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -78.09 -33.14 50.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.15 63.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.45 -35.67 72.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.98 -42.92 99.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.3 OUTLIER -72.47 -37.74 68.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.893 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 244' ' ' ALA . 32.7 mt -66.97 -39.11 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.466 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.5 ttt180 -69.2 -41.29 77.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -79.49 -20.3 47.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.555 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 47.1 mmtt -101.5 -69.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 243' ' ' GLY . 15.7 t-20 -83.85 35.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 38.9 mmtt 34.65 32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.37 68.49 1.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.5 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.5 ' O ' ' CG2' ' A' ' 237' ' ' ILE . . . -143.76 169.24 18.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 146.98 50.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.462 HD12 ' CD1' ' A' ' 237' ' ' ILE . 80.0 mt -87.67 178.25 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -132.95 153.14 51.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.01 134.4 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.065 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.1 -22.36 39.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.449 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -64.54 148.04 51.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.05 128.47 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.09 142.9 50.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.43 130.51 38.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 95.1 m -154.91 153.0 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.63 139.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.52 125.14 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -103.5 -45.82 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -142.51 158.37 43.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.25 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.45 136.57 36.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.7 -66.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.546 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 263' ' ' GLY . 19.1 t-20 -84.53 45.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.24 36.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -68.76 -86.63 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.88 144.26 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.53 140.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.6 t -98.96 118.13 35.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 13.2 mt -116.72 149.62 39.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 75.4 m -156.91 142.03 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 17.4 t -71.89 142.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.529 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.875 0.369 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -129.95 148.93 71.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 110.937 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 120.27 7.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 134.65 -12.02 4.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.0 mtt -80.97 140.38 35.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.2 120.5 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 203' ' ' LEU . 5.1 mp -130.54 125.36 34.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.5 m -94.39 120.41 34.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.76 -174.43 14.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.3 p -123.55 142.38 51.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.116 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.09 120.4 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.3 t -85.16 -41.8 15.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -157.03 155.05 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 210' ' ' LEU . 3.2 mm? -95.08 107.49 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -94.13 149.38 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.55 -31.09 65.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -84.24 -28.75 27.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -168.96 -158.75 13.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.02 131.62 53.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.04 129.83 34.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.37 134.02 56.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.09 137.07 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 224' ' ' THR . 20.8 pt -126.27 -30.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.88 55.24 2.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.18 155.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.23 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.36 44.19 6.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.534 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.459 HG23 ' CD1' ' A' ' 219' ' ' ILE . 90.0 m -144.18 131.5 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.338 . . . . 0.0 111.139 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -115.62 125.9 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -121.9 122.19 38.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.57 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 17.6 t80 -125.52 140.52 52.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.2 tp -110.28 129.79 23.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.658 0.742 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 135.26 30.07 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 39.0 mt -63.1 -23.82 67.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.77 -45.18 87.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.936 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -85.12 -32.8 22.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.43 80.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -58.65 -34.01 70.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.87 -43.79 91.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t80 -72.83 -42.17 64.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 241' ' ' ASN . 22.6 mt -68.13 -40.78 83.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.474 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 11.8 ptm180 -70.11 -35.78 74.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -81.19 -34.59 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 24.0 mmtp -100.75 -59.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 237' ' ' ILE . 2.5 m120 -80.31 19.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.52 26.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.1 46.68 4.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.78 116.33 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -38.21 133.13 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 49.6 mt -69.97 171.28 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -126.14 175.44 7.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.15 132.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.19 -27.56 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.528 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -63.2 147.88 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -81.03 126.99 32.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.72 138.3 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -85.63 135.12 33.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.2 m -156.33 154.58 30.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 269' ' ' SER . 43.2 mt -134.4 142.16 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.21 119.35 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.67 -46.4 5.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -150.15 158.39 44.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -120.54 129.38 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.32 156.54 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -70.09 159.58 53.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 48.21 34.97 4.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 42.18 36.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.07 -81.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.61 146.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 267' ' ' SER . 53.7 t -113.44 138.8 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.433 ' N ' HG11 ' A' ' 266' ' ' VAL . 8.6 t -100.78 117.76 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.7 mt -116.69 157.69 25.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' ILE . 73.0 p -154.72 142.0 19.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.31 132.14 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.1 m -125.29 142.23 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.2 m -69.54 171.13 9.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.83 137.45 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 p -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.7 p -62.04 133.05 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.75 -106.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -82.09 172.54 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -83.1 154.1 24.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.04 -57.12 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -118.6 112.96 20.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -52.27 147.42 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 192' ' ' LEU . 74.3 t -100.77 -42.85 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.499 ' O ' ' CD1' ' A' ' 192' ' ' LEU . 3.9 pp 33.69 46.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.4 m -94.22 146.23 24.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -46.6 -28.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -88.54 -28.53 20.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.7 64.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.2 mt -47.99 154.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -134.01 146.37 59.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.547 0.689 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 115.17 3.97 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.683 2.256 . . . . 0.0 112.361 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 139.76 -11.04 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 19.1 mtt -73.77 132.7 42.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.0 mp -93.14 113.59 25.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 203' ' ' LEU . 2.0 mp -130.88 134.13 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.0 m -83.12 118.12 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -114.73 160.55 13.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.0 p -122.53 137.07 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.21 120.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.0 t -86.27 -45.53 11.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.1 m -156.99 156.01 32.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 210' ' ' LEU . 1.2 mm? -91.5 124.31 35.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -107.89 164.83 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -22.78 35.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.471 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 4.0 p80 -98.09 -20.68 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -179.95 -149.28 8.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.476 ' CE2' HD13 ' A' ' 210' ' ' LEU . 27.0 m-85 -133.99 138.4 45.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.973 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 132.85 33.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.95 129.45 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.97 126.89 31.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.8 pt -119.95 -20.06 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 221' ' ' VAL . . . 82.51 51.99 4.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.478 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 220' ' ' GLY . 93.2 t -141.75 141.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.01 116.59 28.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 104.05 -42.85 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.518 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.5 m -74.44 125.42 28.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -114.74 132.09 56.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.93 124.54 51.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 5.5 t80 -123.27 143.39 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 14.2 tp -113.29 134.55 21.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.943 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 144.45 53.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.303 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 17.4 mt -63.03 -26.44 68.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.6 -44.18 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -82.19 -42.09 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.57 -48.95 73.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 36.0 tt0 -62.85 -33.99 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.68 -42.65 91.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.555 ' CE1' HD11 ' A' ' 252' ' ' LEU . 3.9 t80 -72.29 -37.36 69.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 241' ' ' ASN . 30.6 mt -69.66 -47.27 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.465 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.3 ptp180 -59.45 -40.52 87.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -79.98 -21.55 43.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 236' ' ' TYR . 37.4 mmtm -99.14 -72.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 237' ' ' ILE . 22.0 t-20 -83.69 35.85 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 241' ' ' ASN . 20.2 mtpp 34.44 33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 81.47 70.64 1.33 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -148.25 137.69 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 111.117 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -44.52 147.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 69.1 mt -86.34 -175.09 5.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -122.55 176.75 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 147.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.26 24.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -72.07 148.01 46.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -81.0 126.97 32.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CE1' ' A' ' 236' ' ' TYR . 15.4 tp -136.66 135.97 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -76.07 134.43 40.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 73.9 m -152.64 144.85 23.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.417 ' CD1' ' HA3' ' A' ' 271' ' ' GLY . 65.2 mt -133.77 138.9 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.96 119.44 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -106.48 -30.49 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -151.78 149.85 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.05 133.09 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -84.35 150.99 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -60.39 -67.61 2.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -88.13 41.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 44.15 42.74 6.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.63 -73.12 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.447 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.23 136.87 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 42.3 t -104.28 139.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 114.03 26.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 17.1 mt -111.76 149.45 31.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.6 m -149.12 150.43 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.12 118.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 255' ' ' ILE . . . -125.91 -48.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -172.76 158.38 3.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.847 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 35.2 p -90.78 177.06 6.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -156.86 143.1 18.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 93.6 t -51.97 -45.05 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 28.9 t -54.92 112.23 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 50.5 p -154.09 134.83 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -129.06 139.36 52.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 30.3 mt -87.89 149.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -125.04 84.29 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.068 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 283' ' ' GLN . 22.9 m -140.98 134.11 29.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.06 -26.09 14.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.489 ' O ' ' CG2' ' A' ' 281' ' ' THR . 3.3 pm0 -149.89 172.81 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -99.55 111.56 23.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 36.5 m -165.12 128.7 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -149.23 150.41 32.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -108.53 113.05 25.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 34.5 tp -107.4 113.95 27.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -128.83 120.68 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -78.62 79.78 5.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.426 ' C ' HD21 ' A' ' 291' ' ' LEU . 2.1 tt -103.22 136.78 42.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.3 m -124.69 168.96 12.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -172.91 -169.99 36.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 149.1 66.69 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.1 t -173.43 142.03 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.5 m -116.64 141.52 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.0 m -141.58 126.91 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 55.7 m -119.91 146.71 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.819 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -156.7 42.35 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.5 m -62.23 113.3 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.849 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 m -126.67 109.9 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.825 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.43 -78.23 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -88.35 156.86 18.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -68.29 100.65 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.3 m -80.03 152.92 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 42.87 39.85 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.76 142.02 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.45 47.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.32 -42.11 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.8 p -84.82 146.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.17 -31.24 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.1 -44.5 88.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.69 86.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.096 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.2 mt -40.05 155.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -108.21 147.65 36.0 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.894 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 140.87 43.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 103.76 7.22 42.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 47.4 mtt -80.66 139.26 36.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.84 108.62 19.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.436 HD11 ' N ' ' A' ' 203' ' ' LEU . 4.4 mp -124.28 150.98 44.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.3 m -117.48 117.06 28.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -119.65 -172.63 15.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.45 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.546 HG23 ' CD1' ' A' ' 251' ' ' TYR . 7.6 p -129.02 139.62 51.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 111.138 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.18 120.41 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.9 t -86.41 -38.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.5 p -157.0 155.75 31.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.64 123.96 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.76 168.28 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.99 -24.19 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -92.02 -14.56 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.541 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . 175.82 -167.44 39.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.09 137.07 53.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 128.59 36.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.5 135.55 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -86.55 135.71 33.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.74 -13.49 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.81 50.71 23.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.49 155.97 39.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.127 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.14 122.26 43.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.73 36.95 17.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 42.5 m -151.65 123.59 8.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -114.17 131.37 56.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.04 135.32 53.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.541 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 9.1 t80 -129.76 142.74 50.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.462 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 10.3 tp -113.99 133.44 22.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.71 143.22 50.35 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 25.6 mt -62.67 -22.92 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.34 -44.23 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -83.25 -33.21 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.0 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.23 -42.2 99.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.69 -41.45 96.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.49 ' CE1' HD12 ' A' ' 252' ' ' LEU . 2.4 t80 -72.41 -40.05 67.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 241' ' ' ASN . 43.5 mt -68.09 -43.01 85.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 8.1 ptm180 -66.61 -40.3 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 37.8 mm-40 -79.96 -20.15 46.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 21.4 mmtm -101.31 -69.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 243' ' ' GLY . 12.3 t-20 -84.37 32.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.8 OUTLIER 37.32 28.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.58 64.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.448 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.428 ' HB3' ' ND2' ' A' ' 241' ' ' ASN . . . -143.49 130.94 21.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 111.054 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -46.77 155.14 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.38 175.54 6.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -129.38 134.46 47.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.78 141.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.16 -27.0 16.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.67 148.36 52.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.546 ' CD1' HG23 ' A' ' 206' ' ' THR . 11.1 m-85 -81.99 130.27 35.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.49 HD12 ' CE1' ' A' ' 236' ' ' TYR . 38.1 tp -123.64 138.35 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -81.24 134.9 35.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 58.0 m -157.5 150.6 23.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.5 mt -127.13 139.56 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.89 123.09 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.39 -46.17 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -144.74 152.09 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.79 122.01 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 55.0 mttt -79.3 133.11 36.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -36.43 -45.48 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -109.09 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -78.33 61.51 3.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -93.95 -81.13 1.5 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 266' ' ' VAL . 90.4 t -132.24 143.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.435 ' N ' HG11 ' A' ' 265' ' ' VAL . 34.8 t -113.02 139.96 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 266' ' ' VAL . 17.9 t -99.69 131.32 45.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 20.5 mt -126.69 157.63 38.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 97.3 p -157.08 143.54 18.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.6 t -71.01 131.46 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.92 70.07 2.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.459 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -60.49 -48.48 81.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.826 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 24.1 t -42.53 110.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -92.55 85.13 5.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.08 -43.86 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 58.8 m -113.15 45.45 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 16.0 m -157.12 130.14 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.23 148.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 45.8 mm -49.31 139.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -115.57 106.74 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 13.4 t -156.4 159.27 38.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.143 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -116.07 165.25 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -49.17 97.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -173.61 131.97 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.9 t -56.92 160.84 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -118.31 -35.14 3.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.34 136.26 57.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 39.9 tp -134.78 -50.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -156.65 142.36 17.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -61.63 127.96 33.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.56 148.25 49.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 40.7 p -131.3 136.67 48.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -145.76 81.57 0.21 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 136.17 32.23 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.691 2.26 . . . . 0.0 112.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.8 m -152.16 140.85 20.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.9 m -44.57 160.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.4 t -135.32 167.8 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.816 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.8 p -49.6 151.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.852 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.1 71.88 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -51.37 128.44 22.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 m -79.39 121.73 25.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.57 -59.99 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -66.35 174.61 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -54.86 134.02 48.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.4 p -50.87 -42.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -154.86 117.7 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -110.49 47.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 190' ' ' ARG . 4.8 t 34.04 53.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 192' ' ' LEU . 2.9 tt -109.31 -41.29 4.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.9 m -66.64 165.9 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -83.88 -47.04 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.8 -40.68 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.33 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 mt -42.41 160.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -129.45 153.66 80.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 109.45 2.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.7 28.97 1.01 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.6 mtt -96.4 136.74 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.89 111.99 23.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.9 mp -131.09 149.14 52.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -102.1 120.22 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.91 177.71 17.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.2 p -126.68 136.83 52.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.468 HG21 ' CG ' ' A' ' 250' ' ' GLN . 94.5 t -60.95 122.74 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.1 t -86.07 -46.02 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.6 p -157.07 156.03 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 210' ' ' LEU . 7.1 mp -100.13 127.8 46.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -113.3 144.79 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.461 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -64.57 -23.61 67.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -94.9 -39.44 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -153.47 -159.48 9.14 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.438 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.44 ' CE2' ' CD2' ' A' ' 230' ' ' LEU . 58.9 m-85 -133.66 132.77 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.93 125.28 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.09 137.03 34.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.97 -30.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.48 47.6 5.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 138.48 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.14 109.61 20.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.86 36.86 3.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 63.5 m -150.06 128.67 12.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.314 . . . . 0.0 111.128 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -114.66 126.33 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.82 127.66 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.567 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 18.2 t80 -132.26 126.44 33.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 17.6 tp -104.94 130.27 23.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.19 49.9 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.461 ' CD1' ' O ' ' A' ' 212' ' ' ASP . 31.1 mt -63.29 -29.26 70.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.61 -45.21 93.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -80.27 -42.1 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.0 98.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.85 -30.38 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.41 -43.88 84.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.563 ' CE1' HD12 ' A' ' 252' ' ' LEU . 0.8 OUTLIER -73.29 -37.81 66.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 241' ' ' ASN . 17.3 mt -68.25 -50.89 53.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.461 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 26.2 ptt85 -57.03 -40.08 76.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -80.04 -31.47 39.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 26.3 mmtt -88.28 -69.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 15.9 t-20 -83.58 35.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASN . 60.9 mttp 34.21 33.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.3 58.59 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.453 ' HB3' ' ND2' ' A' ' 241' ' ' ASN . . . -136.55 128.0 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -40.32 130.59 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 237' ' ' ILE . 21.2 mt -70.04 -175.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -127.75 178.52 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 249' ' ' GLY . 59.2 t -92.09 153.43 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.427 ' N ' HG12 ' A' ' 248' ' ' VAL . . . 63.27 12.57 45.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.485 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.468 ' CG ' HG21 ' A' ' 207' ' ' VAL . 4.6 pt20 -82.4 147.98 28.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.94 126.81 31.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -135.04 142.25 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 -96.47 133.06 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 92.0 m -146.76 159.69 43.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 269' ' ' SER . 86.1 mt -136.74 137.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.12 131.24 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.24 -41.53 5.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -150.68 153.06 34.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.8 t -123.76 121.28 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 261' ' ' GLY . 24.7 tptt -127.6 143.25 51.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.404 ' N ' ' HG3' ' A' ' 260' ' ' LYS . . . 54.77 165.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.452 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 262' ' ' ASN . 38.3 p30 -95.6 40.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 142.1 40.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.443 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -108.25 -95.0 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.6 137.43 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.61 139.89 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.161 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.6 t -99.12 125.2 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 39.0 mt -121.02 152.09 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 255' ' ' ILE . 93.8 p -159.77 143.23 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.9 122.39 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.154 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.97 99.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -84.67 85.92 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.5 m -152.87 177.06 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -63.22 107.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.64 -42.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 74.1 p -100.13 163.27 12.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 66.8 p -147.9 170.64 17.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.162 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.8 141.22 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 280' ' ' ALA . 4.9 mp -58.8 142.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.443 ' N ' HG22 ' A' ' 279' ' ' ILE . . . -67.61 -26.44 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 81.1 p -97.31 154.52 17.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . 0.414 ' OE1' ' NE2' ' A' ' 284' ' ' GLN . 23.3 mt-10 -79.38 158.1 27.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -105.73 34.4 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.414 ' NE2' ' OE1' ' A' ' 282' ' ' GLU . 6.0 pt20 -105.73 161.04 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 68.5 p -133.51 138.54 46.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -153.58 160.89 42.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -93.89 112.05 23.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.63 -178.75 3.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -150.36 130.51 13.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -129.9 158.91 38.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.561 ' C ' ' CD2' ' A' ' 291' ' ' LEU . 0.0 OUTLIER -64.09 149.2 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 6.4 t -163.15 108.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 167.52 146.28 4.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.454 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.41 30.41 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 4.9 m -87.26 146.93 25.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 35.1 t -103.98 -52.4 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.3 m -90.3 122.43 33.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.371 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.3 t -47.0 154.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.903 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 162.32 -145.95 11.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 t -129.69 110.93 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 99.1 p -99.75 85.84 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -131.72 60.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -121.01 127.61 51.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -140.55 122.51 15.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -41.08 138.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.12 90.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -87.7 119.19 27.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 192' ' ' LEU . 29.2 t -94.3 -34.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 191' ' ' VAL . 1.3 pt? 34.59 45.36 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 196' ' ' ALA . 62.3 m -121.54 142.97 49.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -44.09 -23.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 193' ' ' SER . 2.1 mp0 -74.97 -38.94 61.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -109.43 17.97 20.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.2 mt -105.64 143.85 33.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.94 150.77 63.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.721 . . . . 0.0 110.891 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.354 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.43 11.79 3.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.4 mtt -99.14 130.95 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 274' ' ' GLU . 5.5 mp -86.42 107.94 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.26 130.72 53.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.975 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -93.55 129.4 39.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -136.01 -173.04 12.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.531 HG22 ' CD1' ' A' ' 251' ' ' TYR . 5.6 p -130.89 140.07 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 111.114 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.99 119.94 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.1 t -86.36 -39.74 16.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.3 m -157.01 156.02 32.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.413 ' CD1' HG23 ' A' ' 248' ' ' VAL . 8.4 mp -106.76 125.41 50.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -117.24 144.62 44.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.431 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 2.6 m-20 -66.36 -17.76 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -95.23 -27.39 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -170.02 -159.05 14.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -133.34 129.44 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 126.17 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.95 135.31 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.78 133.65 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 pt -123.09 -22.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.06 50.03 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -143.53 147.79 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.41 124.32 35.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.4 -51.72 1.83 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.535 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -59.92 124.95 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -115.8 132.01 56.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.25 125.83 53.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 14.1 t80 -123.32 137.13 54.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.0 tp -112.79 132.34 22.32 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.58 0.705 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 140.59 43.0 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.345 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 212' ' ' ASP . 28.9 mt -63.08 -19.88 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.77 -44.53 66.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.64 -35.54 39.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -72.47 -43.05 64.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 11.3 tt0 -58.46 -36.81 74.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.75 -43.18 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.2 OUTLIER -72.1 -38.52 69.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.461 HG12 ' CD2' ' A' ' 246' ' ' LEU . 22.0 mt -66.3 -39.01 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.113 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -69.18 -41.98 76.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -79.83 -21.65 43.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.546 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 24.1 mmtt -100.17 -67.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 243' ' ' GLY . 22.3 t-20 -84.3 32.81 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' ASN . 76.2 mttt 37.94 27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 85.94 61.58 1.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.405 ' HB2' ' ND2' ' A' ' 241' ' ' ASN . . . -142.65 134.12 26.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.86 148.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.461 ' CD2' HG12 ' A' ' 237' ' ' ILE . 94.5 mt -78.58 -177.66 5.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.6 145.89 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 210' ' ' LEU . 78.1 t -72.2 128.53 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.56 -27.13 20.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.93 147.96 48.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.531 ' CD1' HG22 ' A' ' 206' ' ' THR . 12.6 m-85 -80.97 132.01 35.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.73 141.45 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.74 133.86 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 85.1 m -155.28 151.13 27.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.02 147.0 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 200' ' ' GLY . 2.9 t -72.72 120.28 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -107.07 -48.47 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -137.77 135.37 36.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.35 122.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -126.05 134.34 51.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 65.75 -157.77 47.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.99 -42.5 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.93 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -130.72 32.2 3.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -90.53 -101.37 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.72 134.78 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.25 139.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.7 m -99.1 117.12 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 13.9 mt -110.9 157.66 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -148.63 142.0 25.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 36.1 t -75.21 141.61 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.071 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -140.7 107.38 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 271' ' ' GLY . 6.7 p-80 -36.53 -59.61 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 30.4 t -171.38 119.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 202' ' ' LEU . 45.7 mm-40 -94.92 82.1 3.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.76 -37.44 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 84.9 p -100.06 123.94 44.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 44.2 p -129.63 36.16 4.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -170.74 169.88 6.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.44 147.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.05 95.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.0 t -165.19 157.74 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.12 178.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -130.35 151.04 51.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -88.19 88.82 7.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.7 p -51.07 171.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -51.84 -179.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -123.55 -177.33 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -164.43 120.76 1.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.59 122.25 39.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -167.26 120.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.97 134.68 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 6.9 m -127.88 56.31 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.44 150.56 33.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.498 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -7.97 22.39 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 69.9 m -140.55 144.04 35.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -84.36 99.85 10.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 181' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.497 ' HG ' ' N ' ' A' ' 287' ' ' ASN . 2.5 m -63.01 78.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.812 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 179' ' ' GLY . 1.9 p -103.92 96.77 6.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 132.11 -124.01 3.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.9 m -57.27 172.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 110.848 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.2 p -124.0 178.69 5.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.36 162.94 24.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -82.36 167.17 18.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.768 0.318 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.98 170.89 13.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.2 t -112.46 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -107.46 104.55 14.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -93.26 145.38 24.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.2 p -110.92 24.62 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.62 105.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 m -115.39 159.47 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.79 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.1 pm0 -68.7 -10.82 58.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.83 -15.64 34.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.3 mt -59.86 151.73 25.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -127.55 143.91 49.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.55 0.691 . . . . 0.0 110.897 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 109.1 2.23 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 146.98 -11.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.7 mtm -79.1 141.27 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.833 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.1 108.08 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 203' ' ' LEU . 3.6 mm? -117.3 128.44 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -94.3 130.87 40.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.11 -163.64 9.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.5 p -131.11 146.03 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.194 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.43 121.67 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.3 t -85.83 -43.05 13.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.467 ' HA ' ' CG2' ' A' ' 248' ' ' VAL . 5.2 m -157.05 156.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.859 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.49 125.1 50.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -116.95 162.17 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -22.93 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -96.15 -9.82 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 177.3 -161.4 28.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.627 ' CD1' ' CB ' ' A' ' 233' ' ' ALA . 84.4 m-85 -132.86 137.55 46.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.961 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.95 129.91 36.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.71 143.1 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.46 133.78 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.8 pt -125.1 -18.96 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.94 51.7 17.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 150.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.834 0.349 . . . . 0.0 111.116 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -93.84 119.2 32.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.96 43.68 13.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.1 m -155.22 123.71 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -113.43 131.42 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.79 48.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 13.0 t80 -122.92 140.48 52.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.475 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 23.5 tp -113.81 133.69 22.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.475 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.78 146.76 61.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.316 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.07 -22.76 67.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.4 -45.01 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -81.96 -37.7 26.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.627 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.32 -46.1 85.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.058 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -65.21 -39.26 92.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.7 -43.24 89.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.567 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 2.2 t80 -72.64 -42.26 64.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 233' ' ' ALA . 18.7 mt -65.23 -38.94 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.146 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.452 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 1.2 ttt85 -68.79 -43.72 75.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -79.0 -21.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.567 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 39.2 mmtt -99.31 -68.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.06 34.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 241' ' ' ASN . 79.5 mttt 34.73 34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 78.1 74.63 1.01 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -152.24 118.73 5.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -35.61 135.76 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' A' ' 215' ' ' TYR . 51.7 mt -69.22 -175.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.416 ' HG3' ' C ' ' A' ' 246' ' ' LEU . 3.4 mtpm? -144.7 130.06 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 209' ' ' SER . 23.9 t -50.62 126.05 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 109.83 -31.37 7.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.462 ' NE2' HD23 ' A' ' 246' ' ' LEU . 9.1 pt20 -62.99 148.17 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.909 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -80.73 130.82 35.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -124.3 145.32 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.18 127.48 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 35.0 m -147.2 155.19 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 269' ' ' SER . 95.3 mt -133.03 139.43 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.29 119.39 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -103.9 -48.07 4.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -138.6 140.28 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.8 t -122.16 129.11 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -85.41 176.29 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -87.97 -54.51 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -85.85 30.64 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 45.5 32.03 3.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.01 -74.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.8 t -132.68 134.24 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.33 139.6 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.7 t -99.97 118.4 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.3 mt -113.64 149.88 33.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 255' ' ' ILE . 52.3 p -145.94 142.01 28.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.93 134.65 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -151.82 107.73 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 272' ' ' HIS . 23.8 p-80 -87.38 37.05 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.857 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 5.0 m -107.29 91.96 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 276' ' ' SER . 18.3 pt-20 -168.16 134.84 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 274' ' ' GLU . 4.8 t 34.97 32.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 274' ' ' GLU . 59.8 p -52.83 -43.4 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 79.8 p -103.26 146.56 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.104 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.84 100.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.09 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 23.1 mt -81.65 142.3 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.68 83.76 2.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 25.3 p -131.71 171.03 13.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -110.95 121.52 45.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.06 158.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.69 110.06 8.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.1 t -144.13 141.83 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -118.02 68.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.497 ' N ' ' HG ' ' A' ' 180' ' ' SER . 1.3 p30 -163.12 147.53 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 22.0 tp -120.82 148.62 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.09 169.49 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -125.25 97.43 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -123.46 159.13 29.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.3 t -161.84 130.67 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -122.36 73.09 0.38 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 84.13 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.706 2.271 . . . . 0.0 112.316 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.3 m -109.04 110.64 21.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 28.1 t -86.08 152.07 23.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.509 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 98.6 p -90.33 50.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 m -109.32 84.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.3 86.98 1.53 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.528 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.1 m -129.16 171.21 12.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 0.0 110.878 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 t -76.83 165.76 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -86.76 56.25 4.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -123.15 103.93 8.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.16 132.19 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 50.7 t -41.07 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -42.05 100.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -137.59 145.48 42.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 24.5 t -118.9 61.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 192' ' ' LEU . 4.2 mm? -110.26 -44.25 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 45.3 m -120.35 162.37 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.97 77.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -61.68 -28.6 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.68 -31.56 46.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt -60.82 135.22 57.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -100.4 148.93 35.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.567 0.698 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 129.91 8.04 3.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.9 mtt -76.16 140.36 41.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.5 108.62 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 26.4 mt -130.39 141.1 50.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.4 m -119.57 122.23 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.3 -177.61 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -124.16 138.08 54.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.47 122.88 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -88.23 -40.68 13.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.97 156.07 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.465 ' CD2' HG21 ' A' ' 248' ' ' VAL . 3.8 mm? -99.86 115.42 29.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.25 137.21 37.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -57.2 -20.55 27.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -94.5 -38.3 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -161.24 -161.94 12.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.531 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.552 ' CE1' HD23 ' A' ' 230' ' ' LEU . 41.3 m-85 -117.63 132.14 56.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.01 133.54 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.76 142.66 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.4 123.07 33.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.7 -33.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.03 37.35 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.443 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.4 t -113.11 146.29 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -97.13 98.75 10.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.03 46.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 91.2 m -158.3 124.1 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -116.7 123.92 48.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.01 129.33 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.094 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 18.9 t80 -130.48 137.65 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.46 ' C ' ' CD1' ' A' ' 228' ' ' LEU . 1.7 tm? -107.87 126.81 28.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.455 ' N ' HD11 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.78 131.66 21.66 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.688 2.259 . . . . 0.0 112.372 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.552 HD23 ' CE1' ' A' ' 215' ' ' TYR . 30.5 mt -62.4 -24.75 67.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.6 mt -65.6 -41.27 92.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -42.51 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 228' ' ' LEU . . . -59.3 -34.14 71.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.45 -34.01 70.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.41 -43.66 76.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.86 -37.79 67.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 242' ' ' LYS . 32.4 mt -68.42 -42.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 28.3 ptt180 -68.73 -35.98 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.448 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 12.1 mm100 -78.38 -39.9 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -98.1 -74.93 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 237' ' ' ILE . 4.4 m120 -52.47 -16.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 237' ' ' ILE . 32.5 mttp 59.54 36.53 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.41 46.88 5.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -136.57 117.42 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -49.57 135.54 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.53 HD11 ' CE2' ' A' ' 215' ' ' TYR . 28.3 mt -62.6 179.2 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -131.27 170.8 14.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 210' ' ' LEU . 19.3 t -87.73 128.66 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.55 -21.93 37.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.36 148.0 51.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -81.0 127.17 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.96 135.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -93.28 125.31 37.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 13.3 m -140.28 157.64 45.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.84 140.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 200' ' ' GLY . 39.0 t -61.04 119.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -99.87 -46.89 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -140.1 152.89 46.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.417 ' C ' ' HE2' ' A' ' 260' ' ' LYS . 71.9 t -124.0 127.29 73.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 259' ' ' VAL . 0.3 OUTLIER -97.72 167.72 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -88.92 171.1 38.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.514 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 261' ' ' GLY . 3.0 p-10 45.52 40.67 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 40.47 47.34 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.54 -98.56 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 266' ' ' VAL . 13.6 t -120.59 146.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.451 ' N ' HG13 ' A' ' 265' ' ' VAL . 53.1 t -113.02 139.99 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 266' ' ' VAL . 2.3 m -98.97 115.44 28.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.0 mt -113.23 148.77 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 46.3 m -158.78 142.07 14.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 2.4 m -74.97 142.86 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.08 -97.58 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.482 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -92.75 141.06 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.844 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 54.6 m -120.64 -175.22 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -87.81 101.6 13.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.83 -38.1 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 29.1 t -44.06 -42.36 6.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 15.1 t -120.34 160.09 23.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -172.56 137.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.42 150.87 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -131.78 95.15 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.5 m -145.89 136.41 24.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -106.29 151.85 24.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 284' ' ' GLN . 0.0 OUTLIER -165.31 169.68 15.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 283' ' ' GLN . 36.8 mt-30 -34.6 115.43 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 69.4 m -104.38 127.22 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -158.28 122.57 4.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -157.43 132.35 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.448 HD13 ' N ' ' A' ' 289' ' ' ASN . 1.4 tm? -155.13 119.39 4.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.448 ' N ' HD13 ' A' ' 288' ' ' LEU . 19.0 p30 -73.33 133.95 44.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -165.47 155.96 13.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 291' ' ' LEU . 0.0 OUTLIER -168.0 175.3 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 31.2 t -172.26 152.61 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.46 83.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 120.05 6.89 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 296' ' ' SER . 3.9 m 62.75 32.84 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 295' ' ' SER . 3.0 m -36.49 108.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.3 t -128.16 124.68 37.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.3 m -116.08 130.2 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 85.07 154.9 23.11 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 p -95.13 99.51 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.862 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.4 p -143.5 122.61 12.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.25 -175.36 25.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -127.41 150.08 49.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -72.72 137.22 45.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 89.1 t -47.16 -66.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -112.83 42.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 40.11 35.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 t 37.51 39.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tp -94.2 92.17 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.9 m -146.85 144.98 29.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.09 69.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.146 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.74 -10.22 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -91.08 -22.86 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt -67.49 162.87 22.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -153.26 155.25 31.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.561 0.696 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 113.56 3.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.398 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.47 4.11 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.3 mtt -90.62 130.89 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.93 109.02 20.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -123.63 127.99 49.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m -97.78 119.45 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.42 -172.31 14.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.469 HG22 ' CD1' ' A' ' 251' ' ' TYR . 1.2 p -128.55 139.32 52.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.29 122.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -92.62 -40.43 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.98 156.09 32.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 210' ' ' LEU . 8.0 mp -109.28 125.15 51.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.87 150.97 34.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -70.17 -17.05 63.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -98.06 -25.77 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -172.27 -169.74 35.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.08 131.23 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.945 0.403 . . . . 0.0 110.929 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.04 124.44 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.92 130.16 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.09 137.07 36.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 pt -123.44 -31.84 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.58 44.43 6.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.05 140.43 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.71 111.56 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.15 37.83 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 93.1 m -154.87 123.36 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 111.162 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.34 123.03 47.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.41 127.68 53.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.558 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 23.5 t80 -131.07 137.34 49.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.474 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 20.1 tp -109.29 128.61 25.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.73 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.474 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.76 143.42 50.77 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -26.81 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.4 -40.46 95.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.408 ' HD2' ' CG2' ' A' ' 270' ' ' VAL . 0.5 OUTLIER -83.13 -35.72 25.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.456 ' CB ' HD21 ' A' ' 228' ' ' LEU . . . -68.57 -48.54 63.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -58.23 -35.32 71.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.7 -46.02 76.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.5 OUTLIER -71.3 -36.93 71.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.983 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.441 HG12 ' CD2' ' A' ' 246' ' ' LEU . 21.7 mt -68.89 -38.92 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.47 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 2.7 ttm-85 -69.02 -41.18 78.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.5 -19.98 48.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 7.5 mmtp -101.82 -69.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 244' ' ' ALA . 17.1 t-20 -84.16 33.52 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 241' ' ' ASN . 53.8 mttt 34.63 34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.47 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 77.75 73.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.484 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.457 ' HB2' ' ND2' ' A' ' 241' ' ' ASN . . . -151.3 124.4 8.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 244' ' ' ALA . 20.4 mmtm -37.22 144.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.441 ' CD2' HG12 ' A' ' 237' ' ' ILE . 13.8 mt -80.95 178.9 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.76 127.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 108.18 -27.24 14.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -63.44 148.0 49.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.469 ' CD1' HG22 ' A' ' 206' ' ' THR . 15.5 m-85 -81.03 127.28 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.3 tp -121.04 139.36 53.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -88.87 132.47 34.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 43.3 m -153.04 153.74 33.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 256' ' ' VAL . 72.9 mt -136.8 143.75 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.41 ' N ' HG23 ' A' ' 255' ' ' ILE . 2.8 t -68.48 121.45 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -101.62 -41.97 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -150.67 155.98 40.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.19 119.2 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 261' ' ' GLY . 35.6 tttp -86.42 135.03 33.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . 35.92 -149.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -120.35 72.5 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.81 24.04 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -95.46 -87.39 1.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.19 148.98 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 267' ' ' SER . 47.2 t -119.46 139.97 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 266' ' ' VAL . 3.0 t -100.01 118.08 35.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 16.4 mt -111.97 150.16 30.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 255' ' ' ILE . 1.4 t -146.28 146.98 30.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.432 HG13 ' CG ' ' A' ' 236' ' ' TYR . 28.9 m -74.7 136.16 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -157.38 101.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 271' ' ' GLY . 5.1 p-80 -35.76 132.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 24.2 p -164.0 174.68 11.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -66.06 98.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 276' ' ' SER . 93.0 t -97.43 -46.22 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 275' ' ' VAL . 1.4 p -35.36 126.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 13.2 t -160.0 154.69 24.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -113.73 170.97 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.36 140.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -124.36 -19.52 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 13.6 t -84.44 160.87 20.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . 0.52 ' CD ' ' N ' ' A' ' 282' ' ' GLU . 1.4 pm0 -135.16 -179.95 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -153.87 125.86 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -55.86 162.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 17.7 t -92.47 92.5 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -70.92 175.21 5.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -142.75 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.2 tp -163.8 144.53 8.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -71.06 133.69 46.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -96.93 90.37 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 13.6 mt -135.11 161.57 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.976 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.8 t -118.01 111.31 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -168.54 156.53 28.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -27.2 26.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.735 2.29 . . . . 0.0 112.322 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 18.8 m -85.41 109.11 18.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.0 t -134.56 138.79 44.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.3 t -127.03 149.86 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.875 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.0 p -45.45 -58.06 3.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.885 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 150.48 -168.14 30.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.2 p -130.79 1.98 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.4 m -117.91 122.84 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -75.13 -68.23 1.59 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.91 157.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -137.28 159.1 42.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 81.2 t -110.76 -48.56 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -105.49 95.61 5.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -88.53 135.02 33.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.17 35.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.08 83.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 17.9 m -138.99 160.93 38.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -48.54 -54.87 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.125 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.7 -17.43 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -90.49 -21.87 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 69.6 mt -60.01 -179.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -153.22 148.16 19.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.85 10.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.05 6.19 6.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.0 mtt -89.78 127.71 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.4 mp -89.61 109.87 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 26.4 mt -131.49 127.05 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m -84.13 119.66 25.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.94 163.84 12.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -113.5 135.47 53.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.812 0.339 . . . . 0.0 111.146 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.99 121.06 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 41.8 t -86.17 -45.09 11.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 85.1 p -157.02 155.97 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.63 129.22 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -116.31 151.88 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.05 -21.78 62.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -96.74 -17.19 20.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 179.55 -158.88 23.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.29 135.8 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.921 0.391 . . . . 0.0 110.897 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.44 129.55 35.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.1 128.4 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.01 132.82 36.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.48 -19.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 221' ' ' VAL . . . 73.18 57.68 5.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 220' ' ' GLY . 45.7 t -139.86 139.79 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.79 94.23 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.26 39.38 0.87 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 85.5 m -156.98 131.59 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.63 123.76 48.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.02 122.99 47.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -124.84 142.42 51.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.471 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 19.7 tp -113.75 134.6 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.609 0.718 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.471 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.83 142.55 47.95 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.1 -22.2 66.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.91 -43.26 79.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HD2' ' CG2' ' A' ' 270' ' ' VAL . 0.9 OUTLIER -81.76 -33.22 31.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -75.15 -51.87 12.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -60.26 -36.92 78.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.49 -41.57 98.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.564 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 4.9 t80 -73.25 -41.83 63.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 241' ' ' ASN . 47.0 mt -63.02 -39.85 86.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.6 ptm180 -69.77 -35.68 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.415 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 6.5 mm100 -81.4 -29.22 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.564 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 14.1 mmmt -107.99 -63.39 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 237' ' ' ILE . 2.7 m-20 -80.73 21.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.9 mmtm 35.82 30.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.15 40.33 8.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -104.81 113.37 26.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -40.39 126.3 2.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.412 ' CD1' HD12 ' A' ' 237' ' ' ILE . 15.4 mt -64.23 -175.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -137.31 -175.91 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 98.4 t -97.53 145.79 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.79 81.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -82.86 148.01 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -80.95 128.66 33.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 12.5 tp -131.4 142.89 50.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -98.89 131.59 44.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 97.1 m -154.03 163.05 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.63 150.37 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.51 121.57 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 269' ' ' SER . 3.9 mp0 -104.75 -40.56 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -142.99 148.83 37.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.08 126.03 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.3 144.57 36.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.34 -65.52 3.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -86.71 37.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 46.98 36.39 8.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.04 -82.48 0.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.79 134.31 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 38.1 t -108.86 139.98 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 t -99.07 121.48 41.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.42 154.13 32.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.406 ' N ' ' OE1' ' A' ' 257' ' ' GLU . 36.4 t -154.05 152.41 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.84 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.405 ' CG2' ' HD2' ' A' ' 232' ' ' LYS . 20.2 m -80.09 139.99 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.8 92.12 0.48 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 273' ' ' SER . 11.1 m170 -38.88 -41.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 272' ' ' HIS . 85.2 p 35.5 41.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 273' ' ' SER . 48.4 tt0 -35.65 106.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLU . 88.6 t -35.93 -47.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.9 t -66.59 80.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 53.1 m -142.37 132.67 24.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.96 145.31 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 17.2 mm -77.87 136.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.92 -18.89 14.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 80.6 p -80.39 163.3 23.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.0 165.22 21.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -103.43 126.74 50.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -66.81 129.85 41.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.435 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 37.5 t -86.1 143.48 28.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.435 ' CG ' ' O ' ' A' ' 285' ' ' SER . 98.6 m95 -159.53 134.34 7.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -137.94 135.9 36.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -101.3 163.75 12.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -85.63 170.66 12.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -142.45 130.2 21.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 39.7 tp -135.48 133.99 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.2 m -112.28 176.98 4.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 165.48 -159.71 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 129.75 18.08 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.247 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 27.5 m -139.72 158.35 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.1 t -135.94 136.05 40.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.507 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.1 t -91.83 108.48 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.866 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 t -102.13 161.12 13.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -178.85 62.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -69.25 134.72 49.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 m -117.65 173.5 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -111.74 -151.48 11.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.29 142.21 28.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -78.53 175.36 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.7 t -91.29 -49.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -99.86 93.37 5.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.43 ' CB ' ' CZ ' ' A' ' 190' ' ' ARG . 0.3 OUTLIER -137.52 148.23 45.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.917 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.6 t -48.8 -44.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 9.7 tt -39.95 111.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.9 t -155.42 164.03 39.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -43.16 -24.7 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.46 -40.47 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.46 24.52 12.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.2 mt -110.53 172.41 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -134.39 151.48 76.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 121.2 7.89 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.368 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.25 5.28 3.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.1 mtt -96.42 133.59 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.324 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -85.43 116.28 23.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.423 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.0 mp -120.92 130.22 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.3 m -97.99 126.15 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -138.46 -177.12 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.531 HG23 ' CD1' ' A' ' 251' ' ' TYR . 12.5 p -121.69 141.29 51.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.93 120.04 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.8 t -86.18 -39.29 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.1 m -157.02 156.01 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.9 mp -108.53 122.9 48.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.08 156.96 20.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.35 -23.52 57.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -94.53 -22.17 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.5 -164.89 27.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.491 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.403 ' CE1' HD12 ' A' ' 246' ' ' LEU . 75.0 m-85 -127.55 133.21 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.91 128.28 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.01 132.64 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.97 136.67 36.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 pt -127.4 -26.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.78 56.29 2.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.503 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 89.5 t -139.88 132.82 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.36 46.45 1.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 167.48 42.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.414 HG22 ' CG2' ' A' ' 266' ' ' VAL . 54.5 m -160.43 124.42 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -107.32 125.13 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.99 125.66 53.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.559 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.417 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 20.2 tp -104.3 132.06 21.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.3 Cg_endo -69.75 146.62 60.82 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.312 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 23.7 mt -63.03 -26.58 68.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.41 -44.39 89.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -82.39 -41.89 19.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.76 -46.3 84.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -62.7 -38.82 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -65.44 -44.67 86.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.55 ' CD1' ' HG3' ' A' ' 240' ' ' LYS . 83.5 t80 -70.13 -38.66 75.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 41.3 mt -69.21 -44.28 80.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.469 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.5 ptm180 -69.65 -37.44 76.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -81.52 -27.14 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 236' ' ' TYR . 7.2 mmpt? -107.75 -64.91 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.1 m120 -81.62 25.5 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ASN . 1.2 pmtp? 32.74 34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 102.31 -45.27 1.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -34.42 120.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -53.61 152.7 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.464 HD22 ' NE2' ' A' ' 250' ' ' GLN . 17.7 mt -76.3 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -132.12 129.82 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.8 t -46.67 131.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 105.73 -30.22 10.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.464 ' NE2' HD22 ' A' ' 246' ' ' LEU . 10.2 pt20 -62.93 147.97 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.942 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.531 ' CD1' HG23 ' A' ' 206' ' ' THR . 10.6 m-85 -81.02 130.21 34.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.468 HD13 ' CE2' ' A' ' 236' ' ' TYR . 15.4 tp -123.93 145.06 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -94.28 129.05 41.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.964 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 63.7 m -148.43 151.99 36.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 256' ' ' VAL . 38.5 mt -130.79 145.95 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 255' ' ' ILE . 6.2 t -70.29 122.58 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -105.5 -45.23 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -138.78 136.53 35.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 36.1 t -122.67 125.74 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 261' ' ' GLY . 34.7 ttpt -90.14 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -37.25 -60.06 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -93.44 174.34 7.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -80.66 51.76 4.3 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -77.18 -80.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.97 133.89 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 111.133 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.414 ' CG2' HG22 ' A' ' 224' ' ' THR . 22.1 t -106.34 139.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.1 t -101.43 125.72 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 45.6 mt -116.51 157.16 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 60.1 p -151.45 156.76 41.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 41.7 t -78.19 131.85 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -88.55 -111.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -134.98 -176.4 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.742 0.306 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 59.5 p -84.29 163.6 19.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.95 146.87 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' A' ' 275' ' ' VAL . 45.1 t -85.46 31.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.9 t -82.36 40.58 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 8.9 t -105.43 143.52 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -52.11 147.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 21.1 mt -52.51 150.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -121.46 113.15 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 10.1 t -72.39 137.65 46.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -146.39 176.72 9.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -49.87 -49.55 49.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -107.89 103.07 12.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 64.2 m -131.76 173.78 10.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -89.84 174.78 7.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -136.55 173.03 12.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.1 tp 64.39 41.9 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -71.38 166.98 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -74.06 137.68 43.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -167.5 164.86 14.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.4 t -169.37 165.94 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 174.44 157.78 16.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -174.12 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.697 2.265 . . . . 0.0 112.33 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.6 t -133.79 -57.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.1 t -97.64 137.64 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.476 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 88.4 p -169.19 152.28 4.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.861 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -55.14 7.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.57 175.84 49.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 m -107.29 120.39 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.897 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.4 t -146.15 115.22 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.22 -161.51 28.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.72 175.16 11.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.817 0.341 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -60.01 161.86 6.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.9 t -52.91 -17.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.0 m120 37.84 51.79 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -69.58 132.51 46.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.49 64.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 192' ' ' LEU . 4.3 mm? -105.34 -48.1 3.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.5 p -172.77 157.92 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.48 58.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.33 -38.6 85.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.1 -25.1 63.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.6 mt -60.85 -178.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -160.8 154.22 18.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 126.37 13.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.676 2.25 . . . . 0.0 112.377 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 127.74 0.84 6.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.8 mtt -90.05 128.7 36.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.36 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.6 mp -89.46 117.33 28.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.79 128.96 41.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 31.6 m -85.02 124.33 31.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.86 169.25 20.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.44 HG22 ' CD1' ' A' ' 251' ' ' TYR . 2.7 p -119.24 138.12 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.83 121.99 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.8 t -86.49 -42.01 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -157.04 156.3 32.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -106.75 125.13 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.91 154.89 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -72.81 -18.99 61.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -97.52 -30.41 12.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.563 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -165.13 -165.6 22.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -127.94 131.74 49.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.78 125.9 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.1 t -112.22 132.87 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -79.96 131.79 35.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 224' ' ' THR . 31.1 pt -124.05 -18.77 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.78 40.06 89.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.95 138.04 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.23 127.93 34.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.82 56.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.46 HG21 ' CD1' ' A' ' 219' ' ' ILE . 56.4 m -149.97 123.87 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -109.37 130.73 55.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.563 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -131.72 140.25 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 268' ' ' LEU . 22.6 tp -114.99 133.17 22.69 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.76 145.24 56.59 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.3 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 30.7 mt -63.38 -21.63 66.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.11 -44.7 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -78.25 -30.69 48.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -77.01 -44.32 31.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -58.34 -33.4 69.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.58 -43.9 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.557 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 0.8 OUTLIER -72.89 -35.49 67.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 241' ' ' ASN . 39.8 mt -70.64 -40.9 77.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.182 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.475 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 16.2 ptt85 -69.52 -37.44 77.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -80.76 -39.14 27.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.557 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 63.3 mmtt -94.05 -57.58 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 243' ' ' GLY . 2.5 m120 -81.99 23.26 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.1 OUTLIER 34.09 32.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.79 45.4 7.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -122.92 112.29 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.13 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -34.19 132.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 237' ' ' ILE . 31.2 mt -65.44 -176.56 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.91 141.89 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.68 151.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.29 -21.49 6.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.36 148.53 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.44 ' CD1' HG22 ' A' ' 206' ' ' THR . 11.3 m-85 -85.01 128.31 34.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -126.08 135.73 52.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -92.75 131.49 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 82.6 m -152.74 162.98 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 256' ' ' VAL . 44.6 mt -137.19 144.44 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.402 ' N ' HG23 ' A' ' 255' ' ' ILE . 9.3 t -66.43 119.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -106.65 -46.91 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -132.26 136.02 46.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.15 132.84 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -84.37 158.0 21.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -51.59 -94.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 263' ' ' GLY . 20.0 p-10 -73.67 64.13 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 36.57 42.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -66.47 -73.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 75.5 t -133.87 133.44 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.364 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 19.0 t -105.15 137.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.429 ' C ' ' CD2' ' A' ' 268' ' ' LEU . 2.5 m -99.66 138.71 36.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.493 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 1.0 OUTLIER -121.05 148.35 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.3 p -151.75 141.87 22.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.45 141.82 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -157.95 -45.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -82.31 127.25 33.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 91.48 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.41 98.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.0 t -39.09 -42.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.3 t -40.58 -45.53 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 55.7 p 38.64 40.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.159 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -99.45 95.66 7.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 8.1 mt -103.32 152.36 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -81.55 14.96 2.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.045 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 p -126.16 135.55 51.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -149.65 162.03 41.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -164.01 118.33 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -61.66 157.56 17.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 10.8 t -69.18 109.6 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -150.68 143.52 24.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 43.5 44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 27.3 tp -110.3 94.02 4.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -144.91 171.45 14.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -79.18 142.5 36.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.5 tt -40.76 133.38 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 89.6 p -157.65 114.65 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -165.44 141.39 6.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.52 9.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 14.9 t -104.91 109.54 21.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 51.9 p -88.16 97.46 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 t -60.86 98.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.914 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.4 t -114.99 41.75 2.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.03 -130.31 3.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.9 m -130.16 154.47 47.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p -102.93 144.0 31.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.57 156.48 27.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -120.94 166.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.0 115.79 8.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 m -83.5 -20.31 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -124.36 97.39 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -122.26 137.7 54.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.0 44.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.417 ' C ' HD22 ' A' ' 192' ' ' LEU . 2.6 tt -118.19 -45.07 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 2.8 m -75.49 146.84 40.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.73 -9.99 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.81 -14.24 60.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -126.62 -9.05 6.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.4 mt -63.97 161.4 15.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.432 ' N ' ' HE2' ' A' ' 201' ' ' MET . 49.7 mtmt -158.61 154.01 22.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.718 . . . . 0.0 110.84 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 107.26 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.722 2.282 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.69 7.01 3.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.432 ' HE2' ' N ' ' A' ' 198' ' ' LYS . 8.6 mtt -92.8 132.66 36.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.41 112.22 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mp -131.16 129.44 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.892 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.7 m -76.99 117.84 18.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -121.06 152.08 16.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -107.58 141.54 38.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.09 121.06 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.1 t -86.45 -46.13 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -157.07 156.42 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.437 HD13 ' N ' ' A' ' 210' ' ' LEU . 9.0 mp -103.23 126.9 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -115.21 156.41 25.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.82 -24.04 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -87.96 -32.44 18.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.541 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.6 -159.55 18.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 233' ' ' ALA . 96.3 m-85 -125.19 139.92 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.32 130.83 44.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.97 146.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.55 129.68 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.468 HD13 ' CG2' ' A' ' 224' ' ' THR . 31.8 pt -121.76 -27.58 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.03 34.64 6.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.84 127.54 64.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.33 94.55 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.37 -33.47 0.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.468 ' CG2' HD13 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -92.66 151.04 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 111.163 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.78 121.09 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.14 127.62 54.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.541 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 6.2 t80 -132.09 137.03 47.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 11.1 tp -105.96 131.76 21.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 139.42 39.97 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.672 2.248 . . . . 0.0 112.321 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.436 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 26.3 mt -63.11 -21.0 65.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 12.4 mt -70.79 -45.02 65.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.87 -28.03 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 215' ' ' TYR . . . -79.9 -49.13 12.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 33.3 tt0 -58.02 -44.38 87.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 236' ' ' TYR . 6.8 pt-20 -60.9 -40.43 93.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.5 ' CE1' HD13 ' A' ' 252' ' ' LEU . 1.2 t80 -73.12 -36.82 66.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 241' ' ' ASN . 31.1 mt -70.02 -40.95 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.472 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 4.8 ptm180 -69.1 -39.55 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -80.19 -19.93 45.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 19.0 mmmt -105.88 -67.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.11 29.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.0 pttm 37.44 28.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.41 50.46 4.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -125.58 122.27 36.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.67 138.44 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.425 HD12 ' CE2' ' A' ' 215' ' ' TYR . 18.4 mt -71.99 -174.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -127.79 -174.93 3.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.91 144.16 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.98 3.52 11.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 251' ' ' TYR . 0.8 OUTLIER -66.66 144.87 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.883 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.481 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 23.7 m-85 -80.8 126.66 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.5 HD13 ' CE1' ' A' ' 236' ' ' TYR . 6.0 tp -136.75 137.15 39.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -81.58 132.42 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 89.9 m -149.64 152.05 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.8 mt -137.08 146.44 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.4 t -74.24 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.33 -44.02 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -143.57 144.23 31.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.95 123.69 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -88.57 121.73 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 38.37 -143.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.468 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.26 63.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.92 0.391 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 138.53 35.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.83 -109.65 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.14 148.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.128 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.16 139.32 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.8 m -98.95 120.73 39.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 25.7 mt -115.57 151.95 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.5 t -155.81 151.89 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 20.9 m -89.26 128.79 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.122 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.3 -100.09 2.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -159.13 130.42 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -111.69 135.4 52.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -83.8 98.2 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.67 -53.46 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.2 m -55.61 176.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 43.5 p -137.38 162.51 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.73 167.75 15.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 5.4 mp -53.49 143.51 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -62.74 100.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 14.7 t -158.91 140.45 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -116.07 151.21 36.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -51.41 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -39.55 101.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 32.8 t -131.87 143.23 50.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -74.85 94.97 2.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -63.99 128.28 35.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.44 111.04 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -142.61 141.14 31.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -89.29 168.08 12.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -50.12 169.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 39.5 t -167.37 155.36 9.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -103.82 -158.07 24.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -13.85 35.15 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 0.0 112.311 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 3.2 m -42.67 -51.16 5.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 38.6 m -55.41 131.05 44.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.7 t 68.39 42.15 1.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 t -98.88 103.45 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 107.45 -133.1 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -55.0 156.62 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.838 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.3 t -118.17 101.19 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.17 3.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -62.48 161.99 10.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -74.58 102.35 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.3 m -76.94 -16.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 189' ' ' ASN . 7.2 t30 -128.76 96.0 4.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -161.89 160.5 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.6 m -85.52 51.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.92 114.48 15.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 196' ' ' ALA . 29.5 p -174.35 159.28 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -43.51 -27.86 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -102.48 -18.53 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -107.86 18.88 20.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.068 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.44 -177.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.441 ' HG2' ' CE ' ' A' ' 201' ' ' MET . 14.1 ptmt -170.26 142.4 1.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 115.79 4.26 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 2.248 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 129.6 9.78 3.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.441 ' CE ' ' HG2' ' A' ' 198' ' ' LYS . 64.5 mtm -98.1 135.73 39.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.16 119.94 32.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 203' ' ' LEU . 5.7 mp -131.87 135.07 46.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 m -99.84 121.52 41.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.66 174.17 19.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 p -118.37 136.29 53.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.193 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.57 127.83 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.176 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.7 t -92.27 -46.11 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.9 p -157.03 155.28 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 215' ' ' TYR . 7.4 mt -100.35 133.39 44.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.84 152.31 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -64.88 -23.02 67.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.66 -47.22 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -160.63 -165.07 16.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.543 ' CD1' HD23 ' A' ' 210' ' ' LEU . 45.0 m-85 -118.15 132.96 56.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -91.58 132.96 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.06 145.31 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -89.4 124.52 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 pt -121.88 -25.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.23 47.58 10.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.81 141.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -93.9 114.19 26.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 92.13 36.34 6.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.54 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.6 m -147.48 123.96 11.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -111.35 130.87 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.54 135.49 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 59.0 t80 -131.76 141.85 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.474 ' CD2' ' HE3' ' A' ' 232' ' ' LYS . 1.7 tm? -120.59 126.58 26.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HD2' ' CD2' ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.77 131.04 20.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.2 -21.64 66.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.91 -45.11 87.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 233' ' ' ALA . 0.0 OUTLIER -70.45 -37.84 74.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.48 ' N ' ' HG3' ' A' ' 232' ' ' LYS . . . -75.34 -26.62 58.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -64.98 -31.67 73.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.11 -44.69 52.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.51 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.4 t80 -73.05 -37.65 66.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 241' ' ' ASN . 51.7 mt -70.02 -41.87 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.462 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.2 ptm180 -67.12 -40.2 86.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.445 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 74.9 mm-40 -80.15 -19.95 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.51 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 64.9 mmtt -103.94 -68.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 237' ' ' ILE . 11.7 t-20 -84.17 33.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 241' ' ' ASN . 74.3 mttt 34.48 32.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.94 69.16 1.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.425 ' O ' ' CG2' ' A' ' 237' ' ' ILE . . . -137.55 -177.25 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -92.66 154.04 18.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.95 152.55 21.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.0 140.18 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.7 135.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 93.97 -18.34 56.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -63.06 148.07 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.89 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -80.85 127.05 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.25 138.24 53.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.7 136.56 32.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 88.8 m -151.18 163.02 39.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.1 mt -136.17 145.5 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 5.9 t -68.02 122.31 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.22 -43.92 5.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -144.77 145.08 31.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.9 129.14 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -103.86 127.24 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -43.74 167.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 263' ' ' GLY . 7.2 p-10 45.43 37.27 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 37.34 47.58 1.53 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.54 -85.11 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 48.9 t -121.94 136.84 57.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 111.149 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.2 137.76 38.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.408 ' C ' HD22 ' A' ' 268' ' ' LEU . 1.8 t -102.11 122.41 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 268' ' ' LEU . 0.3 OUTLIER -114.33 142.87 45.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.3 m -156.97 145.76 19.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.51 123.53 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -114.1 -97.81 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -110.93 -55.67 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.8 t 70.66 50.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.894 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.12 70.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.83 82.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.134 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.2 t -46.64 -41.63 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 81.4 p -129.77 121.93 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -102.44 100.09 10.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.8 mp -69.1 145.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.16 95.51 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.1 t -70.88 142.3 51.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.65 167.36 11.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.54 143.12 46.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -98.82 171.8 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 33.7 t -61.13 164.93 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -78.41 163.67 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -115.83 -18.19 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 37.3 mt -87.31 36.86 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 66.2 t30 53.45 46.9 25.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -112.18 111.99 23.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.7 tp -126.12 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 37.2 m -154.82 172.05 18.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -110.49 146.06 17.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 296' ' ' SER . 53.4 Cg_endo -69.8 -43.32 2.69 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.277 . . . . 0.0 112.31 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 294' ' ' PRO . 2.0 t -34.61 95.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 294' ' ' PRO . 98.6 p -167.52 134.59 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.842 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 70.6 p -172.6 120.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 69.8 m -119.32 151.43 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 63.97 176.29 4.22 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.3 m -59.32 160.75 6.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 m -155.31 150.23 26.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 37.73 -144.59 0.17 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -119.6 156.44 30.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -40.18 127.45 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.9 t -57.99 -52.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 190' ' ' ARG . 7.7 m120 -164.01 140.4 6.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 189' ' ' ASN . 0.0 OUTLIER -34.68 149.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 193' ' ' SER . 30.9 m -89.45 -28.66 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.8 tp -42.08 -24.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 191' ' ' VAL . 11.3 p -45.17 159.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.39 61.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -93.21 -19.19 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -126.19 31.41 5.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.404 ' N ' HG12 ' A' ' 259' ' ' VAL . 48.5 mt -45.81 161.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -123.49 145.16 46.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 136.28 32.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.649 2.233 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 121.59 -29.28 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.5 mtt -61.45 132.15 52.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.57 108.0 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.55 132.76 54.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.4 m -89.0 120.01 30.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.95 166.22 12.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.36 56.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.18 121.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -89.23 -44.69 10.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.5 m -156.99 151.09 24.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.72 123.51 40.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -112.0 158.6 19.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.81 -21.55 57.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -92.86 -20.11 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 175.3 -171.64 44.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.558 ' CE1' HD13 ' A' ' 246' ' ' LEU . 89.0 m-85 -112.23 131.6 55.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.907 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.01 129.35 34.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.45 138.53 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.81 134.79 34.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.07 -21.14 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.22 54.87 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -148.38 138.53 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.22 125.66 36.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.87 -49.9 0.94 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 47.1 m -76.37 124.25 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 225' ' ' ARG . 4.3 ptp180 -116.53 127.99 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.01 128.75 56.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 8.0 t80 -124.75 136.35 53.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.74 130.83 22.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.0 110.943 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 145.14 56.29 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.299 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 22.4 mt -63.03 -19.2 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -44.77 88.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -81.16 -28.91 34.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 215' ' ' TYR . . . -73.12 -47.17 46.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -62.89 -38.36 90.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.35 -44.54 87.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 11.3 t80 -72.04 -41.23 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 40.9 mt -69.26 -41.03 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.482 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 21.8 ptt180 -70.05 -35.96 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.07 -36.17 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 27.4 mmtp -98.92 -58.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.4 m-20 -80.51 19.82 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm 38.25 26.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.53 44.36 5.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.509 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 -179.01 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -104.02 119.45 38.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.558 HD13 ' CE1' ' A' ' 215' ' ' TYR . 21.8 mt -62.14 -179.9 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -136.07 -175.53 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.87 149.43 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 67.16 14.98 64.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -87.52 148.06 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -81.05 128.54 33.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.4 tp -133.07 145.13 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.62 136.08 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.5 m -153.99 163.02 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.3 mt -136.92 150.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.6 t -70.43 125.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -103.14 -46.73 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -145.42 146.61 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 197' ' ' LEU . 14.6 t -123.96 132.4 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 3.1 tppp? -78.73 150.51 32.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -35.96 -38.81 0.24 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.449 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -125.85 -176.54 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -76.07 48.21 2.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -80.31 -84.87 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.2 134.35 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 139.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.5 t -98.96 120.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 40.8 mt -111.71 154.46 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 23.2 p -152.68 141.97 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.852 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 21.1 m -73.12 134.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.11 -75.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.502 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.01 151.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.7 t -125.81 166.53 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.21 79.73 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.32 -48.65 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 t -41.8 -42.69 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 83.2 m -54.61 109.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -36.3 113.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.06 137.53 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -102.73 24.59 10.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.7 m -91.42 122.37 33.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 283' ' ' GLN . 15.0 tp10 -67.72 153.4 43.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.422 ' N ' ' HG3' ' A' ' 282' ' ' GLU . 18.8 tp60 -161.77 136.47 7.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.95 113.81 23.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.3 m -57.02 138.47 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -88.54 146.05 25.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -45.44 119.31 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.26 147.18 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -167.92 163.6 13.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -93.38 117.32 29.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.409 ' N ' HD21 ' A' ' 291' ' ' LEU . 0.6 OUTLIER -75.87 132.1 40.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 p -85.91 131.71 34.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 163.79 -179.43 38.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 90.7 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.652 2.235 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.3 p -87.62 107.11 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 p -101.51 -48.89 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.819 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.3 t 68.72 45.82 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 t -83.96 -44.95 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.894 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -155.43 74.79 0.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.6 p -102.61 42.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 m -59.33 138.76 57.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.28 157.3 28.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.445 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 -63.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -62.72 171.53 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -101.35 -19.39 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -127.32 43.84 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -50.66 153.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.0 t -114.91 72.65 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.128 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.41 0.86 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 79.3 p -85.17 154.19 22.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' CB ' ' HA3' ' A' ' 263' ' ' GLY . . . -75.27 -21.3 58.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.81 -21.93 43.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.85 54.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 mt -82.17 168.81 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -146.1 144.72 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 129.66 18.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.6 -1.34 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.75 140.5 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.6 mp -102.44 113.29 26.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.66 133.07 53.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -95.63 120.47 35.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.54 -169.93 12.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.0 p -131.96 137.91 48.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.354 . . . . 0.0 111.16 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.46 127.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.5 t -96.03 -40.59 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.6 m -154.93 156.02 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.555 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.8 mm? -100.33 110.22 22.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.32 139.1 31.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -16.41 59.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -97.76 -36.74 10.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -159.58 -150.64 5.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.602 ' CE2' ' CD1' ' A' ' 246' ' ' LEU . 84.4 m-85 -133.13 132.14 41.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.911 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.9 131.4 37.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.82 145.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -92.52 128.97 38.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.56 -31.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.8 50.84 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.492 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.79 151.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.106 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 222' ' ' ASP . 3.1 t0 -92.65 110.64 22.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.73 55.59 2.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 87.7 m -156.03 122.97 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 0.0 111.191 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 266' ' ' VAL . 68.8 mtt180 -116.13 129.47 56.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.448 ' CB ' HD23 ' A' ' 268' ' ' LEU . . . -119.77 128.98 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 16.0 t80 -131.97 135.01 46.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.514 ' C ' ' CD1' ' A' ' 228' ' ' LEU . 1.4 tm? -107.76 127.03 28.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 53.5 Cg_endo -69.79 128.99 16.8 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.67 2.246 . . . . 0.0 112.346 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.05 -22.05 48.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.6 mt -64.83 -45.03 87.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -83.44 -30.52 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.464 ' CB ' HD12 ' A' ' 228' ' ' LEU . . . -68.07 -36.21 79.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.94 -39.29 94.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -62.41 -43.81 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.561 ' CE2' ' HE3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -73.14 -47.07 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 241' ' ' ASN . 34.8 mt -61.15 -49.4 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.47 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.6 ptm180 -58.1 -43.17 86.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.465 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 8.4 mm100 -80.36 -19.89 45.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 2.0 mmmp? -100.9 -75.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.2 t-20 -80.66 41.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER 33.28 34.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 75.45 54.16 5.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -131.66 120.27 22.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -33.85 146.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.602 ' CD1' ' CE2' ' A' ' 215' ' ' TYR . 11.8 mt -78.14 179.63 6.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -123.33 171.05 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 210' ' ' LEU . 75.3 t -92.54 139.83 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.33 -20.58 36.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -63.07 148.06 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.97 127.17 32.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.12 140.27 52.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.71 136.18 45.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 96.9 m -151.51 162.89 40.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.18 140.62 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.5 t -69.1 120.89 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.27 -39.7 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -144.81 141.64 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.1 t -120.66 130.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -82.25 145.7 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.33 -69.62 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.512 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.26 39.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.411 ' HA3' ' CB ' ' A' ' 194' ' ' ALA . . . 38.58 34.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.517 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.11 -53.53 25.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.66 143.52 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 225' ' ' ARG . 43.2 t -126.95 140.07 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.414 ' C ' HD22 ' A' ' 268' ' ' LEU . 4.3 t -98.98 142.08 30.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 268' ' ' LEU . 1.2 mm? -123.82 143.64 50.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 p -143.07 152.69 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.16 141.51 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -179.25 118.66 0.61 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -106.76 73.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -86.03 146.88 26.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.15 97.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.67 -4.44 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 277' ' ' THR . 23.6 m -91.87 143.19 26.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 277' ' ' THR . 2.6 t 28.98 40.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 276' ' ' SER . . . -109.63 98.13 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 49.5 mm -67.52 154.69 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.27 28.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.0 t -88.88 152.6 21.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -167.73 135.59 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -73.1 141.6 47.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -50.27 128.71 20.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 28.7 t -114.94 96.25 5.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -92.04 125.92 36.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -139.09 105.85 5.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 288' ' ' LEU . 0.6 OUTLIER -87.75 151.69 22.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -118.48 130.17 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -93.88 87.95 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -50.12 173.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 27.1 t -155.55 138.26 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 155.38 -179.51 31.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -16.77 37.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.368 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.7 t -48.12 142.73 4.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 48.3 m -87.55 42.08 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.9 t 65.81 49.26 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.6 t -124.14 -43.61 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.09 173.41 23.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.502 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 t -69.18 146.35 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.848 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.7 m -59.05 -52.87 63.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -118.36 133.2 10.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -89.44 -51.49 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.344 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -115.08 122.86 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.7 m -54.78 -19.42 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -171.1 131.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -90.44 136.53 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.1 t -110.64 72.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.413 ' C ' ' HB2' ' A' ' 196' ' ' ALA . 1.6 pt? -112.36 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 t -46.56 172.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.57 -37.5 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.21 -33.21 72.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.413 ' HB2' ' C ' ' A' ' 192' ' ' LEU . . . -73.77 -28.98 61.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.41 149.75 16.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -119.59 149.24 47.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 0.0 110.895 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 116.87 4.76 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.43 -9.83 3.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.452 ' O ' ' CG2' ' A' ' 255' ' ' ILE . 11.8 mtt -79.74 140.6 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.763 0.316 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.51 122.17 36.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 203' ' ' LEU . 4.5 mp -131.25 125.23 32.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 m -92.51 119.09 31.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.63 16.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 p -118.23 139.8 50.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.99 134.59 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.9 t -109.91 -33.88 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -157.03 156.12 32.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.83 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 10.0 mt -113.86 137.6 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.01 164.95 19.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.69 -26.49 40.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.448 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 3.6 p80 -93.59 -17.7 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.75 -162.1 27.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.456 ' CE1' HD11 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.94 139.93 46.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.926 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.85 130.5 34.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.32 131.59 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.59 134.69 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.2 pt -125.1 -21.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.92 7.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.36 135.7 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -88.68 107.24 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.92 36.93 4.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.5 m -153.01 125.31 8.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.103 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -114.08 131.75 56.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.22 134.89 54.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.475 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 24.3 t80 -127.17 140.4 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.47 ' CD1' ' HD2' ' A' ' 229' ' ' PRO . 24.9 tp -113.76 130.35 23.88 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.47 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.68 146.59 61.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.268 . . . . 0.0 112.364 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 31.3 mt -62.14 -19.9 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.77 -44.71 95.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -41.47 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.4 ' HB1' ' CD2' ' A' ' 228' ' ' LEU . . . -65.11 -48.51 73.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 12.4 tt0 -62.96 -37.73 88.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.91 -42.4 90.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.538 ' CD2' ' HD3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -72.91 -38.92 66.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 241' ' ' ASN . 66.0 mt -69.28 -40.5 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.466 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 14.3 ptm180 -70.23 -35.33 73.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -79.98 -40.43 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.538 ' HD3' ' CD2' ' A' ' 236' ' ' TYR . 0.0 OUTLIER -93.91 -55.39 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 237' ' ' ILE . 10.5 t-20 -81.43 19.12 1.03 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 241' ' ' ASN . 51.5 mttt 38.06 27.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.99 67.5 1.44 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -146.35 151.47 37.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 111.152 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.47 154.91 2.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.456 HD11 ' CE1' ' A' ' 215' ' ' TYR . 66.8 mt -95.72 171.37 8.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.89 133.05 47.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.09 136.06 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.48 -23.19 34.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.451 ' NE2' HD23 ' A' ' 246' ' ' LEU . 6.7 pt20 -63.19 148.0 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.915 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.11 127.05 32.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.8 tp -127.61 137.1 52.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -84.42 131.58 34.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 32.3 m -145.99 153.54 40.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 256' ' ' VAL . 15.2 mt -135.45 147.01 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.465 ' N ' HG21 ' A' ' 255' ' ' ILE . 40.0 t -66.93 124.52 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -105.65 -44.42 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -146.79 161.22 41.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.3 130.08 75.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -108.54 117.48 34.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -46.39 157.04 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.518 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 m120 58.87 25.46 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.912 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.47 45.75 4.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -74.57 -72.27 1.04 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 266' ' ' VAL . 94.8 t -129.04 134.43 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.402 ' N ' HG11 ' A' ' 265' ' ' VAL . 23.8 t -112.46 136.2 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.2 t -100.82 116.02 31.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.69 156.68 25.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 255' ' ' ILE . 82.3 p -152.53 142.1 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 p -82.58 143.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -136.62 106.27 0.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 271' ' ' GLY . 10.8 m80 -37.31 137.36 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 49.2 m -152.48 152.72 32.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 49.0 39.56 14.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.2 p -52.02 -40.26 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' THR . 28.2 m -40.29 -41.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' SER . 13.3 t 33.17 41.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -91.0 34.17 0.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.087 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 280' ' ' ALA . 4.6 mm -82.45 155.1 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 279' ' ' ILE . . . -102.86 101.76 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.9 p -139.42 169.73 17.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . 0.412 ' C ' ' CD ' ' A' ' 283' ' ' GLN . 12.9 pt-20 -170.35 140.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.412 ' CD ' ' C ' ' A' ' 282' ' ' GLU . 23.7 mp0 -148.65 140.46 23.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.462 ' CD ' ' C ' ' A' ' 284' ' ' GLN . 4.1 pp0? -87.57 151.95 22.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.1 p -129.59 116.64 19.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -44.11 150.52 0.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -59.23 148.43 31.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.7 tp -120.09 88.78 3.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 290' ' ' ASN . 4.9 m120 -161.65 131.39 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 289' ' ' ASN . 8.3 p30 -35.21 -45.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.6 tp -94.4 123.17 37.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 56.7 p -38.43 116.33 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -84.12 146.42 22.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.476 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 59.8 p -111.63 152.73 27.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -43.3 135.21 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.51 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 29.3 t -144.21 127.96 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.896 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 m -155.07 173.0 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 51.2 77.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.9 p -120.79 -41.78 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 m -118.78 -69.51 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 186' ' ' LYS . . . -60.26 176.55 3.76 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.479 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 185' ' ' GLY . 14.1 ptpt 42.51 48.54 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -79.64 179.08 7.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 189' ' ' ASN . 63.9 t -128.54 75.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 188' ' ' VAL . 3.1 m-20 35.23 45.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 192' ' ' LEU . 12.4 ttm-85 -96.18 38.22 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.0 t 39.67 27.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 190' ' ' ARG . 3.1 mp -141.96 123.17 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 47.4 m -163.06 -177.16 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.34 -26.63 3.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.73 -26.55 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -86.5 6.27 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.99 -176.47 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -158.88 152.4 19.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 132.83 24.09 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 120.52 -10.7 10.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.483 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.4 mtt -73.94 127.58 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -88.74 113.52 24.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 18.5 mt -129.69 134.92 47.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.46 117.03 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -120.12 154.85 16.33 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.9 p -104.85 132.86 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.03 120.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.2 t -86.0 -46.01 10.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.1 p -156.76 155.85 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.92 139.0 39.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.1 161.65 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -72.54 -19.05 61.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -93.35 -39.51 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.567 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -166.39 -162.04 16.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.47 ' CZ ' HD13 ' A' ' 246' ' ' LEU . 92.8 m-85 -120.58 130.34 54.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.929 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.42 133.94 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.2 t -115.95 139.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 -8.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.45 52.78 24.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.506 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.8 t -146.82 134.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -87.18 109.76 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.92 -49.17 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.452 HG21 ' CG2' ' A' ' 266' ' ' VAL . 48.6 m -68.21 124.1 22.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -111.3 131.17 55.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.22 134.79 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.567 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 36.7 t80 -131.81 143.41 50.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 229' ' ' PRO . 0.3 OUTLIER -113.7 126.22 28.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.955 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.489 ' N ' HD12 ' A' ' 228' ' ' LEU . 53.9 Cg_endo -69.73 129.13 17.09 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.94 -14.91 52.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.79 -45.06 53.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -83.17 -36.84 24.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 228' ' ' LEU . . . -64.78 -31.49 72.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -64.39 -41.19 96.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -63.64 -43.43 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.511 ' CZ ' ' HG3' ' A' ' 240' ' ' LYS . 18.3 t80 -72.1 -37.56 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 241' ' ' ASN . 76.5 mt -69.43 -45.82 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.2 ptp180 -61.47 -40.94 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -80.06 -21.17 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.511 ' HG3' ' CZ ' ' A' ' 236' ' ' TYR . 29.0 mmtm -99.44 -71.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 237' ' ' ILE . 17.2 t-20 -83.75 35.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' ASN . 25.5 mtpp 36.41 30.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.52 73.95 1.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -158.3 153.95 26.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.085 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 162.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.47 HD13 ' CZ ' ' A' ' 215' ' ' TYR . 59.0 mt -95.31 -178.1 4.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 247' ' ' LYS . 3.4 mppt? -116.77 174.9 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.5 t -102.04 144.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.82 -6.09 20.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.79 147.94 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -80.99 127.24 32.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.7 tp -128.64 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -97.67 124.25 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -142.64 163.06 33.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 269' ' ' SER . 91.6 mt -137.07 138.44 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.409 ' N ' HG22 ' A' ' 255' ' ' ILE . 15.7 t -65.25 120.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -105.81 -33.5 7.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -144.0 133.45 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.98 132.08 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -87.41 157.64 19.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -68.1 -65.21 2.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.68 41.33 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.3 37.24 1.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -62.22 -74.74 0.37 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.77 135.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 224' ' ' THR . 8.4 t -105.97 139.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.424 ' C ' ' CD2' ' A' ' 268' ' ' LEU . 7.5 m -100.39 139.54 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 268' ' ' LEU . 1.1 mm? -121.19 153.0 38.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 255' ' ' ILE . 45.8 p -159.9 141.97 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.93 133.9 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -160.19 103.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -78.28 62.72 3.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.791 0.329 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 5.0 t -114.67 122.64 47.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -83.25 98.31 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.66 -59.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 m -130.18 125.05 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 43.4 p -42.57 143.39 0.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -98.61 -177.13 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.464 ' CG2' HG22 ' A' ' 281' ' ' THR . 11.1 mt -86.5 142.22 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -97.21 20.89 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.464 HG22 ' CG2' ' A' ' 279' ' ' ILE . 11.0 t -143.81 144.63 31.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -123.68 162.71 22.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.65 157.4 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -60.47 155.95 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.6 t -137.66 120.54 16.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.422 ' C ' ' CD1' ' A' ' 286' ' ' TRP . 5.0 t-105 -122.57 138.58 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -144.51 129.62 18.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -82.15 174.43 11.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -151.44 111.8 4.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -64.63 -47.66 77.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -116.24 179.19 4.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.0 t -149.31 134.25 17.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -122.35 146.2 16.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.512 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -175.63 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.347 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.6 t -145.5 154.19 41.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 60.6 p -74.79 141.92 44.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.444 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.2 t -73.51 145.2 45.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 0.0 110.825 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.9 m -85.27 106.66 16.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -149.45 92.5 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 m -65.02 -61.81 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -46.09 165.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 153.95 -64.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -40.35 -60.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -161.5 106.67 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.71 145.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 190' ' ' ARG . 50.9 t-20 38.93 48.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 ttp180 -36.64 123.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 m -57.06 -18.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.23 109.74 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.4 m -82.68 174.43 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -44.41 -44.85 8.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -51.85 -54.1 32.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.5 -21.74 61.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.25 -175.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -161.21 149.65 12.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.867 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 108.84 2.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.72 -5.82 3.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.3 mtm -86.83 142.69 27.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.05 125.34 44.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 mp -132.01 125.95 32.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -98.04 119.5 36.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.16 -165.18 11.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.1 p -129.92 138.75 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 128.54 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.1 t -87.8 -45.99 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.1 m -156.91 155.95 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.67 112.89 25.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.403 ' CG ' HD23 ' A' ' 216' ' ' LEU . 14.3 mm-40 -94.28 143.25 26.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.74 -19.13 65.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.49 -29.96 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.545 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -166.64 -155.68 9.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.557 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.485 ' CE2' HD11 ' A' ' 246' ' ' LEU . 89.8 m-85 -125.49 125.85 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 110.897 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.403 HD23 ' CG ' ' A' ' 211' ' ' GLU . 2.0 mm? -86.39 133.94 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.936 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.01 141.56 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.79 131.44 34.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.1 pt -127.28 -29.42 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.44 41.09 21.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.443 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.4 t -121.78 144.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 111.074 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.75 108.09 20.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.35 33.79 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 95.8 m -143.6 123.13 13.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -116.07 120.49 39.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.95 134.36 55.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.545 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.8 t80 -132.0 144.0 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 229' ' ' PRO . 1.7 tm? -113.67 126.9 27.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 110.926 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.503 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 136.15 32.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 31.9 mt -62.9 -24.35 67.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.79 -42.24 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.57 -39.25 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 228' ' ' LEU . . . -61.0 -48.66 80.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -58.58 -37.97 76.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -64.25 -42.52 96.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 3.0 t80 -73.03 -40.02 65.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 241' ' ' ASN . 24.3 mt -68.1 -40.03 82.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.472 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.3 ptm180 -69.92 -37.98 76.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -81.38 -27.36 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 66.9 mmtt -107.38 -63.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 237' ' ' ILE . 2.4 m120 -81.37 24.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.0 mtpt 34.77 31.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.79 44.54 7.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -112.91 113.48 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -41.51 125.74 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 215' ' ' TYR . 16.2 mt -58.94 -175.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -144.17 152.12 40.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.7 t -67.08 143.56 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.95 -21.06 16.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 252' ' ' LEU . 0.9 OUTLIER -65.49 148.32 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.954 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -80.97 133.04 35.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 250' ' ' GLN . 24.2 tp -134.48 135.09 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.31 136.5 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 37.8 m -148.55 151.35 34.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 256' ' ' VAL . 90.3 mt -131.52 138.69 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 255' ' ' ILE . 17.2 t -62.73 123.71 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -106.82 -45.62 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -134.37 148.86 50.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 63.1 t -119.27 126.74 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.25 118.53 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -40.79 -56.88 2.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 263' ' ' GLY . 28.1 t30 -85.69 35.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.59 42.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -76.14 -74.21 0.95 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.6 130.99 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.19 139.95 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.1 t -99.38 120.75 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 27.9 mt -116.3 152.14 34.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 58.2 m -146.8 147.71 31.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.79 127.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -114.21 85.41 0.39 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -83.78 40.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 58.1 p -120.32 40.14 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -103.79 91.42 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.44 -10.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.187 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 7.7 t -113.27 127.75 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 81.4 p -109.23 130.4 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -120.31 104.15 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.113 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 78.0 mt -92.95 145.98 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -126.72 86.16 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.0 t -60.98 139.22 58.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -151.21 156.66 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -118.0 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -126.64 166.4 17.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 15.0 t -171.08 105.74 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -134.08 109.82 9.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.44 124.8 6.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 13.8 mt -152.59 -175.72 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -166.34 113.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -152.06 169.06 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.89 92.01 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.6 t -79.07 91.66 4.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -148.03 146.26 15.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -9.38 25.97 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 97.4 p -97.07 134.84 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 29.6 m -76.72 -42.92 39.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.42 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.0 t -129.9 -60.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.863 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -138.1 163.52 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.97 -73.74 1.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.8 t -103.06 108.33 19.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 t -123.1 -42.99 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.19 -145.48 4.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -44.8 123.85 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 189' ' ' ASN . 0.1 OUTLIER -58.9 139.64 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.7 p -38.22 -29.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 187' ' ' ASN . 2.8 p-10 -142.72 124.51 15.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.0 ptt-85 -64.17 128.53 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.43 37.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.78 81.16 1.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -164.01 154.92 15.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.83 96.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -66.1 -19.82 65.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.89 58.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -47.07 161.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -110.14 148.51 38.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.711 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 116.93 4.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.84 -2.92 7.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 34.3 mtt -68.07 141.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.23 111.04 20.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -124.74 137.86 54.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.4 m -112.64 125.38 54.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.32 161.01 25.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.426 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 251' ' ' TYR . 4.0 p -103.57 140.08 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.5 122.38 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.5 t -87.56 -43.36 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.1 m -156.81 155.77 32.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.58 123.73 44.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.56 147.57 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -65.09 -27.42 68.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -90.6 -32.41 16.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -164.62 -159.19 10.9 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.554 ' CE1' HD11 ' A' ' 246' ' ' LEU . 94.6 m-85 -125.71 129.51 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.01 134.05 33.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.98 142.2 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.45 124.11 33.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.94 -27.39 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.03 40.69 10.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 64.9 t -128.59 142.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.127 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.51 126.63 38.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 98.99 -48.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.6 m -69.13 123.23 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -114.97 129.69 56.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.11 128.98 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 27.4 t80 -131.85 134.34 45.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 229' ' ' PRO . 1.7 tm? -109.21 126.4 29.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.451 ' N ' HD11 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.74 133.77 26.42 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.495 ' CD2' ' CE2' ' A' ' 215' ' ' TYR . 48.9 mt -61.2 -21.86 64.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 -44.99 85.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.455 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 1.6 tmtp? -77.5 -31.54 53.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.9 -39.77 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -59.43 -33.87 71.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.33 -45.85 75.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.9 t80 -72.3 -38.04 68.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 241' ' ' ASN . 51.6 mt -69.79 -42.45 80.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.47 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 17.9 ptt180 -69.77 -36.56 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -81.39 -34.74 31.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.536 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 1.2 mmmp? -99.66 -60.03 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 237' ' ' ILE . 8.6 m-20 -80.81 21.32 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm 36.99 28.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.97 46.88 4.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.46 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.25 177.56 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -100.12 137.59 38.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.554 HD11 ' CE1' ' A' ' 215' ' ' TYR . 23.5 mt -73.43 162.37 29.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -128.38 149.68 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.19 150.57 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.82 3.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.53 148.32 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.449 ' CD1' HG23 ' A' ' 206' ' ' THR . 11.8 m-85 -80.94 129.87 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.85 140.77 52.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -87.62 128.33 35.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.9 m -147.14 149.8 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 256' ' ' VAL . 79.8 mt -134.54 139.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.445 ' N ' HG22 ' A' ' 255' ' ' ILE . 30.7 t -62.71 119.05 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -97.05 -40.04 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -153.62 152.94 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -123.22 127.96 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.41 178.01 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.69 -74.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 263' ' ' GLY . 1.4 m120 -80.12 45.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.72 37.98 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.97 5.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 266' ' ' VAL . 57.5 t -132.78 146.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.461 ' N ' HG11 ' A' ' 265' ' ' VAL . 27.8 t -113.33 139.33 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.9 t -99.3 118.57 36.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.88 146.98 46.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 5.6 p -147.09 145.47 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.415 HG21 ' NZ ' ' A' ' 232' ' ' LYS . 27.3 m -76.87 122.57 31.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.096 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -138.56 94.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -44.34 152.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 67.4 m -44.83 163.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -138.39 112.43 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.05 -58.95 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.15 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.3 m -75.24 85.36 2.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 12.8 t -101.42 147.74 25.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.167 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -89.82 100.85 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.19 148.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.25 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 9.8 t -121.99 144.23 49.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 174.26 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -136.38 173.8 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -53.33 163.75 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.955 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 60.8 m -148.58 129.99 14.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -141.96 160.25 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.89 137.41 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 8.9 mp -104.78 119.37 38.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -40.3 148.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -85.13 99.19 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.33 89.89 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 86.0 p -139.03 127.35 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.91 153.05 2.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.5 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -17.02 37.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 65.7 m -52.24 96.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 42.9 m -74.35 166.26 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.814 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 t 43.25 42.22 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.9 m -111.3 85.38 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.48 156.75 28.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.8 m -118.0 -49.58 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 m -54.93 173.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.04 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -118.34 129.97 55.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.616 ' ND2' ' N ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -126.43 177.25 6.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.3 137.44 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 60.33 42.88 14.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.71 142.81 38.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.46 71.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.2 tp -130.29 41.18 3.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 196' ' ' ALA . 24.0 p -139.86 140.03 36.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.94 -38.21 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -75.56 -29.9 59.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -58.88 164.12 3.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -140.05 151.47 65.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.2 20.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 113.29 -6.12 25.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.85 138.83 56.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 3.9 mp -94.44 110.13 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.13 141.65 50.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -111.56 124.63 52.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.24 -174.75 13.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.7 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.03 120.69 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 t -86.47 -41.87 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 56.4 p -156.4 156.0 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 210' ' ' LEU . 9.5 mp -105.01 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -115.34 145.21 42.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -67.48 -17.87 64.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -97.24 -20.05 18.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.95 -166.78 34.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 246' ' ' LEU . 85.0 m-85 -125.79 132.95 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.417 ' CD1' ' NH2' ' A' ' 225' ' ' ARG . 1.5 mm? -88.85 132.17 34.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.897 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.15 135.17 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.1 126.97 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 pt -119.01 -18.56 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.02 43.13 8.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.55 127.29 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.107 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.91 130.33 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.64 -43.41 1.76 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.8 m -73.92 132.0 42.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.787 0.327 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.417 ' NH2' ' CD1' ' A' ' 216' ' ' LEU . 6.9 tpm_? -109.33 123.18 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.96 126.92 55.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 9.0 t80 -132.01 139.21 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 268' ' ' LEU . 15.3 tp -112.73 133.41 21.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' A' ' 228' ' ' LEU . 54.0 Cg_endo -69.72 139.49 40.48 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.11 -25.08 68.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.57 -45.05 73.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -78.09 -33.14 50.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.15 63.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.45 -35.67 72.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.98 -42.92 99.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.3 OUTLIER -72.47 -37.74 68.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.893 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 244' ' ' ALA . 32.7 mt -66.97 -39.11 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.466 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.5 ttt180 -69.2 -41.29 77.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -79.49 -20.3 47.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.555 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 47.1 mmtt -101.5 -69.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 243' ' ' GLY . 15.7 t-20 -83.85 35.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 38.9 mmtt 34.65 32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.37 68.49 1.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.5 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.5 ' O ' ' CG2' ' A' ' 237' ' ' ILE . . . -143.76 169.24 18.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 146.98 50.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.462 HD12 ' CD1' ' A' ' 237' ' ' ILE . 80.0 mt -87.67 178.25 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -132.95 153.14 51.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.01 134.4 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.065 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.1 -22.36 39.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.449 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -64.54 148.04 51.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.05 128.47 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.09 142.9 50.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.43 130.51 38.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 95.1 m -154.91 153.0 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.63 139.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.52 125.14 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -103.5 -45.82 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -142.51 158.37 43.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.25 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.45 136.57 36.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.7 -66.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.546 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 263' ' ' GLY . 19.1 t-20 -84.53 45.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.24 36.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -68.76 -86.63 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.88 144.26 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.53 140.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.6 t -98.96 118.13 35.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' A' ' 228' ' ' LEU . 13.2 mt -116.72 149.62 39.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 75.4 m -156.91 142.03 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 17.4 t -71.89 142.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 272' ' ' HIS . . . -98.07 -37.01 4.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.529 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 271' ' ' GLY . 28.2 p80 42.55 28.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.9 t -148.38 148.01 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 69.12 41.77 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.27 -25.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 99.6 p -62.57 130.61 45.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 12.1 t -92.45 156.0 17.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -43.6 165.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 21.3 mt -50.4 150.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -101.53 101.15 11.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.0 p -104.53 119.97 40.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -85.88 -25.08 26.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -85.96 155.69 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -156.21 174.54 15.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 55.2 m -78.56 148.71 33.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -92.44 163.31 13.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -122.82 164.58 18.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.5 tp -138.88 123.01 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -87.5 173.2 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -172.8 172.13 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 15.4 mt 60.55 53.25 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.5 m -120.17 120.44 36.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -152.0 145.68 13.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.478 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -178.6 2.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.356 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 83.1 p -155.12 166.99 31.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 81.1 p -112.14 173.94 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.7 t -107.13 127.78 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -71.28 -49.87 38.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 116.37 -130.5 9.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -106.14 122.3 45.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.0 110.879 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -150.17 154.98 38.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.44 -161.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.444 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -94.53 -46.26 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -159.24 154.78 25.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.8 m -80.36 132.14 32.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.177 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 190' ' ' ARG . 20.9 t30 42.33 43.65 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 0.0 OUTLIER -36.34 147.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.38 -16.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.171 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 tt -59.53 107.72 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 56.0 m -146.27 171.63 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.97 -29.17 7.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.01 -32.36 71.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.07 60.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.9 mt -57.83 152.28 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -129.95 148.93 71.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 110.937 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 120.27 7.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 134.65 -12.02 4.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.0 mtt -80.97 140.38 35.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.9 mp -95.2 120.5 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 203' ' ' LEU . 5.1 mp -130.54 125.36 34.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.5 m -94.39 120.41 34.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.76 -174.43 14.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.3 p -123.55 142.38 51.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.116 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.09 120.4 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.3 t -85.16 -41.8 15.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -157.03 155.05 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 210' ' ' LEU . 3.2 mm? -95.08 107.49 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -94.13 149.38 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.55 -31.09 65.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -84.24 -28.75 27.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -168.96 -158.75 13.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.02 131.62 53.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.04 129.83 34.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.37 134.02 56.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.09 137.07 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 224' ' ' THR . 20.8 pt -126.27 -30.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.88 55.24 2.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.18 155.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.23 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.36 44.19 6.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.534 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.459 HG23 ' CD1' ' A' ' 219' ' ' ILE . 90.0 m -144.18 131.5 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.338 . . . . 0.0 111.139 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -115.62 125.9 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -121.9 122.19 38.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.57 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 17.6 t80 -125.52 140.52 52.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 12.2 tp -110.28 129.79 23.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.658 0.742 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 135.26 30.07 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 39.0 mt -63.1 -23.82 67.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.77 -45.18 87.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.936 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -85.12 -32.8 22.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.43 80.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -58.65 -34.01 70.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.87 -43.79 91.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t80 -72.83 -42.17 64.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 241' ' ' ASN . 22.6 mt -68.13 -40.78 83.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.474 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 11.8 ptm180 -70.11 -35.78 74.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -81.19 -34.59 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 24.0 mmtp -100.75 -59.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 237' ' ' ILE . 2.5 m120 -80.31 19.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.52 26.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.1 46.68 4.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.78 116.33 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -38.21 133.13 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 49.6 mt -69.97 171.28 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -126.14 175.44 7.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.15 132.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.19 -27.56 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.528 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -63.2 147.88 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -81.03 126.99 32.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.72 138.3 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -85.63 135.12 33.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.2 m -156.33 154.58 30.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 269' ' ' SER . 43.2 mt -134.4 142.16 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.21 119.35 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.67 -46.4 5.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -150.15 158.39 44.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -120.54 129.38 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.32 156.54 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -70.09 159.58 53.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 48.21 34.97 4.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 42.18 36.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.07 -81.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.61 146.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 267' ' ' SER . 53.7 t -113.44 138.8 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.433 ' N ' HG11 ' A' ' 266' ' ' VAL . 8.6 t -100.78 117.76 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.7 mt -116.69 157.69 25.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' ILE . 73.0 p -154.72 142.0 19.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.31 132.14 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -157.87 93.27 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -69.18 -51.93 33.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 90.8 p -53.74 173.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -137.64 126.58 24.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 276' ' ' SER . 27.7 m -99.79 -43.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.174 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 275' ' ' VAL . 30.2 t -49.32 151.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 34.7 p -82.08 164.63 21.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -86.73 155.59 20.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 66.9 mt -51.44 142.0 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.452 ' CB ' ' HG3' ' A' ' 282' ' ' GLU . . . -75.42 -20.11 59.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 45.79 28.6 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . 0.452 ' HG3' ' CB ' ' A' ' 280' ' ' ALA . 32.9 mt-10 -61.19 123.5 17.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.17 -43.27 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -42.79 114.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 68.3 m -111.31 126.65 55.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -55.34 -35.47 65.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -48.64 157.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.71 101.74 11.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -161.11 147.45 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -106.43 130.1 54.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.82 95.37 10.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.9 m -97.91 125.46 42.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.01 82.94 0.57 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 108.97 2.2 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.6 t -62.69 140.8 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.9 t -153.55 145.26 23.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -134.01 146.37 59.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.547 0.689 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 115.17 3.97 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.683 2.256 . . . . 0.0 112.361 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 139.76 -11.04 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.595 ' HB3' HD11 ' A' ' 203' ' ' LEU . 19.1 mtt -73.77 132.7 42.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.0 mp -93.14 113.59 25.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 203' ' ' LEU . 2.0 mp -130.88 134.13 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.0 m -83.12 118.12 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -114.73 160.55 13.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.0 p -122.53 137.07 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.21 120.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.0 t -86.27 -45.53 11.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.1 m -156.99 156.01 32.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' A' ' 215' ' ' TYR . 1.2 mm? -91.5 124.31 35.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -107.89 164.83 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -22.78 35.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.534 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 4.0 p80 -98.09 -20.68 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -179.95 -149.28 8.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.577 ' HD2' HD13 ' A' ' 210' ' ' LEU . 27.0 m-85 -133.99 138.4 45.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.973 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 132.85 33.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.95 129.45 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.97 126.89 31.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.8 pt -119.95 -20.06 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.51 51.99 4.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.75 141.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.01 116.59 28.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 104.05 -42.85 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.518 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.5 m -74.44 125.42 28.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -114.74 132.09 56.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.93 124.54 51.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 5.5 t80 -123.27 143.39 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 268' ' ' LEU . 14.2 tp -113.29 134.55 21.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.477 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.85 144.45 53.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.303 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 17.4 mt -63.03 -26.44 68.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.6 -44.18 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -82.19 -42.09 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -64.57 -48.95 73.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 36.0 tt0 -62.85 -33.99 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.68 -42.65 91.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE1' ' CD1' ' A' ' 252' ' ' LEU . 3.9 t80 -72.29 -37.36 69.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.686 HG12 HD21 ' A' ' 246' ' ' LEU . 30.6 mt -69.66 -47.27 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.3 ptp180 -59.45 -40.52 87.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -79.98 -21.55 43.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 236' ' ' TYR . 37.4 mmtm -99.14 -72.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.77 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.0 t-20 -83.69 35.85 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 241' ' ' ASN . 20.2 mtpp 34.44 33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 81.47 70.64 1.33 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.77 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -148.25 137.69 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 111.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -44.52 147.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.712 HD22 HE22 ' A' ' 250' ' ' GLN . 69.1 mt -86.34 -175.09 5.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -122.55 176.75 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 147.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.26 24.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.712 HE22 HD22 ' A' ' 246' ' ' LEU . 4.3 pt20 -72.07 148.01 46.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -81.0 126.97 32.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.513 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 15.4 tp -136.66 135.97 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -76.07 134.43 40.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.639 ' HB3' HD22 ' A' ' 268' ' ' LEU . 73.9 m -152.64 144.85 23.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.641 HD12 ' HA3' ' A' ' 271' ' ' GLY . 65.2 mt -133.77 138.9 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.96 119.44 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -106.48 -30.49 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -151.78 149.85 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.05 133.09 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -84.35 150.99 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -60.39 -67.61 2.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -88.13 41.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 44.15 42.74 6.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.63 -73.12 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.447 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.23 136.87 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 42.3 t -104.28 139.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 114.03 26.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 254' ' ' CYS . 17.1 mt -111.76 149.45 31.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.6 m -149.12 150.43 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.12 118.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.641 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.842 0.353 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.44 ' H ' ' CE ' ' A' ' 201' ' ' MET . 3.5 mptt -108.21 147.65 36.0 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.894 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 140.87 43.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 103.76 7.22 42.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.44 ' CE ' ' H ' ' A' ' 198' ' ' LYS . 47.4 mtt -80.66 139.26 36.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.5 mp -88.84 108.62 19.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 202' ' ' LEU . 4.4 mp -124.28 150.98 44.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.3 m -117.48 117.06 28.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -119.65 -172.63 15.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.45 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 251' ' ' TYR . 7.6 p -129.02 139.62 51.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 111.138 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.18 120.41 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.9 t -86.41 -38.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.5 p -157.0 155.75 31.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.64 123.96 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.76 168.28 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.863 ' O ' HD11 ' A' ' 230' ' ' LEU . 7.4 p-10 -85.99 -24.19 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -92.02 -14.56 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . 175.82 -167.44 39.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.09 137.07 53.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 128.59 36.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.5 135.55 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -86.55 135.71 33.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.74 -13.49 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.81 50.71 23.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 222' ' ' ASP . 38.4 t -134.49 155.97 39.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.127 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 221' ' ' VAL . 13.8 t70 -102.14 122.26 43.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.73 36.95 17.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 42.5 m -151.65 123.59 8.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -114.17 131.37 56.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.04 135.32 53.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 9.1 t80 -129.76 142.74 50.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.882 HD12 ' HD2' ' A' ' 229' ' ' PRO . 10.3 tp -113.99 133.44 22.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.882 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.71 143.22 50.35 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.863 HD11 ' O ' ' A' ' 212' ' ' ASP . 25.6 mt -62.67 -22.92 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.34 -44.23 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -83.25 -33.21 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.0 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.23 -42.2 99.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.69 -41.45 96.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.546 ' HB2' HG21 ' A' ' 270' ' ' VAL . 2.4 t80 -72.41 -40.05 67.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 241' ' ' ASN . 43.5 mt -68.09 -43.01 85.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 8.1 ptm180 -66.61 -40.3 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 37.8 mm-40 -79.96 -20.15 46.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 21.4 mmtm -101.31 -69.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.781 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 12.3 t-20 -84.37 32.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.8 OUTLIER 37.32 28.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.58 64.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.448 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.781 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.49 130.94 21.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 111.054 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -46.77 155.14 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 237' ' ' ILE . 14.3 mt -94.38 175.54 6.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -129.38 134.46 47.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.78 141.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.16 -27.0 16.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.67 148.36 52.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.61 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.1 m-85 -81.99 130.27 35.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.462 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 38.1 tp -123.64 138.35 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -81.24 134.9 35.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.609 ' HB3' HD22 ' A' ' 268' ' ' LEU . 58.0 m -157.5 150.6 23.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.5 mt -127.13 139.56 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.89 123.09 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.39 -46.17 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -144.74 152.09 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.79 122.01 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 55.0 mttt -79.3 133.11 36.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -36.43 -45.48 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -109.09 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -78.33 61.51 3.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -93.95 -81.13 1.5 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.24 143.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.02 139.96 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 17.9 t -99.69 131.32 45.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 254' ' ' CYS . 20.5 mt -126.69 157.63 38.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 97.3 p -157.08 143.54 18.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 236' ' ' TYR . 38.6 t -71.01 131.46 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.459 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -129.45 153.66 80.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 109.45 2.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.7 28.97 1.01 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 255' ' ' ILE . 28.6 mtt -96.4 136.74 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.862 ' C ' HD12 ' A' ' 203' ' ' LEU . 3.6 mp -96.89 111.99 23.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.862 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.9 mp -131.09 149.14 52.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -102.1 120.22 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.91 177.71 17.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.2 p -126.68 136.83 52.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 122.74 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.1 t -86.07 -46.02 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.6 p -157.07 156.03 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.13 127.8 46.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -113.3 144.79 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.648 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -64.57 -23.61 67.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -94.9 -39.44 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -153.47 -159.48 9.14 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.438 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.639 ' CE2' HD23 ' A' ' 230' ' ' LEU . 58.9 m-85 -133.66 132.77 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.93 125.28 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.09 137.03 34.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.97 -30.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.48 47.6 5.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 138.48 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.14 109.61 20.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.86 36.86 3.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 266' ' ' VAL . 63.5 m -150.06 128.67 12.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.314 . . . . 0.0 111.128 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -114.66 126.33 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.521 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -114.82 127.66 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 18.2 t80 -132.26 126.44 33.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 229' ' ' PRO . 17.6 tp -104.94 130.27 23.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 143.19 49.9 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.1 mt -63.29 -29.26 70.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.61 -45.21 93.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -80.27 -42.1 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.0 98.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.85 -30.38 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.41 -43.88 84.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' CE1' HD11 ' A' ' 252' ' ' LEU . 0.8 OUTLIER -73.29 -37.81 66.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 246' ' ' LEU . 17.3 mt -68.25 -50.89 53.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 26.2 ptt85 -57.03 -40.08 76.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -80.04 -31.47 39.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 26.3 mmtt -88.28 -69.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.745 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.9 t-20 -83.58 35.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASN . 60.9 mttp 34.21 33.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.3 58.59 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -136.55 128.0 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -40.32 130.59 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.731 HD21 HG12 ' A' ' 237' ' ' ILE . 21.2 mt -70.04 -175.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -127.75 178.52 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 249' ' ' GLY . 59.2 t -92.09 153.43 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . . . 63.27 12.57 45.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.485 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.561 HE22 HD22 ' A' ' 246' ' ' LEU . 4.6 pt20 -82.4 147.98 28.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.94 126.81 31.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.572 HD11 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -135.04 142.25 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.478 ' O ' HG22 ' A' ' 270' ' ' VAL . 45.6 p-10 -96.47 133.06 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 92.0 m -146.76 159.69 43.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 201' ' ' MET . 86.1 mt -136.74 137.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.12 131.24 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.24 -41.53 5.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -150.68 153.06 34.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.8 t -123.76 121.28 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -127.6 143.25 51.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 54.77 165.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.452 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 262' ' ' ASN . 38.3 p30 -95.6 40.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 142.1 40.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.443 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -108.25 -95.0 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.6 137.43 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 224' ' ' THR . 77.9 t -114.61 139.89 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.161 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.6 t -99.12 125.2 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.521 ' CD1' ' HB1' ' A' ' 226' ' ' ALA . 39.0 mt -121.02 152.09 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 255' ' ' ILE . 93.8 p -159.77 143.23 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 253' ' ' ASN . 56.9 t -80.9 122.39 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.445 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.94 150.77 63.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.721 . . . . 0.0 110.891 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.354 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.43 11.79 3.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.4 mtt -99.14 130.95 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.583 ' C ' HD22 ' A' ' 203' ' ' LEU . 5.5 mp -86.42 107.94 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.3 mm? -121.26 130.72 53.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.975 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -93.55 129.4 39.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -136.01 -173.04 12.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 251' ' ' TYR . 5.6 p -130.89 140.07 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 111.114 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.99 119.94 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.1 t -86.36 -39.74 16.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.3 m -157.01 156.02 32.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.413 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.4 mp -106.76 125.41 50.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -117.24 144.62 44.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.769 ' O ' HD11 ' A' ' 230' ' ' LEU . 2.6 m-20 -66.36 -17.76 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -95.23 -27.39 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -170.02 -159.05 14.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.472 ' CD1' HD12 ' A' ' 246' ' ' LEU . 63.7 m-85 -133.34 129.44 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 126.17 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.95 135.31 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.78 133.65 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 pt -123.09 -22.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.06 50.03 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -143.53 147.79 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.41 124.32 35.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.4 -51.72 1.83 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.535 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -59.92 124.95 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -115.8 132.01 56.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -115.25 125.83 53.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 14.1 t80 -123.32 137.13 54.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 233' ' ' ALA . 13.0 tp -112.79 132.34 22.32 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.58 0.705 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 140.59 43.0 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.345 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.769 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.9 mt -63.08 -19.88 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.77 -44.53 66.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HG3' HG23 ' A' ' 270' ' ' VAL . 0.4 OUTLIER -79.64 -35.54 39.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.444 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -72.47 -43.05 64.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 11.3 tt0 -58.46 -36.81 74.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.75 -43.18 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.2 OUTLIER -72.1 -38.52 69.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.671 HG12 HD21 ' A' ' 246' ' ' LEU . 22.0 mt -66.3 -39.01 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.113 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -69.18 -41.98 76.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -79.83 -21.65 43.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.548 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 24.1 mmtt -100.17 -67.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.748 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.3 t-20 -84.3 32.81 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' ASN . 76.2 mttt 37.94 27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 85.94 61.58 1.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.748 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -142.65 134.12 26.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.86 148.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.671 HD21 HG12 ' A' ' 237' ' ' ILE . 94.5 mt -78.58 -177.66 5.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.6 145.89 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.2 128.53 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.56 -27.13 20.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.93 147.96 48.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 206' ' ' THR . 12.6 m-85 -80.97 132.01 35.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.73 141.45 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.74 133.86 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.702 ' HB3' HD22 ' A' ' 268' ' ' LEU . 85.1 m -155.28 151.13 27.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.02 147.0 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 200' ' ' GLY . 2.9 t -72.72 120.28 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -107.07 -48.47 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -137.77 135.37 36.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.35 122.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -126.05 134.34 51.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 65.75 -157.77 47.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.99 -42.5 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.93 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -130.72 32.2 3.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -90.53 -101.37 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.72 134.78 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.25 139.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.7 m -99.1 117.12 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.9 mt -110.9 157.66 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -148.63 142.0 25.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 232' ' ' LYS . 36.1 t -75.21 141.61 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.071 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -127.55 143.91 49.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.55 0.691 . . . . 0.0 110.897 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 109.1 2.23 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 146.98 -11.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.7 mtm -79.1 141.27 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.833 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.1 108.08 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.3 128.44 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -94.3 130.87 40.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.11 -163.64 9.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.5 p -131.11 146.03 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.194 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.43 121.67 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.3 t -85.83 -43.05 13.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.575 ' HA ' HG22 ' A' ' 248' ' ' VAL . 5.2 m -157.05 156.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.859 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 246' ' ' LEU . 6.5 mp -106.49 125.1 50.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -116.95 162.17 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.5 m-20 -83.23 -22.93 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -96.15 -9.82 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 177.3 -161.4 28.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.647 ' CD2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -132.86 137.55 46.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.961 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.95 129.91 36.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.71 143.1 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.46 133.78 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.8 pt -125.1 -18.96 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.94 51.7 17.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 150.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.834 0.349 . . . . 0.0 111.116 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -93.84 119.2 32.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.96 43.68 13.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.1 m -155.22 123.71 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -113.43 131.42 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.79 48.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 13.0 t80 -122.92 140.48 52.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.721 HD12 ' HD2' ' A' ' 229' ' ' PRO . 23.5 tp -113.81 133.69 22.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.721 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.78 146.76 61.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.316 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.865 HD11 ' O ' ' A' ' 212' ' ' ASP . 74.5 mt -63.07 -22.76 67.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.4 -45.01 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 270' ' ' VAL . 15.0 mmtm -81.96 -37.7 26.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.627 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.32 -46.1 85.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.058 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -65.21 -39.26 92.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.7 -43.24 89.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 2.2 t80 -72.64 -42.26 64.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 233' ' ' ALA . 18.7 mt -65.23 -38.94 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.146 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.462 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 1.2 ttt85 -68.79 -43.72 75.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -79.0 -21.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 39.2 mmtt -99.31 -68.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.06 34.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 241' ' ' ASN . 79.5 mttt 34.73 34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 78.1 74.63 1.01 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -152.24 118.73 5.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -35.61 135.76 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.647 HD12 ' CD2' ' A' ' 215' ' ' TYR . 51.7 mt -69.22 -175.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 246' ' ' LEU . 3.4 mtpm? -144.7 130.06 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 209' ' ' SER . 23.9 t -50.62 126.05 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 109.83 -31.37 7.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.496 ' NE2' HD22 ' A' ' 246' ' ' LEU . 9.1 pt20 -62.99 148.17 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.909 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -80.73 130.82 35.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.455 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -124.3 145.32 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.18 127.48 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 268' ' ' LEU . 35.0 m -147.2 155.19 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 271' ' ' GLY . 95.3 mt -133.03 139.43 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.29 119.39 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -103.9 -48.07 4.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -138.6 140.28 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.8 t -122.16 129.11 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -85.41 176.29 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -87.97 -54.51 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -85.85 30.64 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 45.5 32.03 3.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.01 -74.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.8 t -132.68 134.24 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.33 139.6 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.7 t -99.97 118.4 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 254' ' ' CYS . 18.3 mt -113.64 149.88 33.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 255' ' ' ILE . 52.3 p -145.94 142.01 28.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 232' ' ' LYS . 17.3 m -73.93 134.65 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.853 0.358 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -100.4 148.93 35.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.567 0.698 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 129.91 8.04 3.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.706 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.9 mtt -76.16 140.36 41.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 203' ' ' LEU . 5.4 mp -86.5 108.62 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -130.39 141.1 50.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.4 m -119.57 122.23 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.3 -177.61 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -124.16 138.08 54.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.47 122.88 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -88.23 -40.68 13.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.97 156.07 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 248' ' ' VAL . 3.8 mm? -99.86 115.42 29.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.442 ' OE1' HD21 ' A' ' 216' ' ' LEU . 24.3 mt-10 -98.25 137.21 37.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 230' ' ' LEU . 8.5 t0 -57.2 -20.55 27.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -94.5 -38.3 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -161.24 -161.94 12.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.531 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.937 ' CE2' HD12 ' A' ' 246' ' ' LEU . 41.3 m-85 -117.63 132.14 56.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.442 HD21 ' OE1' ' A' ' 211' ' ' GLU . 1.9 mm? -92.01 133.54 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.76 142.66 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.4 123.07 33.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.7 -33.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.03 37.35 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.443 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.4 t -113.11 146.29 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -97.13 98.75 10.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.03 46.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 91.2 m -158.3 124.1 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -116.7 123.92 48.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -116.01 129.33 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 18.9 t80 -130.48 137.65 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.86 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -107.87 126.81 28.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.86 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.78 131.66 21.66 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.688 2.259 . . . . 0.0 112.372 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.702 HD23 ' HE1' ' A' ' 215' ' ' TYR . 30.5 mt -62.4 -24.75 67.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.6 mt -65.6 -41.27 92.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -42.51 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -59.3 -34.14 71.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.45 -34.01 70.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.41 -43.66 76.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.86 -37.79 67.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 241' ' ' ASN . 32.4 mt -68.42 -42.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 28.3 ptt180 -68.73 -35.98 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 12.1 mm100 -78.38 -39.9 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -98.1 -74.93 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m120 -52.47 -16.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 237' ' ' ILE . 32.5 mttp 59.54 36.53 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.41 46.88 5.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -136.57 117.42 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -49.57 135.54 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 215' ' ' TYR . 28.3 mt -62.6 179.2 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -131.27 170.8 14.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.55 HG23 HD23 ' A' ' 210' ' ' LEU . 19.3 t -87.73 128.66 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.55 -21.93 37.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.717 ' OE1' HD22 ' A' ' 246' ' ' LEU . 1.5 pt20 -64.36 148.0 51.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -81.0 127.17 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.96 135.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.756 ' O ' HG12 ' A' ' 270' ' ' VAL . 1.1 p-10 -93.28 125.31 37.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 13.3 m -140.28 157.64 45.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 201' ' ' MET . 73.3 mt -136.84 140.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 200' ' ' GLY . 39.0 t -61.04 119.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -99.87 -46.89 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -140.1 152.89 46.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.438 ' C ' ' HE2' ' A' ' 260' ' ' LYS . 71.9 t -124.0 127.29 73.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.438 ' HE2' ' C ' ' A' ' 259' ' ' VAL . 0.3 OUTLIER -97.72 167.72 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -88.92 171.1 38.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.514 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 261' ' ' GLY . 3.0 p-10 45.52 40.67 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 40.47 47.34 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.54 -98.56 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.59 146.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.02 139.99 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 m -98.97 115.44 28.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 226' ' ' ALA . 12.0 mt -113.23 148.77 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 46.3 m -158.78 142.07 14.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 253' ' ' ASN . 2.4 m -74.97 142.86 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.482 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -153.26 155.25 31.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.561 0.696 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 113.56 3.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.398 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.47 4.11 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.3 mtt -90.62 130.89 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.7 mp -91.93 109.02 20.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.66 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.7 mm? -123.63 127.99 49.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m -97.78 119.45 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.42 -172.31 14.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.521 HG23 ' CD1' ' A' ' 251' ' ' TYR . 1.2 p -128.55 139.32 52.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.29 122.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -92.62 -40.43 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.98 156.09 32.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.28 125.15 51.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.87 150.97 34.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.767 ' O ' HD11 ' A' ' 230' ' ' LEU . 40.3 m-20 -70.17 -17.05 63.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -98.06 -25.77 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -172.27 -169.74 35.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 246' ' ' LEU . 82.6 m-85 -122.08 131.23 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.945 0.403 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.04 124.44 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.92 130.16 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.09 137.07 36.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 pt -123.44 -31.84 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.58 44.43 6.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.05 140.43 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.71 111.56 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.15 37.83 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 93.1 m -154.87 123.36 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 111.162 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.34 123.03 47.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.41 127.68 53.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 23.5 t80 -131.07 137.34 49.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.987 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.1 tp -109.29 128.61 25.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.73 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.76 143.42 50.77 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.767 HD11 ' O ' ' A' ' 212' ' ' ASP . 75.2 mt -62.99 -26.81 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.4 -40.46 95.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.854 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -83.13 -35.72 25.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.54 63.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -58.23 -35.32 71.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.7 -46.02 76.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.695 ' HB2' HG21 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -71.3 -36.93 71.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.983 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.852 HG12 HD21 ' A' ' 246' ' ' LEU . 21.7 mt -68.89 -38.92 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 2.7 ttm-85 -69.02 -41.18 78.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.5 -19.98 48.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 7.5 mmtp -101.82 -69.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.567 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 17.1 t-20 -84.16 33.52 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 241' ' ' ASN . 53.8 mttt 34.63 34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 77.75 73.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.484 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.567 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -151.3 124.4 8.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 244' ' ' ALA . 20.4 mmtm -37.22 144.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.852 HD21 HG12 ' A' ' 237' ' ' ILE . 13.8 mt -80.95 178.9 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.76 127.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 108.18 -27.24 14.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -63.44 148.0 49.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.521 ' CD1' HG23 ' A' ' 206' ' ' THR . 15.5 m-85 -81.03 127.28 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.3 tp -121.04 139.36 53.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -88.87 132.47 34.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.741 ' HB3' HD22 ' A' ' 268' ' ' LEU . 43.3 m -153.04 153.74 33.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 201' ' ' MET . 72.9 mt -136.8 143.75 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.48 121.45 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -101.62 -41.97 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -150.67 155.98 40.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.19 119.2 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 261' ' ' GLY . 35.6 tttp -86.42 135.03 33.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . 35.92 -149.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -120.35 72.5 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.81 24.04 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -95.46 -87.39 1.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.19 148.98 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.46 139.97 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.0 t -100.01 118.08 35.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 254' ' ' CYS . 16.4 mt -111.97 150.16 30.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 255' ' ' ILE . 1.4 t -146.28 146.98 30.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.854 HG22 ' HD2' ' A' ' 232' ' ' LYS . 28.9 m -74.7 136.16 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.882 0.373 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -153.22 148.16 19.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.85 10.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.05 6.19 6.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.0 mtt -89.78 127.71 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.4 mp -89.61 109.87 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -131.49 127.05 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m -84.13 119.66 25.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.94 163.84 12.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 251' ' ' TYR . 1.3 p -113.5 135.47 53.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.812 0.339 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.99 121.06 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 248' ' ' VAL . 41.8 t -86.17 -45.09 11.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 85.1 p -157.02 155.97 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.47 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.1 mp -101.63 129.22 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -116.31 151.88 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 230' ' ' LEU . 5.8 m-20 -71.05 -21.78 62.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -96.74 -17.19 20.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 179.55 -158.88 23.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.468 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.6 m-85 -131.29 135.8 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.921 0.391 . . . . 0.0 110.897 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.44 129.55 35.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.1 128.4 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.01 132.82 36.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.48 -19.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.18 57.68 5.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.86 139.79 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.79 94.23 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.26 39.38 0.87 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 85.5 m -156.98 131.59 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.63 123.76 48.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.02 122.99 47.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -124.84 142.42 51.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.683 HD12 ' HD2' ' A' ' 229' ' ' PRO . 19.7 tp -113.75 134.6 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.609 0.718 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.83 142.55 47.95 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 212' ' ' ASP . 79.1 mt -63.1 -22.2 66.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.91 -43.26 79.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.968 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.9 OUTLIER -81.76 -33.22 31.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -75.15 -51.87 12.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -60.26 -36.92 78.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.49 -41.57 98.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 4.9 t80 -73.25 -41.83 63.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 241' ' ' ASN . 47.0 mt -63.02 -39.85 86.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.6 ptm180 -69.77 -35.68 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 6.5 mm100 -81.4 -29.22 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 14.1 mmmt -107.99 -63.39 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.765 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.7 m-20 -80.73 21.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.9 mmtm 35.82 30.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.15 40.33 8.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -104.81 113.37 26.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -40.39 126.3 2.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 237' ' ' ILE . 15.4 mt -64.23 -175.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -137.31 -175.91 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 208' ' ' SER . 98.4 t -97.53 145.79 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.79 81.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.41 HE22 HD22 ' A' ' 246' ' ' LEU . 5.1 pt20 -82.86 148.01 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.436 ' HA ' HG22 ' A' ' 206' ' ' THR . 15.1 m-85 -80.95 128.66 33.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 12.5 tp -131.4 142.89 50.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -98.89 131.59 44.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.739 ' HB3' HD22 ' A' ' 268' ' ' LEU . 97.1 m -154.03 163.05 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.453 ' O ' HD23 ' A' ' 268' ' ' LEU . 70.0 mt -134.63 150.37 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.51 121.57 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 269' ' ' SER . 3.9 mp0 -104.75 -40.56 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -142.99 148.83 37.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.08 126.03 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.3 144.57 36.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.34 -65.52 3.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -86.71 37.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 46.98 36.39 8.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.04 -82.48 0.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.79 134.31 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 38.1 t -108.86 139.98 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 t -99.07 121.48 41.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 254' ' ' CYS . 11.5 mt -118.42 154.13 32.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.406 ' N ' ' OE1' ' A' ' 257' ' ' GLU . 36.4 t -154.05 152.41 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.84 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.968 HG22 ' HD2' ' A' ' 232' ' ' LYS . 20.2 m -80.09 139.99 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -134.39 151.48 76.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 121.2 7.89 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.368 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.25 5.28 3.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.1 mtt -96.42 133.59 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.324 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -85.43 116.28 23.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.0 mp -120.92 130.22 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.3 m -97.99 126.15 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -138.46 -177.12 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.509 HG23 ' CE1' ' A' ' 251' ' ' TYR . 12.5 p -121.69 141.29 51.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.93 120.04 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.8 t -86.18 -39.29 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.1 m -157.02 156.01 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 246' ' ' LEU . 6.9 mp -108.53 122.9 48.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.08 156.96 20.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.579 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.7 m-20 -75.35 -23.52 57.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -94.53 -22.17 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.5 -164.89 27.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.491 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 246' ' ' LEU . 75.0 m-85 -127.55 133.21 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.91 128.28 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.01 132.64 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.97 136.67 36.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 pt -127.4 -26.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.78 56.29 2.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.503 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 89.5 t -139.88 132.82 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.36 46.45 1.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 167.48 42.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.563 ' CG2' HG21 ' A' ' 266' ' ' VAL . 54.5 m -160.43 124.42 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -107.32 125.13 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.99 125.66 53.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.742 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.2 tp -104.3 132.06 21.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.742 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.3 Cg_endo -69.75 146.62 60.82 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.312 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 212' ' ' ASP . 23.7 mt -63.03 -26.58 68.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.41 -44.39 89.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 270' ' ' VAL . 26.9 mmtm -82.39 -41.89 19.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.76 -46.3 84.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -62.7 -38.82 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -65.44 -44.67 86.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CD1' ' HG3' ' A' ' 240' ' ' LYS . 83.5 t80 -70.13 -38.66 75.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 41.3 mt -69.21 -44.28 80.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.5 ptm180 -69.65 -37.44 76.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -81.52 -27.14 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CD1' ' A' ' 236' ' ' TYR . 7.2 mmpt? -107.75 -64.91 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.1 m120 -81.62 25.5 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ASN . 1.2 pmtp? 32.74 34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 102.31 -45.27 1.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -34.42 120.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -53.61 152.7 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.609 HD22 ' NE2' ' A' ' 250' ' ' GLN . 17.7 mt -76.3 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -132.12 129.82 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.8 t -46.67 131.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 105.73 -30.22 10.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.609 ' NE2' HD22 ' A' ' 246' ' ' LEU . 10.2 pt20 -62.93 147.97 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.942 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.509 ' CE1' HG23 ' A' ' 206' ' ' THR . 10.6 m-85 -81.02 130.21 34.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 145.06 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -94.28 129.05 41.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.964 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.782 ' HB3' HD22 ' A' ' 268' ' ' LEU . 63.7 m -148.43 151.99 36.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 201' ' ' MET . 38.5 mt -130.79 145.95 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 203' ' ' LEU . 6.2 t -70.29 122.58 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -105.5 -45.23 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -138.78 136.53 35.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 36.1 t -122.67 125.74 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 261' ' ' GLY . 34.7 ttpt -90.14 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -37.25 -60.06 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -93.44 174.34 7.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -80.66 51.76 4.3 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -77.18 -80.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.97 133.89 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 111.133 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 224' ' ' THR . 22.1 t -106.34 139.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.1 t -101.43 125.72 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 254' ' ' CYS . 45.6 mt -116.51 157.16 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 60.1 p -151.45 156.76 41.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 232' ' ' LYS . 41.7 t -78.19 131.85 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -160.8 154.22 18.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 126.37 13.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.676 2.25 . . . . 0.0 112.377 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 127.74 0.84 6.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.8 mtt -90.05 128.7 36.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.36 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.6 mp -89.46 117.33 28.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 203' ' ' LEU . 3.9 mp -130.79 128.96 41.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 31.6 m -85.02 124.33 31.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.86 169.25 20.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 251' ' ' TYR . 2.7 p -119.24 138.12 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.83 121.99 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.8 t -86.49 -42.01 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.437 ' HA ' HG22 ' A' ' 248' ' ' VAL . 1.8 t -157.04 156.3 32.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -106.75 125.13 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.91 154.89 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.633 ' O ' HD11 ' A' ' 230' ' ' LEU . 10.1 p-10 -72.81 -18.99 61.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -97.52 -30.41 12.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -165.13 -165.6 22.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -127.94 131.74 49.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.78 125.9 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.1 t -112.22 132.87 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -79.96 131.79 35.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 pt -124.05 -18.77 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.78 40.06 89.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.95 138.04 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.23 127.93 34.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.82 56.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.477 ' CG2' HG21 ' A' ' 266' ' ' VAL . 56.4 m -149.97 123.87 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -109.37 130.73 55.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -131.72 140.25 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.738 HD12 ' HD2' ' A' ' 229' ' ' PRO . 22.6 tp -114.99 133.17 22.69 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.738 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.76 145.24 56.59 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.3 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 212' ' ' ASP . 30.7 mt -63.38 -21.63 66.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.11 -44.7 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.824 ' HD2' HG22 ' A' ' 270' ' ' VAL . 17.5 tppt? -78.25 -30.69 48.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -77.01 -44.32 31.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -58.34 -33.4 69.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.58 -43.9 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 0.8 OUTLIER -72.89 -35.49 67.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 241' ' ' ASN . 39.8 mt -70.64 -40.9 77.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.182 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.486 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 16.2 ptt85 -69.52 -37.44 77.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -80.76 -39.14 27.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 63.3 mmtt -94.05 -57.58 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.637 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -81.99 23.26 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.1 OUTLIER 34.09 32.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.79 45.4 7.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -122.92 112.29 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.13 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -34.19 132.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.2 mt -65.44 -176.56 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.91 141.89 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 209' ' ' SER . 92.3 t -57.68 151.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.29 -21.49 6.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.36 148.53 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.413 ' HA ' HG22 ' A' ' 206' ' ' THR . 11.3 m-85 -85.01 128.31 34.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.0 tp -126.08 135.73 52.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -92.75 131.49 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 82.6 m -152.74 162.98 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.19 144.44 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 9.3 t -66.43 119.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -106.65 -46.91 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -132.26 136.02 46.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.15 132.84 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.4 ' CB ' ' H ' ' A' ' 265' ' ' VAL . 13.3 tptm -84.37 158.0 21.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -51.59 -94.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 263' ' ' GLY . 20.0 p-10 -73.67 64.13 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 36.57 42.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -66.47 -73.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.4 ' H ' ' CB ' ' A' ' 260' ' ' LYS . 75.5 t -133.87 133.44 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.364 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 224' ' ' THR . 19.0 t -105.15 137.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' SER . . . . . 0.755 ' C ' HD22 ' A' ' 268' ' ' LEU . 2.5 m -99.66 138.71 36.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 267' ' ' SER . 1.0 OUTLIER -121.05 148.35 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.3 p -151.75 141.87 22.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.824 HG22 ' HD2' ' A' ' 232' ' ' LYS . 33.7 m -79.45 141.82 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.53 ' N ' ' HE3' ' A' ' 201' ' ' MET . 49.7 mtmt -158.61 154.01 22.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.718 . . . . 0.0 110.84 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 107.26 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.722 2.282 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.69 7.01 3.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.558 ' HB3' HD11 ' A' ' 203' ' ' LEU . 8.6 mtt -92.8 132.66 36.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.41 112.22 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 201' ' ' MET . 2.1 mp -131.16 129.44 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.7 m -76.99 117.84 18.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -121.06 152.08 16.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -107.58 141.54 38.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.09 121.06 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.1 t -86.45 -46.13 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -157.07 156.42 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.23 126.9 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -115.21 156.41 25.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.659 ' O ' HD11 ' A' ' 230' ' ' LEU . 13.5 t70 -72.82 -24.04 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -87.96 -32.44 18.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.6 -159.55 18.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 246' ' ' LEU . 96.3 m-85 -125.19 139.92 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.32 130.83 44.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.97 146.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.55 129.68 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.506 HD11 ' CG2' ' A' ' 224' ' ' THR . 31.8 pt -121.76 -27.58 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.03 34.64 6.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.84 127.54 64.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.33 94.55 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.37 -33.47 0.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.506 ' CG2' HD11 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -92.66 151.04 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 111.163 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.78 121.09 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.14 127.62 54.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 6.2 t80 -132.09 137.03 47.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.49 HD23 ' HB2' ' A' ' 233' ' ' ALA . 11.1 tp -105.96 131.76 21.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 139.42 39.97 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.672 2.248 . . . . 0.0 112.321 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.659 HD11 ' O ' ' A' ' 212' ' ' ASP . 26.3 mt -63.11 -21.0 65.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 12.4 mt -70.79 -45.02 65.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.0 OUTLIER -81.87 -28.03 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.49 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -79.9 -49.13 12.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 33.3 tt0 -58.02 -44.38 87.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 236' ' ' TYR . 6.8 pt-20 -60.9 -40.43 93.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.652 ' CE1' HD11 ' A' ' 252' ' ' LEU . 1.2 t80 -73.12 -36.82 66.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 241' ' ' ASN . 31.1 mt -70.02 -40.95 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 4.8 ptm180 -69.1 -39.55 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -80.19 -19.93 45.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 19.0 mmmt -105.88 -67.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.72 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.5 t-20 -84.11 29.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.0 pttm 37.44 28.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.41 50.46 4.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.72 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -125.58 122.27 36.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.67 138.44 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.626 HD12 ' CD2' ' A' ' 215' ' ' TYR . 18.4 mt -71.99 -174.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -127.79 -174.93 3.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.91 144.16 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.98 3.52 11.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 251' ' ' TYR . 0.8 OUTLIER -66.66 144.87 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.883 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.481 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 23.7 m-85 -80.8 126.66 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 236' ' ' TYR . 6.0 tp -136.75 137.15 39.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.692 ' O ' HG12 ' A' ' 270' ' ' VAL . 21.5 t-20 -81.58 132.42 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 89.9 m -149.64 152.05 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.8 mt -137.08 146.44 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.4 t -74.24 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.33 -44.02 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -143.57 144.23 31.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.95 123.69 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -88.57 121.73 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 38.37 -143.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.468 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.26 63.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.92 0.391 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 138.53 35.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.83 -109.65 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.14 148.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.128 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.16 139.32 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.8 m -98.95 120.73 39.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 25.7 mt -115.57 151.95 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.5 t -155.81 151.89 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 253' ' ' ASN . 20.9 m -89.26 128.79 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.91 0.386 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HG2' ' CE ' ' A' ' 201' ' ' MET . 14.1 ptmt -170.26 142.4 1.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 115.79 4.26 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 2.248 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 129.6 9.78 3.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.465 ' CE ' ' HG2' ' A' ' 198' ' ' LYS . 64.5 mtm -98.1 135.73 39.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.693 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.4 mp -93.16 119.94 32.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.7 mp -131.87 135.07 46.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 m -99.84 121.52 41.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.66 174.17 19.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' CE1' ' A' ' 251' ' ' TYR . 1.5 p -118.37 136.29 53.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.193 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.57 127.83 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.176 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.7 t -92.27 -46.11 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.9 p -157.03 155.28 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 246' ' ' LEU . 7.4 mt -100.35 133.39 44.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.84 152.31 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -64.88 -23.02 67.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.66 -47.22 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -160.63 -165.07 16.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.643 ' CD1' HD22 ' A' ' 210' ' ' LEU . 45.0 m-85 -118.15 132.96 56.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -91.58 132.96 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.06 145.31 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -89.4 124.52 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 pt -121.88 -25.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.23 47.58 10.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.81 141.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -93.9 114.19 26.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 92.13 36.34 6.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.54 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.6 m -147.48 123.96 11.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -111.35 130.87 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.54 135.49 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 59.0 t80 -131.76 141.85 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.853 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -120.59 126.58 26.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.853 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.77 131.04 20.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 215' ' ' TYR . 21.4 mt -63.2 -21.64 66.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.91 -45.11 87.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.888 ' HD3' HG12 ' A' ' 270' ' ' VAL . 0.0 OUTLIER -70.45 -37.84 74.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.464 ' N ' ' HG3' ' A' ' 232' ' ' LYS . . . -75.34 -26.62 58.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -64.98 -31.67 73.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.11 -44.69 52.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.4 t80 -73.05 -37.65 66.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.643 HG21 ' O ' ' A' ' 244' ' ' ALA . 51.7 mt -70.02 -41.87 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.2 ptm180 -67.12 -40.2 86.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 74.9 mm-40 -80.15 -19.95 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.513 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 64.9 mmtt -103.94 -68.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.85 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.7 t-20 -84.17 33.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 241' ' ' ASN . 74.3 mttt 34.48 32.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.94 69.16 1.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.85 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -137.55 -177.25 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -92.66 154.04 18.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.725 ' O ' HD11 ' A' ' 210' ' ' LEU . 19.1 mt -89.95 152.55 21.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.0 140.18 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.7 135.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 93.97 -18.34 56.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -63.06 148.07 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.89 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.2 m-85 -80.85 127.05 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.25 138.24 53.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.7 136.56 32.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 88.8 m -151.18 163.02 39.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.1 mt -136.17 145.5 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 5.9 t -68.02 122.31 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.22 -43.92 5.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -144.77 145.08 31.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.9 129.14 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -103.86 127.24 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -43.74 167.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 263' ' ' GLY . 7.2 p-10 45.43 37.27 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 37.34 47.58 1.53 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.54 -85.11 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 48.9 t -121.94 136.84 57.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 111.149 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.2 137.76 38.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' SER . . . . . 0.504 ' C ' HD22 ' A' ' 268' ' ' LEU . 1.8 t -102.11 122.41 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.556 ' O ' HD22 ' A' ' 228' ' ' LEU . 0.3 OUTLIER -114.33 142.87 45.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.3 m -156.97 145.76 19.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.888 HG12 ' HD3' ' A' ' 232' ' ' LYS . 7.2 p -83.51 123.53 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.512 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.638 ' C ' HG21 ' A' ' 259' ' ' VAL . 48.5 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.824 0.345 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -123.49 145.16 46.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 136.28 32.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.649 2.233 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 121.59 -29.28 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.5 mtt -61.45 132.15 52.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.671 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.3 mp -100.57 108.0 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.671 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.1 mm? -121.55 132.76 54.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.4 m -89.0 120.01 30.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.95 166.22 12.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.36 56.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.18 121.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -89.23 -44.69 10.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.5 m -156.99 151.09 24.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.72 123.51 40.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -112.0 158.6 19.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.81 -21.55 57.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -92.86 -20.11 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 175.3 -171.64 44.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 246' ' ' LEU . 89.0 m-85 -112.23 131.6 55.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.907 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.01 129.35 34.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.45 138.53 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.81 134.79 34.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.07 -21.14 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.22 54.87 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -148.38 138.53 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.22 125.66 36.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.87 -49.9 0.94 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 47.1 m -76.37 124.25 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 225' ' ' ARG . 4.3 ptp180 -116.53 127.99 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.01 128.75 56.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.559 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 8.0 t80 -124.75 136.35 53.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 229' ' ' PRO . 7.2 tp -105.74 130.83 22.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.826 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.75 145.14 56.29 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.299 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 22.4 mt -63.03 -19.2 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -44.77 88.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -81.16 -28.91 34.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 215' ' ' TYR . . . -73.12 -47.17 46.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -62.89 -38.36 90.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.35 -44.54 87.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.661 ' HB2' HG21 ' A' ' 270' ' ' VAL . 11.3 t80 -72.04 -41.23 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 241' ' ' ASN . 40.9 mt -69.26 -41.03 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.491 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 21.8 ptt180 -70.05 -35.96 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.07 -36.17 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.468 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 27.4 mmtp -98.92 -58.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.656 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m-20 -80.51 19.82 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm 38.25 26.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.53 44.36 5.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.509 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -102.7 -179.01 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -104.02 119.45 38.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.666 HD12 ' CE1' ' A' ' 215' ' ' TYR . 21.8 mt -62.14 -179.9 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -136.07 -175.53 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.87 149.43 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 67.16 14.98 64.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -87.52 148.06 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -81.05 128.54 33.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 236' ' ' TYR . 10.4 tp -133.07 145.13 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.62 136.08 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.5 m -153.99 163.02 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.3 mt -136.92 150.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.6 t -70.43 125.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -103.14 -46.73 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -145.42 146.61 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 197' ' ' LEU . 14.6 t -123.96 132.4 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 3.1 tppp? -78.73 150.51 32.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -35.96 -38.81 0.24 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.449 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -125.85 -176.54 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -76.07 48.21 2.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -80.31 -84.87 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.2 134.35 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 139.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.5 t -98.96 120.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 40.8 mt -111.71 154.46 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 23.2 p -152.68 141.97 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.852 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 236' ' ' TYR . 21.1 m -73.12 134.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.502 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -146.1 144.72 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 129.66 18.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.6 -1.34 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.75 140.5 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.6 mp -102.44 113.29 26.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.66 133.07 53.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -95.63 120.47 35.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.54 -169.93 12.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.0 p -131.96 137.91 48.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.354 . . . . 0.0 111.16 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.46 127.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.5 t -96.03 -40.59 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.6 m -154.93 156.02 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.8 mm? -100.33 110.22 22.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.32 139.1 31.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.506 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -63.06 -16.41 59.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -97.76 -36.74 10.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -159.58 -150.64 5.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 1.099 ' CE2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.13 132.14 41.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.911 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.9 131.4 37.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.82 145.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -92.52 128.97 38.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.56 -31.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.8 50.84 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.492 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.79 151.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.106 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 222' ' ' ASP . 3.1 t0 -92.65 110.64 22.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.73 55.59 2.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 87.7 m -156.03 122.97 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 0.0 111.191 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 266' ' ' VAL . 68.8 mtt180 -116.13 129.47 56.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -119.77 128.98 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 16.0 t80 -131.97 135.01 46.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.832 HD13 ' N ' ' A' ' 229' ' ' PRO . 1.4 tm? -107.76 127.03 28.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.832 ' N ' HD13 ' A' ' 228' ' ' LEU . 53.5 Cg_endo -69.79 128.99 16.8 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.67 2.246 . . . . 0.0 112.346 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.656 HD23 ' HE1' ' A' ' 215' ' ' TYR . 18.4 mt -58.05 -22.05 48.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.6 mt -64.83 -45.03 87.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -83.44 -30.52 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -68.07 -36.21 79.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.94 -39.29 94.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -62.41 -43.81 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.568 ' CE2' ' HE3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -73.14 -47.07 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.807 HG12 HD21 ' A' ' 246' ' ' LEU . 34.8 mt -61.15 -49.4 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.48 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.6 ptm180 -58.1 -43.17 86.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.479 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 8.4 mm100 -80.36 -19.89 45.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 2.0 mmmp? -100.9 -75.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.2 t-20 -80.66 41.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER 33.28 34.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 75.45 54.16 5.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -131.66 120.27 22.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -33.85 146.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 1.099 HD12 ' CE2' ' A' ' 215' ' ' TYR . 11.8 mt -78.14 179.63 6.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -123.33 171.05 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 75.3 t -92.54 139.83 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.33 -20.58 36.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -63.07 148.06 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.97 127.17 32.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.12 140.27 52.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.71 136.18 45.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 96.9 m -151.51 162.89 40.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.18 140.62 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.5 t -69.1 120.89 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.27 -39.7 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -144.81 141.64 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.1 t -120.66 130.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -82.25 145.7 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.33 -69.62 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.512 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.26 39.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 38.58 34.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.517 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.11 -53.53 25.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.66 143.52 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 225' ' ' ARG . 43.2 t -126.95 140.07 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' SER . . . . . 0.862 ' C ' HD22 ' A' ' 268' ' ' LEU . 4.3 t -98.98 142.08 30.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.862 HD22 ' C ' ' A' ' 267' ' ' SER . 1.2 mm? -123.82 143.64 50.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 p -143.07 152.69 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 236' ' ' TYR . 58.6 t -79.16 141.51 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.078 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.493 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -119.59 149.24 47.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 0.0 110.895 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 256' ' ' VAL . 53.8 Cg_endo -69.78 116.87 4.76 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.43 -9.83 3.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.719 ' O ' HG23 ' A' ' 255' ' ' ILE . 11.8 mtt -79.74 140.6 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.763 0.316 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.51 122.17 36.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 256' ' ' VAL . 4.5 mp -131.25 125.23 32.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 m -92.51 119.09 31.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.63 16.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 p -118.23 139.8 50.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.484 HG11 HD21 ' A' ' 210' ' ' LEU . 61.9 t -60.99 134.59 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.9 t -109.91 -33.88 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.43 ' C ' HD23 ' A' ' 210' ' ' LEU . 1.8 t -157.03 156.12 32.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.83 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 215' ' ' TYR . 10.0 mt -113.86 137.6 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.01 164.95 19.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.777 ' O ' HD11 ' A' ' 230' ' ' LEU . 6.1 p-10 -79.69 -26.49 40.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.519 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 3.6 p80 -93.59 -17.7 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.476 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -177.75 -162.1 27.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.785 ' CE1' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.94 139.93 46.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.926 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.85 130.5 34.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.32 131.59 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.59 134.69 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.2 pt -125.1 -21.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.92 7.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.36 135.7 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -88.68 107.24 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.92 36.93 4.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.5 m -153.01 125.31 8.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.103 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -114.08 131.75 56.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -118.22 134.89 54.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.476 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.3 t80 -127.17 140.4 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.897 HD12 ' HD2' ' A' ' 229' ' ' PRO . 24.9 tp -113.76 130.35 23.88 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.897 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.68 146.59 61.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.268 . . . . 0.0 112.364 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.3 mt -62.14 -19.9 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.77 -44.71 95.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -41.47 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -65.11 -48.51 73.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 12.4 tt0 -62.96 -37.73 88.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.91 -42.4 90.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.533 ' CD2' ' HD3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -72.91 -38.92 66.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.961 HD11 HD11 ' A' ' 246' ' ' LEU . 66.0 mt -69.28 -40.5 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 14.3 ptm180 -70.23 -35.33 73.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -79.98 -40.43 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.533 ' HD3' ' CD2' ' A' ' 236' ' ' TYR . 0.0 OUTLIER -93.91 -55.39 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 237' ' ' ILE . 10.5 t-20 -81.43 19.12 1.03 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 241' ' ' ASN . 51.5 mttt 38.06 27.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.99 67.5 1.44 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -146.35 151.47 37.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 111.152 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.47 154.91 2.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.961 HD11 HD11 ' A' ' 237' ' ' ILE . 66.8 mt -95.72 171.37 8.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.89 133.05 47.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.09 136.06 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.48 -23.19 34.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.447 ' OE1' HD22 ' A' ' 246' ' ' LEU . 1.7 pt20 -63.19 148.0 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.915 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.11 127.05 32.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.8 tp -127.61 137.1 52.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -84.42 131.58 34.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.585 ' HB3' HD22 ' A' ' 268' ' ' LEU . 32.3 m -145.99 153.54 40.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 201' ' ' MET . 15.2 mt -135.45 147.01 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 199' ' ' PRO . 40.0 t -66.93 124.52 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -105.65 -44.42 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -146.79 161.22 41.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.3 130.08 75.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -108.54 117.48 34.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -46.39 157.04 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.518 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 m120 58.87 25.46 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.912 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.47 45.75 4.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -74.57 -72.27 1.04 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.04 134.43 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.46 136.2 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.2 t -100.82 116.02 31.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.657 HD12 ' HB1' ' A' ' 226' ' ' ALA . 18.5 mt -115.69 156.68 25.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 255' ' ' ILE . 82.3 p -152.53 142.1 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 p -82.58 143.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -158.88 152.4 19.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 132.83 24.09 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 120.52 -10.7 10.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.483 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.4 mtt -73.94 127.58 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.7 mp -88.74 113.52 24.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 202' ' ' LEU . 18.5 mt -129.69 134.92 47.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.46 117.03 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -120.12 154.85 16.33 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.9 p -104.85 132.86 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.03 120.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.2 t -86.0 -46.01 10.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.1 p -156.76 155.85 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 215' ' ' TYR . 8.7 mt -102.92 139.0 39.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.1 161.65 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.485 ' O ' HD11 ' A' ' 230' ' ' LEU . 55.2 m-20 -72.54 -19.05 61.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -93.35 -39.51 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -166.39 -162.04 16.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.817 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.8 m-85 -120.58 130.34 54.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.929 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.42 133.94 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.2 t -115.95 139.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 -8.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.45 52.78 24.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.506 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.8 t -146.82 134.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -87.18 109.76 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.92 -49.17 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.607 ' CG2' HG21 ' A' ' 266' ' ' VAL . 48.6 m -68.21 124.1 22.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -111.3 131.17 55.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.22 134.79 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 36.7 t80 -131.81 143.41 50.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.915 HD12 ' HB2' ' A' ' 233' ' ' ALA . 0.3 OUTLIER -113.7 126.22 28.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.955 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.743 ' HD2' HD13 ' A' ' 228' ' ' LEU . 53.9 Cg_endo -69.73 129.13 17.09 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.6 mt -62.94 -14.91 52.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.79 -45.06 53.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -83.17 -36.84 24.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -64.78 -31.49 72.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -64.39 -41.19 96.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -63.64 -43.43 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 240' ' ' LYS . 18.3 t80 -72.1 -37.56 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 241' ' ' ASN . 76.5 mt -69.43 -45.82 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.2 ptp180 -61.47 -40.94 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -80.06 -21.17 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 236' ' ' TYR . 29.0 mmtm -99.44 -71.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 237' ' ' ILE . 17.2 t-20 -83.75 35.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' ASN . 25.5 mtpp 36.41 30.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.52 73.95 1.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -158.3 153.95 26.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 162.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 215' ' ' TYR . 59.0 mt -95.31 -178.1 4.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 247' ' ' LYS . 3.4 mppt? -116.77 174.9 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.5 t -102.04 144.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.82 -6.09 20.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.79 147.94 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -80.99 127.24 32.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.7 tp -128.64 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -97.67 124.25 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -142.64 163.06 33.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 271' ' ' GLY . 91.6 mt -137.07 138.44 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.25 120.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -105.81 -33.5 7.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -144.0 133.45 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.98 132.08 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -87.41 157.64 19.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -68.1 -65.21 2.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.68 41.33 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.3 37.24 1.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -62.22 -74.74 0.37 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.77 135.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.607 HG21 ' CG2' ' A' ' 224' ' ' THR . 8.4 t -105.97 139.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' SER . . . . . 0.773 ' C ' HD22 ' A' ' 268' ' ' LEU . 7.5 m -100.39 139.54 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 267' ' ' SER . 1.1 mm? -121.19 153.0 38.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 255' ' ' ILE . 45.8 p -159.9 141.97 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.93 133.9 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.457 ' O ' HD11 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -161.21 149.65 12.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.867 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 108.84 2.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.72 -5.82 3.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 255' ' ' ILE . 14.3 mtm -86.83 142.69 27.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.05 125.34 44.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 203' ' ' LEU . 4.5 mp -132.01 125.95 32.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -98.04 119.5 36.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.16 -165.18 11.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.1 p -129.92 138.75 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 128.54 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.1 t -87.8 -45.99 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.1 m -156.91 155.95 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.564 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.4 mm? -92.67 112.89 25.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.28 143.25 26.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.74 -19.13 65.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.49 -29.96 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -166.64 -155.68 9.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.557 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.959 ' CE2' HD12 ' A' ' 246' ' ' LEU . 89.8 m-85 -125.49 125.85 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 110.897 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.39 133.94 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.01 141.56 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.79 131.44 34.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.1 pt -127.28 -29.42 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.44 41.09 21.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.443 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.4 t -121.78 144.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 111.074 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.75 108.09 20.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.35 33.79 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 95.8 m -143.6 123.13 13.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -116.07 120.49 39.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -115.95 134.36 55.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.8 t80 -132.0 144.0 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.855 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -113.67 126.9 27.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 110.926 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.855 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 136.15 32.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.499 HD23 ' HE1' ' A' ' 215' ' ' TYR . 31.9 mt -62.9 -24.35 67.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.79 -42.24 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.57 -39.25 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -61.0 -48.66 80.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -58.58 -37.97 76.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -64.25 -42.52 96.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.701 ' CD2' HG11 ' A' ' 270' ' ' VAL . 3.0 t80 -73.03 -40.02 65.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 241' ' ' ASN . 24.3 mt -68.1 -40.03 82.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.3 ptm180 -69.92 -37.98 76.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -81.38 -27.36 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 66.9 mmtt -107.38 -63.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.726 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.4 m120 -81.37 24.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.0 mtpt 34.77 31.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.79 44.54 7.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -112.91 113.48 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -41.51 125.74 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.959 HD12 ' CE2' ' A' ' 215' ' ' TYR . 16.2 mt -58.94 -175.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -144.17 152.12 40.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.7 t -67.08 143.56 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.95 -21.06 16.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 252' ' ' LEU . 0.9 OUTLIER -65.49 148.32 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.954 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -80.97 133.04 35.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.444 ' HB2' ' NE2' ' A' ' 250' ' ' GLN . 24.2 tp -134.48 135.09 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.31 136.5 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.716 ' HB3' HD22 ' A' ' 268' ' ' LEU . 37.8 m -148.55 151.35 34.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' MET . 90.3 mt -131.52 138.69 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.73 123.71 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -106.82 -45.62 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -134.37 148.86 50.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 63.1 t -119.27 126.74 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.25 118.53 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -40.79 -56.88 2.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 263' ' ' GLY . 28.1 t30 -85.69 35.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.59 42.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -76.14 -74.21 0.95 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.6 130.99 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.19 139.95 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.1 t -99.38 120.75 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.801 HD12 ' HB1' ' A' ' 226' ' ' ALA . 27.9 mt -116.3 152.14 34.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 58.2 m -146.8 147.71 31.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 236' ' ' TYR . 44.9 t -73.79 127.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -110.14 148.51 38.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.711 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 116.93 4.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.84 -2.92 7.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 255' ' ' ILE . 34.3 mtt -68.07 141.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 203' ' ' LEU . 5.4 mp -87.23 111.04 20.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.9 mm? -124.74 137.86 54.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.4 m -112.64 125.38 54.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.32 161.01 25.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.426 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 251' ' ' TYR . 4.0 p -103.57 140.08 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.5 122.38 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.5 t -87.56 -43.36 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.1 m -156.81 155.77 32.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.58 123.73 44.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.56 147.57 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -65.09 -27.42 68.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -90.6 -32.41 16.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -164.62 -159.19 10.9 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.929 ' CE1' HD12 ' A' ' 246' ' ' LEU . 94.6 m-85 -125.71 129.51 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.01 134.05 33.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.98 142.2 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.45 124.11 33.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.94 -27.39 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.03 40.69 10.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 64.9 t -128.59 142.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.127 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.51 126.63 38.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 98.99 -48.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.6 m -69.13 123.23 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -114.97 129.69 56.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.11 128.98 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.565 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 27.4 t80 -131.85 134.34 45.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.846 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -109.21 126.4 29.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.846 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.74 133.77 26.42 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 215' ' ' TYR . 48.9 mt -61.2 -21.86 64.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 -44.99 85.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HD2' HG22 ' A' ' 270' ' ' VAL . 1.6 tmtp? -77.5 -31.54 53.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.9 -39.77 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -59.43 -33.87 71.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.33 -45.85 75.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.666 ' HB2' HG21 ' A' ' 270' ' ' VAL . 1.9 t80 -72.3 -38.04 68.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.623 HG23 ' HB2' ' A' ' 241' ' ' ASN . 51.6 mt -69.79 -42.45 80.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 17.9 ptt180 -69.77 -36.56 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -81.39 -34.74 31.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.551 ' HG3' ' CD2' ' A' ' 236' ' ' TYR . 1.2 mmmp? -99.66 -60.03 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 244' ' ' ALA . 8.6 m-20 -80.81 21.32 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 238' ' ' ARG . 8.8 mmmm 36.99 28.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.97 46.88 4.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.46 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -106.25 177.56 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -100.12 137.59 38.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.929 HD12 ' CE1' ' A' ' 215' ' ' TYR . 23.5 mt -73.43 162.37 29.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -128.38 149.68 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.19 150.57 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.82 3.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.53 148.32 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.553 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.8 m-85 -80.94 129.87 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.85 140.77 52.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.518 ' O ' HG12 ' A' ' 270' ' ' VAL . 3.7 p30 -87.62 128.33 35.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.749 ' HB3' HD22 ' A' ' 268' ' ' LEU . 83.9 m -147.14 149.8 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 201' ' ' MET . 79.8 mt -134.54 139.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 200' ' ' GLY . 30.7 t -62.71 119.05 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -97.05 -40.04 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -153.62 152.94 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -123.22 127.96 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.41 178.01 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.69 -74.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 263' ' ' GLY . 1.4 m120 -80.12 45.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.72 37.98 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.97 5.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 146.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 27.8 t -113.33 139.33 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.9 t -99.3 118.57 36.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 254' ' ' CYS . 12.2 mt -120.88 146.98 46.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 5.6 p -147.09 145.47 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 236' ' ' TYR . 27.3 m -76.87 122.57 31.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.096 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.9 0.381 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -140.05 151.47 65.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.2 20.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 113.29 -6.12 25.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.533 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.7 mtt -67.85 138.83 56.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 202' ' ' LEU . 3.9 mp -94.44 110.13 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 202' ' ' LEU . 23.7 mt -131.13 141.65 50.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -111.56 124.63 52.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.24 -174.75 13.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.7 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.03 120.69 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 t -86.47 -41.87 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 56.4 p -156.4 156.0 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 248' ' ' VAL . 9.5 mp -105.01 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -115.34 145.21 42.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.771 ' O ' HD11 ' A' ' 230' ' ' LEU . 24.1 m-20 -67.48 -17.87 64.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -97.24 -20.05 18.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.95 -166.78 34.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 246' ' ' LEU . 85.0 m-85 -125.79 132.95 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.616 HD12 ' NH2' ' A' ' 225' ' ' ARG . 1.5 mm? -88.85 132.17 34.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.897 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.15 135.17 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.1 126.97 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 pt -119.01 -18.56 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.02 43.13 8.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.55 127.29 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.107 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.91 130.33 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.64 -43.41 1.76 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.8 m -73.92 132.0 42.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.787 0.327 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.616 ' NH2' HD12 ' A' ' 216' ' ' LEU . 6.9 tpm_? -109.33 123.18 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.96 126.92 55.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 9.0 t80 -132.01 139.21 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 229' ' ' PRO . 15.3 tp -112.73 133.41 21.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.0 Cg_endo -69.72 139.49 40.48 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.771 HD11 ' O ' ' A' ' 212' ' ' ASP . 84.1 mt -63.11 -25.08 68.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.57 -45.05 73.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -78.09 -33.14 50.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.15 63.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.45 -35.67 72.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.98 -42.92 99.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.3 OUTLIER -72.47 -37.74 68.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.893 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 244' ' ' ALA . 32.7 mt -66.97 -39.11 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.5 ttt180 -69.2 -41.29 77.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -79.49 -20.3 47.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 47.1 mmtt -101.5 -69.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.681 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.7 t-20 -83.85 35.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 38.9 mmtt 34.65 32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.37 68.49 1.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.5 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.76 169.24 18.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 146.98 50.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 215' ' ' TYR . 80.0 mt -87.67 178.25 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -132.95 153.14 51.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 210' ' ' LEU . 37.1 t -78.01 134.4 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.065 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.1 -22.36 39.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.449 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -64.54 148.04 51.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.05 128.47 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 252' ' ' LEU . 6.7 tp -123.09 142.9 50.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -92.43 130.51 38.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.681 ' HB3' HD22 ' A' ' 268' ' ' LEU . 95.1 m -154.91 153.0 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 201' ' ' MET . 96.6 mt -133.63 139.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.52 125.14 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -103.5 -45.82 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -142.51 158.37 43.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.25 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.45 136.57 36.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.7 -66.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.546 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 263' ' ' GLY . 19.1 t-20 -84.53 45.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.24 36.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -68.76 -86.63 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.88 144.26 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.53 140.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.6 t -98.96 118.13 35.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.2 mt -116.72 149.62 39.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 75.4 m -156.91 142.03 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 253' ' ' ASN . 17.4 t -71.89 142.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.529 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.875 0.369 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -129.95 148.93 71.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 110.937 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 120.27 7.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 134.65 -12.02 4.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.576 ' O ' HG23 ' A' ' 255' ' ' ILE . 15.0 mtt -80.97 140.38 35.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.614 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -95.2 120.5 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.1 mp -130.54 125.36 34.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.5 m -94.39 120.41 34.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.76 -174.43 14.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.3 p -123.55 142.38 51.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.116 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.09 120.4 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.3 t -85.16 -41.8 15.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -157.03 155.05 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.561 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 mm? -95.08 107.49 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -94.13 149.38 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.425 ' O ' HD11 ' A' ' 230' ' ' LEU . 26.7 t70 -72.55 -31.09 65.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -84.24 -28.75 27.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -168.96 -158.75 13.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' TYR . . . . . 0.662 ' CD1' HD12 ' A' ' 246' ' ' LEU . 97.0 m-85 -123.02 131.62 53.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 226' ' ' ALA . 3.1 mm? -86.04 129.83 34.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.37 134.02 56.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.09 137.07 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.8 pt -126.27 -30.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.88 55.24 2.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 222' ' ' ASP . 25.2 t -140.18 155.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -101.23 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.36 44.19 6.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.534 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.0 m -144.18 131.5 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.338 . . . . 0.0 111.139 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -115.62 125.9 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -121.9 122.19 38.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 17.6 t80 -125.52 140.52 52.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 229' ' ' PRO . 12.2 tp -110.28 129.79 23.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.658 0.742 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.3 Cg_endo -69.74 135.26 30.07 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 212' ' ' ASP . 39.0 mt -63.1 -23.82 67.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.77 -45.18 87.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.936 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.4 tppp? -85.12 -32.8 22.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.43 80.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -58.65 -34.01 70.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.87 -43.79 91.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t80 -72.83 -42.17 64.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 241' ' ' ASN . 22.6 mt -68.13 -40.78 83.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.485 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 11.8 ptm180 -70.11 -35.78 74.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -81.19 -34.59 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 24.0 mmtp -100.75 -59.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.704 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -80.31 19.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.52 26.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.1 46.68 4.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.78 116.33 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -38.21 133.13 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.662 HD12 ' CD1' ' A' ' 215' ' ' TYR . 49.6 mt -69.97 171.28 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -126.14 175.44 7.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 210' ' ' LEU . 42.7 t -92.15 132.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.19 -27.56 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.528 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -63.2 147.88 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -81.03 126.99 32.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.72 138.3 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -85.63 135.12 33.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.2 m -156.33 154.58 30.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 201' ' ' MET . 43.2 mt -134.4 142.16 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.21 119.35 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.67 -46.4 5.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -150.15 158.39 44.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -120.54 129.38 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.32 156.54 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -70.09 159.58 53.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 48.21 34.97 4.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 42.18 36.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.07 -81.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.61 146.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.7 t -113.44 138.8 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.6 t -100.78 117.76 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.7 mt -116.69 157.69 25.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' ILE . 73.0 p -154.72 142.0 19.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 232' ' ' LYS . 32.9 m -72.31 132.14 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.1 m -125.29 142.23 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.2 m -69.54 171.13 9.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.83 137.45 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 p -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.7 p -62.04 133.05 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.75 -106.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -82.09 172.54 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.1 154.1 24.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.04 -57.12 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -118.6 112.96 20.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -52.27 147.42 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 192' ' ' LEU . 74.3 t -100.77 -42.85 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 192' ' ' LEU . 3.9 pp 33.69 46.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.4 m -94.22 146.23 24.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -46.6 -28.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -88.54 -28.53 20.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.7 64.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.2 mt -47.99 154.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -134.01 146.37 59.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.547 0.689 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 115.17 3.97 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.683 2.256 . . . . 0.0 112.361 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 139.76 -11.04 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.595 ' HB3' HD11 ' A' ' 203' ' ' LEU . 19.1 mtt -73.77 132.7 42.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.0 mp -93.14 113.59 25.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 203' ' ' LEU . 2.0 mp -130.88 134.13 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.787 HG21 HG22 ' A' ' 277' ' ' THR . 6.0 m -83.12 118.12 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -114.73 160.55 13.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.0 p -122.53 137.07 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.21 120.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.0 t -86.27 -45.53 11.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.1 m -156.99 156.01 32.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' A' ' 215' ' ' TYR . 1.2 mm? -91.5 124.31 35.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -107.89 164.83 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -22.78 35.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.534 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 4.0 p80 -98.09 -20.68 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -179.95 -149.28 8.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.577 ' HD2' HD13 ' A' ' 210' ' ' LEU . 27.0 m-85 -133.99 138.4 45.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.973 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 132.85 33.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.95 129.45 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.97 126.89 31.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.8 pt -119.95 -20.06 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.51 51.99 4.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.75 141.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.01 116.59 28.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 104.05 -42.85 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.518 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.5 m -74.44 125.42 28.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -114.74 132.09 56.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.93 124.54 51.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 5.5 t80 -123.27 143.39 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 268' ' ' LEU . 14.2 tp -113.29 134.55 21.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.477 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.85 144.45 53.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.303 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 17.4 mt -63.03 -26.44 68.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.6 -44.18 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -82.19 -42.09 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -64.57 -48.95 73.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 36.0 tt0 -62.85 -33.99 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.68 -42.65 91.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE1' ' CD1' ' A' ' 252' ' ' LEU . 3.9 t80 -72.29 -37.36 69.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.686 HG12 HD21 ' A' ' 246' ' ' LEU . 30.6 mt -69.66 -47.27 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.3 ptp180 -59.45 -40.52 87.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -79.98 -21.55 43.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 236' ' ' TYR . 37.4 mmtm -99.14 -72.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.77 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.0 t-20 -83.69 35.85 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 241' ' ' ASN . 20.2 mtpp 34.44 33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 81.47 70.64 1.33 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.77 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -148.25 137.69 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 111.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -44.52 147.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.712 HD22 HE22 ' A' ' 250' ' ' GLN . 69.1 mt -86.34 -175.09 5.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -122.55 176.75 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 147.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.26 24.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.712 HE22 HD22 ' A' ' 246' ' ' LEU . 4.3 pt20 -72.07 148.01 46.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -81.0 126.97 32.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.513 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 15.4 tp -136.66 135.97 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -76.07 134.43 40.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.639 ' HB3' HD22 ' A' ' 268' ' ' LEU . 73.9 m -152.64 144.85 23.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.641 HD12 ' HA3' ' A' ' 271' ' ' GLY . 65.2 mt -133.77 138.9 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.96 119.44 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -106.48 -30.49 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -151.78 149.85 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.05 133.09 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -84.35 150.99 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -60.39 -67.61 2.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -88.13 41.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 44.15 42.74 6.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.63 -73.12 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.447 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.23 136.87 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 42.3 t -104.28 139.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 114.03 26.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 254' ' ' CYS . 17.1 mt -111.76 149.45 31.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.6 m -149.12 150.43 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.12 118.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.641 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . -125.91 -48.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -172.76 158.38 3.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.847 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 35.2 p -90.78 177.06 6.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -156.86 143.1 18.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 93.6 t -51.97 -45.05 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 28.9 t -54.92 112.23 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' THR . . . . . 0.787 HG22 HG21 ' A' ' 204' ' ' THR . 50.5 p -154.09 134.83 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -129.06 139.36 52.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 30.3 mt -87.89 149.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -125.04 84.29 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.068 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 283' ' ' GLN . 22.9 m -140.98 134.11 29.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.06 -26.09 14.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.489 ' O ' ' CG2' ' A' ' 281' ' ' THR . 3.3 pm0 -149.89 172.81 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -99.55 111.56 23.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 36.5 m -165.12 128.7 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -149.23 150.41 32.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -108.53 113.05 25.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 34.5 tp -107.4 113.95 27.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -128.83 120.68 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -78.62 79.78 5.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 291' ' ' LEU . 2.1 tt -103.22 136.78 42.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.3 m -124.69 168.96 12.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -172.91 -169.99 36.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 149.1 66.69 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.1 t -173.43 142.03 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.5 m -116.64 141.52 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.0 m -141.58 126.91 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 55.7 m -119.91 146.71 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.819 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -156.7 42.35 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.5 m -62.23 113.3 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.849 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 m -126.67 109.9 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.825 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.43 -78.23 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -88.35 156.86 18.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -68.29 100.65 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.3 m -80.03 152.92 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 42.87 39.85 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.76 142.02 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.45 47.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.606 ' C ' HD23 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -94.32 -42.11 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.581 ' N ' HD23 ' A' ' 192' ' ' LEU . 18.8 p -84.82 146.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.17 -31.24 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.1 -44.5 88.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.69 86.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.096 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.2 mt -40.05 155.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.44 ' H ' ' CE ' ' A' ' 201' ' ' MET . 3.5 mptt -108.21 147.65 36.0 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.894 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 140.87 43.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 103.76 7.22 42.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.44 ' CE ' ' H ' ' A' ' 198' ' ' LYS . 47.4 mtt -80.66 139.26 36.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.5 mp -88.84 108.62 19.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 202' ' ' LEU . 4.4 mp -124.28 150.98 44.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.3 m -117.48 117.06 28.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -119.65 -172.63 15.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.45 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 251' ' ' TYR . 7.6 p -129.02 139.62 51.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 111.138 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.18 120.41 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.9 t -86.41 -38.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.5 p -157.0 155.75 31.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.64 123.96 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.76 168.28 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.863 ' O ' HD11 ' A' ' 230' ' ' LEU . 7.4 p-10 -85.99 -24.19 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -92.02 -14.56 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . 175.82 -167.44 39.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.09 137.07 53.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 128.59 36.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.5 135.55 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -86.55 135.71 33.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.74 -13.49 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.81 50.71 23.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 222' ' ' ASP . 38.4 t -134.49 155.97 39.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.127 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 221' ' ' VAL . 13.8 t70 -102.14 122.26 43.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.73 36.95 17.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 42.5 m -151.65 123.59 8.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -114.17 131.37 56.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.04 135.32 53.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 9.1 t80 -129.76 142.74 50.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.882 HD12 ' HD2' ' A' ' 229' ' ' PRO . 10.3 tp -113.99 133.44 22.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.882 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.71 143.22 50.35 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.863 HD11 ' O ' ' A' ' 212' ' ' ASP . 25.6 mt -62.67 -22.92 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.34 -44.23 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -83.25 -33.21 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.0 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.23 -42.2 99.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.69 -41.45 96.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.546 ' HB2' HG21 ' A' ' 270' ' ' VAL . 2.4 t80 -72.41 -40.05 67.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 241' ' ' ASN . 43.5 mt -68.09 -43.01 85.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 8.1 ptm180 -66.61 -40.3 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 37.8 mm-40 -79.96 -20.15 46.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 21.4 mmtm -101.31 -69.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.781 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 12.3 t-20 -84.37 32.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.8 OUTLIER 37.32 28.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.58 64.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.448 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.781 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.49 130.94 21.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 111.054 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -46.77 155.14 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 237' ' ' ILE . 14.3 mt -94.38 175.54 6.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -129.38 134.46 47.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.78 141.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.16 -27.0 16.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.67 148.36 52.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.61 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.1 m-85 -81.99 130.27 35.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.462 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 38.1 tp -123.64 138.35 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -81.24 134.9 35.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.609 ' HB3' HD22 ' A' ' 268' ' ' LEU . 58.0 m -157.5 150.6 23.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.5 mt -127.13 139.56 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.89 123.09 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.39 -46.17 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -144.74 152.09 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.79 122.01 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 55.0 mttt -79.3 133.11 36.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -36.43 -45.48 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -109.09 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -78.33 61.51 3.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -93.95 -81.13 1.5 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.24 143.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.02 139.96 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 17.9 t -99.69 131.32 45.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 254' ' ' CYS . 20.5 mt -126.69 157.63 38.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 97.3 p -157.08 143.54 18.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 236' ' ' TYR . 38.6 t -71.01 131.46 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.92 70.07 2.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.459 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -60.49 -48.48 81.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.826 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 24.1 t -42.53 110.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -92.55 85.13 5.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 276' ' ' SER . 25.1 m -78.08 -43.86 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.501 ' N ' HG23 ' A' ' 275' ' ' VAL . 58.8 m -113.15 45.45 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 16.0 m -157.12 130.14 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.23 148.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 45.8 mm -49.31 139.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -115.57 106.74 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 13.4 t -156.4 159.27 38.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.143 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -116.07 165.25 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -49.17 97.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -173.61 131.97 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.9 t -56.92 160.84 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -118.31 -35.14 3.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.34 136.26 57.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 39.9 tp -134.78 -50.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -156.65 142.36 17.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -61.63 127.96 33.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.56 148.25 49.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 40.7 p -131.3 136.67 48.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -145.76 81.57 0.21 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 136.17 32.23 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.691 2.26 . . . . 0.0 112.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.8 m -152.16 140.85 20.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.9 m -44.57 160.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.4 t -135.32 167.8 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.816 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.8 p -49.6 151.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.852 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.1 71.88 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -51.37 128.44 22.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 m -79.39 121.73 25.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.57 -59.99 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -66.35 174.61 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -54.86 134.02 48.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 189' ' ' ASN . 8.4 p -50.87 -42.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.448 ' N ' HG13 ' A' ' 188' ' ' VAL . 56.7 t30 -154.86 117.7 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -110.49 47.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 190' ' ' ARG . 4.8 t 34.04 53.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 192' ' ' LEU . 2.9 tt -109.31 -41.29 4.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.9 m -66.64 165.9 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -83.88 -47.04 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.8 -40.68 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.33 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 mt -42.41 160.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -129.45 153.66 80.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 109.45 2.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.7 28.97 1.01 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 255' ' ' ILE . 28.6 mtt -96.4 136.74 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.862 ' C ' HD12 ' A' ' 203' ' ' LEU . 3.6 mp -96.89 111.99 23.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.862 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.9 mp -131.09 149.14 52.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -102.1 120.22 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.91 177.71 17.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.2 p -126.68 136.83 52.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 122.74 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.1 t -86.07 -46.02 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.6 p -157.07 156.03 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.13 127.8 46.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -113.3 144.79 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.648 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -64.57 -23.61 67.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -94.9 -39.44 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -153.47 -159.48 9.14 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.438 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.639 ' CE2' HD23 ' A' ' 230' ' ' LEU . 58.9 m-85 -133.66 132.77 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.93 125.28 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.09 137.03 34.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.97 -30.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.48 47.6 5.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 138.48 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.14 109.61 20.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.86 36.86 3.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 266' ' ' VAL . 63.5 m -150.06 128.67 12.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.314 . . . . 0.0 111.128 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -114.66 126.33 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.521 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -114.82 127.66 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 18.2 t80 -132.26 126.44 33.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 229' ' ' PRO . 17.6 tp -104.94 130.27 23.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 143.19 49.9 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.1 mt -63.29 -29.26 70.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.61 -45.21 93.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -80.27 -42.1 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.0 98.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.85 -30.38 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.41 -43.88 84.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' CE1' HD11 ' A' ' 252' ' ' LEU . 0.8 OUTLIER -73.29 -37.81 66.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 246' ' ' LEU . 17.3 mt -68.25 -50.89 53.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 26.2 ptt85 -57.03 -40.08 76.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -80.04 -31.47 39.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 26.3 mmtt -88.28 -69.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.745 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.9 t-20 -83.58 35.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASN . 60.9 mttp 34.21 33.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.3 58.59 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -136.55 128.0 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -40.32 130.59 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.731 HD21 HG12 ' A' ' 237' ' ' ILE . 21.2 mt -70.04 -175.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -127.75 178.52 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 249' ' ' GLY . 59.2 t -92.09 153.43 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . . . 63.27 12.57 45.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.485 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.561 HE22 HD22 ' A' ' 246' ' ' LEU . 4.6 pt20 -82.4 147.98 28.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.94 126.81 31.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.572 HD11 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -135.04 142.25 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.478 ' O ' HG22 ' A' ' 270' ' ' VAL . 45.6 p-10 -96.47 133.06 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 92.0 m -146.76 159.69 43.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 201' ' ' MET . 86.1 mt -136.74 137.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.12 131.24 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.24 -41.53 5.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -150.68 153.06 34.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.8 t -123.76 121.28 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -127.6 143.25 51.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 54.77 165.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.452 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 262' ' ' ASN . 38.3 p30 -95.6 40.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 142.1 40.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.443 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -108.25 -95.0 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.6 137.43 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 224' ' ' THR . 77.9 t -114.61 139.89 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.161 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.6 t -99.12 125.2 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.521 ' CD1' ' HB1' ' A' ' 226' ' ' ALA . 39.0 mt -121.02 152.09 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 255' ' ' ILE . 93.8 p -159.77 143.23 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 253' ' ' ASN . 56.9 t -80.9 122.39 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.445 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . -111.97 99.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.67 85.92 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.897 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.5 m -152.87 177.06 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -63.22 107.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 276' ' ' SER . 27.0 m -48.64 -42.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.437 ' N ' HG23 ' A' ' 275' ' ' VAL . 74.1 p -100.13 163.27 12.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 66.8 p -147.9 170.64 17.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.162 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.8 141.22 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.91 HG22 ' H ' ' A' ' 281' ' ' THR . 4.9 mp -58.8 142.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.44 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.91 ' H ' HG22 ' A' ' 279' ' ' ILE . 81.1 p -97.31 154.52 17.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -79.38 158.1 27.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -105.73 34.4 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -105.73 161.04 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 68.5 p -133.51 138.54 46.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -153.58 160.89 42.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -93.89 112.05 23.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.63 -178.75 3.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -150.36 130.51 13.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -129.9 158.91 38.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.83 ' O ' HD13 ' A' ' 291' ' ' LEU . 0.0 OUTLIER -64.09 149.2 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.681 ' N ' HD22 ' A' ' 291' ' ' LEU . 6.4 t -163.15 108.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 167.52 146.28 4.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.454 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.41 30.41 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 4.9 m -87.26 146.93 25.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 35.1 t -103.98 -52.4 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.3 m -90.3 122.43 33.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.371 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.3 t -47.0 154.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.903 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 162.32 -145.95 11.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 t -129.69 110.93 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 99.1 p -99.75 85.84 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -131.72 60.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -121.01 127.61 51.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -140.55 122.51 15.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -41.08 138.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.12 90.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -87.7 119.19 27.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.616 ' C ' HD23 ' A' ' 192' ' ' LEU . 29.2 t -94.3 -34.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 191' ' ' VAL . 1.3 pt? 34.59 45.36 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.449 ' HB2' HG12 ' A' ' 191' ' ' VAL . 62.3 m -121.54 142.97 49.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -44.09 -23.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 193' ' ' SER . 2.1 mp0 -74.97 -38.94 61.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -109.43 17.97 20.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.2 mt -105.64 143.85 33.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.94 150.77 63.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.721 . . . . 0.0 110.891 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.354 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.43 11.79 3.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.4 mtt -99.14 130.95 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 274' ' ' GLU . 5.5 mp -86.42 107.94 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.3 mm? -121.26 130.72 53.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.975 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -93.55 129.4 39.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -136.01 -173.04 12.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 251' ' ' TYR . 5.6 p -130.89 140.07 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 111.114 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.99 119.94 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.1 t -86.36 -39.74 16.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.3 m -157.01 156.02 32.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.413 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.4 mp -106.76 125.41 50.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -117.24 144.62 44.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.769 ' O ' HD11 ' A' ' 230' ' ' LEU . 2.6 m-20 -66.36 -17.76 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -95.23 -27.39 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -170.02 -159.05 14.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.472 ' CD1' HD12 ' A' ' 246' ' ' LEU . 63.7 m-85 -133.34 129.44 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 126.17 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.95 135.31 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.78 133.65 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 pt -123.09 -22.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.06 50.03 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -143.53 147.79 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.41 124.32 35.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.4 -51.72 1.83 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.535 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -59.92 124.95 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -115.8 132.01 56.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -115.25 125.83 53.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 14.1 t80 -123.32 137.13 54.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 233' ' ' ALA . 13.0 tp -112.79 132.34 22.32 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.58 0.705 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 140.59 43.0 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.345 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.769 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.9 mt -63.08 -19.88 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.77 -44.53 66.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HG3' HG23 ' A' ' 270' ' ' VAL . 0.4 OUTLIER -79.64 -35.54 39.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.444 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -72.47 -43.05 64.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 11.3 tt0 -58.46 -36.81 74.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.75 -43.18 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.2 OUTLIER -72.1 -38.52 69.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.671 HG12 HD21 ' A' ' 246' ' ' LEU . 22.0 mt -66.3 -39.01 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.113 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -69.18 -41.98 76.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -79.83 -21.65 43.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.548 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 24.1 mmtt -100.17 -67.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.748 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.3 t-20 -84.3 32.81 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' ASN . 76.2 mttt 37.94 27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 85.94 61.58 1.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.748 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -142.65 134.12 26.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.86 148.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.671 HD21 HG12 ' A' ' 237' ' ' ILE . 94.5 mt -78.58 -177.66 5.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.6 145.89 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.2 128.53 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.56 -27.13 20.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.93 147.96 48.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 206' ' ' THR . 12.6 m-85 -80.97 132.01 35.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.73 141.45 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.74 133.86 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.702 ' HB3' HD22 ' A' ' 268' ' ' LEU . 85.1 m -155.28 151.13 27.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.02 147.0 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 200' ' ' GLY . 2.9 t -72.72 120.28 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -107.07 -48.47 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -137.77 135.37 36.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.35 122.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -126.05 134.34 51.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 65.75 -157.77 47.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.99 -42.5 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.93 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -130.72 32.2 3.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -90.53 -101.37 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.72 134.78 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.25 139.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.7 m -99.1 117.12 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.9 mt -110.9 157.66 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -148.63 142.0 25.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 232' ' ' LYS . 36.1 t -75.21 141.61 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.071 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -140.7 107.38 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 271' ' ' GLY . 6.7 p-80 -36.53 -59.61 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 30.4 t -171.38 119.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.832 ' HB2' HD21 ' A' ' 202' ' ' LEU . 45.7 mm-40 -94.92 82.1 3.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.76 -37.44 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 84.9 p -100.06 123.94 44.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 44.2 p -129.63 36.16 4.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -170.74 169.88 6.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 279' ' ' ILE . 3.7 mp -75.44 147.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.05 95.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.0 t -165.19 157.74 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.12 178.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -130.35 151.04 51.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -88.19 88.82 7.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.7 p -51.07 171.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -51.84 -179.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -123.55 -177.33 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 288' ' ' LEU . 0.7 OUTLIER -164.43 120.76 1.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.59 122.25 39.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -167.26 120.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.97 134.68 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 6.9 m -127.88 56.31 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.44 150.56 33.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.498 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -7.97 22.39 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 69.9 m -140.55 144.04 35.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -84.36 99.85 10.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 181' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 m -63.01 78.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.812 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 179' ' ' GLY . 1.9 p -103.92 96.77 6.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 132.11 -124.01 3.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.9 m -57.27 172.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 110.848 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.2 p -124.0 178.69 5.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.36 162.94 24.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -82.36 167.17 18.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.768 0.318 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.98 170.89 13.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.2 t -112.46 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -107.46 104.55 14.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -93.26 145.38 24.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 191' ' ' VAL . 9.2 p -110.92 24.62 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.62 105.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 m -115.39 159.47 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.79 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 14.1 pm0 -68.7 -10.82 58.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.83 -15.64 34.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.3 mt -59.86 151.73 25.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -127.55 143.91 49.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.55 0.691 . . . . 0.0 110.897 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 109.1 2.23 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 146.98 -11.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.7 mtm -79.1 141.27 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.833 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.1 108.08 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.3 128.44 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -94.3 130.87 40.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.11 -163.64 9.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.5 p -131.11 146.03 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.194 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.43 121.67 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.3 t -85.83 -43.05 13.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.575 ' HA ' HG22 ' A' ' 248' ' ' VAL . 5.2 m -157.05 156.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.859 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 246' ' ' LEU . 6.5 mp -106.49 125.1 50.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -116.95 162.17 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.5 m-20 -83.23 -22.93 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -96.15 -9.82 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 177.3 -161.4 28.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.647 ' CD2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -132.86 137.55 46.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.961 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.95 129.91 36.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.71 143.1 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.46 133.78 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.8 pt -125.1 -18.96 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.94 51.7 17.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 150.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.834 0.349 . . . . 0.0 111.116 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -93.84 119.2 32.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.96 43.68 13.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.1 m -155.22 123.71 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -113.43 131.42 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.79 48.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 13.0 t80 -122.92 140.48 52.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.721 HD12 ' HD2' ' A' ' 229' ' ' PRO . 23.5 tp -113.81 133.69 22.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.721 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.78 146.76 61.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.316 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.865 HD11 ' O ' ' A' ' 212' ' ' ASP . 74.5 mt -63.07 -22.76 67.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.4 -45.01 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 270' ' ' VAL . 15.0 mmtm -81.96 -37.7 26.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.627 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.32 -46.1 85.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.058 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -65.21 -39.26 92.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.7 -43.24 89.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 2.2 t80 -72.64 -42.26 64.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 233' ' ' ALA . 18.7 mt -65.23 -38.94 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.146 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.462 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 1.2 ttt85 -68.79 -43.72 75.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -79.0 -21.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 39.2 mmtt -99.31 -68.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.06 34.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 241' ' ' ASN . 79.5 mttt 34.73 34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 78.1 74.63 1.01 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -152.24 118.73 5.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -35.61 135.76 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.647 HD12 ' CD2' ' A' ' 215' ' ' TYR . 51.7 mt -69.22 -175.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 246' ' ' LEU . 3.4 mtpm? -144.7 130.06 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 209' ' ' SER . 23.9 t -50.62 126.05 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 109.83 -31.37 7.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.496 ' NE2' HD22 ' A' ' 246' ' ' LEU . 9.1 pt20 -62.99 148.17 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.909 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -80.73 130.82 35.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.455 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -124.3 145.32 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.18 127.48 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 268' ' ' LEU . 35.0 m -147.2 155.19 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 271' ' ' GLY . 95.3 mt -133.03 139.43 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.29 119.39 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -103.9 -48.07 4.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -138.6 140.28 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.8 t -122.16 129.11 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -85.41 176.29 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -87.97 -54.51 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -85.85 30.64 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 45.5 32.03 3.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.01 -74.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.8 t -132.68 134.24 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.33 139.6 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.7 t -99.97 118.4 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 254' ' ' CYS . 18.3 mt -113.64 149.88 33.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 255' ' ' ILE . 52.3 p -145.94 142.01 28.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 232' ' ' LYS . 17.3 m -73.93 134.65 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . -151.82 107.73 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.464 ' O ' ' CG ' ' A' ' 272' ' ' HIS . 7.2 p80 -87.38 37.05 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.857 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 5.0 m -107.29 91.96 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 276' ' ' SER . 18.3 pt-20 -168.16 134.84 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 275' ' ' VAL . 4.8 t 34.97 32.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 274' ' ' GLU . 59.8 p -52.83 -43.4 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 79.8 p -103.26 146.56 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.104 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.84 100.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.09 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.404 HD12 HG13 ' A' ' 275' ' ' VAL . 23.1 mt -81.65 142.3 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.68 83.76 2.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 25.3 p -131.71 171.03 13.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -110.95 121.52 45.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.06 158.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.69 110.06 8.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.1 t -144.13 141.83 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -118.02 68.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -163.12 147.53 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 22.0 tp -120.82 148.62 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.09 169.49 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -125.25 97.43 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -123.46 159.13 29.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.3 t -161.84 130.67 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -122.36 73.09 0.38 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 84.13 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.706 2.271 . . . . 0.0 112.316 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.3 m -109.04 110.64 21.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 28.1 t -86.08 152.07 23.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.509 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 98.6 p -90.33 50.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 m -109.32 84.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.3 86.98 1.53 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.528 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.1 m -129.16 171.21 12.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 0.0 110.878 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 t -76.83 165.76 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -86.76 56.25 4.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -123.15 103.93 8.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.16 132.19 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 50.7 t -41.07 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -42.05 100.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -137.59 145.48 42.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.473 HG13 HD21 ' A' ' 197' ' ' LEU . 24.5 t -118.9 61.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.26 -44.25 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 45.3 m -120.35 162.37 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.97 77.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -61.68 -28.6 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.68 -31.56 46.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.473 HD21 HG13 ' A' ' 191' ' ' VAL . 71.8 mt -60.82 135.22 57.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -100.4 148.93 35.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.567 0.698 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 129.91 8.04 3.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.706 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.9 mtt -76.16 140.36 41.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 203' ' ' LEU . 5.4 mp -86.5 108.62 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -130.39 141.1 50.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.4 m -119.57 122.23 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.3 -177.61 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -124.16 138.08 54.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.47 122.88 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -88.23 -40.68 13.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.97 156.07 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 248' ' ' VAL . 3.8 mm? -99.86 115.42 29.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.442 ' OE1' HD21 ' A' ' 216' ' ' LEU . 24.3 mt-10 -98.25 137.21 37.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 230' ' ' LEU . 8.5 t0 -57.2 -20.55 27.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -94.5 -38.3 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -161.24 -161.94 12.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.531 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.937 ' CE2' HD12 ' A' ' 246' ' ' LEU . 41.3 m-85 -117.63 132.14 56.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.442 HD21 ' OE1' ' A' ' 211' ' ' GLU . 1.9 mm? -92.01 133.54 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.76 142.66 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.4 123.07 33.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.7 -33.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.03 37.35 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.443 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.4 t -113.11 146.29 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -97.13 98.75 10.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.03 46.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 91.2 m -158.3 124.1 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -116.7 123.92 48.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -116.01 129.33 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 18.9 t80 -130.48 137.65 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.86 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -107.87 126.81 28.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.86 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.78 131.66 21.66 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.688 2.259 . . . . 0.0 112.372 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.702 HD23 ' HE1' ' A' ' 215' ' ' TYR . 30.5 mt -62.4 -24.75 67.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.6 mt -65.6 -41.27 92.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -42.51 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -59.3 -34.14 71.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.45 -34.01 70.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.41 -43.66 76.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.86 -37.79 67.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 241' ' ' ASN . 32.4 mt -68.42 -42.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 28.3 ptt180 -68.73 -35.98 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 12.1 mm100 -78.38 -39.9 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -98.1 -74.93 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m120 -52.47 -16.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 237' ' ' ILE . 32.5 mttp 59.54 36.53 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.41 46.88 5.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -136.57 117.42 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -49.57 135.54 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 215' ' ' TYR . 28.3 mt -62.6 179.2 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -131.27 170.8 14.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.55 HG23 HD23 ' A' ' 210' ' ' LEU . 19.3 t -87.73 128.66 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.55 -21.93 37.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.717 ' OE1' HD22 ' A' ' 246' ' ' LEU . 1.5 pt20 -64.36 148.0 51.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -81.0 127.17 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.96 135.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.756 ' O ' HG12 ' A' ' 270' ' ' VAL . 1.1 p-10 -93.28 125.31 37.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 13.3 m -140.28 157.64 45.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 201' ' ' MET . 73.3 mt -136.84 140.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 200' ' ' GLY . 39.0 t -61.04 119.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -99.87 -46.89 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -140.1 152.89 46.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.438 ' C ' ' HE2' ' A' ' 260' ' ' LYS . 71.9 t -124.0 127.29 73.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.438 ' HE2' ' C ' ' A' ' 259' ' ' VAL . 0.3 OUTLIER -97.72 167.72 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -88.92 171.1 38.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.514 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 261' ' ' GLY . 3.0 p-10 45.52 40.67 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 40.47 47.34 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.54 -98.56 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.59 146.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.02 139.99 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 m -98.97 115.44 28.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 226' ' ' ALA . 12.0 mt -113.23 148.77 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 46.3 m -158.78 142.07 14.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 253' ' ' ASN . 2.4 m -74.97 142.86 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.08 -97.58 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.482 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -92.75 141.06 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.844 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 54.6 m -120.64 -175.22 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 274' ' ' GLU . 1.7 pm0 -87.81 101.6 13.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.83 -38.1 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 29.1 t -44.06 -42.36 6.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 15.1 t -120.34 160.09 23.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -172.56 137.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.42 150.87 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -131.78 95.15 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.5 m -145.89 136.41 24.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -106.29 151.85 24.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 284' ' ' GLN . 0.0 OUTLIER -165.31 169.68 15.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 283' ' ' GLN . 36.8 mt-30 -34.6 115.43 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 69.4 m -104.38 127.22 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -158.28 122.57 4.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -157.43 132.35 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.543 HD13 ' N ' ' A' ' 289' ' ' ASN . 1.4 tm? -155.13 119.39 4.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.543 ' N ' HD13 ' A' ' 288' ' ' LEU . 19.0 p30 -73.33 133.95 44.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -165.47 155.96 13.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 292' ' ' SER . 0.0 OUTLIER -168.0 175.3 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.597 ' N ' HD22 ' A' ' 291' ' ' LEU . 31.2 t -172.26 152.61 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.46 83.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 120.05 6.89 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 296' ' ' SER . 3.9 m 62.75 32.84 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 295' ' ' SER . 3.0 m -36.49 108.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.3 t -128.16 124.68 37.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.3 m -116.08 130.2 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 85.07 154.9 23.11 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 p -95.13 99.51 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.862 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.4 p -143.5 122.61 12.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.25 -175.36 25.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -127.41 150.08 49.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -72.72 137.22 45.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.764 HG12 ' OD1' ' A' ' 189' ' ' ASN . 89.1 t -47.16 -66.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.764 ' OD1' HG12 ' A' ' 188' ' ' VAL . 10.6 m-20 -112.83 42.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 40.11 35.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 t 37.51 39.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tp -94.2 92.17 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.9 m -146.85 144.98 29.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.09 69.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.146 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.74 -10.22 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -91.08 -22.86 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt -67.49 162.87 22.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -153.26 155.25 31.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.561 0.696 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 113.56 3.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.398 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.47 4.11 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.3 mtt -90.62 130.89 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.7 mp -91.93 109.02 20.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.66 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.7 mm? -123.63 127.99 49.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m -97.78 119.45 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.42 -172.31 14.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.521 HG23 ' CD1' ' A' ' 251' ' ' TYR . 1.2 p -128.55 139.32 52.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.29 122.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -92.62 -40.43 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.98 156.09 32.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.28 125.15 51.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.87 150.97 34.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.767 ' O ' HD11 ' A' ' 230' ' ' LEU . 40.3 m-20 -70.17 -17.05 63.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -98.06 -25.77 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -172.27 -169.74 35.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 246' ' ' LEU . 82.6 m-85 -122.08 131.23 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.945 0.403 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.04 124.44 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.92 130.16 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.09 137.07 36.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 pt -123.44 -31.84 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.58 44.43 6.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.05 140.43 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.71 111.56 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.15 37.83 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 93.1 m -154.87 123.36 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 111.162 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.34 123.03 47.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.41 127.68 53.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 23.5 t80 -131.07 137.34 49.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.987 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.1 tp -109.29 128.61 25.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.73 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.76 143.42 50.77 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.767 HD11 ' O ' ' A' ' 212' ' ' ASP . 75.2 mt -62.99 -26.81 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.4 -40.46 95.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.854 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -83.13 -35.72 25.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.54 63.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -58.23 -35.32 71.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.7 -46.02 76.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.695 ' HB2' HG21 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -71.3 -36.93 71.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.983 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.852 HG12 HD21 ' A' ' 246' ' ' LEU . 21.7 mt -68.89 -38.92 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 2.7 ttm-85 -69.02 -41.18 78.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.5 -19.98 48.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 7.5 mmtp -101.82 -69.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.567 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 17.1 t-20 -84.16 33.52 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 241' ' ' ASN . 53.8 mttt 34.63 34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 77.75 73.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.484 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.567 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -151.3 124.4 8.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 244' ' ' ALA . 20.4 mmtm -37.22 144.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.852 HD21 HG12 ' A' ' 237' ' ' ILE . 13.8 mt -80.95 178.9 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.76 127.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 108.18 -27.24 14.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -63.44 148.0 49.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.521 ' CD1' HG23 ' A' ' 206' ' ' THR . 15.5 m-85 -81.03 127.28 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.3 tp -121.04 139.36 53.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -88.87 132.47 34.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.741 ' HB3' HD22 ' A' ' 268' ' ' LEU . 43.3 m -153.04 153.74 33.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 201' ' ' MET . 72.9 mt -136.8 143.75 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.48 121.45 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -101.62 -41.97 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -150.67 155.98 40.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.19 119.2 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 261' ' ' GLY . 35.6 tttp -86.42 135.03 33.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . 35.92 -149.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -120.35 72.5 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.81 24.04 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -95.46 -87.39 1.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.19 148.98 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.46 139.97 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.0 t -100.01 118.08 35.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 254' ' ' CYS . 16.4 mt -111.97 150.16 30.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 255' ' ' ILE . 1.4 t -146.28 146.98 30.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.854 HG22 ' HD2' ' A' ' 232' ' ' LYS . 28.9 m -74.7 136.16 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -157.38 101.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 271' ' ' GLY . 5.1 p-80 -35.76 132.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 24.2 p -164.0 174.68 11.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -66.06 98.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 276' ' ' SER . 93.0 t -97.43 -46.22 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 275' ' ' VAL . 1.4 p -35.36 126.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 13.2 t -160.0 154.69 24.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -113.73 170.97 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.36 140.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -124.36 -19.52 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 13.6 t -84.44 160.87 20.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLU . . . . . 0.52 ' CD ' ' N ' ' A' ' 282' ' ' GLU . 1.4 pm0 -135.16 -179.95 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.447 ' NE2' ' HA ' ' A' ' 283' ' ' GLN . 5.9 mm-40 -153.87 125.86 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -55.86 162.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 17.7 t -92.47 92.5 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -70.92 175.21 5.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -142.75 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.2 tp -163.8 144.53 8.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.465 ' OD1' HD12 ' A' ' 291' ' ' LEU . 13.4 t-20 -71.06 133.69 46.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -96.93 90.37 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.465 HD12 ' OD1' ' A' ' 289' ' ' ASN . 13.6 mt -135.11 161.57 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.8 t -118.01 111.31 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -168.54 156.53 28.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -27.2 26.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.735 2.29 . . . . 0.0 112.322 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 18.8 m -85.41 109.11 18.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.0 t -134.56 138.79 44.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.3 t -127.03 149.86 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.875 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.0 p -45.45 -58.06 3.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.885 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 150.48 -168.14 30.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.2 p -130.79 1.98 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.4 m -117.91 122.84 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -75.13 -68.23 1.59 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.91 157.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -137.28 159.1 42.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 81.2 t -110.76 -48.56 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -105.49 95.61 5.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -88.53 135.02 33.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.17 35.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.08 83.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 196' ' ' ALA . 17.9 m -138.99 160.93 38.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -48.54 -54.87 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.125 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.7 -17.43 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 193' ' ' SER . . . -90.49 -21.87 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 69.6 mt -60.01 -179.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -153.22 148.16 19.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.85 10.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.05 6.19 6.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.0 mtt -89.78 127.71 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.4 mp -89.61 109.87 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -131.49 127.05 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m -84.13 119.66 25.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.94 163.84 12.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 251' ' ' TYR . 1.3 p -113.5 135.47 53.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.812 0.339 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.99 121.06 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 248' ' ' VAL . 41.8 t -86.17 -45.09 11.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 85.1 p -157.02 155.97 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.47 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.1 mp -101.63 129.22 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -116.31 151.88 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 230' ' ' LEU . 5.8 m-20 -71.05 -21.78 62.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -96.74 -17.19 20.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 179.55 -158.88 23.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.468 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.6 m-85 -131.29 135.8 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.921 0.391 . . . . 0.0 110.897 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.44 129.55 35.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.1 128.4 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.01 132.82 36.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.48 -19.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.18 57.68 5.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.86 139.79 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.79 94.23 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.26 39.38 0.87 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 85.5 m -156.98 131.59 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.63 123.76 48.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.02 122.99 47.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -124.84 142.42 51.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.683 HD12 ' HD2' ' A' ' 229' ' ' PRO . 19.7 tp -113.75 134.6 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.609 0.718 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.83 142.55 47.95 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 212' ' ' ASP . 79.1 mt -63.1 -22.2 66.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.91 -43.26 79.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.968 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.9 OUTLIER -81.76 -33.22 31.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -75.15 -51.87 12.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -60.26 -36.92 78.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.49 -41.57 98.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 4.9 t80 -73.25 -41.83 63.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 241' ' ' ASN . 47.0 mt -63.02 -39.85 86.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.6 ptm180 -69.77 -35.68 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 6.5 mm100 -81.4 -29.22 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 14.1 mmmt -107.99 -63.39 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.765 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.7 m-20 -80.73 21.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.9 mmtm 35.82 30.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.15 40.33 8.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -104.81 113.37 26.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -40.39 126.3 2.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 237' ' ' ILE . 15.4 mt -64.23 -175.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -137.31 -175.91 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 208' ' ' SER . 98.4 t -97.53 145.79 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.79 81.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.41 HE22 HD22 ' A' ' 246' ' ' LEU . 5.1 pt20 -82.86 148.01 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.436 ' HA ' HG22 ' A' ' 206' ' ' THR . 15.1 m-85 -80.95 128.66 33.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 12.5 tp -131.4 142.89 50.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -98.89 131.59 44.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.739 ' HB3' HD22 ' A' ' 268' ' ' LEU . 97.1 m -154.03 163.05 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.453 ' O ' HD23 ' A' ' 268' ' ' LEU . 70.0 mt -134.63 150.37 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.51 121.57 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 269' ' ' SER . 3.9 mp0 -104.75 -40.56 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -142.99 148.83 37.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.08 126.03 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.3 144.57 36.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.34 -65.52 3.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -86.71 37.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 46.98 36.39 8.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.04 -82.48 0.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.79 134.31 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 38.1 t -108.86 139.98 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 t -99.07 121.48 41.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 254' ' ' CYS . 11.5 mt -118.42 154.13 32.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.406 ' N ' ' OE1' ' A' ' 257' ' ' GLU . 36.4 t -154.05 152.41 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.84 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.968 HG22 ' HD2' ' A' ' 232' ' ' LYS . 20.2 m -80.09 139.99 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.8 92.12 0.48 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 273' ' ' SER . 11.1 m170 -38.88 -41.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 272' ' ' HIS . 85.2 p 35.5 41.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 273' ' ' SER . 48.4 tt0 -35.65 106.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLU . 88.6 t -35.93 -47.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.9 t -66.59 80.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 53.1 m -142.37 132.67 24.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.96 145.31 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 17.2 mm -77.87 136.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.92 -18.89 14.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 80.6 p -80.39 163.3 23.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.0 165.22 21.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -103.43 126.74 50.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -66.81 129.85 41.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.435 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 37.5 t -86.1 143.48 28.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.435 ' CG ' ' O ' ' A' ' 285' ' ' SER . 98.6 m95 -159.53 134.34 7.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -137.94 135.9 36.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.804 ' H ' HD23 ' A' ' 288' ' ' LEU . 2.6 pt? -101.3 163.75 12.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -85.63 170.66 12.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -142.45 130.2 21.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 39.7 tp -135.48 133.99 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.2 m -112.28 176.98 4.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 165.48 -159.71 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 129.75 18.08 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.247 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 27.5 m -139.72 158.35 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.1 t -135.94 136.05 40.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.507 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.1 t -91.83 108.48 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.866 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 t -102.13 161.12 13.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -178.85 62.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -69.25 134.72 49.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 m -117.65 173.5 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -111.74 -151.48 11.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.29 142.21 28.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -78.53 175.36 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.7 t -91.29 -49.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -99.86 93.37 5.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 190' ' ' ARG . 0.3 OUTLIER -137.52 148.23 45.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.917 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.6 t -48.8 -44.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 192' ' ' LEU . 9.7 tt -39.95 111.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.9 t -155.42 164.03 39.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' HG11 ' A' ' 259' ' ' VAL . . . -43.16 -24.7 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.46 -40.47 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.46 24.52 12.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.2 mt -110.53 172.41 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -134.39 151.48 76.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 121.2 7.89 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.368 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.25 5.28 3.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.1 mtt -96.42 133.59 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.324 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -85.43 116.28 23.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.0 mp -120.92 130.22 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.3 m -97.99 126.15 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -138.46 -177.12 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.509 HG23 ' CE1' ' A' ' 251' ' ' TYR . 12.5 p -121.69 141.29 51.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.93 120.04 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.8 t -86.18 -39.29 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.1 m -157.02 156.01 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 246' ' ' LEU . 6.9 mp -108.53 122.9 48.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.08 156.96 20.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.579 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.7 m-20 -75.35 -23.52 57.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -94.53 -22.17 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.5 -164.89 27.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.491 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 246' ' ' LEU . 75.0 m-85 -127.55 133.21 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.91 128.28 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.01 132.64 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.97 136.67 36.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 pt -127.4 -26.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.78 56.29 2.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.503 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 89.5 t -139.88 132.82 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.36 46.45 1.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 167.48 42.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.563 ' CG2' HG21 ' A' ' 266' ' ' VAL . 54.5 m -160.43 124.42 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -107.32 125.13 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.99 125.66 53.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.742 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.2 tp -104.3 132.06 21.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.742 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.3 Cg_endo -69.75 146.62 60.82 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.312 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 212' ' ' ASP . 23.7 mt -63.03 -26.58 68.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.41 -44.39 89.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 270' ' ' VAL . 26.9 mmtm -82.39 -41.89 19.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.76 -46.3 84.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -62.7 -38.82 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -65.44 -44.67 86.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CD1' ' HG3' ' A' ' 240' ' ' LYS . 83.5 t80 -70.13 -38.66 75.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 41.3 mt -69.21 -44.28 80.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.5 ptm180 -69.65 -37.44 76.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -81.52 -27.14 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CD1' ' A' ' 236' ' ' TYR . 7.2 mmpt? -107.75 -64.91 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.1 m120 -81.62 25.5 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ASN . 1.2 pmtp? 32.74 34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 102.31 -45.27 1.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -34.42 120.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -53.61 152.7 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.609 HD22 ' NE2' ' A' ' 250' ' ' GLN . 17.7 mt -76.3 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -132.12 129.82 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.8 t -46.67 131.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 105.73 -30.22 10.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.609 ' NE2' HD22 ' A' ' 246' ' ' LEU . 10.2 pt20 -62.93 147.97 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.942 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.509 ' CE1' HG23 ' A' ' 206' ' ' THR . 10.6 m-85 -81.02 130.21 34.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 145.06 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -94.28 129.05 41.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.964 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.782 ' HB3' HD22 ' A' ' 268' ' ' LEU . 63.7 m -148.43 151.99 36.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 201' ' ' MET . 38.5 mt -130.79 145.95 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 203' ' ' LEU . 6.2 t -70.29 122.58 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -105.5 -45.23 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -138.78 136.53 35.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 194' ' ' ALA . 36.1 t -122.67 125.74 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 261' ' ' GLY . 34.7 ttpt -90.14 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -37.25 -60.06 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -93.44 174.34 7.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -80.66 51.76 4.3 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -77.18 -80.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.97 133.89 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 111.133 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 224' ' ' THR . 22.1 t -106.34 139.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.1 t -101.43 125.72 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 254' ' ' CYS . 45.6 mt -116.51 157.16 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 60.1 p -151.45 156.76 41.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 232' ' ' LYS . 41.7 t -78.19 131.85 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 255' ' ' ILE . . . -88.55 -111.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -134.98 -176.4 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.742 0.306 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 59.5 p -84.29 163.6 19.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.95 146.87 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 275' ' ' VAL . 45.1 t -85.46 31.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.9 t -82.36 40.58 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 8.9 t -105.43 143.52 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -52.11 147.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 21.1 mt -52.51 150.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -121.46 113.15 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 10.1 t -72.39 137.65 46.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -146.39 176.72 9.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -49.87 -49.55 49.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -107.89 103.07 12.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 64.2 m -131.76 173.78 10.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -89.84 174.78 7.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -136.55 173.03 12.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.1 tp 64.39 41.9 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -71.38 166.98 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -74.06 137.68 43.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -167.5 164.86 14.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.4 t -169.37 165.94 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 174.44 157.78 16.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -174.12 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.697 2.265 . . . . 0.0 112.33 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.6 t -133.79 -57.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.1 t -97.64 137.64 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.476 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 88.4 p -169.19 152.28 4.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.861 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -55.14 7.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.57 175.84 49.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 m -107.29 120.39 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.897 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.4 t -146.15 115.22 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.22 -161.51 28.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.72 175.16 11.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.817 0.341 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -60.01 161.86 6.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 188' ' ' VAL . 10.9 t -52.91 -17.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 37.84 51.79 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -69.58 132.51 46.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.538 ' O ' HG12 ' A' ' 191' ' ' VAL . 58.7 t -103.49 64.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.34 -48.1 3.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.5 p -172.77 157.92 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.48 58.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.33 -38.6 85.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.1 -25.1 63.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.6 mt -60.85 -178.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -160.8 154.22 18.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 126.37 13.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.676 2.25 . . . . 0.0 112.377 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 127.74 0.84 6.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.8 mtt -90.05 128.7 36.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.36 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.6 mp -89.46 117.33 28.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 203' ' ' LEU . 3.9 mp -130.79 128.96 41.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 31.6 m -85.02 124.33 31.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.86 169.25 20.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 251' ' ' TYR . 2.7 p -119.24 138.12 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.83 121.99 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.8 t -86.49 -42.01 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.437 ' HA ' HG22 ' A' ' 248' ' ' VAL . 1.8 t -157.04 156.3 32.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -106.75 125.13 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.91 154.89 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.633 ' O ' HD11 ' A' ' 230' ' ' LEU . 10.1 p-10 -72.81 -18.99 61.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -97.52 -30.41 12.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -165.13 -165.6 22.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -127.94 131.74 49.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.78 125.9 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.1 t -112.22 132.87 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -79.96 131.79 35.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 pt -124.05 -18.77 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.78 40.06 89.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.95 138.04 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.23 127.93 34.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.82 56.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.477 ' CG2' HG21 ' A' ' 266' ' ' VAL . 56.4 m -149.97 123.87 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -109.37 130.73 55.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -131.72 140.25 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.738 HD12 ' HD2' ' A' ' 229' ' ' PRO . 22.6 tp -114.99 133.17 22.69 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.738 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.76 145.24 56.59 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.3 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 212' ' ' ASP . 30.7 mt -63.38 -21.63 66.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.11 -44.7 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.824 ' HD2' HG22 ' A' ' 270' ' ' VAL . 17.5 tppt? -78.25 -30.69 48.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -77.01 -44.32 31.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -58.34 -33.4 69.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.58 -43.9 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 0.8 OUTLIER -72.89 -35.49 67.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 241' ' ' ASN . 39.8 mt -70.64 -40.9 77.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.182 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.486 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 16.2 ptt85 -69.52 -37.44 77.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -80.76 -39.14 27.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 63.3 mmtt -94.05 -57.58 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.637 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -81.99 23.26 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.1 OUTLIER 34.09 32.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.79 45.4 7.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -122.92 112.29 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.13 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -34.19 132.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.2 mt -65.44 -176.56 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.91 141.89 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 209' ' ' SER . 92.3 t -57.68 151.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.29 -21.49 6.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.36 148.53 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.413 ' HA ' HG22 ' A' ' 206' ' ' THR . 11.3 m-85 -85.01 128.31 34.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.0 tp -126.08 135.73 52.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -92.75 131.49 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 82.6 m -152.74 162.98 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.19 144.44 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 9.3 t -66.43 119.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -106.65 -46.91 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -132.26 136.02 46.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.15 132.84 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.4 ' CB ' ' H ' ' A' ' 265' ' ' VAL . 13.3 tptm -84.37 158.0 21.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -51.59 -94.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 263' ' ' GLY . 20.0 p-10 -73.67 64.13 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 36.57 42.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -66.47 -73.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.4 ' H ' ' CB ' ' A' ' 260' ' ' LYS . 75.5 t -133.87 133.44 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.364 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 224' ' ' THR . 19.0 t -105.15 137.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.755 ' C ' HD22 ' A' ' 268' ' ' LEU . 2.5 m -99.66 138.71 36.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 267' ' ' SER . 1.0 OUTLIER -121.05 148.35 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.3 p -151.75 141.87 22.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.824 HG22 ' HD2' ' A' ' 232' ' ' LYS . 33.7 m -79.45 141.82 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -157.95 -45.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -82.31 127.25 33.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 91.48 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.41 98.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.0 t -39.09 -42.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.3 t -40.58 -45.53 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 55.7 p 38.64 40.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.159 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -99.45 95.66 7.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 8.1 mt -103.32 152.36 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -81.55 14.96 2.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.045 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 p -126.16 135.55 51.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -149.65 162.03 41.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -164.01 118.33 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -61.66 157.56 17.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 10.8 t -69.18 109.6 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -150.68 143.52 24.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 43.5 44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 27.3 tp -110.3 94.02 4.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -144.91 171.45 14.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -79.18 142.5 36.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 292' ' ' SER . 6.5 tt -40.76 133.38 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.632 ' N ' HD23 ' A' ' 291' ' ' LEU . 89.6 p -157.65 114.65 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -165.44 141.39 6.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.52 9.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 14.9 t -104.91 109.54 21.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 51.9 p -88.16 97.46 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 t -60.86 98.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.914 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.4 t -114.99 41.75 2.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.03 -130.31 3.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.9 m -130.16 154.47 47.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p -102.93 144.0 31.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.57 156.48 27.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -120.94 166.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.0 115.79 8.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 m -83.5 -20.31 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -124.36 97.39 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -122.26 137.7 54.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.0 44.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 193' ' ' SER . 2.6 tt -118.19 -45.07 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.455 ' N ' HD23 ' A' ' 192' ' ' LEU . 2.8 m -75.49 146.84 40.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 197' ' ' LEU . . . -60.73 -9.99 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.81 -14.24 60.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -126.62 -9.05 6.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 194' ' ' ALA . 34.4 mt -63.97 161.4 15.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.53 ' N ' ' HE3' ' A' ' 201' ' ' MET . 49.7 mtmt -158.61 154.01 22.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.718 . . . . 0.0 110.84 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 107.26 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.722 2.282 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.69 7.01 3.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.558 ' HB3' HD11 ' A' ' 203' ' ' LEU . 8.6 mtt -92.8 132.66 36.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.41 112.22 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 201' ' ' MET . 2.1 mp -131.16 129.44 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.7 m -76.99 117.84 18.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -121.06 152.08 16.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -107.58 141.54 38.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.09 121.06 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.1 t -86.45 -46.13 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -157.07 156.42 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.23 126.9 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -115.21 156.41 25.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.659 ' O ' HD11 ' A' ' 230' ' ' LEU . 13.5 t70 -72.82 -24.04 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -87.96 -32.44 18.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.6 -159.55 18.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 246' ' ' LEU . 96.3 m-85 -125.19 139.92 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.32 130.83 44.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.97 146.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.55 129.68 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.506 HD11 ' CG2' ' A' ' 224' ' ' THR . 31.8 pt -121.76 -27.58 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.03 34.64 6.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.84 127.54 64.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.33 94.55 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.37 -33.47 0.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.506 ' CG2' HD11 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -92.66 151.04 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 111.163 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.78 121.09 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.14 127.62 54.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 6.2 t80 -132.09 137.03 47.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.49 HD23 ' HB2' ' A' ' 233' ' ' ALA . 11.1 tp -105.96 131.76 21.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 139.42 39.97 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.672 2.248 . . . . 0.0 112.321 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.659 HD11 ' O ' ' A' ' 212' ' ' ASP . 26.3 mt -63.11 -21.0 65.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 12.4 mt -70.79 -45.02 65.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.0 OUTLIER -81.87 -28.03 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.49 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -79.9 -49.13 12.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 33.3 tt0 -58.02 -44.38 87.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 236' ' ' TYR . 6.8 pt-20 -60.9 -40.43 93.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.652 ' CE1' HD11 ' A' ' 252' ' ' LEU . 1.2 t80 -73.12 -36.82 66.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 241' ' ' ASN . 31.1 mt -70.02 -40.95 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 4.8 ptm180 -69.1 -39.55 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -80.19 -19.93 45.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 19.0 mmmt -105.88 -67.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.72 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.5 t-20 -84.11 29.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.0 pttm 37.44 28.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.41 50.46 4.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.72 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -125.58 122.27 36.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.67 138.44 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.626 HD12 ' CD2' ' A' ' 215' ' ' TYR . 18.4 mt -71.99 -174.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -127.79 -174.93 3.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.91 144.16 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.98 3.52 11.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 251' ' ' TYR . 0.8 OUTLIER -66.66 144.87 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.883 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.481 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 23.7 m-85 -80.8 126.66 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 236' ' ' TYR . 6.0 tp -136.75 137.15 39.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.692 ' O ' HG12 ' A' ' 270' ' ' VAL . 21.5 t-20 -81.58 132.42 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 89.9 m -149.64 152.05 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.8 mt -137.08 146.44 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.4 t -74.24 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.33 -44.02 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -143.57 144.23 31.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.95 123.69 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -88.57 121.73 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 38.37 -143.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.468 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.26 63.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.92 0.391 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 138.53 35.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.83 -109.65 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.14 148.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.128 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.16 139.32 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.8 m -98.95 120.73 39.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 25.7 mt -115.57 151.95 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.5 t -155.81 151.89 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 253' ' ' ASN . 20.9 m -89.26 128.79 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.3 -100.09 2.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -159.13 130.42 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -111.69 135.4 52.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -83.8 98.2 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.67 -53.46 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.2 m -55.61 176.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 43.5 p -137.38 162.51 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.73 167.75 15.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.723 ' H ' HD12 ' A' ' 279' ' ' ILE . 5.4 mp -53.49 143.51 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -62.74 100.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 14.7 t -158.91 140.45 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -116.07 151.21 36.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -51.41 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -39.55 101.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 32.8 t -131.87 143.23 50.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -74.85 94.97 2.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -63.99 128.28 35.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.44 111.04 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -142.61 141.14 31.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -89.29 168.08 12.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -50.12 169.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 39.5 t -167.37 155.36 9.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -103.82 -158.07 24.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -13.85 35.15 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 0.0 112.311 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 3.2 m -42.67 -51.16 5.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 38.6 m -55.41 131.05 44.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.7 t 68.39 42.15 1.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 t -98.88 103.45 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 107.45 -133.1 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -55.0 156.62 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.838 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.3 t -118.17 101.19 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.17 3.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -62.48 161.99 10.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -74.58 102.35 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.3 m -76.94 -16.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 189' ' ' ASN . 7.2 t30 -128.76 96.0 4.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -161.89 160.5 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.6 m -85.52 51.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.92 114.48 15.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 196' ' ' ALA . 29.5 p -174.35 159.28 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -43.51 -27.86 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -102.48 -18.53 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -107.86 18.88 20.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.068 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.44 -177.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HG2' ' CE ' ' A' ' 201' ' ' MET . 14.1 ptmt -170.26 142.4 1.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 115.79 4.26 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 2.248 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 129.6 9.78 3.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.465 ' CE ' ' HG2' ' A' ' 198' ' ' LYS . 64.5 mtm -98.1 135.73 39.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.693 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.4 mp -93.16 119.94 32.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.7 mp -131.87 135.07 46.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 m -99.84 121.52 41.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.66 174.17 19.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' CE1' ' A' ' 251' ' ' TYR . 1.5 p -118.37 136.29 53.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.193 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.57 127.83 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.176 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.7 t -92.27 -46.11 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.9 p -157.03 155.28 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 246' ' ' LEU . 7.4 mt -100.35 133.39 44.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.84 152.31 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -64.88 -23.02 67.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.66 -47.22 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -160.63 -165.07 16.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.643 ' CD1' HD22 ' A' ' 210' ' ' LEU . 45.0 m-85 -118.15 132.96 56.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -91.58 132.96 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.06 145.31 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -89.4 124.52 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 pt -121.88 -25.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.23 47.58 10.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.81 141.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -93.9 114.19 26.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 92.13 36.34 6.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.54 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.6 m -147.48 123.96 11.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -111.35 130.87 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.54 135.49 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 59.0 t80 -131.76 141.85 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.853 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -120.59 126.58 26.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.853 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.77 131.04 20.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 215' ' ' TYR . 21.4 mt -63.2 -21.64 66.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.91 -45.11 87.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.888 ' HD3' HG12 ' A' ' 270' ' ' VAL . 0.0 OUTLIER -70.45 -37.84 74.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.464 ' N ' ' HG3' ' A' ' 232' ' ' LYS . . . -75.34 -26.62 58.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -64.98 -31.67 73.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.11 -44.69 52.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.4 t80 -73.05 -37.65 66.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.643 HG21 ' O ' ' A' ' 244' ' ' ALA . 51.7 mt -70.02 -41.87 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.2 ptm180 -67.12 -40.2 86.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 74.9 mm-40 -80.15 -19.95 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.513 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 64.9 mmtt -103.94 -68.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.85 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.7 t-20 -84.17 33.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 241' ' ' ASN . 74.3 mttt 34.48 32.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.94 69.16 1.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.85 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -137.55 -177.25 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -92.66 154.04 18.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.725 ' O ' HD11 ' A' ' 210' ' ' LEU . 19.1 mt -89.95 152.55 21.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.0 140.18 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.7 135.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 93.97 -18.34 56.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -63.06 148.07 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.89 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.2 m-85 -80.85 127.05 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.25 138.24 53.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.7 136.56 32.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 88.8 m -151.18 163.02 39.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.1 mt -136.17 145.5 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 5.9 t -68.02 122.31 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.22 -43.92 5.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -144.77 145.08 31.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.9 129.14 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -103.86 127.24 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -43.74 167.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 263' ' ' GLY . 7.2 p-10 45.43 37.27 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 37.34 47.58 1.53 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.54 -85.11 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 48.9 t -121.94 136.84 57.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 111.149 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.2 137.76 38.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.504 ' C ' HD22 ' A' ' 268' ' ' LEU . 1.8 t -102.11 122.41 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.556 ' O ' HD22 ' A' ' 228' ' ' LEU . 0.3 OUTLIER -114.33 142.87 45.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.3 m -156.97 145.76 19.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.888 HG12 ' HD3' ' A' ' 232' ' ' LYS . 7.2 p -83.51 123.53 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -114.1 -97.81 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -110.93 -55.67 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.8 t 70.66 50.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.894 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.12 70.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.83 82.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.134 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.2 t -46.64 -41.63 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 81.4 p -129.77 121.93 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -102.44 100.09 10.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 279' ' ' ILE . 4.8 mp -69.1 145.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.16 95.51 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.1 t -70.88 142.3 51.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.65 167.36 11.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.54 143.12 46.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -98.82 171.8 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 33.7 t -61.13 164.93 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -78.41 163.67 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -115.83 -18.19 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 37.3 mt -87.31 36.86 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 66.2 t30 53.45 46.9 25.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -112.18 111.99 23.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.7 tp -126.12 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 37.2 m -154.82 172.05 18.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -110.49 146.06 17.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 296' ' ' SER . 53.4 Cg_endo -69.8 -43.32 2.69 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.277 . . . . 0.0 112.31 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 294' ' ' PRO . 2.0 t -34.61 95.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 294' ' ' PRO . 98.6 p -167.52 134.59 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.842 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 70.6 p -172.6 120.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 69.8 m -119.32 151.43 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 63.97 176.29 4.22 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.3 m -59.32 160.75 6.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 m -155.31 150.23 26.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 37.73 -144.59 0.17 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -119.6 156.44 30.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -40.18 127.45 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.9 t -57.99 -52.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 190' ' ' ARG . 7.7 m120 -164.01 140.4 6.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 189' ' ' ASN . 0.0 OUTLIER -34.68 149.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 193' ' ' SER . 30.9 m -89.45 -28.66 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.8 tp -42.08 -24.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 191' ' ' VAL . 11.3 p -45.17 159.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.39 61.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -93.21 -19.19 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -126.19 31.41 5.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.638 ' C ' HG21 ' A' ' 259' ' ' VAL . 48.5 mt -45.81 161.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -123.49 145.16 46.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 136.28 32.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.649 2.233 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 121.59 -29.28 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.5 mtt -61.45 132.15 52.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.671 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.3 mp -100.57 108.0 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.671 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.1 mm? -121.55 132.76 54.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.4 m -89.0 120.01 30.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.95 166.22 12.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.36 56.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.18 121.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -89.23 -44.69 10.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.5 m -156.99 151.09 24.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.72 123.51 40.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -112.0 158.6 19.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.81 -21.55 57.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -92.86 -20.11 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 175.3 -171.64 44.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 246' ' ' LEU . 89.0 m-85 -112.23 131.6 55.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.907 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.01 129.35 34.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.45 138.53 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.81 134.79 34.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.07 -21.14 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.22 54.87 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -148.38 138.53 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.22 125.66 36.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.87 -49.9 0.94 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 47.1 m -76.37 124.25 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 225' ' ' ARG . 4.3 ptp180 -116.53 127.99 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.01 128.75 56.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.559 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 8.0 t80 -124.75 136.35 53.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 229' ' ' PRO . 7.2 tp -105.74 130.83 22.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.826 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.75 145.14 56.29 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.299 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 22.4 mt -63.03 -19.2 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -44.77 88.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -81.16 -28.91 34.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 215' ' ' TYR . . . -73.12 -47.17 46.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -62.89 -38.36 90.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.35 -44.54 87.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.661 ' HB2' HG21 ' A' ' 270' ' ' VAL . 11.3 t80 -72.04 -41.23 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 241' ' ' ASN . 40.9 mt -69.26 -41.03 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.491 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 21.8 ptt180 -70.05 -35.96 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.07 -36.17 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.468 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 27.4 mmtp -98.92 -58.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.656 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m-20 -80.51 19.82 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm 38.25 26.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.53 44.36 5.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.509 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -102.7 -179.01 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -104.02 119.45 38.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.666 HD12 ' CE1' ' A' ' 215' ' ' TYR . 21.8 mt -62.14 -179.9 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -136.07 -175.53 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.87 149.43 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 67.16 14.98 64.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -87.52 148.06 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -81.05 128.54 33.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 236' ' ' TYR . 10.4 tp -133.07 145.13 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.62 136.08 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.5 m -153.99 163.02 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.3 mt -136.92 150.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.6 t -70.43 125.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -103.14 -46.73 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -145.42 146.61 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 197' ' ' LEU . 14.6 t -123.96 132.4 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 3.1 tppp? -78.73 150.51 32.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -35.96 -38.81 0.24 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.449 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -125.85 -176.54 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -76.07 48.21 2.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -80.31 -84.87 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.2 134.35 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 139.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.5 t -98.96 120.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 40.8 mt -111.71 154.46 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 23.2 p -152.68 141.97 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.852 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 236' ' ' TYR . 21.1 m -73.12 134.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.11 -75.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.502 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.01 151.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.7 t -125.81 166.53 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.21 79.73 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.32 -48.65 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 t -41.8 -42.69 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 83.2 m -54.61 109.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -36.3 113.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 281' ' ' THR . 5.8 mt -93.06 137.53 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -102.73 24.59 10.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 279' ' ' ILE . 11.7 m -91.42 122.37 33.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 283' ' ' GLN . 15.0 tp10 -67.72 153.4 43.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.41 ' N ' ' HG3' ' A' ' 282' ' ' GLU . 18.8 tp60 -161.77 136.47 7.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.95 113.81 23.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.3 m -57.02 138.47 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -88.54 146.05 25.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -45.44 119.31 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.26 147.18 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -167.92 163.6 13.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -93.38 117.32 29.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.87 132.1 40.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 p -85.91 131.71 34.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 163.79 -179.43 38.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 90.7 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.652 2.235 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.3 p -87.62 107.11 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 p -101.51 -48.89 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.819 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.3 t 68.72 45.82 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 t -83.96 -44.95 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.894 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -155.43 74.79 0.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.6 p -102.61 42.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 m -59.33 138.76 57.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.28 157.3 28.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.445 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 -63.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -62.72 171.53 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -101.35 -19.39 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -127.32 43.84 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -50.66 153.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 191' ' ' VAL . 89.0 t -114.91 72.65 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.41 0.86 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 79.3 p -85.17 154.19 22.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 263' ' ' GLY . . . -75.27 -21.3 58.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.81 -21.93 43.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.85 54.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 mt -82.17 168.81 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -146.1 144.72 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 129.66 18.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.6 -1.34 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.75 140.5 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.427 HD13 HG11 ' A' ' 275' ' ' VAL . 4.6 mp -102.44 113.29 26.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.66 133.07 53.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -95.63 120.47 35.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.54 -169.93 12.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.0 p -131.96 137.91 48.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.354 . . . . 0.0 111.16 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.46 127.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.5 t -96.03 -40.59 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.6 m -154.93 156.02 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.8 mm? -100.33 110.22 22.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.32 139.1 31.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.506 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -63.06 -16.41 59.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -97.76 -36.74 10.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -159.58 -150.64 5.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 1.099 ' CE2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.13 132.14 41.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.911 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.9 131.4 37.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.82 145.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -92.52 128.97 38.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.56 -31.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.8 50.84 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.492 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.79 151.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.106 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 222' ' ' ASP . 3.1 t0 -92.65 110.64 22.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.73 55.59 2.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 87.7 m -156.03 122.97 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 0.0 111.191 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 266' ' ' VAL . 68.8 mtt180 -116.13 129.47 56.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -119.77 128.98 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 16.0 t80 -131.97 135.01 46.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.832 HD13 ' N ' ' A' ' 229' ' ' PRO . 1.4 tm? -107.76 127.03 28.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.832 ' N ' HD13 ' A' ' 228' ' ' LEU . 53.5 Cg_endo -69.79 128.99 16.8 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.67 2.246 . . . . 0.0 112.346 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.656 HD23 ' HE1' ' A' ' 215' ' ' TYR . 18.4 mt -58.05 -22.05 48.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.6 mt -64.83 -45.03 87.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -83.44 -30.52 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -68.07 -36.21 79.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.94 -39.29 94.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -62.41 -43.81 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.568 ' CE2' ' HE3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -73.14 -47.07 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.807 HG12 HD21 ' A' ' 246' ' ' LEU . 34.8 mt -61.15 -49.4 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.48 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.6 ptm180 -58.1 -43.17 86.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.479 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 8.4 mm100 -80.36 -19.89 45.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 2.0 mmmp? -100.9 -75.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.2 t-20 -80.66 41.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER 33.28 34.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 75.45 54.16 5.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -131.66 120.27 22.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -33.85 146.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 1.099 HD12 ' CE2' ' A' ' 215' ' ' TYR . 11.8 mt -78.14 179.63 6.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -123.33 171.05 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 75.3 t -92.54 139.83 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.33 -20.58 36.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -63.07 148.06 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.97 127.17 32.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.12 140.27 52.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.71 136.18 45.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 96.9 m -151.51 162.89 40.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.18 140.62 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.5 t -69.1 120.89 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.27 -39.7 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -144.81 141.64 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.1 t -120.66 130.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -82.25 145.7 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.33 -69.62 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.512 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.26 39.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 194' ' ' ALA . . . 38.58 34.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.517 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.11 -53.53 25.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.66 143.52 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 225' ' ' ARG . 43.2 t -126.95 140.07 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.862 ' C ' HD22 ' A' ' 268' ' ' LEU . 4.3 t -98.98 142.08 30.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.862 HD22 ' C ' ' A' ' 267' ' ' SER . 1.2 mm? -123.82 143.64 50.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 p -143.07 152.69 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 236' ' ' TYR . 58.6 t -79.16 141.51 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.078 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -179.25 118.66 0.61 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -106.76 73.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 275' ' ' VAL . 3.3 m -86.03 146.88 26.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.15 97.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 273' ' ' SER . 0.7 OUTLIER -115.67 -4.44 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 277' ' ' THR . 23.6 m -91.87 143.19 26.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 277' ' ' THR . 2.6 t 28.98 40.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 276' ' ' SER . . . -109.63 98.13 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 280' ' ' ALA . 49.5 mm -67.52 154.69 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.453 ' N ' HG22 ' A' ' 279' ' ' ILE . . . -85.27 28.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.0 t -88.88 152.6 21.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -167.73 135.59 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -73.1 141.6 47.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -50.27 128.71 20.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 28.7 t -114.94 96.25 5.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -92.04 125.92 36.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -139.09 105.85 5.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 288' ' ' LEU . 0.6 OUTLIER -87.75 151.69 22.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -118.48 130.17 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -93.88 87.95 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -50.12 173.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 27.1 t -155.55 138.26 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 155.38 -179.51 31.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -16.77 37.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.368 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.7 t -48.12 142.73 4.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 48.3 m -87.55 42.08 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.9 t 65.81 49.26 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.6 t -124.14 -43.61 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.09 173.41 23.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.502 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 t -69.18 146.35 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.848 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.7 m -59.05 -52.87 63.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -118.36 133.2 10.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -89.44 -51.49 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.344 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -115.08 122.86 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.7 m -54.78 -19.42 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -171.1 131.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -90.44 136.53 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.1 t -110.64 72.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 192' ' ' LEU . 1.6 pt? -112.36 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 t -46.56 172.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.57 -37.5 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.21 -33.21 72.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.421 ' HB3' ' C ' ' A' ' 192' ' ' LEU . . . -73.77 -28.98 61.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.41 149.75 16.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -119.59 149.24 47.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 0.0 110.895 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 256' ' ' VAL . 53.8 Cg_endo -69.78 116.87 4.76 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.43 -9.83 3.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.719 ' O ' HG23 ' A' ' 255' ' ' ILE . 11.8 mtt -79.74 140.6 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.763 0.316 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.51 122.17 36.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 256' ' ' VAL . 4.5 mp -131.25 125.23 32.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 m -92.51 119.09 31.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.63 16.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 p -118.23 139.8 50.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.484 HG11 HD21 ' A' ' 210' ' ' LEU . 61.9 t -60.99 134.59 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.9 t -109.91 -33.88 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.43 ' C ' HD23 ' A' ' 210' ' ' LEU . 1.8 t -157.03 156.12 32.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.83 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 215' ' ' TYR . 10.0 mt -113.86 137.6 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.01 164.95 19.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.777 ' O ' HD11 ' A' ' 230' ' ' LEU . 6.1 p-10 -79.69 -26.49 40.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.519 ' H ' ' CD2' ' A' ' 213' ' ' HIS . 3.6 p80 -93.59 -17.7 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.476 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -177.75 -162.1 27.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.785 ' CE1' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.94 139.93 46.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.926 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.85 130.5 34.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.32 131.59 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.59 134.69 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.2 pt -125.1 -21.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.92 7.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.36 135.7 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -88.68 107.24 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.92 36.93 4.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.5 m -153.01 125.31 8.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.103 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -114.08 131.75 56.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -118.22 134.89 54.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.476 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.3 t80 -127.17 140.4 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.897 HD12 ' HD2' ' A' ' 229' ' ' PRO . 24.9 tp -113.76 130.35 23.88 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.897 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.68 146.59 61.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.268 . . . . 0.0 112.364 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.3 mt -62.14 -19.9 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.77 -44.71 95.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -41.47 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -65.11 -48.51 73.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 12.4 tt0 -62.96 -37.73 88.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.91 -42.4 90.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.533 ' CD2' ' HD3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -72.91 -38.92 66.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.961 HD11 HD11 ' A' ' 246' ' ' LEU . 66.0 mt -69.28 -40.5 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 14.3 ptm180 -70.23 -35.33 73.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -79.98 -40.43 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.533 ' HD3' ' CD2' ' A' ' 236' ' ' TYR . 0.0 OUTLIER -93.91 -55.39 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 237' ' ' ILE . 10.5 t-20 -81.43 19.12 1.03 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 241' ' ' ASN . 51.5 mttt 38.06 27.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.99 67.5 1.44 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -146.35 151.47 37.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 111.152 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.47 154.91 2.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.961 HD11 HD11 ' A' ' 237' ' ' ILE . 66.8 mt -95.72 171.37 8.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.89 133.05 47.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.09 136.06 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.48 -23.19 34.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.447 ' OE1' HD22 ' A' ' 246' ' ' LEU . 1.7 pt20 -63.19 148.0 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.915 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.11 127.05 32.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.8 tp -127.61 137.1 52.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -84.42 131.58 34.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.585 ' HB3' HD22 ' A' ' 268' ' ' LEU . 32.3 m -145.99 153.54 40.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 201' ' ' MET . 15.2 mt -135.45 147.01 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 199' ' ' PRO . 40.0 t -66.93 124.52 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -105.65 -44.42 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -146.79 161.22 41.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.3 130.08 75.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -108.54 117.48 34.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -46.39 157.04 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.518 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 m120 58.87 25.46 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.912 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.47 45.75 4.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -74.57 -72.27 1.04 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.04 134.43 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.46 136.2 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.2 t -100.82 116.02 31.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.657 HD12 ' HB1' ' A' ' 226' ' ' ALA . 18.5 mt -115.69 156.68 25.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 255' ' ' ILE . 82.3 p -152.53 142.1 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 p -82.58 143.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -136.62 106.27 0.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 271' ' ' GLY . 10.8 m80 -37.31 137.36 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 49.2 m -152.48 152.72 32.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 49.0 39.56 14.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 277' ' ' THR . 8.2 p -52.02 -40.26 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' THR . 28.2 m -40.29 -41.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 277' ' ' THR . 13.3 t 33.17 41.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -91.0 34.17 0.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.087 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 280' ' ' ALA . 4.6 mm -82.45 155.1 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.452 ' N ' HG22 ' A' ' 279' ' ' ILE . . . -102.86 101.76 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.9 p -139.42 169.73 17.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLU . . . . . 0.412 ' C ' ' CD ' ' A' ' 283' ' ' GLN . 12.9 pt-20 -170.35 140.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.412 ' CD ' ' C ' ' A' ' 282' ' ' GLU . 23.7 mp0 -148.65 140.46 23.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.462 ' CD ' ' C ' ' A' ' 284' ' ' GLN . 4.1 pp0? -87.57 151.95 22.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.1 p -129.59 116.64 19.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -44.11 150.52 0.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -59.23 148.43 31.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.7 tp -120.09 88.78 3.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 290' ' ' ASN . 4.9 m120 -161.65 131.39 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 289' ' ' ASN . 8.3 p30 -35.21 -45.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.6 tp -94.4 123.17 37.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 56.7 p -38.43 116.33 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -84.12 146.42 22.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.476 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 59.8 p -111.63 152.73 27.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -43.3 135.21 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.51 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 29.3 t -144.21 127.96 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.896 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 m -155.07 173.0 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 51.2 77.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.9 p -120.79 -41.78 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 m -118.78 -69.51 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 186' ' ' LYS . . . -60.26 176.55 3.76 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.479 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 185' ' ' GLY . 14.1 ptpt 42.51 48.54 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -79.64 179.08 7.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 189' ' ' ASN . 63.9 t -128.54 75.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 188' ' ' VAL . 3.1 m-20 35.23 45.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 192' ' ' LEU . 12.4 ttm-85 -96.18 38.22 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.596 ' O ' HG12 ' A' ' 191' ' ' VAL . 16.0 t 39.67 27.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 190' ' ' ARG . 3.1 mp -141.96 123.17 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 47.4 m -163.06 -177.16 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.34 -26.63 3.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.73 -26.55 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -86.5 6.27 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.99 -176.47 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -158.88 152.4 19.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 132.83 24.09 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 120.52 -10.7 10.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.483 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.4 mtt -73.94 127.58 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.7 mp -88.74 113.52 24.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 202' ' ' LEU . 18.5 mt -129.69 134.92 47.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.46 117.03 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -120.12 154.85 16.33 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.9 p -104.85 132.86 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.03 120.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.2 t -86.0 -46.01 10.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.1 p -156.76 155.85 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 215' ' ' TYR . 8.7 mt -102.92 139.0 39.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.1 161.65 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.485 ' O ' HD11 ' A' ' 230' ' ' LEU . 55.2 m-20 -72.54 -19.05 61.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -93.35 -39.51 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -166.39 -162.04 16.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.817 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.8 m-85 -120.58 130.34 54.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.929 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.42 133.94 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.2 t -115.95 139.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 -8.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.45 52.78 24.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.506 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.8 t -146.82 134.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -87.18 109.76 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.92 -49.17 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.607 ' CG2' HG21 ' A' ' 266' ' ' VAL . 48.6 m -68.21 124.1 22.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -111.3 131.17 55.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.22 134.79 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 36.7 t80 -131.81 143.41 50.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.915 HD12 ' HB2' ' A' ' 233' ' ' ALA . 0.3 OUTLIER -113.7 126.22 28.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.955 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.743 ' HD2' HD13 ' A' ' 228' ' ' LEU . 53.9 Cg_endo -69.73 129.13 17.09 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.6 mt -62.94 -14.91 52.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.79 -45.06 53.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -83.17 -36.84 24.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -64.78 -31.49 72.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -64.39 -41.19 96.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -63.64 -43.43 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 240' ' ' LYS . 18.3 t80 -72.1 -37.56 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 241' ' ' ASN . 76.5 mt -69.43 -45.82 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.2 ptp180 -61.47 -40.94 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -80.06 -21.17 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 236' ' ' TYR . 29.0 mmtm -99.44 -71.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 237' ' ' ILE . 17.2 t-20 -83.75 35.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' ASN . 25.5 mtpp 36.41 30.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.52 73.95 1.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -158.3 153.95 26.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 162.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 215' ' ' TYR . 59.0 mt -95.31 -178.1 4.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 247' ' ' LYS . 3.4 mppt? -116.77 174.9 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.5 t -102.04 144.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.82 -6.09 20.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.79 147.94 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -80.99 127.24 32.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.7 tp -128.64 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -97.67 124.25 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -142.64 163.06 33.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 271' ' ' GLY . 91.6 mt -137.07 138.44 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.25 120.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -105.81 -33.5 7.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -144.0 133.45 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.98 132.08 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -87.41 157.64 19.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -68.1 -65.21 2.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.68 41.33 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.3 37.24 1.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -62.22 -74.74 0.37 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.77 135.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.607 HG21 ' CG2' ' A' ' 224' ' ' THR . 8.4 t -105.97 139.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.773 ' C ' HD22 ' A' ' 268' ' ' LEU . 7.5 m -100.39 139.54 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 267' ' ' SER . 1.1 mm? -121.19 153.0 38.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 255' ' ' ILE . 45.8 p -159.9 141.97 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.93 133.9 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.457 ' O ' HD11 ' A' ' 255' ' ' ILE . . . -160.19 103.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -78.28 62.72 3.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.791 0.329 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 5.0 t -114.67 122.64 47.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -83.25 98.31 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.66 -59.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 m -130.18 125.05 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 43.4 p -42.57 143.39 0.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -98.61 -177.13 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.746 HG22 ' H ' ' A' ' 281' ' ' THR . 11.1 mt -86.5 142.22 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -97.21 20.89 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.746 ' H ' HG22 ' A' ' 279' ' ' ILE . 11.0 t -143.81 144.63 31.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -123.68 162.71 22.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.65 157.4 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -60.47 155.95 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.6 t -137.66 120.54 16.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.422 ' C ' ' CD1' ' A' ' 286' ' ' TRP . 5.0 t-105 -122.57 138.58 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -144.51 129.62 18.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 288' ' ' LEU . 1.6 pt? -82.15 174.43 11.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -151.44 111.8 4.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -64.63 -47.66 77.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -116.24 179.19 4.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.0 t -149.31 134.25 17.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -122.35 146.2 16.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.512 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -175.63 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.347 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.6 t -145.5 154.19 41.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 60.6 p -74.79 141.92 44.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.444 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.2 t -73.51 145.2 45.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 0.0 110.825 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.9 m -85.27 106.66 16.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -149.45 92.5 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 m -65.02 -61.81 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -46.09 165.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 153.95 -64.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -40.35 -60.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -161.5 106.67 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.71 145.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 190' ' ' ARG . 50.9 t-20 38.93 48.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 ttp180 -36.64 123.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 m -57.06 -18.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.23 109.74 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.4 m -82.68 174.43 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -44.41 -44.85 8.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -51.85 -54.1 32.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.5 -21.74 61.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.25 -175.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -161.21 149.65 12.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.867 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 108.84 2.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.72 -5.82 3.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 255' ' ' ILE . 14.3 mtm -86.83 142.69 27.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.05 125.34 44.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 203' ' ' LEU . 4.5 mp -132.01 125.95 32.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -98.04 119.5 36.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.16 -165.18 11.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.1 p -129.92 138.75 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 128.54 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.1 t -87.8 -45.99 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.1 m -156.91 155.95 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.564 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.4 mm? -92.67 112.89 25.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.28 143.25 26.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.74 -19.13 65.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.49 -29.96 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -166.64 -155.68 9.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.557 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.959 ' CE2' HD12 ' A' ' 246' ' ' LEU . 89.8 m-85 -125.49 125.85 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 110.897 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.39 133.94 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.01 141.56 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.79 131.44 34.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.1 pt -127.28 -29.42 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.44 41.09 21.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.443 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.4 t -121.78 144.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 111.074 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.75 108.09 20.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.35 33.79 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 95.8 m -143.6 123.13 13.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -116.07 120.49 39.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -115.95 134.36 55.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.8 t80 -132.0 144.0 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.855 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -113.67 126.9 27.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 110.926 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.855 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 136.15 32.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.499 HD23 ' HE1' ' A' ' 215' ' ' TYR . 31.9 mt -62.9 -24.35 67.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.79 -42.24 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.57 -39.25 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -61.0 -48.66 80.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -58.58 -37.97 76.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -64.25 -42.52 96.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.701 ' CD2' HG11 ' A' ' 270' ' ' VAL . 3.0 t80 -73.03 -40.02 65.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 241' ' ' ASN . 24.3 mt -68.1 -40.03 82.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.3 ptm180 -69.92 -37.98 76.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -81.38 -27.36 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 66.9 mmtt -107.38 -63.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.726 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.4 m120 -81.37 24.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.0 mtpt 34.77 31.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.79 44.54 7.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -112.91 113.48 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -41.51 125.74 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.959 HD12 ' CE2' ' A' ' 215' ' ' TYR . 16.2 mt -58.94 -175.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -144.17 152.12 40.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.7 t -67.08 143.56 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.95 -21.06 16.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 252' ' ' LEU . 0.9 OUTLIER -65.49 148.32 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.954 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -80.97 133.04 35.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.444 ' HB2' ' NE2' ' A' ' 250' ' ' GLN . 24.2 tp -134.48 135.09 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.31 136.5 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.716 ' HB3' HD22 ' A' ' 268' ' ' LEU . 37.8 m -148.55 151.35 34.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' MET . 90.3 mt -131.52 138.69 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.73 123.71 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -106.82 -45.62 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -134.37 148.86 50.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 63.1 t -119.27 126.74 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.25 118.53 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -40.79 -56.88 2.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 263' ' ' GLY . 28.1 t30 -85.69 35.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.59 42.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -76.14 -74.21 0.95 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.6 130.99 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.19 139.95 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.1 t -99.38 120.75 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.801 HD12 ' HB1' ' A' ' 226' ' ' ALA . 27.9 mt -116.3 152.14 34.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 58.2 m -146.8 147.71 31.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 236' ' ' TYR . 44.9 t -73.79 127.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -114.21 85.41 0.39 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -83.78 40.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 58.1 p -120.32 40.14 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -103.79 91.42 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.44 -10.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.187 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 7.7 t -113.27 127.75 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 81.4 p -109.23 130.4 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -120.31 104.15 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.113 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 78.0 mt -92.95 145.98 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -126.72 86.16 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.0 t -60.98 139.22 58.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -151.21 156.66 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -118.0 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -126.64 166.4 17.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 15.0 t -171.08 105.74 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -134.08 109.82 9.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.44 124.8 6.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 13.8 mt -152.59 -175.72 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -166.34 113.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -152.06 169.06 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.89 92.01 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.6 t -79.07 91.66 4.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -148.03 146.26 15.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -9.38 25.97 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 97.4 p -97.07 134.84 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 29.6 m -76.72 -42.92 39.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.42 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.0 t -129.9 -60.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.863 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -138.1 163.52 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.97 -73.74 1.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.8 t -103.06 108.33 19.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 t -123.1 -42.99 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.19 -145.48 4.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -44.8 123.85 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 189' ' ' ASN . 3.3 t-20 -58.9 139.64 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.7 p -38.22 -29.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 187' ' ' ASN . 2.8 p-10 -142.72 124.51 15.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.0 ptt-85 -64.17 128.53 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 191' ' ' VAL . 20.4 t -93.43 37.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.78 81.16 1.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -164.01 154.92 15.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.83 96.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -66.1 -19.82 65.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.89 58.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -47.07 161.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -110.14 148.51 38.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.711 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 116.93 4.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.84 -2.92 7.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 255' ' ' ILE . 34.3 mtt -68.07 141.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 203' ' ' LEU . 5.4 mp -87.23 111.04 20.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.9 mm? -124.74 137.86 54.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.4 m -112.64 125.38 54.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.32 161.01 25.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.426 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 251' ' ' TYR . 4.0 p -103.57 140.08 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.5 122.38 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.5 t -87.56 -43.36 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.1 m -156.81 155.77 32.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.58 123.73 44.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.56 147.57 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -65.09 -27.42 68.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -90.6 -32.41 16.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -164.62 -159.19 10.9 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.929 ' CE1' HD12 ' A' ' 246' ' ' LEU . 94.6 m-85 -125.71 129.51 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.01 134.05 33.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.98 142.2 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.45 124.11 33.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.94 -27.39 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.03 40.69 10.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 64.9 t -128.59 142.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.127 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.51 126.63 38.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 98.99 -48.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.6 m -69.13 123.23 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -114.97 129.69 56.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.11 128.98 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.565 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 27.4 t80 -131.85 134.34 45.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.846 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -109.21 126.4 29.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.846 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.74 133.77 26.42 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 215' ' ' TYR . 48.9 mt -61.2 -21.86 64.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 -44.99 85.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HD2' HG22 ' A' ' 270' ' ' VAL . 1.6 tmtp? -77.5 -31.54 53.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.9 -39.77 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -59.43 -33.87 71.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.33 -45.85 75.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.666 ' HB2' HG21 ' A' ' 270' ' ' VAL . 1.9 t80 -72.3 -38.04 68.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.623 HG23 ' HB2' ' A' ' 241' ' ' ASN . 51.6 mt -69.79 -42.45 80.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 17.9 ptt180 -69.77 -36.56 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -81.39 -34.74 31.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.551 ' HG3' ' CD2' ' A' ' 236' ' ' TYR . 1.2 mmmp? -99.66 -60.03 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 244' ' ' ALA . 8.6 m-20 -80.81 21.32 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 238' ' ' ARG . 8.8 mmmm 36.99 28.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.97 46.88 4.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.46 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -106.25 177.56 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -100.12 137.59 38.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.929 HD12 ' CE1' ' A' ' 215' ' ' TYR . 23.5 mt -73.43 162.37 29.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -128.38 149.68 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.19 150.57 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.82 3.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.53 148.32 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.553 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.8 m-85 -80.94 129.87 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.85 140.77 52.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.518 ' O ' HG12 ' A' ' 270' ' ' VAL . 3.7 p30 -87.62 128.33 35.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.749 ' HB3' HD22 ' A' ' 268' ' ' LEU . 83.9 m -147.14 149.8 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 201' ' ' MET . 79.8 mt -134.54 139.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 200' ' ' GLY . 30.7 t -62.71 119.05 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -97.05 -40.04 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -153.62 152.94 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -123.22 127.96 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.41 178.01 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.69 -74.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 263' ' ' GLY . 1.4 m120 -80.12 45.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.72 37.98 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.97 5.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 146.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 27.8 t -113.33 139.33 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.9 t -99.3 118.57 36.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 254' ' ' CYS . 12.2 mt -120.88 146.98 46.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 5.6 p -147.09 145.47 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 236' ' ' TYR . 27.3 m -76.87 122.57 31.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.096 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -138.56 94.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -44.34 152.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 67.4 m -44.83 163.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -138.39 112.43 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.05 -58.95 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.15 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.3 m -75.24 85.36 2.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 12.8 t -101.42 147.74 25.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.167 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -89.82 100.85 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.19 148.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.25 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 9.8 t -121.99 144.23 49.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 174.26 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -136.38 173.8 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -53.33 163.75 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.955 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 60.8 m -148.58 129.99 14.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -141.96 160.25 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.89 137.41 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 8.9 mp -104.78 119.37 38.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -40.3 148.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -85.13 99.19 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.33 89.89 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 86.0 p -139.03 127.35 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.91 153.05 2.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.5 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -17.02 37.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 65.7 m -52.24 96.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 42.9 m -74.35 166.26 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.814 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 t 43.25 42.22 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.9 m -111.3 85.38 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.48 156.75 28.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.8 m -118.0 -49.58 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 m -54.93 173.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.04 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -118.34 129.97 55.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 187' ' ' ASN . 0.4 OUTLIER -126.43 177.25 6.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.3 137.44 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 60.33 42.88 14.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.71 142.81 38.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.688 HG13 ' HB1' ' A' ' 196' ' ' ALA . 94.7 t -111.46 71.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.2 tp -130.29 41.18 3.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 196' ' ' ALA . 24.0 p -139.86 140.03 36.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.94 -38.21 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.688 ' HB1' HG13 ' A' ' 191' ' ' VAL . . . -75.56 -29.9 59.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -58.88 164.12 3.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -140.05 151.47 65.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.2 20.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 113.29 -6.12 25.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.533 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.7 mtt -67.85 138.83 56.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 202' ' ' LEU . 3.9 mp -94.44 110.13 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 202' ' ' LEU . 23.7 mt -131.13 141.65 50.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -111.56 124.63 52.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.24 -174.75 13.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.7 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.03 120.69 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 t -86.47 -41.87 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 56.4 p -156.4 156.0 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 248' ' ' VAL . 9.5 mp -105.01 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -115.34 145.21 42.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.771 ' O ' HD11 ' A' ' 230' ' ' LEU . 24.1 m-20 -67.48 -17.87 64.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -97.24 -20.05 18.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.95 -166.78 34.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 246' ' ' LEU . 85.0 m-85 -125.79 132.95 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.616 HD12 ' NH2' ' A' ' 225' ' ' ARG . 1.5 mm? -88.85 132.17 34.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.897 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.15 135.17 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.1 126.97 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 pt -119.01 -18.56 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.02 43.13 8.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.55 127.29 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.107 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.91 130.33 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.64 -43.41 1.76 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.8 m -73.92 132.0 42.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.787 0.327 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.616 ' NH2' HD12 ' A' ' 216' ' ' LEU . 6.9 tpm_? -109.33 123.18 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.96 126.92 55.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 9.0 t80 -132.01 139.21 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 229' ' ' PRO . 15.3 tp -112.73 133.41 21.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.0 Cg_endo -69.72 139.49 40.48 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.771 HD11 ' O ' ' A' ' 212' ' ' ASP . 84.1 mt -63.11 -25.08 68.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.57 -45.05 73.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -78.09 -33.14 50.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.15 63.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.45 -35.67 72.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.98 -42.92 99.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.3 OUTLIER -72.47 -37.74 68.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.893 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 244' ' ' ALA . 32.7 mt -66.97 -39.11 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.5 ttt180 -69.2 -41.29 77.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -79.49 -20.3 47.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 47.1 mmtt -101.5 -69.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.681 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.7 t-20 -83.85 35.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 38.9 mmtt 34.65 32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.37 68.49 1.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.5 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.76 169.24 18.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 146.98 50.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 215' ' ' TYR . 80.0 mt -87.67 178.25 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -132.95 153.14 51.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 210' ' ' LEU . 37.1 t -78.01 134.4 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.065 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.1 -22.36 39.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.449 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -64.54 148.04 51.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.05 128.47 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 252' ' ' LEU . 6.7 tp -123.09 142.9 50.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -92.43 130.51 38.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.681 ' HB3' HD22 ' A' ' 268' ' ' LEU . 95.1 m -154.91 153.0 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 201' ' ' MET . 96.6 mt -133.63 139.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.52 125.14 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -103.5 -45.82 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -142.51 158.37 43.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.25 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.45 136.57 36.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.7 -66.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.546 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 263' ' ' GLY . 19.1 t-20 -84.53 45.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.24 36.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -68.76 -86.63 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.88 144.26 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.53 140.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.6 t -98.96 118.13 35.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.2 mt -116.72 149.62 39.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 75.4 m -156.91 142.03 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 253' ' ' ASN . 17.4 t -71.89 142.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 272' ' ' HIS . . . -98.07 -37.01 4.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.529 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 271' ' ' GLY . 28.2 p80 42.55 28.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.9 t -148.38 148.01 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 69.12 41.77 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.27 -25.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 99.6 p -62.57 130.61 45.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 12.1 t -92.45 156.0 17.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -43.6 165.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 21.3 mt -50.4 150.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -101.53 101.15 11.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.0 p -104.53 119.97 40.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -85.88 -25.08 26.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 283' ' ' GLN . 4.0 pm0 -85.96 155.69 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -156.21 174.54 15.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 55.2 m -78.56 148.71 33.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -92.44 163.31 13.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -122.82 164.58 18.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.5 tp -138.88 123.01 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -87.5 173.2 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -172.8 172.13 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 15.4 mt 60.55 53.25 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.5 m -120.17 120.44 36.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -152.0 145.68 13.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.478 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -178.6 2.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.356 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 83.1 p -155.12 166.99 31.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 81.1 p -112.14 173.94 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.7 t -107.13 127.78 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -71.28 -49.87 38.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 116.37 -130.5 9.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -106.14 122.3 45.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.0 110.879 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -150.17 154.98 38.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.44 -161.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.444 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -94.53 -46.26 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -159.24 154.78 25.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.8 m -80.36 132.14 32.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.177 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 190' ' ' ARG . 16.7 t-20 42.33 43.65 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 0.0 OUTLIER -36.34 147.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.38 -16.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.171 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 tt -59.53 107.72 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 56.0 m -146.27 171.63 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.97 -29.17 7.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.01 -32.36 71.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.07 60.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.9 mt -57.83 152.28 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -129.95 148.93 71.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 110.937 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 120.27 7.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 134.65 -12.02 4.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.576 ' O ' HG23 ' A' ' 255' ' ' ILE . 15.0 mtt -80.97 140.38 35.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.614 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -95.2 120.5 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.1 mp -130.54 125.36 34.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.5 m -94.39 120.41 34.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.76 -174.43 14.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.3 p -123.55 142.38 51.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.116 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.09 120.4 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.3 t -85.16 -41.8 15.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -157.03 155.05 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.561 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 mm? -95.08 107.49 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -94.13 149.38 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.425 ' O ' HD11 ' A' ' 230' ' ' LEU . 26.7 t70 -72.55 -31.09 65.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -84.24 -28.75 27.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -168.96 -158.75 13.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.662 ' CD1' HD12 ' A' ' 246' ' ' LEU . 97.0 m-85 -123.02 131.62 53.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 226' ' ' ALA . 3.1 mm? -86.04 129.83 34.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.37 134.02 56.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.09 137.07 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.8 pt -126.27 -30.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.88 55.24 2.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 222' ' ' ASP . 25.2 t -140.18 155.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -101.23 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.36 44.19 6.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.534 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.0 m -144.18 131.5 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.338 . . . . 0.0 111.139 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -115.62 125.9 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -121.9 122.19 38.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 17.6 t80 -125.52 140.52 52.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 229' ' ' PRO . 12.2 tp -110.28 129.79 23.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.658 0.742 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.3 Cg_endo -69.74 135.26 30.07 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 212' ' ' ASP . 39.0 mt -63.1 -23.82 67.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.77 -45.18 87.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.936 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.4 tppp? -85.12 -32.8 22.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.43 80.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -58.65 -34.01 70.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.87 -43.79 91.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t80 -72.83 -42.17 64.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 241' ' ' ASN . 22.6 mt -68.13 -40.78 83.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.485 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 11.8 ptm180 -70.11 -35.78 74.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -81.19 -34.59 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 24.0 mmtp -100.75 -59.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.704 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -80.31 19.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.52 26.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.1 46.68 4.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.78 116.33 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -38.21 133.13 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.662 HD12 ' CD1' ' A' ' 215' ' ' TYR . 49.6 mt -69.97 171.28 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -126.14 175.44 7.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 210' ' ' LEU . 42.7 t -92.15 132.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.19 -27.56 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.528 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -63.2 147.88 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -81.03 126.99 32.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.72 138.3 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -85.63 135.12 33.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.2 m -156.33 154.58 30.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 201' ' ' MET . 43.2 mt -134.4 142.16 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.21 119.35 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.67 -46.4 5.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -150.15 158.39 44.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -120.54 129.38 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.32 156.54 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -70.09 159.58 53.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 48.21 34.97 4.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 42.18 36.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.07 -81.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.61 146.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.7 t -113.44 138.8 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.6 t -100.78 117.76 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.7 mt -116.69 157.69 25.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' ILE . 73.0 p -154.72 142.0 19.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 232' ' ' LYS . 32.9 m -72.31 132.14 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -157.87 93.27 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -69.18 -51.93 33.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 90.8 p -53.74 173.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -137.64 126.58 24.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 276' ' ' SER . 27.7 m -99.79 -43.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.174 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.48 ' N ' HG23 ' A' ' 275' ' ' VAL . 30.2 t -49.32 151.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 34.7 p -82.08 164.63 21.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -86.73 155.59 20.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.894 HG22 ' H ' ' A' ' 281' ' ' THR . 66.9 mt -51.44 142.0 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.522 ' HB1' ' HG3' ' A' ' 282' ' ' GLU . . . -75.42 -20.11 59.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.894 ' H ' HG22 ' A' ' 279' ' ' ILE . 0.7 OUTLIER 45.79 28.6 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLU . . . . . 0.522 ' HG3' ' HB1' ' A' ' 280' ' ' ALA . 32.9 mt-10 -61.19 123.5 17.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.17 -43.27 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -42.79 114.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 68.3 m -111.31 126.65 55.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -55.34 -35.47 65.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -48.64 157.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.71 101.74 11.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -161.11 147.45 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -106.43 130.1 54.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.82 95.37 10.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.9 m -97.91 125.46 42.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.01 82.94 0.57 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 108.97 2.2 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.6 t -62.69 140.8 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.9 t -153.55 145.26 23.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -134.01 146.37 59.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.547 0.689 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 115.17 3.97 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.683 2.256 . . . . 0.0 112.361 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 139.76 -11.04 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.595 ' HB3' HD11 ' A' ' 203' ' ' LEU . 19.1 mtt -73.77 132.7 42.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.0 mp -93.14 113.59 25.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 203' ' ' LEU . 2.0 mp -130.88 134.13 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.0 m -83.12 118.12 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -114.73 160.55 13.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.0 p -122.53 137.07 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.21 120.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.0 t -86.27 -45.53 11.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.1 m -156.99 156.01 32.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' A' ' 215' ' ' TYR . 1.2 mm? -91.5 124.31 35.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -107.89 164.83 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -22.78 35.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.534 ' CD2' ' H ' ' A' ' 213' ' ' HIS . 4.0 p80 -98.09 -20.68 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -179.95 -149.28 8.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.577 ' HD2' HD13 ' A' ' 210' ' ' LEU . 27.0 m-85 -133.99 138.4 45.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.973 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 132.85 33.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.95 129.45 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.97 126.89 31.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.8 pt -119.95 -20.06 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.51 51.99 4.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.75 141.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.01 116.59 28.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 104.05 -42.85 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.518 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.5 m -74.44 125.42 28.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -114.74 132.09 56.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.93 124.54 51.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 5.5 t80 -123.27 143.39 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 268' ' ' LEU . 14.2 tp -113.29 134.55 21.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.477 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.85 144.45 53.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.303 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 17.4 mt -63.03 -26.44 68.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.6 -44.18 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -82.19 -42.09 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -64.57 -48.95 73.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 36.0 tt0 -62.85 -33.99 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.68 -42.65 91.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE1' ' CD1' ' A' ' 252' ' ' LEU . 3.9 t80 -72.29 -37.36 69.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.686 HG12 HD21 ' A' ' 246' ' ' LEU . 30.6 mt -69.66 -47.27 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.3 ptp180 -59.45 -40.52 87.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -79.98 -21.55 43.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 236' ' ' TYR . 37.4 mmtm -99.14 -72.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.77 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.0 t-20 -83.69 35.85 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 241' ' ' ASN . 20.2 mtpp 34.44 33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 81.47 70.64 1.33 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.77 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -148.25 137.69 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 111.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -44.52 147.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.712 HD22 HE22 ' A' ' 250' ' ' GLN . 69.1 mt -86.34 -175.09 5.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -122.55 176.75 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 147.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.26 24.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.712 HE22 HD22 ' A' ' 246' ' ' LEU . 4.3 pt20 -72.07 148.01 46.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -81.0 126.97 32.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.513 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 15.4 tp -136.66 135.97 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -76.07 134.43 40.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.639 ' HB3' HD22 ' A' ' 268' ' ' LEU . 73.9 m -152.64 144.85 23.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.641 HD12 ' HA3' ' A' ' 271' ' ' GLY . 65.2 mt -133.77 138.9 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.96 119.44 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -106.48 -30.49 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -151.78 149.85 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.05 133.09 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -84.35 150.99 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -60.39 -67.61 2.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -88.13 41.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 44.15 42.74 6.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.63 -73.12 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.447 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.23 136.87 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 42.3 t -104.28 139.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 114.03 26.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 254' ' ' CYS . 17.1 mt -111.76 149.45 31.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.6 m -149.12 150.43 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.12 118.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.641 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.842 0.353 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.44 ' H ' ' CE ' ' A' ' 201' ' ' MET . 3.5 mptt -108.21 147.65 36.0 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.894 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 140.87 43.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 103.76 7.22 42.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.44 ' CE ' ' H ' ' A' ' 198' ' ' LYS . 47.4 mtt -80.66 139.26 36.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.5 mp -88.84 108.62 19.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 202' ' ' LEU . 4.4 mp -124.28 150.98 44.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.3 m -117.48 117.06 28.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -119.65 -172.63 15.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.45 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 251' ' ' TYR . 7.6 p -129.02 139.62 51.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 111.138 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.18 120.41 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.9 t -86.41 -38.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.5 p -157.0 155.75 31.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.64 123.96 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.76 168.28 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.863 ' O ' HD11 ' A' ' 230' ' ' LEU . 7.4 p-10 -85.99 -24.19 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -92.02 -14.56 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . 175.82 -167.44 39.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.09 137.07 53.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 128.59 36.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.5 135.55 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -86.55 135.71 33.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.74 -13.49 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.81 50.71 23.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 222' ' ' ASP . 38.4 t -134.49 155.97 39.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.127 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 221' ' ' VAL . 13.8 t70 -102.14 122.26 43.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.73 36.95 17.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 42.5 m -151.65 123.59 8.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -114.17 131.37 56.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.04 135.32 53.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 9.1 t80 -129.76 142.74 50.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.882 HD12 ' HD2' ' A' ' 229' ' ' PRO . 10.3 tp -113.99 133.44 22.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.882 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.71 143.22 50.35 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.863 HD11 ' O ' ' A' ' 212' ' ' ASP . 25.6 mt -62.67 -22.92 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.34 -44.23 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -83.25 -33.21 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.0 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.23 -42.2 99.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.69 -41.45 96.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.546 ' HB2' HG21 ' A' ' 270' ' ' VAL . 2.4 t80 -72.41 -40.05 67.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 241' ' ' ASN . 43.5 mt -68.09 -43.01 85.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 8.1 ptm180 -66.61 -40.3 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 37.8 mm-40 -79.96 -20.15 46.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 21.4 mmtm -101.31 -69.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.781 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 12.3 t-20 -84.37 32.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.8 OUTLIER 37.32 28.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.58 64.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.448 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.781 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.49 130.94 21.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 111.054 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -46.77 155.14 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 237' ' ' ILE . 14.3 mt -94.38 175.54 6.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -129.38 134.46 47.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.78 141.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.16 -27.0 16.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.67 148.36 52.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.61 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.1 m-85 -81.99 130.27 35.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.462 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 38.1 tp -123.64 138.35 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -81.24 134.9 35.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.609 ' HB3' HD22 ' A' ' 268' ' ' LEU . 58.0 m -157.5 150.6 23.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.5 mt -127.13 139.56 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.89 123.09 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.39 -46.17 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -144.74 152.09 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.79 122.01 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 55.0 mttt -79.3 133.11 36.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -36.43 -45.48 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -109.09 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -78.33 61.51 3.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -93.95 -81.13 1.5 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.24 143.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.02 139.96 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 17.9 t -99.69 131.32 45.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 254' ' ' CYS . 20.5 mt -126.69 157.63 38.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 97.3 p -157.08 143.54 18.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 236' ' ' TYR . 38.6 t -71.01 131.46 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.459 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -129.45 153.66 80.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 109.45 2.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.7 28.97 1.01 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 255' ' ' ILE . 28.6 mtt -96.4 136.74 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.862 ' C ' HD12 ' A' ' 203' ' ' LEU . 3.6 mp -96.89 111.99 23.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.862 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.9 mp -131.09 149.14 52.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -102.1 120.22 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.91 177.71 17.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.2 p -126.68 136.83 52.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 122.74 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.1 t -86.07 -46.02 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.6 p -157.07 156.03 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.13 127.8 46.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -113.3 144.79 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.648 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -64.57 -23.61 67.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -94.9 -39.44 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -153.47 -159.48 9.14 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.438 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.639 ' CE2' HD23 ' A' ' 230' ' ' LEU . 58.9 m-85 -133.66 132.77 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.93 125.28 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.09 137.03 34.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.97 -30.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.48 47.6 5.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 138.48 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.14 109.61 20.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.86 36.86 3.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 266' ' ' VAL . 63.5 m -150.06 128.67 12.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.314 . . . . 0.0 111.128 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -114.66 126.33 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.521 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -114.82 127.66 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 18.2 t80 -132.26 126.44 33.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 229' ' ' PRO . 17.6 tp -104.94 130.27 23.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 143.19 49.9 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.1 mt -63.29 -29.26 70.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.61 -45.21 93.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -80.27 -42.1 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.0 98.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.85 -30.38 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.41 -43.88 84.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' CE1' HD11 ' A' ' 252' ' ' LEU . 0.8 OUTLIER -73.29 -37.81 66.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 246' ' ' LEU . 17.3 mt -68.25 -50.89 53.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 26.2 ptt85 -57.03 -40.08 76.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -80.04 -31.47 39.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 26.3 mmtt -88.28 -69.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.745 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.9 t-20 -83.58 35.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASN . 60.9 mttp 34.21 33.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.3 58.59 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -136.55 128.0 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -40.32 130.59 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.731 HD21 HG12 ' A' ' 237' ' ' ILE . 21.2 mt -70.04 -175.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -127.75 178.52 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 249' ' ' GLY . 59.2 t -92.09 153.43 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . . . 63.27 12.57 45.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.485 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.561 HE22 HD22 ' A' ' 246' ' ' LEU . 4.6 pt20 -82.4 147.98 28.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.94 126.81 31.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.572 HD11 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -135.04 142.25 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.478 ' O ' HG22 ' A' ' 270' ' ' VAL . 45.6 p-10 -96.47 133.06 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 92.0 m -146.76 159.69 43.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 201' ' ' MET . 86.1 mt -136.74 137.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.12 131.24 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.24 -41.53 5.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -150.68 153.06 34.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.8 t -123.76 121.28 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -127.6 143.25 51.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 54.77 165.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.452 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 262' ' ' ASN . 38.3 p30 -95.6 40.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 142.1 40.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.443 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -108.25 -95.0 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.6 137.43 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 224' ' ' THR . 77.9 t -114.61 139.89 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.161 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.6 t -99.12 125.2 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.521 ' CD1' ' HB1' ' A' ' 226' ' ' ALA . 39.0 mt -121.02 152.09 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 255' ' ' ILE . 93.8 p -159.77 143.23 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 253' ' ' ASN . 56.9 t -80.9 122.39 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.445 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.94 150.77 63.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.721 . . . . 0.0 110.891 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.354 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.43 11.79 3.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.4 mtt -99.14 130.95 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.583 ' C ' HD22 ' A' ' 203' ' ' LEU . 5.5 mp -86.42 107.94 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.3 mm? -121.26 130.72 53.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.975 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -93.55 129.4 39.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -136.01 -173.04 12.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 251' ' ' TYR . 5.6 p -130.89 140.07 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 111.114 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.99 119.94 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.1 t -86.36 -39.74 16.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.3 m -157.01 156.02 32.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.413 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.4 mp -106.76 125.41 50.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -117.24 144.62 44.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.769 ' O ' HD11 ' A' ' 230' ' ' LEU . 2.6 m-20 -66.36 -17.76 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -95.23 -27.39 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -170.02 -159.05 14.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.472 ' CD1' HD12 ' A' ' 246' ' ' LEU . 63.7 m-85 -133.34 129.44 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 126.17 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.95 135.31 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.78 133.65 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 pt -123.09 -22.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.06 50.03 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -143.53 147.79 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.41 124.32 35.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.4 -51.72 1.83 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.535 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -59.92 124.95 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -115.8 132.01 56.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -115.25 125.83 53.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 14.1 t80 -123.32 137.13 54.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 233' ' ' ALA . 13.0 tp -112.79 132.34 22.32 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.58 0.705 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 140.59 43.0 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.345 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.769 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.9 mt -63.08 -19.88 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.77 -44.53 66.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HG3' HG23 ' A' ' 270' ' ' VAL . 0.4 OUTLIER -79.64 -35.54 39.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.444 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -72.47 -43.05 64.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 11.3 tt0 -58.46 -36.81 74.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.75 -43.18 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.2 OUTLIER -72.1 -38.52 69.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.671 HG12 HD21 ' A' ' 246' ' ' LEU . 22.0 mt -66.3 -39.01 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.113 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -69.18 -41.98 76.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -79.83 -21.65 43.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.548 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 24.1 mmtt -100.17 -67.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.748 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.3 t-20 -84.3 32.81 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' ASN . 76.2 mttt 37.94 27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 85.94 61.58 1.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.748 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -142.65 134.12 26.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.86 148.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.671 HD21 HG12 ' A' ' 237' ' ' ILE . 94.5 mt -78.58 -177.66 5.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.6 145.89 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.2 128.53 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.56 -27.13 20.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.93 147.96 48.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 206' ' ' THR . 12.6 m-85 -80.97 132.01 35.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.73 141.45 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.74 133.86 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.702 ' HB3' HD22 ' A' ' 268' ' ' LEU . 85.1 m -155.28 151.13 27.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.02 147.0 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 200' ' ' GLY . 2.9 t -72.72 120.28 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -107.07 -48.47 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -137.77 135.37 36.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.35 122.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -126.05 134.34 51.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 65.75 -157.77 47.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.99 -42.5 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.93 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -130.72 32.2 3.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -90.53 -101.37 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.72 134.78 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.25 139.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.7 m -99.1 117.12 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.9 mt -110.9 157.66 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -148.63 142.0 25.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 232' ' ' LYS . 36.1 t -75.21 141.61 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.071 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.856 0.36 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -127.55 143.91 49.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.55 0.691 . . . . 0.0 110.897 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 109.1 2.23 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 146.98 -11.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.7 mtm -79.1 141.27 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.833 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.1 108.08 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.3 128.44 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -94.3 130.87 40.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.11 -163.64 9.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.5 p -131.11 146.03 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.194 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.43 121.67 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.3 t -85.83 -43.05 13.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.575 ' HA ' HG22 ' A' ' 248' ' ' VAL . 5.2 m -157.05 156.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.859 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 246' ' ' LEU . 6.5 mp -106.49 125.1 50.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -116.95 162.17 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.5 m-20 -83.23 -22.93 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -96.15 -9.82 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 177.3 -161.4 28.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.647 ' CD2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -132.86 137.55 46.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.961 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.95 129.91 36.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.71 143.1 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.46 133.78 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.8 pt -125.1 -18.96 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.94 51.7 17.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 150.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.834 0.349 . . . . 0.0 111.116 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -93.84 119.2 32.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.96 43.68 13.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.1 m -155.22 123.71 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -113.43 131.42 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.79 48.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 13.0 t80 -122.92 140.48 52.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.721 HD12 ' HD2' ' A' ' 229' ' ' PRO . 23.5 tp -113.81 133.69 22.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.721 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.78 146.76 61.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.316 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.865 HD11 ' O ' ' A' ' 212' ' ' ASP . 74.5 mt -63.07 -22.76 67.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.4 -45.01 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 270' ' ' VAL . 15.0 mmtm -81.96 -37.7 26.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.627 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.32 -46.1 85.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.058 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -65.21 -39.26 92.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.7 -43.24 89.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 2.2 t80 -72.64 -42.26 64.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 233' ' ' ALA . 18.7 mt -65.23 -38.94 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.146 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.462 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 1.2 ttt85 -68.79 -43.72 75.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -79.0 -21.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 39.2 mmtt -99.31 -68.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.06 34.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 241' ' ' ASN . 79.5 mttt 34.73 34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 78.1 74.63 1.01 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -152.24 118.73 5.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -35.61 135.76 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.647 HD12 ' CD2' ' A' ' 215' ' ' TYR . 51.7 mt -69.22 -175.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 246' ' ' LEU . 3.4 mtpm? -144.7 130.06 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 209' ' ' SER . 23.9 t -50.62 126.05 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 109.83 -31.37 7.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.496 ' NE2' HD22 ' A' ' 246' ' ' LEU . 9.1 pt20 -62.99 148.17 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.909 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -80.73 130.82 35.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.455 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -124.3 145.32 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.18 127.48 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 268' ' ' LEU . 35.0 m -147.2 155.19 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 271' ' ' GLY . 95.3 mt -133.03 139.43 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.29 119.39 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -103.9 -48.07 4.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -138.6 140.28 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.8 t -122.16 129.11 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -85.41 176.29 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -87.97 -54.51 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -85.85 30.64 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 45.5 32.03 3.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.01 -74.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.8 t -132.68 134.24 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.33 139.6 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.7 t -99.97 118.4 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 254' ' ' CYS . 18.3 mt -113.64 149.88 33.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 255' ' ' ILE . 52.3 p -145.94 142.01 28.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 232' ' ' LYS . 17.3 m -73.93 134.65 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.853 0.358 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -100.4 148.93 35.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.567 0.698 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 129.91 8.04 3.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.706 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.9 mtt -76.16 140.36 41.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 203' ' ' LEU . 5.4 mp -86.5 108.62 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -130.39 141.1 50.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.4 m -119.57 122.23 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.3 -177.61 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -124.16 138.08 54.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.47 122.88 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -88.23 -40.68 13.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.97 156.07 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 248' ' ' VAL . 3.8 mm? -99.86 115.42 29.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.442 ' OE1' HD21 ' A' ' 216' ' ' LEU . 24.3 mt-10 -98.25 137.21 37.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 230' ' ' LEU . 8.5 t0 -57.2 -20.55 27.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -94.5 -38.3 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -161.24 -161.94 12.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.531 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.937 ' CE2' HD12 ' A' ' 246' ' ' LEU . 41.3 m-85 -117.63 132.14 56.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.442 HD21 ' OE1' ' A' ' 211' ' ' GLU . 1.9 mm? -92.01 133.54 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.76 142.66 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.4 123.07 33.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.7 -33.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.03 37.35 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.443 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.4 t -113.11 146.29 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -97.13 98.75 10.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.03 46.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 91.2 m -158.3 124.1 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -116.7 123.92 48.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -116.01 129.33 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 18.9 t80 -130.48 137.65 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.86 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -107.87 126.81 28.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.86 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.78 131.66 21.66 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.688 2.259 . . . . 0.0 112.372 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.702 HD23 ' HE1' ' A' ' 215' ' ' TYR . 30.5 mt -62.4 -24.75 67.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.6 mt -65.6 -41.27 92.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -42.51 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -59.3 -34.14 71.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.45 -34.01 70.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.41 -43.66 76.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.86 -37.79 67.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 241' ' ' ASN . 32.4 mt -68.42 -42.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 28.3 ptt180 -68.73 -35.98 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 12.1 mm100 -78.38 -39.9 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -98.1 -74.93 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m120 -52.47 -16.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 237' ' ' ILE . 32.5 mttp 59.54 36.53 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.41 46.88 5.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -136.57 117.42 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -49.57 135.54 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 215' ' ' TYR . 28.3 mt -62.6 179.2 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -131.27 170.8 14.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.55 HG23 HD23 ' A' ' 210' ' ' LEU . 19.3 t -87.73 128.66 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.55 -21.93 37.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.717 ' OE1' HD22 ' A' ' 246' ' ' LEU . 1.5 pt20 -64.36 148.0 51.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -81.0 127.17 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.96 135.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.756 ' O ' HG12 ' A' ' 270' ' ' VAL . 1.1 p-10 -93.28 125.31 37.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 13.3 m -140.28 157.64 45.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 201' ' ' MET . 73.3 mt -136.84 140.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 200' ' ' GLY . 39.0 t -61.04 119.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -99.87 -46.89 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -140.1 152.89 46.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.438 ' C ' ' HE2' ' A' ' 260' ' ' LYS . 71.9 t -124.0 127.29 73.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.438 ' HE2' ' C ' ' A' ' 259' ' ' VAL . 0.3 OUTLIER -97.72 167.72 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -88.92 171.1 38.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.514 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 261' ' ' GLY . 3.0 p-10 45.52 40.67 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 40.47 47.34 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.54 -98.56 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.59 146.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.02 139.99 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 m -98.97 115.44 28.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 226' ' ' ALA . 12.0 mt -113.23 148.77 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 46.3 m -158.78 142.07 14.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 253' ' ' ASN . 2.4 m -74.97 142.86 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.482 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.871 0.367 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -153.26 155.25 31.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.561 0.696 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 113.56 3.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.398 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.47 4.11 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.3 mtt -90.62 130.89 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.7 mp -91.93 109.02 20.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.66 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.7 mm? -123.63 127.99 49.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m -97.78 119.45 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.42 -172.31 14.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.521 HG23 ' CD1' ' A' ' 251' ' ' TYR . 1.2 p -128.55 139.32 52.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.29 122.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -92.62 -40.43 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.98 156.09 32.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.28 125.15 51.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.87 150.97 34.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.767 ' O ' HD11 ' A' ' 230' ' ' LEU . 40.3 m-20 -70.17 -17.05 63.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -98.06 -25.77 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -172.27 -169.74 35.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 246' ' ' LEU . 82.6 m-85 -122.08 131.23 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.945 0.403 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.04 124.44 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.92 130.16 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.09 137.07 36.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 pt -123.44 -31.84 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.58 44.43 6.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.05 140.43 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.71 111.56 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.15 37.83 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 93.1 m -154.87 123.36 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 111.162 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.34 123.03 47.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.41 127.68 53.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 23.5 t80 -131.07 137.34 49.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.987 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.1 tp -109.29 128.61 25.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.73 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.76 143.42 50.77 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.767 HD11 ' O ' ' A' ' 212' ' ' ASP . 75.2 mt -62.99 -26.81 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.4 -40.46 95.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.854 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -83.13 -35.72 25.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.54 63.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -58.23 -35.32 71.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.7 -46.02 76.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.695 ' HB2' HG21 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -71.3 -36.93 71.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.983 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.852 HG12 HD21 ' A' ' 246' ' ' LEU . 21.7 mt -68.89 -38.92 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 2.7 ttm-85 -69.02 -41.18 78.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.5 -19.98 48.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 7.5 mmtp -101.82 -69.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.567 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 17.1 t-20 -84.16 33.52 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 241' ' ' ASN . 53.8 mttt 34.63 34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 77.75 73.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.484 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.567 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -151.3 124.4 8.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 244' ' ' ALA . 20.4 mmtm -37.22 144.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.852 HD21 HG12 ' A' ' 237' ' ' ILE . 13.8 mt -80.95 178.9 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.76 127.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 108.18 -27.24 14.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -63.44 148.0 49.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.521 ' CD1' HG23 ' A' ' 206' ' ' THR . 15.5 m-85 -81.03 127.28 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.3 tp -121.04 139.36 53.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -88.87 132.47 34.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.741 ' HB3' HD22 ' A' ' 268' ' ' LEU . 43.3 m -153.04 153.74 33.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 201' ' ' MET . 72.9 mt -136.8 143.75 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.48 121.45 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -101.62 -41.97 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -150.67 155.98 40.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.19 119.2 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 261' ' ' GLY . 35.6 tttp -86.42 135.03 33.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . 35.92 -149.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -120.35 72.5 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.81 24.04 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -95.46 -87.39 1.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.19 148.98 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.46 139.97 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.0 t -100.01 118.08 35.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 254' ' ' CYS . 16.4 mt -111.97 150.16 30.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 255' ' ' ILE . 1.4 t -146.28 146.98 30.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.854 HG22 ' HD2' ' A' ' 232' ' ' LYS . 28.9 m -74.7 136.16 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.882 0.373 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -153.22 148.16 19.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.85 10.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.05 6.19 6.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.0 mtt -89.78 127.71 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.4 mp -89.61 109.87 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -131.49 127.05 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m -84.13 119.66 25.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.94 163.84 12.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 251' ' ' TYR . 1.3 p -113.5 135.47 53.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.812 0.339 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.99 121.06 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 248' ' ' VAL . 41.8 t -86.17 -45.09 11.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 85.1 p -157.02 155.97 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.47 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.1 mp -101.63 129.22 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -116.31 151.88 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 230' ' ' LEU . 5.8 m-20 -71.05 -21.78 62.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -96.74 -17.19 20.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 179.55 -158.88 23.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.468 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.6 m-85 -131.29 135.8 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.921 0.391 . . . . 0.0 110.897 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.44 129.55 35.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.1 128.4 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.01 132.82 36.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.48 -19.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.18 57.68 5.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.86 139.79 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.79 94.23 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.26 39.38 0.87 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 85.5 m -156.98 131.59 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.63 123.76 48.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.02 122.99 47.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -124.84 142.42 51.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.683 HD12 ' HD2' ' A' ' 229' ' ' PRO . 19.7 tp -113.75 134.6 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.609 0.718 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.83 142.55 47.95 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 212' ' ' ASP . 79.1 mt -63.1 -22.2 66.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.91 -43.26 79.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.968 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.9 OUTLIER -81.76 -33.22 31.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -75.15 -51.87 12.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -60.26 -36.92 78.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.49 -41.57 98.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 4.9 t80 -73.25 -41.83 63.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 241' ' ' ASN . 47.0 mt -63.02 -39.85 86.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.6 ptm180 -69.77 -35.68 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 6.5 mm100 -81.4 -29.22 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 14.1 mmmt -107.99 -63.39 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.765 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.7 m-20 -80.73 21.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.9 mmtm 35.82 30.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.15 40.33 8.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -104.81 113.37 26.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -40.39 126.3 2.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 237' ' ' ILE . 15.4 mt -64.23 -175.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -137.31 -175.91 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 208' ' ' SER . 98.4 t -97.53 145.79 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.79 81.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.41 HE22 HD22 ' A' ' 246' ' ' LEU . 5.1 pt20 -82.86 148.01 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.436 ' HA ' HG22 ' A' ' 206' ' ' THR . 15.1 m-85 -80.95 128.66 33.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 12.5 tp -131.4 142.89 50.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -98.89 131.59 44.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.739 ' HB3' HD22 ' A' ' 268' ' ' LEU . 97.1 m -154.03 163.05 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.453 ' O ' HD23 ' A' ' 268' ' ' LEU . 70.0 mt -134.63 150.37 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.51 121.57 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 269' ' ' SER . 3.9 mp0 -104.75 -40.56 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -142.99 148.83 37.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.08 126.03 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.3 144.57 36.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.34 -65.52 3.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -86.71 37.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 46.98 36.39 8.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.04 -82.48 0.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.79 134.31 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 38.1 t -108.86 139.98 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 t -99.07 121.48 41.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 254' ' ' CYS . 11.5 mt -118.42 154.13 32.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.406 ' N ' ' OE1' ' A' ' 257' ' ' GLU . 36.4 t -154.05 152.41 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.84 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.968 HG22 ' HD2' ' A' ' 232' ' ' LYS . 20.2 m -80.09 139.99 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -134.39 151.48 76.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 121.2 7.89 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.368 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.25 5.28 3.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.1 mtt -96.42 133.59 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.324 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -85.43 116.28 23.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.0 mp -120.92 130.22 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.3 m -97.99 126.15 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -138.46 -177.12 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.509 HG23 ' CE1' ' A' ' 251' ' ' TYR . 12.5 p -121.69 141.29 51.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.93 120.04 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.8 t -86.18 -39.29 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.1 m -157.02 156.01 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 246' ' ' LEU . 6.9 mp -108.53 122.9 48.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.08 156.96 20.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.579 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.7 m-20 -75.35 -23.52 57.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -94.53 -22.17 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.5 -164.89 27.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.491 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 246' ' ' LEU . 75.0 m-85 -127.55 133.21 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.91 128.28 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.01 132.64 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.97 136.67 36.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 pt -127.4 -26.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.78 56.29 2.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.503 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 89.5 t -139.88 132.82 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.36 46.45 1.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 167.48 42.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.563 ' CG2' HG21 ' A' ' 266' ' ' VAL . 54.5 m -160.43 124.42 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -107.32 125.13 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.99 125.66 53.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.742 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.2 tp -104.3 132.06 21.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.742 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.3 Cg_endo -69.75 146.62 60.82 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.312 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 212' ' ' ASP . 23.7 mt -63.03 -26.58 68.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.41 -44.39 89.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 270' ' ' VAL . 26.9 mmtm -82.39 -41.89 19.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.76 -46.3 84.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -62.7 -38.82 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -65.44 -44.67 86.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CD1' ' HG3' ' A' ' 240' ' ' LYS . 83.5 t80 -70.13 -38.66 75.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 41.3 mt -69.21 -44.28 80.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.5 ptm180 -69.65 -37.44 76.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -81.52 -27.14 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CD1' ' A' ' 236' ' ' TYR . 7.2 mmpt? -107.75 -64.91 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.1 m120 -81.62 25.5 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ASN . 1.2 pmtp? 32.74 34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 102.31 -45.27 1.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -34.42 120.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -53.61 152.7 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.609 HD22 ' NE2' ' A' ' 250' ' ' GLN . 17.7 mt -76.3 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -132.12 129.82 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.8 t -46.67 131.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 105.73 -30.22 10.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.609 ' NE2' HD22 ' A' ' 246' ' ' LEU . 10.2 pt20 -62.93 147.97 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.942 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.509 ' CE1' HG23 ' A' ' 206' ' ' THR . 10.6 m-85 -81.02 130.21 34.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 145.06 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -94.28 129.05 41.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.964 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.782 ' HB3' HD22 ' A' ' 268' ' ' LEU . 63.7 m -148.43 151.99 36.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 201' ' ' MET . 38.5 mt -130.79 145.95 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 203' ' ' LEU . 6.2 t -70.29 122.58 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -105.5 -45.23 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -138.78 136.53 35.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 36.1 t -122.67 125.74 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 261' ' ' GLY . 34.7 ttpt -90.14 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -37.25 -60.06 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -93.44 174.34 7.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -80.66 51.76 4.3 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -77.18 -80.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.97 133.89 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 111.133 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 224' ' ' THR . 22.1 t -106.34 139.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.1 t -101.43 125.72 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 254' ' ' CYS . 45.6 mt -116.51 157.16 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 60.1 p -151.45 156.76 41.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 232' ' ' LYS . 41.7 t -78.19 131.85 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -160.8 154.22 18.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 126.37 13.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.676 2.25 . . . . 0.0 112.377 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 127.74 0.84 6.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.8 mtt -90.05 128.7 36.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.36 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.6 mp -89.46 117.33 28.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 203' ' ' LEU . 3.9 mp -130.79 128.96 41.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 31.6 m -85.02 124.33 31.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.86 169.25 20.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 251' ' ' TYR . 2.7 p -119.24 138.12 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.83 121.99 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.8 t -86.49 -42.01 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.437 ' HA ' HG22 ' A' ' 248' ' ' VAL . 1.8 t -157.04 156.3 32.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -106.75 125.13 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.91 154.89 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.633 ' O ' HD11 ' A' ' 230' ' ' LEU . 10.1 p-10 -72.81 -18.99 61.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -97.52 -30.41 12.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -165.13 -165.6 22.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -127.94 131.74 49.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.78 125.9 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.1 t -112.22 132.87 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -79.96 131.79 35.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 pt -124.05 -18.77 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.78 40.06 89.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.95 138.04 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.23 127.93 34.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.82 56.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.477 ' CG2' HG21 ' A' ' 266' ' ' VAL . 56.4 m -149.97 123.87 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -109.37 130.73 55.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -131.72 140.25 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.738 HD12 ' HD2' ' A' ' 229' ' ' PRO . 22.6 tp -114.99 133.17 22.69 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.738 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.76 145.24 56.59 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.3 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 212' ' ' ASP . 30.7 mt -63.38 -21.63 66.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.11 -44.7 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.824 ' HD2' HG22 ' A' ' 270' ' ' VAL . 17.5 tppt? -78.25 -30.69 48.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -77.01 -44.32 31.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -58.34 -33.4 69.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.58 -43.9 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 0.8 OUTLIER -72.89 -35.49 67.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 241' ' ' ASN . 39.8 mt -70.64 -40.9 77.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.182 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.486 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 16.2 ptt85 -69.52 -37.44 77.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -80.76 -39.14 27.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 63.3 mmtt -94.05 -57.58 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.637 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -81.99 23.26 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.1 OUTLIER 34.09 32.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.79 45.4 7.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -122.92 112.29 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.13 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -34.19 132.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.2 mt -65.44 -176.56 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.91 141.89 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 209' ' ' SER . 92.3 t -57.68 151.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.29 -21.49 6.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.36 148.53 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.413 ' HA ' HG22 ' A' ' 206' ' ' THR . 11.3 m-85 -85.01 128.31 34.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.0 tp -126.08 135.73 52.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -92.75 131.49 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 82.6 m -152.74 162.98 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.19 144.44 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 9.3 t -66.43 119.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -106.65 -46.91 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -132.26 136.02 46.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.15 132.84 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.4 ' CB ' ' H ' ' A' ' 265' ' ' VAL . 13.3 tptm -84.37 158.0 21.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -51.59 -94.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 263' ' ' GLY . 20.0 p-10 -73.67 64.13 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 36.57 42.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -66.47 -73.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.4 ' H ' ' CB ' ' A' ' 260' ' ' LYS . 75.5 t -133.87 133.44 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.364 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 224' ' ' THR . 19.0 t -105.15 137.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . 0.755 ' C ' HD22 ' A' ' 268' ' ' LEU . 2.5 m -99.66 138.71 36.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 267' ' ' SER . 1.0 OUTLIER -121.05 148.35 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.3 p -151.75 141.87 22.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.824 HG22 ' HD2' ' A' ' 232' ' ' LYS . 33.7 m -79.45 141.82 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.53 ' N ' ' HE3' ' A' ' 201' ' ' MET . 49.7 mtmt -158.61 154.01 22.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.718 . . . . 0.0 110.84 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 107.26 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.722 2.282 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.69 7.01 3.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.558 ' HB3' HD11 ' A' ' 203' ' ' LEU . 8.6 mtt -92.8 132.66 36.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.41 112.22 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 201' ' ' MET . 2.1 mp -131.16 129.44 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.7 m -76.99 117.84 18.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -121.06 152.08 16.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -107.58 141.54 38.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.09 121.06 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.1 t -86.45 -46.13 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -157.07 156.42 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.23 126.9 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -115.21 156.41 25.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.659 ' O ' HD11 ' A' ' 230' ' ' LEU . 13.5 t70 -72.82 -24.04 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -87.96 -32.44 18.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.6 -159.55 18.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 246' ' ' LEU . 96.3 m-85 -125.19 139.92 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.32 130.83 44.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.97 146.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.55 129.68 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.506 HD11 ' CG2' ' A' ' 224' ' ' THR . 31.8 pt -121.76 -27.58 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.03 34.64 6.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.84 127.54 64.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.33 94.55 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.37 -33.47 0.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.506 ' CG2' HD11 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -92.66 151.04 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 111.163 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.78 121.09 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.14 127.62 54.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 6.2 t80 -132.09 137.03 47.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.49 HD23 ' HB2' ' A' ' 233' ' ' ALA . 11.1 tp -105.96 131.76 21.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 139.42 39.97 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.672 2.248 . . . . 0.0 112.321 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.659 HD11 ' O ' ' A' ' 212' ' ' ASP . 26.3 mt -63.11 -21.0 65.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 12.4 mt -70.79 -45.02 65.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.0 OUTLIER -81.87 -28.03 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.49 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -79.9 -49.13 12.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 33.3 tt0 -58.02 -44.38 87.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 236' ' ' TYR . 6.8 pt-20 -60.9 -40.43 93.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.652 ' CE1' HD11 ' A' ' 252' ' ' LEU . 1.2 t80 -73.12 -36.82 66.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 241' ' ' ASN . 31.1 mt -70.02 -40.95 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 4.8 ptm180 -69.1 -39.55 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -80.19 -19.93 45.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 19.0 mmmt -105.88 -67.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.72 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.5 t-20 -84.11 29.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.0 pttm 37.44 28.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.41 50.46 4.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.72 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -125.58 122.27 36.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.67 138.44 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.626 HD12 ' CD2' ' A' ' 215' ' ' TYR . 18.4 mt -71.99 -174.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -127.79 -174.93 3.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.91 144.16 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.98 3.52 11.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 251' ' ' TYR . 0.8 OUTLIER -66.66 144.87 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.883 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.481 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 23.7 m-85 -80.8 126.66 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 236' ' ' TYR . 6.0 tp -136.75 137.15 39.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.692 ' O ' HG12 ' A' ' 270' ' ' VAL . 21.5 t-20 -81.58 132.42 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 89.9 m -149.64 152.05 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.8 mt -137.08 146.44 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.4 t -74.24 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.33 -44.02 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -143.57 144.23 31.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.95 123.69 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -88.57 121.73 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 38.37 -143.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.468 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.26 63.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.92 0.391 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 138.53 35.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.83 -109.65 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.14 148.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.128 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.16 139.32 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.8 m -98.95 120.73 39.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 25.7 mt -115.57 151.95 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.5 t -155.81 151.89 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 253' ' ' ASN . 20.9 m -89.26 128.79 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.91 0.386 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HG2' ' CE ' ' A' ' 201' ' ' MET . 14.1 ptmt -170.26 142.4 1.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 115.79 4.26 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 2.248 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 129.6 9.78 3.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.465 ' CE ' ' HG2' ' A' ' 198' ' ' LYS . 64.5 mtm -98.1 135.73 39.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.693 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.4 mp -93.16 119.94 32.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.7 mp -131.87 135.07 46.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 m -99.84 121.52 41.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.66 174.17 19.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' CE1' ' A' ' 251' ' ' TYR . 1.5 p -118.37 136.29 53.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.193 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.57 127.83 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.176 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.7 t -92.27 -46.11 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.9 p -157.03 155.28 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 246' ' ' LEU . 7.4 mt -100.35 133.39 44.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.84 152.31 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -64.88 -23.02 67.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.66 -47.22 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -160.63 -165.07 16.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.643 ' CD1' HD22 ' A' ' 210' ' ' LEU . 45.0 m-85 -118.15 132.96 56.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -91.58 132.96 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.06 145.31 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -89.4 124.52 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 pt -121.88 -25.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.23 47.58 10.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.81 141.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -93.9 114.19 26.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 92.13 36.34 6.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.54 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.6 m -147.48 123.96 11.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -111.35 130.87 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.54 135.49 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 59.0 t80 -131.76 141.85 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.853 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -120.59 126.58 26.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.853 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.77 131.04 20.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 215' ' ' TYR . 21.4 mt -63.2 -21.64 66.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.91 -45.11 87.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.888 ' HD3' HG12 ' A' ' 270' ' ' VAL . 0.0 OUTLIER -70.45 -37.84 74.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.464 ' N ' ' HG3' ' A' ' 232' ' ' LYS . . . -75.34 -26.62 58.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -64.98 -31.67 73.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.11 -44.69 52.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.4 t80 -73.05 -37.65 66.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.643 HG21 ' O ' ' A' ' 244' ' ' ALA . 51.7 mt -70.02 -41.87 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.2 ptm180 -67.12 -40.2 86.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 74.9 mm-40 -80.15 -19.95 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.513 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 64.9 mmtt -103.94 -68.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.85 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.7 t-20 -84.17 33.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 241' ' ' ASN . 74.3 mttt 34.48 32.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.94 69.16 1.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.85 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -137.55 -177.25 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -92.66 154.04 18.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.725 ' O ' HD11 ' A' ' 210' ' ' LEU . 19.1 mt -89.95 152.55 21.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.0 140.18 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.7 135.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 93.97 -18.34 56.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -63.06 148.07 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.89 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.2 m-85 -80.85 127.05 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.25 138.24 53.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.7 136.56 32.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 88.8 m -151.18 163.02 39.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.1 mt -136.17 145.5 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 5.9 t -68.02 122.31 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.22 -43.92 5.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -144.77 145.08 31.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.9 129.14 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -103.86 127.24 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -43.74 167.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 263' ' ' GLY . 7.2 p-10 45.43 37.27 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 37.34 47.58 1.53 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.54 -85.11 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 48.9 t -121.94 136.84 57.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 111.149 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.2 137.76 38.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . 0.504 ' C ' HD22 ' A' ' 268' ' ' LEU . 1.8 t -102.11 122.41 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.556 ' O ' HD22 ' A' ' 228' ' ' LEU . 0.3 OUTLIER -114.33 142.87 45.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.3 m -156.97 145.76 19.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.888 HG12 ' HD3' ' A' ' 232' ' ' LYS . 7.2 p -83.51 123.53 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.512 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.638 ' C ' HG21 ' A' ' 259' ' ' VAL . 48.5 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.824 0.345 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -123.49 145.16 46.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 136.28 32.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.649 2.233 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 121.59 -29.28 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.5 mtt -61.45 132.15 52.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.671 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.3 mp -100.57 108.0 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.671 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.1 mm? -121.55 132.76 54.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.4 m -89.0 120.01 30.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.95 166.22 12.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.36 56.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.18 121.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -89.23 -44.69 10.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.5 m -156.99 151.09 24.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.72 123.51 40.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -112.0 158.6 19.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.81 -21.55 57.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -92.86 -20.11 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 175.3 -171.64 44.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 246' ' ' LEU . 89.0 m-85 -112.23 131.6 55.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.907 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.01 129.35 34.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.45 138.53 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.81 134.79 34.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.07 -21.14 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.22 54.87 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -148.38 138.53 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.22 125.66 36.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.87 -49.9 0.94 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 47.1 m -76.37 124.25 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 225' ' ' ARG . 4.3 ptp180 -116.53 127.99 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.01 128.75 56.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.559 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 8.0 t80 -124.75 136.35 53.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 229' ' ' PRO . 7.2 tp -105.74 130.83 22.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.826 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.75 145.14 56.29 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.299 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 22.4 mt -63.03 -19.2 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -44.77 88.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -81.16 -28.91 34.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 215' ' ' TYR . . . -73.12 -47.17 46.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -62.89 -38.36 90.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.35 -44.54 87.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.661 ' HB2' HG21 ' A' ' 270' ' ' VAL . 11.3 t80 -72.04 -41.23 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 241' ' ' ASN . 40.9 mt -69.26 -41.03 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.491 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 21.8 ptt180 -70.05 -35.96 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.07 -36.17 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.468 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 27.4 mmtp -98.92 -58.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.656 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m-20 -80.51 19.82 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm 38.25 26.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.53 44.36 5.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.509 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -102.7 -179.01 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -104.02 119.45 38.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.666 HD12 ' CE1' ' A' ' 215' ' ' TYR . 21.8 mt -62.14 -179.9 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -136.07 -175.53 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.87 149.43 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 67.16 14.98 64.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -87.52 148.06 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -81.05 128.54 33.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 236' ' ' TYR . 10.4 tp -133.07 145.13 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.62 136.08 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.5 m -153.99 163.02 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.3 mt -136.92 150.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.6 t -70.43 125.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -103.14 -46.73 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -145.42 146.61 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 197' ' ' LEU . 14.6 t -123.96 132.4 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 3.1 tppp? -78.73 150.51 32.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -35.96 -38.81 0.24 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.449 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -125.85 -176.54 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -76.07 48.21 2.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -80.31 -84.87 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.2 134.35 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 139.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.5 t -98.96 120.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 40.8 mt -111.71 154.46 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 23.2 p -152.68 141.97 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.852 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 236' ' ' TYR . 21.1 m -73.12 134.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.502 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -146.1 144.72 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 129.66 18.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.6 -1.34 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.75 140.5 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.6 mp -102.44 113.29 26.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.66 133.07 53.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -95.63 120.47 35.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.54 -169.93 12.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.0 p -131.96 137.91 48.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.354 . . . . 0.0 111.16 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.46 127.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.5 t -96.03 -40.59 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.6 m -154.93 156.02 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.8 mm? -100.33 110.22 22.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.32 139.1 31.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.506 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -63.06 -16.41 59.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -97.76 -36.74 10.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -159.58 -150.64 5.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 1.099 ' CE2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.13 132.14 41.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.911 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.9 131.4 37.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.82 145.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -92.52 128.97 38.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.56 -31.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.8 50.84 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.492 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.79 151.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.106 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 222' ' ' ASP . 3.1 t0 -92.65 110.64 22.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.73 55.59 2.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 87.7 m -156.03 122.97 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 0.0 111.191 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 266' ' ' VAL . 68.8 mtt180 -116.13 129.47 56.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -119.77 128.98 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 16.0 t80 -131.97 135.01 46.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.832 HD13 ' N ' ' A' ' 229' ' ' PRO . 1.4 tm? -107.76 127.03 28.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.832 ' N ' HD13 ' A' ' 228' ' ' LEU . 53.5 Cg_endo -69.79 128.99 16.8 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.67 2.246 . . . . 0.0 112.346 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.656 HD23 ' HE1' ' A' ' 215' ' ' TYR . 18.4 mt -58.05 -22.05 48.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.6 mt -64.83 -45.03 87.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -83.44 -30.52 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -68.07 -36.21 79.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.94 -39.29 94.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -62.41 -43.81 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.568 ' CE2' ' HE3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -73.14 -47.07 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.807 HG12 HD21 ' A' ' 246' ' ' LEU . 34.8 mt -61.15 -49.4 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.48 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.6 ptm180 -58.1 -43.17 86.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.479 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 8.4 mm100 -80.36 -19.89 45.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 2.0 mmmp? -100.9 -75.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.2 t-20 -80.66 41.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER 33.28 34.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 75.45 54.16 5.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -131.66 120.27 22.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -33.85 146.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 1.099 HD12 ' CE2' ' A' ' 215' ' ' TYR . 11.8 mt -78.14 179.63 6.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -123.33 171.05 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 75.3 t -92.54 139.83 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.33 -20.58 36.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -63.07 148.06 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.97 127.17 32.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.12 140.27 52.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.71 136.18 45.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 96.9 m -151.51 162.89 40.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.18 140.62 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.5 t -69.1 120.89 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.27 -39.7 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -144.81 141.64 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.1 t -120.66 130.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -82.25 145.7 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.33 -69.62 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.512 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.26 39.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 38.58 34.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.517 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.11 -53.53 25.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.66 143.52 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 225' ' ' ARG . 43.2 t -126.95 140.07 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . 0.862 ' C ' HD22 ' A' ' 268' ' ' LEU . 4.3 t -98.98 142.08 30.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.862 HD22 ' C ' ' A' ' 267' ' ' SER . 1.2 mm? -123.82 143.64 50.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 p -143.07 152.69 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 236' ' ' TYR . 58.6 t -79.16 141.51 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.078 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.493 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -119.59 149.24 47.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 0.0 110.895 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 256' ' ' VAL . 53.8 Cg_endo -69.78 116.87 4.76 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.43 -9.83 3.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.719 ' O ' HG23 ' A' ' 255' ' ' ILE . 11.8 mtt -79.74 140.6 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.763 0.316 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.51 122.17 36.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 256' ' ' VAL . 4.5 mp -131.25 125.23 32.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 m -92.51 119.09 31.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.63 16.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 p -118.23 139.8 50.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.484 HG11 HD21 ' A' ' 210' ' ' LEU . 61.9 t -60.99 134.59 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.9 t -109.91 -33.88 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.43 ' C ' HD23 ' A' ' 210' ' ' LEU . 1.8 t -157.03 156.12 32.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.83 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 215' ' ' TYR . 10.0 mt -113.86 137.6 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.01 164.95 19.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.777 ' O ' HD11 ' A' ' 230' ' ' LEU . 6.1 p-10 -79.69 -26.49 40.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 213' ' ' HIS . 3.6 p80 -93.59 -17.7 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.476 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -177.75 -162.1 27.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.785 ' CE1' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.94 139.93 46.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.926 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.85 130.5 34.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.32 131.59 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.59 134.69 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.2 pt -125.1 -21.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.92 7.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.36 135.7 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -88.68 107.24 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.92 36.93 4.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.5 m -153.01 125.31 8.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.103 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -114.08 131.75 56.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -118.22 134.89 54.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.476 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.3 t80 -127.17 140.4 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.897 HD12 ' HD2' ' A' ' 229' ' ' PRO . 24.9 tp -113.76 130.35 23.88 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.897 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.68 146.59 61.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.268 . . . . 0.0 112.364 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.3 mt -62.14 -19.9 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.77 -44.71 95.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -41.47 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -65.11 -48.51 73.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 12.4 tt0 -62.96 -37.73 88.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.91 -42.4 90.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.533 ' CD2' ' HD3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -72.91 -38.92 66.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.961 HD11 HD11 ' A' ' 246' ' ' LEU . 66.0 mt -69.28 -40.5 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 14.3 ptm180 -70.23 -35.33 73.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -79.98 -40.43 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.533 ' HD3' ' CD2' ' A' ' 236' ' ' TYR . 0.0 OUTLIER -93.91 -55.39 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 237' ' ' ILE . 10.5 t-20 -81.43 19.12 1.03 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 241' ' ' ASN . 51.5 mttt 38.06 27.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.99 67.5 1.44 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -146.35 151.47 37.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 111.152 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.47 154.91 2.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.961 HD11 HD11 ' A' ' 237' ' ' ILE . 66.8 mt -95.72 171.37 8.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.89 133.05 47.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.09 136.06 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.48 -23.19 34.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.586 ' NE2' HD22 ' A' ' 246' ' ' LEU . 6.7 pt20 -63.19 148.0 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.915 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.11 127.05 32.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.8 tp -127.61 137.1 52.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -84.42 131.58 34.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.585 ' HB3' HD22 ' A' ' 268' ' ' LEU . 32.3 m -145.99 153.54 40.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 201' ' ' MET . 15.2 mt -135.45 147.01 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 199' ' ' PRO . 40.0 t -66.93 124.52 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -105.65 -44.42 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -146.79 161.22 41.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.3 130.08 75.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -108.54 117.48 34.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -46.39 157.04 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.518 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 m120 58.87 25.46 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.912 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.47 45.75 4.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -74.57 -72.27 1.04 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.04 134.43 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.46 136.2 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.2 t -100.82 116.02 31.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.657 HD12 ' HB1' ' A' ' 226' ' ' ALA . 18.5 mt -115.69 156.68 25.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 255' ' ' ILE . 82.3 p -152.53 142.1 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 p -82.58 143.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -158.88 152.4 19.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 132.83 24.09 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 120.52 -10.7 10.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.483 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.4 mtt -73.94 127.58 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.7 mp -88.74 113.52 24.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 202' ' ' LEU . 18.5 mt -129.69 134.92 47.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.46 117.03 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -120.12 154.85 16.33 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.9 p -104.85 132.86 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.03 120.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.2 t -86.0 -46.01 10.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.1 p -156.76 155.85 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 215' ' ' TYR . 8.7 mt -102.92 139.0 39.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.1 161.65 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.485 ' O ' HD11 ' A' ' 230' ' ' LEU . 55.2 m-20 -72.54 -19.05 61.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -93.35 -39.51 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -166.39 -162.04 16.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.817 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.8 m-85 -120.58 130.34 54.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.929 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.42 133.94 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.2 t -115.95 139.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 -8.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.45 52.78 24.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.506 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.8 t -146.82 134.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -87.18 109.76 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.92 -49.17 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.607 ' CG2' HG21 ' A' ' 266' ' ' VAL . 48.6 m -68.21 124.1 22.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -111.3 131.17 55.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.22 134.79 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 36.7 t80 -131.81 143.41 50.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.915 HD12 ' HB2' ' A' ' 233' ' ' ALA . 0.3 OUTLIER -113.7 126.22 28.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.955 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.743 ' HD2' HD13 ' A' ' 228' ' ' LEU . 53.9 Cg_endo -69.73 129.13 17.09 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.6 mt -62.94 -14.91 52.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.79 -45.06 53.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -83.17 -36.84 24.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -64.78 -31.49 72.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -64.39 -41.19 96.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -63.64 -43.43 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 240' ' ' LYS . 18.3 t80 -72.1 -37.56 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 241' ' ' ASN . 76.5 mt -69.43 -45.82 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.2 ptp180 -61.47 -40.94 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -80.06 -21.17 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 236' ' ' TYR . 29.0 mmtm -99.44 -71.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 237' ' ' ILE . 17.2 t-20 -83.75 35.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' ASN . 25.5 mtpp 36.41 30.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.52 73.95 1.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -158.3 153.95 26.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 162.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 215' ' ' TYR . 59.0 mt -95.31 -178.1 4.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 247' ' ' LYS . 3.4 mppt? -116.77 174.9 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.5 t -102.04 144.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.82 -6.09 20.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.79 147.94 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -80.99 127.24 32.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.7 tp -128.64 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -97.67 124.25 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -142.64 163.06 33.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 271' ' ' GLY . 91.6 mt -137.07 138.44 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.25 120.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -105.81 -33.5 7.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -144.0 133.45 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.98 132.08 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -87.41 157.64 19.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -68.1 -65.21 2.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.68 41.33 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.3 37.24 1.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -62.22 -74.74 0.37 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.77 135.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.607 HG21 ' CG2' ' A' ' 224' ' ' THR . 8.4 t -105.97 139.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . 0.773 ' C ' HD22 ' A' ' 268' ' ' LEU . 7.5 m -100.39 139.54 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 267' ' ' SER . 1.1 mm? -121.19 153.0 38.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 255' ' ' ILE . 45.8 p -159.9 141.97 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.93 133.9 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.457 ' O ' HD11 ' A' ' 255' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -161.21 149.65 12.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.867 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 108.84 2.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.72 -5.82 3.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 255' ' ' ILE . 14.3 mtm -86.83 142.69 27.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.05 125.34 44.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 203' ' ' LEU . 4.5 mp -132.01 125.95 32.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -98.04 119.5 36.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.16 -165.18 11.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.1 p -129.92 138.75 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 128.54 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.1 t -87.8 -45.99 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.1 m -156.91 155.95 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.564 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.4 mm? -92.67 112.89 25.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.28 143.25 26.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.74 -19.13 65.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.49 -29.96 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -166.64 -155.68 9.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.557 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.959 ' CE2' HD12 ' A' ' 246' ' ' LEU . 89.8 m-85 -125.49 125.85 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 110.897 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.39 133.94 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.01 141.56 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.79 131.44 34.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.1 pt -127.28 -29.42 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.44 41.09 21.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.443 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.4 t -121.78 144.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 111.074 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.75 108.09 20.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.35 33.79 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 95.8 m -143.6 123.13 13.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -116.07 120.49 39.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -115.95 134.36 55.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.8 t80 -132.0 144.0 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.855 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -113.67 126.9 27.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 110.926 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.855 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 136.15 32.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.499 HD23 ' HE1' ' A' ' 215' ' ' TYR . 31.9 mt -62.9 -24.35 67.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.79 -42.24 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.57 -39.25 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -61.0 -48.66 80.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -58.58 -37.97 76.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -64.25 -42.52 96.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.701 ' CD2' HG11 ' A' ' 270' ' ' VAL . 3.0 t80 -73.03 -40.02 65.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 241' ' ' ASN . 24.3 mt -68.1 -40.03 82.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.3 ptm180 -69.92 -37.98 76.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -81.38 -27.36 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 66.9 mmtt -107.38 -63.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.726 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.4 m120 -81.37 24.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.0 mtpt 34.77 31.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.79 44.54 7.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -112.91 113.48 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -41.51 125.74 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.959 HD12 ' CE2' ' A' ' 215' ' ' TYR . 16.2 mt -58.94 -175.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -144.17 152.12 40.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.7 t -67.08 143.56 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.95 -21.06 16.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 252' ' ' LEU . 0.9 OUTLIER -65.49 148.32 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.954 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -80.97 133.04 35.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.444 ' HB2' ' NE2' ' A' ' 250' ' ' GLN . 24.2 tp -134.48 135.09 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.31 136.5 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.716 ' HB3' HD22 ' A' ' 268' ' ' LEU . 37.8 m -148.55 151.35 34.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' MET . 90.3 mt -131.52 138.69 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.73 123.71 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -106.82 -45.62 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -134.37 148.86 50.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 63.1 t -119.27 126.74 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.25 118.53 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -40.79 -56.88 2.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 263' ' ' GLY . 28.1 t30 -85.69 35.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.59 42.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -76.14 -74.21 0.95 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.6 130.99 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.19 139.95 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.1 t -99.38 120.75 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.801 HD12 ' HB1' ' A' ' 226' ' ' ALA . 27.9 mt -116.3 152.14 34.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 58.2 m -146.8 147.71 31.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 236' ' ' TYR . 44.9 t -73.79 127.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 179.96 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -110.14 148.51 38.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.711 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 116.93 4.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.84 -2.92 7.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 255' ' ' ILE . 34.3 mtt -68.07 141.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 203' ' ' LEU . 5.4 mp -87.23 111.04 20.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.9 mm? -124.74 137.86 54.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.4 m -112.64 125.38 54.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.32 161.01 25.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.426 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 251' ' ' TYR . 4.0 p -103.57 140.08 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.5 122.38 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.5 t -87.56 -43.36 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.1 m -156.81 155.77 32.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.58 123.73 44.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.56 147.57 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -65.09 -27.42 68.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -90.6 -32.41 16.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -164.62 -159.19 10.9 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.929 ' CE1' HD12 ' A' ' 246' ' ' LEU . 94.6 m-85 -125.71 129.51 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.01 134.05 33.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.98 142.2 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.45 124.11 33.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.94 -27.39 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.03 40.69 10.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 64.9 t -128.59 142.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.127 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.51 126.63 38.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 98.99 -48.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.6 m -69.13 123.23 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -114.97 129.69 56.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.11 128.98 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.565 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 27.4 t80 -131.85 134.34 45.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.846 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -109.21 126.4 29.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.846 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.74 133.77 26.42 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 215' ' ' TYR . 48.9 mt -61.2 -21.86 64.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 -44.99 85.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HD2' HG22 ' A' ' 270' ' ' VAL . 1.6 tmtp? -77.5 -31.54 53.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.9 -39.77 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -59.43 -33.87 71.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.33 -45.85 75.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.666 ' HB2' HG21 ' A' ' 270' ' ' VAL . 1.9 t80 -72.3 -38.04 68.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.623 HG23 ' HB2' ' A' ' 241' ' ' ASN . 51.6 mt -69.79 -42.45 80.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 17.9 ptt180 -69.77 -36.56 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -81.39 -34.74 31.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.551 ' HG3' ' CD2' ' A' ' 236' ' ' TYR . 1.2 mmmp? -99.66 -60.03 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 244' ' ' ALA . 8.6 m-20 -80.81 21.32 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 238' ' ' ARG . 8.8 mmmm 36.99 28.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.97 46.88 4.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.46 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -106.25 177.56 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -100.12 137.59 38.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.929 HD12 ' CE1' ' A' ' 215' ' ' TYR . 23.5 mt -73.43 162.37 29.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -128.38 149.68 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.19 150.57 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.82 3.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.53 148.32 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.553 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.8 m-85 -80.94 129.87 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.85 140.77 52.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.518 ' O ' HG12 ' A' ' 270' ' ' VAL . 3.7 p30 -87.62 128.33 35.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.749 ' HB3' HD22 ' A' ' 268' ' ' LEU . 83.9 m -147.14 149.8 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 201' ' ' MET . 79.8 mt -134.54 139.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 200' ' ' GLY . 30.7 t -62.71 119.05 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -97.05 -40.04 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -153.62 152.94 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -123.22 127.96 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.41 178.01 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.69 -74.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 263' ' ' GLY . 1.4 m120 -80.12 45.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.72 37.98 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.97 5.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 146.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 27.8 t -113.33 139.33 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.9 t -99.3 118.57 36.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 254' ' ' CYS . 12.2 mt -120.88 146.98 46.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 5.6 p -147.09 145.47 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 236' ' ' TYR . 27.3 m -76.87 122.57 31.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.096 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.9 0.381 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -140.05 151.47 65.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.2 20.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 113.29 -6.12 25.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.533 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.7 mtt -67.85 138.83 56.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 202' ' ' LEU . 3.9 mp -94.44 110.13 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 202' ' ' LEU . 23.7 mt -131.13 141.65 50.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -111.56 124.63 52.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.24 -174.75 13.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.7 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.03 120.69 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 t -86.47 -41.87 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 56.4 p -156.4 156.0 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 248' ' ' VAL . 9.5 mp -105.01 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -115.34 145.21 42.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.771 ' O ' HD11 ' A' ' 230' ' ' LEU . 24.1 m-20 -67.48 -17.87 64.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -97.24 -20.05 18.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.95 -166.78 34.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 246' ' ' LEU . 85.0 m-85 -125.79 132.95 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.616 HD12 ' NH2' ' A' ' 225' ' ' ARG . 1.5 mm? -88.85 132.17 34.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.897 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.15 135.17 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.1 126.97 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 pt -119.01 -18.56 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.02 43.13 8.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.55 127.29 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.107 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.91 130.33 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.64 -43.41 1.76 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.8 m -73.92 132.0 42.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.787 0.327 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.616 ' NH2' HD12 ' A' ' 216' ' ' LEU . 6.9 tpm_? -109.33 123.18 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.96 126.92 55.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 9.0 t80 -132.01 139.21 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 229' ' ' PRO . 15.3 tp -112.73 133.41 21.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.0 Cg_endo -69.72 139.49 40.48 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.771 HD11 ' O ' ' A' ' 212' ' ' ASP . 84.1 mt -63.11 -25.08 68.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.57 -45.05 73.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -78.09 -33.14 50.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.15 63.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.45 -35.67 72.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.98 -42.92 99.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.56 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.3 OUTLIER -72.47 -37.74 68.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.893 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 244' ' ' ALA . 32.7 mt -66.97 -39.11 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.5 ttt180 -69.2 -41.29 77.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -79.49 -20.3 47.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 47.1 mmtt -101.5 -69.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.681 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.7 t-20 -83.85 35.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 38.9 mmtt 34.65 32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.37 68.49 1.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.5 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.76 169.24 18.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 146.98 50.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 215' ' ' TYR . 80.0 mt -87.67 178.25 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -132.95 153.14 51.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 210' ' ' LEU . 37.1 t -78.01 134.4 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.065 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.1 -22.36 39.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.449 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -64.54 148.04 51.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.05 128.47 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 252' ' ' LEU . 6.7 tp -123.09 142.9 50.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -92.43 130.51 38.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.681 ' HB3' HD22 ' A' ' 268' ' ' LEU . 95.1 m -154.91 153.0 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 201' ' ' MET . 96.6 mt -133.63 139.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.52 125.14 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -103.5 -45.82 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -142.51 158.37 43.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.25 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.45 136.57 36.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.7 -66.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.546 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 263' ' ' GLY . 19.1 t-20 -84.53 45.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.24 36.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -68.76 -86.63 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.88 144.26 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.53 140.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.6 t -98.96 118.13 35.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.2 mt -116.72 149.62 39.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 75.4 m -156.91 142.03 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 253' ' ' ASN . 17.4 t -71.89 142.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.529 179.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.875 0.369 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -129.95 148.93 71.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 110.937 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 120.27 7.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 134.65 -12.02 4.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.576 ' O ' HG23 ' A' ' 255' ' ' ILE . 15.0 mtt -80.97 140.38 35.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.614 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -95.2 120.5 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.1 mp -130.54 125.36 34.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.5 m -94.39 120.41 34.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.76 -174.43 14.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.3 p -123.55 142.38 51.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.116 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.09 120.4 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.3 t -85.16 -41.8 15.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -157.03 155.05 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.561 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 mm? -95.08 107.49 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -94.13 149.38 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.425 ' O ' HD11 ' A' ' 230' ' ' LEU . 26.7 t70 -72.55 -31.09 65.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -84.24 -28.75 27.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -168.96 -158.75 13.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' TYR . . . . . 0.662 ' CD1' HD12 ' A' ' 246' ' ' LEU . 97.0 m-85 -123.02 131.62 53.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 226' ' ' ALA . 3.1 mm? -86.04 129.83 34.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.37 134.02 56.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.09 137.07 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.8 pt -126.27 -30.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.88 55.24 2.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 222' ' ' ASP . 25.2 t -140.18 155.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -101.23 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.36 44.19 6.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.534 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.0 m -144.18 131.5 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.338 . . . . 0.0 111.139 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -115.62 125.9 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -121.9 122.19 38.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 17.6 t80 -125.52 140.52 52.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 229' ' ' PRO . 12.2 tp -110.28 129.79 23.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.658 0.742 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.3 Cg_endo -69.74 135.26 30.07 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 212' ' ' ASP . 39.0 mt -63.1 -23.82 67.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.77 -45.18 87.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.936 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.4 tppp? -85.12 -32.8 22.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.43 80.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -58.65 -34.01 70.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.87 -43.79 91.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t80 -72.83 -42.17 64.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 241' ' ' ASN . 22.6 mt -68.13 -40.78 83.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.485 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 11.8 ptm180 -70.11 -35.78 74.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -81.19 -34.59 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 24.0 mmtp -100.75 -59.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.704 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -80.31 19.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.52 26.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.1 46.68 4.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.78 116.33 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -38.21 133.13 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.662 HD12 ' CD1' ' A' ' 215' ' ' TYR . 49.6 mt -69.97 171.28 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -126.14 175.44 7.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 210' ' ' LEU . 42.7 t -92.15 132.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.19 -27.56 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.528 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -63.2 147.88 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -81.03 126.99 32.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.72 138.3 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -85.63 135.12 33.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.2 m -156.33 154.58 30.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 201' ' ' MET . 43.2 mt -134.4 142.16 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.21 119.35 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.67 -46.4 5.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -150.15 158.39 44.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -120.54 129.38 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.32 156.54 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -70.09 159.58 53.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 48.21 34.97 4.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 42.18 36.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.07 -81.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.61 146.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.7 t -113.44 138.8 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.6 t -100.78 117.76 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.7 mt -116.69 157.69 25.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' ILE . 73.0 p -154.72 142.0 19.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 232' ' ' LYS . 32.9 m -72.31 132.14 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.1 m -125.29 142.23 51.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.2 m -69.54 171.13 9.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.849 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.83 137.45 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 p -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.7 p -62.04 133.05 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.75 -106.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.511 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -82.09 172.54 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -83.1 154.1 24.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.04 -57.12 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -118.6 112.96 20.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -52.27 147.42 7.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 192' ' ' LEU . 74.3 t -100.77 -42.85 10.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 192' ' ' LEU . 3.9 pp 33.69 46.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.4 m -94.22 146.23 24.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -46.6 -28.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -88.54 -28.53 20.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -68.26 -18.7 64.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 16.2 mt -47.99 154.58 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -134.01 146.37 59.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.547 0.689 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 115.17 3.97 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.683 2.256 . . . . 0.0 112.361 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 139.76 -11.04 3.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.595 ' HB3' HD11 ' A' ' 203' ' ' LEU . 19.1 mtt -73.77 132.7 42.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.585 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.0 mp -93.14 113.59 25.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 203' ' ' LEU . 2.0 mp -130.88 134.13 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.787 HG21 HG22 ' A' ' 277' ' ' THR . 6.0 m -83.12 118.12 23.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -114.73 160.55 13.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.0 p -122.53 137.07 55.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.21 120.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.0 t -86.27 -45.53 11.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.1 m -156.99 156.01 32.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' A' ' 215' ' ' TYR . 1.2 mm? -91.5 124.31 35.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -107.89 164.83 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -22.78 35.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.534 ' CD2' ' H ' ' A' ' 213' ' ' HIS . 4.0 p80 -98.09 -20.68 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -179.95 -149.28 8.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.577 ' HD2' HD13 ' A' ' 210' ' ' LEU . 27.0 m-85 -133.99 138.4 45.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.973 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 132.85 33.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.95 129.45 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.97 126.89 31.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.8 pt -119.95 -20.06 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.51 51.99 4.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.75 141.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.01 116.59 28.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 104.05 -42.85 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.518 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 33.5 m -74.44 125.42 28.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -114.74 132.09 56.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.93 124.54 51.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.115 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 5.5 t80 -123.27 143.39 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 268' ' ' LEU . 14.2 tp -113.29 134.55 21.88 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.477 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.85 144.45 53.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.684 2.256 . . . . 0.0 112.303 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.419 ' O ' ' CB ' ' A' ' 234' ' ' GLN . 17.4 mt -63.03 -26.44 68.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.6 -44.18 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -82.19 -42.09 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -64.57 -48.95 73.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.419 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 36.0 tt0 -62.85 -33.99 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.68 -42.65 91.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE1' ' CD1' ' A' ' 252' ' ' LEU . 3.9 t80 -72.29 -37.36 69.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.686 HG12 HD21 ' A' ' 246' ' ' LEU . 30.6 mt -69.66 -47.27 72.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.092 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.3 ptp180 -59.45 -40.52 87.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -79.98 -21.55 43.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 236' ' ' TYR . 37.4 mmtm -99.14 -72.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.77 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.0 t-20 -83.69 35.85 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 241' ' ' ASN . 20.2 mtpp 34.44 33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 81.47 70.64 1.33 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.77 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -148.25 137.69 22.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 111.117 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -44.52 147.42 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.712 HD22 HE22 ' A' ' 250' ' ' GLN . 69.1 mt -86.34 -175.09 5.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -122.55 176.75 5.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.41 147.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.26 24.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.496 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.712 HE22 HD22 ' A' ' 246' ' ' LEU . 4.3 pt20 -72.07 148.01 46.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.799 0.333 . . . . 0.0 110.914 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -81.0 126.97 32.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.513 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 15.4 tp -136.66 135.97 38.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -76.07 134.43 40.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.639 ' HB3' HD22 ' A' ' 268' ' ' LEU . 73.9 m -152.64 144.85 23.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.641 HD12 ' HA3' ' A' ' 271' ' ' GLY . 65.2 mt -133.77 138.9 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.117 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.96 119.44 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -106.48 -30.49 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -151.78 149.85 29.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.7 t -122.05 133.09 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -84.35 150.99 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -60.39 -67.61 2.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -88.13 41.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 44.15 42.74 6.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.63 -73.12 0.84 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.447 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.23 136.87 57.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 42.3 t -104.28 139.45 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 114.03 26.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 254' ' ' CYS . 17.1 mt -111.76 149.45 31.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.6 m -149.12 150.43 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.12 118.01 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.641 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . -125.91 -48.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -172.76 158.38 3.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.847 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 35.2 p -90.78 177.06 6.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -156.86 143.1 18.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 93.6 t -51.97 -45.05 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 28.9 t -54.92 112.23 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . 0.787 HG22 HG21 ' A' ' 204' ' ' THR . 50.5 p -154.09 134.83 13.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -129.06 139.36 52.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 30.3 mt -87.89 149.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -125.04 84.29 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.068 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 283' ' ' GLN . 22.9 m -140.98 134.11 29.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.15 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -98.06 -26.09 14.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.489 ' O ' ' CG2' ' A' ' 281' ' ' THR . 3.3 pm0 -149.89 172.81 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -99.55 111.56 23.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 36.5 m -165.12 128.7 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 45.6 p90 -149.23 150.41 32.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -108.53 113.05 25.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 34.5 tp -107.4 113.95 27.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.955 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -128.83 120.68 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -78.62 79.78 5.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 291' ' ' LEU . 2.1 tt -103.22 136.78 42.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.3 m -124.69 168.96 12.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -172.91 -169.99 36.09 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 149.1 66.69 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.371 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.1 t -173.43 142.03 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 14.5 m -116.64 141.52 48.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.0 m -141.58 126.91 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 55.7 m -119.91 146.71 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.819 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -156.7 42.35 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.5 m -62.23 113.3 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.849 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 m -126.67 109.9 12.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.825 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.43 -78.23 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.53 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -88.35 156.86 18.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.329 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -68.29 100.65 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 34.3 m -80.03 152.92 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 42.87 39.85 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -59.76 142.02 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.45 47.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.606 ' C ' HD23 ' A' ' 192' ' ' LEU . 0.9 OUTLIER -94.32 -42.11 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.581 ' N ' HD23 ' A' ' 192' ' ' LEU . 18.8 p -84.82 146.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.17 -31.24 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -65.1 -44.5 88.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -57.91 -44.69 86.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.096 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 55.2 mt -40.05 155.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.44 ' H ' ' CE ' ' A' ' 201' ' ' MET . 3.5 mptt -108.21 147.65 36.0 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.894 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 140.87 43.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 0.0 112.351 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 103.76 7.22 42.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.464 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.44 ' CE ' ' H ' ' A' ' 198' ' ' LYS . 47.4 mtt -80.66 139.26 36.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.5 mp -88.84 108.62 19.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.748 HD12 ' C ' ' A' ' 202' ' ' LEU . 4.4 mp -124.28 150.98 44.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.3 m -117.48 117.06 28.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -119.65 -172.63 15.1 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.45 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.61 HG23 ' CE1' ' A' ' 251' ' ' TYR . 7.6 p -129.02 139.62 51.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.776 0.322 . . . . 0.0 111.138 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.18 120.41 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.163 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.9 t -86.41 -38.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.829 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 44.5 p -157.0 155.75 31.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.64 123.96 50.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -115.76 168.28 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.863 ' O ' HD11 ' A' ' 230' ' ' LEU . 7.4 p-10 -85.99 -24.19 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -92.02 -14.56 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . 175.82 -167.44 39.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.481 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.09 137.07 53.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.9 0.381 . . . . 0.0 110.954 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.77 128.59 36.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.927 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.8 t -112.5 135.55 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -86.55 135.71 33.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.74 -13.49 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.81 50.71 23.02 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 222' ' ' ASP . 38.4 t -134.49 155.97 39.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.127 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 221' ' ' VAL . 13.8 t70 -102.14 122.26 43.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 81.73 36.95 17.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 42.5 m -151.65 123.59 8.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.139 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -114.17 131.37 56.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.04 135.32 53.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 9.1 t80 -129.76 142.74 50.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.882 HD12 ' HD2' ' A' ' 229' ' ' PRO . 10.3 tp -113.99 133.44 22.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.59 0.71 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.882 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.71 143.22 50.35 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.378 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.863 HD11 ' O ' ' A' ' 212' ' ' ASP . 25.6 mt -62.67 -22.92 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.9 mt -62.34 -44.23 96.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -83.25 -33.21 26.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.0 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.23 -42.2 99.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -64.69 -41.45 96.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.546 ' HB2' HG21 ' A' ' 270' ' ' VAL . 2.4 t80 -72.41 -40.05 67.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 241' ' ' ASN . 43.5 mt -68.09 -43.01 85.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 8.1 ptm180 -66.61 -40.3 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 37.8 mm-40 -79.96 -20.15 46.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 21.4 mmtm -101.31 -69.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.781 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 12.3 t-20 -84.37 32.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.8 OUTLIER 37.32 28.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.58 64.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.448 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.781 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.49 130.94 21.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 0.0 111.054 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 pmtp? -46.77 155.14 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.413 HD21 HG12 ' A' ' 237' ' ' ILE . 14.3 mt -94.38 175.54 6.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -129.38 134.46 47.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.78 141.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 95.16 -27.0 16.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.67 148.36 52.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.61 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.1 m-85 -81.99 130.27 35.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.462 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 38.1 tp -123.64 138.35 54.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -81.24 134.9 35.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.609 ' HB3' HD22 ' A' ' 268' ' ' LEU . 58.0 m -157.5 150.6 23.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.5 mt -127.13 139.56 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.89 123.09 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.39 -46.17 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -144.74 152.09 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.79 122.01 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.121 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 55.0 mttt -79.3 133.11 36.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -36.43 -45.48 0.96 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -109.09 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -78.33 61.51 3.86 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.453 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -93.95 -81.13 1.5 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.497 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.24 143.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 111.207 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 34.8 t -113.02 139.96 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 17.9 t -99.69 131.32 45.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 254' ' ' CYS . 20.5 mt -126.69 157.63 38.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 97.3 p -157.08 143.54 18.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 236' ' ' TYR . 38.6 t -71.01 131.46 34.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -79.92 70.07 2.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.459 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -60.49 -48.48 81.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.826 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 24.1 t -42.53 110.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -92.55 85.13 5.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 276' ' ' SER . 25.1 m -78.08 -43.86 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.501 ' N ' HG23 ' A' ' 275' ' ' VAL . 58.8 m -113.15 45.45 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 16.0 m -157.12 130.14 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -41.23 148.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 45.8 mm -49.31 139.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -115.57 106.74 14.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 13.4 t -156.4 159.27 38.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.143 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -116.07 165.25 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -49.17 97.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -173.61 131.97 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.9 t -56.92 160.84 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.821 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -118.31 -35.14 3.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -62.34 136.26 57.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 39.9 tp -134.78 -50.72 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -156.65 142.36 17.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -61.63 127.96 33.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.56 148.25 49.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 40.7 p -131.3 136.67 48.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -145.76 81.57 0.21 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 136.17 32.23 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.691 2.26 . . . . 0.0 112.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.8 m -152.16 140.85 20.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 3.9 m -44.57 160.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.4 t -135.32 167.8 20.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.897 0.38 . . . . 0.0 110.816 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.8 p -49.6 151.75 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.852 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.1 71.88 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.428 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.3 m -51.37 128.44 22.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.346 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 m -79.39 121.73 25.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 97.57 -59.99 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -66.35 174.61 2.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.78 0.324 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -54.86 134.02 48.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 189' ' ' ASN . 8.4 p -50.87 -42.76 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.448 ' N ' HG13 ' A' ' 188' ' ' VAL . 56.7 t30 -154.86 117.7 4.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 191' ' ' VAL . 0.0 OUTLIER -110.49 47.25 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 190' ' ' ARG . 4.8 t 34.04 53.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.163 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 192' ' ' LEU . 2.9 tt -109.31 -41.29 4.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.9 m -66.64 165.9 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -83.88 -47.04 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.8 -40.68 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.33 91.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.079 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 mt -42.41 160.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -129.45 153.66 80.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 109.45 2.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.7 28.97 1.01 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.481 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.481 ' O ' HG23 ' A' ' 255' ' ' ILE . 28.6 mtt -96.4 136.74 36.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.862 ' C ' HD12 ' A' ' 203' ' ' LEU . 3.6 mp -96.89 111.99 23.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.862 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.9 mp -131.09 149.14 52.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.4 m -102.1 120.22 40.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.91 177.71 17.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.459 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.2 p -126.68 136.83 52.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.856 0.36 . . . . 0.0 111.136 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 122.74 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.1 t -86.07 -46.02 10.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 24.6 p -157.07 156.03 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.1 mp -100.13 127.8 46.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -113.3 144.79 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.648 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -64.57 -23.61 67.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -94.9 -39.44 10.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -153.47 -159.48 9.14 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.438 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.639 ' CE2' HD23 ' A' ' 230' ' ' LEU . 58.9 m-85 -133.66 132.77 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.93 125.28 33.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -83.09 137.03 34.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.85 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.97 -30.16 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.48 47.6 5.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.437 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.72 138.48 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.14 109.61 20.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.86 36.86 3.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.604 ' CG2' HG21 ' A' ' 266' ' ' VAL . 63.5 m -150.06 128.67 12.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.314 . . . . 0.0 111.128 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 31.3 ttm-85 -114.66 126.33 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.521 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -114.82 127.66 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 18.2 t80 -132.26 126.44 33.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 229' ' ' PRO . 17.6 tp -104.94 130.27 23.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 143.19 49.9 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.1 mt -63.29 -29.26 70.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 18.0 mt -62.61 -45.21 93.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -80.27 -42.1 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.0 98.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.85 -30.38 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.41 -43.88 84.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' CE1' HD11 ' A' ' 252' ' ' LEU . 0.8 OUTLIER -73.29 -37.81 66.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.731 HG12 HD21 ' A' ' 246' ' ' LEU . 17.3 mt -68.25 -50.89 53.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 26.2 ptt85 -57.03 -40.08 76.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.864 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -80.04 -31.47 39.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 26.3 mmtt -88.28 -69.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.745 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.9 t-20 -83.58 35.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 241' ' ' ASN . 60.9 mttp 34.21 33.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.3 58.59 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.474 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.745 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -136.55 128.0 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 111.124 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -40.32 130.59 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.731 HD21 HG12 ' A' ' 237' ' ' ILE . 21.2 mt -70.04 -175.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -127.75 178.52 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 249' ' ' GLY . 59.2 t -92.09 153.43 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 248' ' ' VAL . . . 63.27 12.57 45.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.485 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.561 HE22 HD22 ' A' ' 246' ' ' LEU . 4.6 pt20 -82.4 147.98 28.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.94 126.81 31.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.572 HD11 ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -135.04 142.25 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.478 ' O ' HG22 ' A' ' 270' ' ' VAL . 45.6 p-10 -96.47 133.06 41.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 92.0 m -146.76 159.69 43.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 201' ' ' MET . 86.1 mt -136.74 137.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.12 131.24 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -104.24 -41.53 5.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -150.68 153.06 34.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.8 t -123.76 121.28 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -127.6 143.25 51.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 54.77 165.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.452 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 262' ' ' ASN . 38.3 p30 -95.6 40.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 0.0 110.858 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 142.1 40.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.443 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -108.25 -95.0 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.504 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.6 137.43 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.604 HG21 ' CG2' ' A' ' 224' ' ' THR . 77.9 t -114.61 139.89 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.161 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.6 t -99.12 125.2 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.521 ' CD1' ' HB1' ' A' ' 226' ' ' ALA . 39.0 mt -121.02 152.09 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.948 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 255' ' ' ILE . 93.8 p -159.77 143.23 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 253' ' ' ASN . 56.9 t -80.9 122.39 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.154 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.445 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . -111.97 99.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.5 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -84.67 85.92 7.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.815 0.34 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 4.5 m -152.87 177.06 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -63.22 107.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 276' ' ' SER . 27.0 m -48.64 -42.01 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.437 ' N ' HG23 ' A' ' 275' ' ' VAL . 74.1 p -100.13 163.27 12.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 66.8 p -147.9 170.64 17.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.162 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.8 141.22 49.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.91 HG22 ' H ' ' A' ' 281' ' ' THR . 4.9 mp -58.8 142.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.44 66.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.91 ' H ' HG22 ' A' ' 279' ' ' ILE . 81.1 p -97.31 154.52 17.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.127 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . 0.414 ' OE1' ' NE2' ' A' ' 284' ' ' GLN . 23.3 mt-10 -79.38 158.1 27.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -105.73 34.4 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.414 ' NE2' ' OE1' ' A' ' 282' ' ' GLU . 6.0 pt20 -105.73 161.04 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.968 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 68.5 p -133.51 138.54 46.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -153.58 160.89 42.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -93.89 112.05 23.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.63 -178.75 3.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -150.36 130.51 13.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -129.9 158.91 38.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 291' ' ' LEU . 0.0 OUTLIER -64.09 149.2 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.681 ' N ' HD22 ' A' ' 291' ' ' LEU . 6.4 t -163.15 108.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 167.52 146.28 4.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.454 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 135.41 30.41 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 4.9 m -87.26 146.93 25.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 35.1 t -103.98 -52.4 2.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.479 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.3 m -90.3 122.43 33.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.371 . . . . 0.0 110.882 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.3 t -47.0 154.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.903 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 162.32 -145.95 11.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 t -129.69 110.93 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.889 0.376 . . . . 0.0 110.875 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 99.1 p -99.75 85.84 3.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -131.72 60.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -121.01 127.61 51.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 110.853 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -140.55 122.51 15.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.1 p -41.08 138.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.12 90.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -87.7 119.19 27.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.616 ' C ' HD23 ' A' ' 192' ' ' LEU . 29.2 t -94.3 -34.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 191' ' ' VAL . 1.3 pt? 34.59 45.36 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.449 ' HB2' HG12 ' A' ' 191' ' ' VAL . 62.3 m -121.54 142.97 49.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -44.09 -23.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 193' ' ' SER . 2.1 mp0 -74.97 -38.94 61.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -109.43 17.97 20.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.2 mt -105.64 143.85 33.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -123.94 150.77 63.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.615 0.721 . . . . 0.0 110.891 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.687 2.258 . . . . 0.0 112.354 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.43 11.79 3.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.4 mtt -99.14 130.95 45.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 274' ' ' GLU . 5.5 mp -86.42 107.94 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.583 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.3 mm? -121.26 130.72 53.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.975 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -93.55 129.4 39.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -136.01 -173.04 12.83 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 251' ' ' TYR . 5.6 p -130.89 140.07 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 111.114 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.2 t -61.99 119.94 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.1 t -86.36 -39.74 16.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.3 m -157.01 156.02 32.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.413 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.4 mp -106.76 125.41 50.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -117.24 144.62 44.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.769 ' O ' HD11 ' A' ' 230' ' ' LEU . 2.6 m-20 -66.36 -17.76 64.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -95.23 -27.39 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -170.02 -159.05 14.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.462 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.472 ' CD1' HD12 ' A' ' 246' ' ' LEU . 63.7 m-85 -133.34 129.44 37.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 0.0 110.885 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.95 126.17 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.927 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.0 t -111.95 135.31 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -81.78 133.65 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 pt -123.09 -22.76 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.06 50.03 4.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.48 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 90.7 t -143.53 147.79 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.41 124.32 35.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 95.4 -51.72 1.83 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.535 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -59.92 124.95 21.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.746 0.308 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -115.8 132.01 56.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 268' ' ' LEU . . . -115.25 125.83 53.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 14.1 t80 -123.32 137.13 54.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 233' ' ' ALA . 13.0 tp -112.79 132.34 22.32 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.58 0.705 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 140.59 43.0 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.345 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.769 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.9 mt -63.08 -19.88 64.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 15.4 mt -70.77 -44.53 66.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HG3' HG23 ' A' ' 270' ' ' VAL . 0.4 OUTLIER -79.64 -35.54 39.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.444 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -72.47 -43.05 64.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 11.3 tt0 -58.46 -36.81 74.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.75 -43.18 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.2 OUTLIER -72.1 -38.52 69.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.671 HG12 HD21 ' A' ' 246' ' ' LEU . 22.0 mt -66.3 -39.01 83.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.113 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 0.4 OUTLIER -69.18 -41.98 76.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -79.83 -21.65 43.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.548 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 24.1 mmtt -100.17 -67.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.748 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 22.3 t-20 -84.3 32.81 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' ASN . 76.2 mttt 37.94 27.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 85.94 61.58 1.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.748 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -142.65 134.12 26.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.86 148.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.671 HD21 HG12 ' A' ' 237' ' ' ILE . 94.5 mt -78.58 -177.66 5.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.6 145.89 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 78.1 t -72.2 128.53 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.164 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 104.56 -27.13 20.35 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -62.93 147.96 48.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 206' ' ' THR . 12.6 m-85 -80.97 132.01 35.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.933 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.73 141.45 51.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.74 133.86 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.702 ' HB3' HD22 ' A' ' 268' ' ' LEU . 85.1 m -155.28 151.13 27.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.02 147.0 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 200' ' ' GLY . 2.9 t -72.72 120.28 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -107.07 -48.47 3.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -137.77 135.37 36.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.9 t -122.35 122.26 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -126.05 134.34 51.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 65.75 -157.77 47.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -117.99 -42.5 2.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 110.93 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -130.72 32.2 3.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -90.53 -101.37 1.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.72 134.78 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.867 0.365 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 39.8 t -108.25 139.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.7 m -99.1 117.12 32.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.9 mt -110.9 157.66 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.6 m -148.63 142.0 25.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 232' ' ' LYS . 36.1 t -75.21 141.61 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.071 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -140.7 107.38 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 271' ' ' GLY . 6.7 p-80 -36.53 -59.61 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 30.4 t -171.38 119.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.846 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.832 ' HB2' HD21 ' A' ' 202' ' ' LEU . 45.7 mm-40 -94.92 82.1 3.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.76 -37.44 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 84.9 p -100.06 123.94 44.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 44.2 p -129.63 36.16 4.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.115 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -170.74 169.88 6.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.107 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 279' ' ' ILE . 3.7 mp -75.44 147.43 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -58.05 95.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.0 t -165.19 157.74 15.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.12 178.32 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -130.35 151.04 51.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -88.19 88.82 7.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.7 p -51.07 171.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -51.84 -179.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -123.55 -177.33 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 288' ' ' LEU . 0.7 OUTLIER -164.43 120.76 1.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.59 122.25 39.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 38.9 p-10 -167.26 120.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.97 134.68 57.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 6.9 m -127.88 56.31 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -58.44 150.56 33.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.498 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -7.97 22.39 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.348 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 69.9 m -140.55 144.04 35.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.5 m -84.36 99.85 10.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 181' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 m -63.01 78.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.812 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 179' ' ' GLY . 1.9 p -103.92 96.77 6.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 132.11 -124.01 3.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.9 m -57.27 172.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 110.848 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.2 p -124.0 178.69 5.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.871 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.36 162.94 24.91 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -82.36 167.17 18.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.768 0.318 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -83.98 170.89 13.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.2 t -112.46 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -107.46 104.55 14.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -93.26 145.38 24.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 191' ' ' VAL . 9.2 p -110.92 24.62 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.2 tp -65.62 105.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.2 m -115.39 159.47 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.79 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.091 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 14.1 pm0 -68.7 -10.82 58.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -88.83 -15.64 34.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 58.3 mt -59.86 151.73 25.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -127.55 143.91 49.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.55 0.691 . . . . 0.0 110.897 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 109.1 2.23 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 146.98 -11.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 16.7 mtm -79.1 141.27 37.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.833 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.1 108.08 20.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.945 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.3 128.44 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -94.3 130.87 40.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.11 -163.64 9.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.5 p -131.11 146.03 52.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 111.194 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.43 121.67 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.3 t -85.83 -43.05 13.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.575 ' HA ' HG22 ' A' ' 248' ' ' VAL . 5.2 m -157.05 156.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.859 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.487 HD21 ' C ' ' A' ' 246' ' ' LEU . 6.5 mp -106.49 125.1 50.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -116.95 162.17 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.5 m-20 -83.23 -22.93 32.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -96.15 -9.82 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 177.3 -161.4 28.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.647 ' CD2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -132.86 137.55 46.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.961 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.95 129.91 36.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.71 143.1 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.46 133.78 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.826 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.8 pt -125.1 -18.96 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 70.94 51.7 17.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.15 150.05 34.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.834 0.349 . . . . 0.0 111.116 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -93.84 119.2 32.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 77.96 43.68 13.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.1 m -155.22 123.71 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.9 ttm105 -113.43 131.42 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.43 123.79 48.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 13.0 t80 -122.92 140.48 52.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.721 HD12 ' HD2' ' A' ' 229' ' ' PRO . 23.5 tp -113.81 133.69 22.22 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.721 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.78 146.76 61.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.316 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.865 HD11 ' O ' ' A' ' 212' ' ' ASP . 74.5 mt -63.07 -22.76 67.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.4 -45.01 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.959 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 270' ' ' VAL . 15.0 mmtm -81.96 -37.7 26.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.627 ' CB ' ' CD1' ' A' ' 215' ' ' TYR . . . -64.32 -46.1 85.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.058 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -65.21 -39.26 92.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.7 -43.24 89.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.915 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 2.2 t80 -72.64 -42.26 64.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 233' ' ' ALA . 18.7 mt -65.23 -38.94 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.146 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.462 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 1.2 ttt85 -68.79 -43.72 75.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -79.0 -21.82 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 39.2 mmtt -99.31 -68.96 0.78 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.5 t-20 -84.06 34.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 241' ' ' ASN . 79.5 mttt 34.73 34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 78.1 74.63 1.01 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -152.24 118.73 5.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.873 0.368 . . . . 0.0 111.15 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -35.61 135.76 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.647 HD12 ' CD2' ' A' ' 215' ' ' TYR . 51.7 mt -69.22 -175.71 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.426 ' HG3' ' C ' ' A' ' 246' ' ' LEU . 3.4 mtpm? -144.7 130.06 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 209' ' ' SER . 23.9 t -50.62 126.05 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 109.83 -31.37 7.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.496 ' NE2' HD22 ' A' ' 246' ' ' LEU . 9.1 pt20 -62.99 148.17 48.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.909 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -80.73 130.82 35.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.455 ' CD1' ' CE1' ' A' ' 236' ' ' TYR . 14.0 tp -124.3 145.32 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -93.18 127.48 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.66 ' HB3' HD22 ' A' ' 268' ' ' LEU . 35.0 m -147.2 155.19 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 271' ' ' GLY . 95.3 mt -133.03 139.43 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.29 119.39 7.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.126 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -103.9 -48.07 4.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -138.6 140.28 38.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.8 t -122.16 129.11 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -85.41 176.29 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -87.97 -54.51 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -85.85 30.64 0.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.381 . . . . 0.0 110.921 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 45.5 32.03 3.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.01 -74.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.8 t -132.68 134.24 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.33 139.6 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.7 t -99.97 118.4 36.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.66 HD22 ' HB3' ' A' ' 254' ' ' CYS . 18.3 mt -113.64 149.88 33.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 255' ' ' ILE . 52.3 p -145.94 142.01 28.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 232' ' ' LYS . 17.3 m -73.93 134.65 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 255' ' ' ILE . . . -151.82 107.73 0.35 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.475 ' O ' ' CD2' ' A' ' 272' ' ' HIS . 23.8 p-80 -87.38 37.05 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.857 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 5.0 m -107.29 91.96 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 276' ' ' SER . 18.3 pt-20 -168.16 134.84 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 275' ' ' VAL . 4.8 t 34.97 32.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.152 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 274' ' ' GLU . 59.8 p -52.83 -43.4 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 79.8 p -103.26 146.56 28.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.104 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.84 100.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.09 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.404 HD12 HG13 ' A' ' 275' ' ' VAL . 23.1 mt -81.65 142.3 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.68 83.76 2.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.044 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 25.3 p -131.71 171.03 13.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.127 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -110.95 121.52 45.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.06 158.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.69 110.06 8.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.1 t -144.13 141.83 30.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -118.02 68.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.909 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -163.12 147.53 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 22.0 tp -120.82 148.62 43.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -155.09 169.49 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -125.25 97.43 5.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -123.46 159.13 29.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.3 t -161.84 130.67 4.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -122.36 73.09 0.38 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 84.13 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.706 2.271 . . . . 0.0 112.316 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.3 m -109.04 110.64 21.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 28.1 t -86.08 152.07 23.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.509 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 98.6 p -90.33 50.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.865 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 m -109.32 84.85 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.3 86.98 1.53 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.528 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.1 m -129.16 171.21 12.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 0.0 110.878 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 t -76.83 165.76 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -86.76 56.25 4.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -123.15 103.93 8.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -155.16 132.19 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 50.7 t -41.07 147.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -42.05 100.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -137.59 145.48 42.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.473 HG13 HD21 ' A' ' 197' ' ' LEU . 24.5 t -118.9 61.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.26 -44.25 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 45.3 m -120.35 162.37 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.55 -33.97 77.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -61.68 -28.6 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -78.68 -31.56 46.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.473 HD21 HG13 ' A' ' 191' ' ' VAL . 71.8 mt -60.82 135.22 57.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.3 ptmm? -100.4 148.93 35.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.567 0.698 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 109.81 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 129.91 8.04 3.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.706 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.9 mtt -76.16 140.36 41.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 203' ' ' LEU . 5.4 mp -86.5 108.62 18.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -130.39 141.1 50.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.4 m -119.57 122.23 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.3 -177.61 14.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.3 p -124.16 138.08 54.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.341 . . . . 0.0 111.142 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.47 122.88 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.103 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.3 t -88.23 -40.68 13.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.97 156.07 32.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 248' ' ' VAL . 3.8 mm? -99.86 115.42 29.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.442 ' OE1' HD21 ' A' ' 216' ' ' LEU . 24.3 mt-10 -98.25 137.21 37.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 230' ' ' LEU . 8.5 t0 -57.2 -20.55 27.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -94.5 -38.3 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -161.24 -161.94 12.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.531 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.937 ' CE2' HD12 ' A' ' 246' ' ' LEU . 41.3 m-85 -117.63 132.14 56.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 110.969 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.442 HD21 ' OE1' ' A' ' 211' ' ' GLU . 1.9 mm? -92.01 133.54 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 17.4 t -112.76 142.66 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.4 123.07 33.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.9 pt -120.7 -33.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.03 37.35 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.443 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.4 t -113.11 146.29 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -97.13 98.75 10.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 107.03 46.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.501 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 91.2 m -158.3 124.1 4.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -116.7 123.92 48.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -116.01 129.33 56.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.094 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 18.9 t80 -130.48 137.65 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.86 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -107.87 126.81 28.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.648 0.737 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.86 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.78 131.66 21.66 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.688 2.259 . . . . 0.0 112.372 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.702 HD23 ' HE1' ' A' ' 215' ' ' TYR . 30.5 mt -62.4 -24.75 67.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.6 mt -65.6 -41.27 92.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -42.51 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -59.3 -34.14 71.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.45 -34.01 70.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.41 -43.66 76.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -72.86 -37.79 67.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.641 HG23 ' HB2' ' A' ' 241' ' ' ASN . 32.4 mt -68.42 -42.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 239' ' ' GLN . 28.3 ptt180 -68.73 -35.98 77.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 12.1 mm100 -78.38 -39.9 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -98.1 -74.93 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m120 -52.47 -16.17 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 237' ' ' ILE . 32.5 mttp 59.54 36.53 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.41 46.88 5.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.533 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -136.57 117.42 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.067 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -49.57 135.54 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.937 HD12 ' CE2' ' A' ' 215' ' ' TYR . 28.3 mt -62.6 179.2 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -131.27 170.8 14.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.55 HG23 HD23 ' A' ' 210' ' ' LEU . 19.3 t -87.73 128.66 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 103.55 -21.93 37.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.717 ' OE1' HD22 ' A' ' 246' ' ' LEU . 1.5 pt20 -64.36 148.0 51.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -81.0 127.17 32.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.96 135.2 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.756 ' O ' HG12 ' A' ' 270' ' ' VAL . 1.1 p-10 -93.28 125.31 37.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 13.3 m -140.28 157.64 45.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 201' ' ' MET . 73.3 mt -136.84 140.85 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 200' ' ' GLY . 39.0 t -61.04 119.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -99.87 -46.89 5.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -140.1 152.89 46.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.438 ' C ' ' HE2' ' A' ' 260' ' ' LYS . 71.9 t -124.0 127.29 73.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.438 ' HE2' ' C ' ' A' ' 259' ' ' VAL . 0.3 OUTLIER -97.72 167.72 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.413 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -88.92 171.1 38.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.514 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 261' ' ' GLY . 3.0 p-10 45.52 40.67 6.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 40.47 47.34 3.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -71.54 -98.56 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.59 146.9 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.02 139.99 35.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 m -98.97 115.44 28.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 226' ' ' ALA . 12.0 mt -113.23 148.77 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 46.3 m -158.78 142.07 14.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 253' ' ' ASN . 2.4 m -74.97 142.86 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.098 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -129.08 -97.58 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.482 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -92.75 141.06 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.0 110.844 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 54.6 m -120.64 -175.22 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 274' ' ' GLU . 1.7 pm0 -87.81 101.6 13.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.83 -38.1 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 29.1 t -44.06 -42.36 6.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 15.1 t -120.34 160.09 23.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -172.56 137.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.14 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.42 150.87 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -131.78 95.15 3.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.5 m -145.89 136.41 24.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -106.29 151.85 24.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 284' ' ' GLN . 0.0 OUTLIER -165.31 169.68 15.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 283' ' ' GLN . 36.8 mt-30 -34.6 115.43 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 69.4 m -104.38 127.22 52.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -158.28 122.57 4.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -157.43 132.35 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.543 HD13 ' N ' ' A' ' 289' ' ' ASN . 1.4 tm? -155.13 119.39 4.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.543 ' N ' HD13 ' A' ' 288' ' ' LEU . 19.0 p30 -73.33 133.95 44.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -165.47 155.96 13.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 292' ' ' SER . 0.0 OUTLIER -168.0 175.3 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.597 ' N ' HD22 ' A' ' 291' ' ' LEU . 31.2 t -172.26 152.61 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 142.46 83.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 120.05 6.89 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.352 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 296' ' ' SER . 3.9 m 62.75 32.84 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 295' ' ' SER . 3.0 m -36.49 108.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.3 t -128.16 124.68 37.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.856 0.36 . . . . 0.0 110.852 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.3 m -116.08 130.2 56.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 85.07 154.9 23.11 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 p -95.13 99.51 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.862 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.4 p -143.5 122.61 12.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.25 -175.36 25.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -127.41 150.08 49.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -72.72 137.22 45.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.764 HG12 ' OD1' ' A' ' 189' ' ' ASN . 89.1 t -47.16 -66.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.764 ' OD1' HG12 ' A' ' 188' ' ' VAL . 10.6 m-20 -112.83 42.93 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 40.11 35.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 t 37.51 39.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tp -94.2 92.17 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.9 m -146.85 144.98 29.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.09 69.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.146 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.74 -10.22 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -91.08 -22.86 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt -67.49 162.87 22.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -153.26 155.25 31.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.561 0.696 . . . . 0.0 110.898 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 113.56 3.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.398 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.47 4.11 4.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.466 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 255' ' ' ILE . 12.3 mtt -90.62 130.89 36.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.7 mp -91.93 109.02 20.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.66 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.7 mm? -123.63 127.99 49.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.948 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.5 m -97.78 119.45 36.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -122.42 -172.31 14.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.522 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.521 HG23 ' CD1' ' A' ' 251' ' ' TYR . 1.2 p -128.55 139.32 52.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 111.128 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.9 t -61.29 122.76 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.6 t -92.62 -40.43 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.8 t -156.98 156.09 32.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.28 125.15 51.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.87 150.97 34.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.767 ' O ' HD11 ' A' ' 230' ' ' LEU . 40.3 m-20 -70.17 -17.05 63.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -98.06 -25.77 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -172.27 -169.74 35.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.669 ' CE1' HD12 ' A' ' 246' ' ' LEU . 82.6 m-85 -122.08 131.23 53.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.945 0.403 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.04 124.44 32.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.92 130.16 66.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.09 137.07 36.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 pt -123.44 -31.84 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.58 44.43 6.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.05 140.43 46.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.71 111.56 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 103.15 37.83 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 93.1 m -154.87 123.36 6.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 111.162 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.34 123.03 47.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -118.41 127.68 53.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 23.5 t80 -131.07 137.34 49.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.987 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.1 tp -109.29 128.61 25.11 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.634 0.73 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.987 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.76 143.42 50.77 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 0.0 112.38 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.767 HD11 ' O ' ' A' ' 212' ' ' ASP . 75.2 mt -62.99 -26.81 69.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.915 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.4 -40.46 95.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.854 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -83.13 -35.72 25.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.54 63.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.147 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -58.23 -35.32 71.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.7 -46.02 76.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.695 ' HB2' HG21 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -71.3 -36.93 71.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.983 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.852 HG12 HD21 ' A' ' 246' ' ' LEU . 21.7 mt -68.89 -38.92 79.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.481 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 2.7 ttm-85 -69.02 -41.18 78.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.5 -19.98 48.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 7.5 mmtp -101.82 -69.93 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.567 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 17.1 t-20 -84.16 33.52 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 241' ' ' ASN . 53.8 mttt 34.63 34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 238' ' ' ARG . . . 77.75 73.03 1.1 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.484 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.567 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -151.3 124.4 8.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 111.112 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 244' ' ' ALA . 20.4 mmtm -37.22 144.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.852 HD21 HG12 ' A' ' 237' ' ' ILE . 13.8 mt -80.95 178.9 8.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -130.04 130.4 44.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 93.5 t -55.76 127.54 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 108.18 -27.24 14.64 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.462 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -63.44 148.0 49.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.812 0.339 . . . . 0.0 110.862 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.521 ' CD1' HG23 ' A' ' 206' ' ' THR . 15.5 m-85 -81.03 127.28 32.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 21.3 tp -121.04 139.36 53.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -88.87 132.47 34.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.875 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.741 ' HB3' HD22 ' A' ' 268' ' ' LEU . 43.3 m -153.04 153.74 33.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 201' ' ' MET . 72.9 mt -136.8 143.75 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.48 121.45 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.104 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -101.62 -41.97 6.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -150.67 155.98 40.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.19 119.2 56.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 261' ' ' GLY . 35.6 tttp -86.42 135.03 33.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . 35.92 -149.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -120.35 72.5 0.95 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.81 24.04 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -95.46 -87.39 1.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.514 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.19 148.98 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.381 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.46 139.97 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.0 t -100.01 118.08 35.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 254' ' ' CYS . 16.4 mt -111.97 150.16 30.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 255' ' ' ILE . 1.4 t -146.28 146.98 30.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.854 HG22 ' HD2' ' A' ' 232' ' ' LYS . 28.9 m -74.7 136.16 25.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.088 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -157.38 101.43 0.2 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.504 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 271' ' ' GLY . 5.1 p-80 -35.76 132.38 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 0.0 110.847 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 24.2 p -164.0 174.68 11.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -66.06 98.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 276' ' ' SER . 93.0 t -97.43 -46.22 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.111 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 275' ' ' VAL . 1.4 p -35.36 126.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 13.2 t -160.0 154.69 24.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -113.73 170.97 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.067 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.36 140.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -124.36 -19.52 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 13.6 t -84.44 160.87 20.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . 0.52 ' N ' ' CD ' ' A' ' 282' ' ' GLU . 1.4 pm0 -135.16 -179.95 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -153.87 125.86 7.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -55.86 162.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 17.7 t -92.47 92.5 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -70.92 175.21 5.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -142.75 158.22 43.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.2 tp -163.8 144.53 8.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.465 ' OD1' HD12 ' A' ' 291' ' ' LEU . 13.4 t-20 -71.06 133.69 46.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -96.93 90.37 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.465 HD12 ' OD1' ' A' ' 289' ' ' ASN . 13.6 mt -135.11 161.57 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.976 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.8 t -118.01 111.31 18.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -168.54 156.53 28.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -27.2 26.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.735 2.29 . . . . 0.0 112.322 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 18.8 m -85.41 109.11 18.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.0 t -134.56 138.79 44.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.3 t -127.03 149.86 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.875 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.0 p -45.45 -58.06 3.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.885 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 150.48 -168.14 30.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.2 p -130.79 1.98 4.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.855 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.4 m -117.91 122.84 44.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -75.13 -68.23 1.59 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.91 157.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.772 0.32 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -137.28 159.1 42.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 81.2 t -110.76 -48.56 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -105.49 95.61 5.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -88.53 135.02 33.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.17 35.32 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.08 83.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 196' ' ' ALA . 17.9 m -138.99 160.93 38.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -48.54 -54.87 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.125 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.7 -17.43 15.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 193' ' ' SER . . . -90.49 -21.87 21.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 69.6 mt -60.01 -179.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -153.22 148.16 19.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.606 0.717 . . . . 0.0 110.879 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.85 10.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.639 2.226 . . . . 0.0 112.329 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.05 6.19 6.48 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 28.0 mtt -89.78 127.71 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.4 mp -89.61 109.87 20.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 202' ' ' LEU . 26.4 mt -131.49 127.05 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m -84.13 119.66 25.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.94 163.84 12.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 251' ' ' TYR . 1.3 p -113.5 135.47 53.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.812 0.339 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.99 121.06 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 248' ' ' VAL . 41.8 t -86.17 -45.09 11.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 85.1 p -157.02 155.97 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.47 HD21 ' C ' ' A' ' 246' ' ' LEU . 8.1 mp -101.63 129.22 47.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -116.31 151.88 34.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.598 ' O ' HD11 ' A' ' 230' ' ' LEU . 5.8 m-20 -71.05 -21.78 62.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -96.74 -17.19 20.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 179.55 -158.88 23.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.468 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.6 m-85 -131.29 135.8 47.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.921 0.391 . . . . 0.0 110.897 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.44 129.55 35.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.1 128.4 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.01 132.82 36.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.48 -19.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.18 57.68 5.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 45.7 t -139.86 139.79 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.79 94.23 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 116.26 39.38 0.87 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 85.5 m -156.98 131.59 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.63 123.76 48.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.02 122.99 47.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -124.84 142.42 51.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.683 HD12 ' HD2' ' A' ' 229' ' ' PRO . 19.7 tp -113.75 134.6 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.609 0.718 . . . . 0.0 110.879 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.83 142.55 47.95 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.674 2.25 . . . . 0.0 112.347 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 212' ' ' ASP . 79.1 mt -63.1 -22.2 66.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.91 -43.26 79.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.968 ' HD2' HG22 ' A' ' 270' ' ' VAL . 0.9 OUTLIER -81.76 -33.22 31.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -75.15 -51.87 12.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -60.26 -36.92 78.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -62.49 -41.57 98.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 4.9 t80 -73.25 -41.83 63.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.956 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 241' ' ' ASN . 47.0 mt -63.02 -39.85 86.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.6 ptm180 -69.77 -35.68 75.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 6.5 mm100 -81.4 -29.22 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 14.1 mmmt -107.99 -63.39 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.765 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.7 m-20 -80.73 21.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.9 mmtm 35.82 30.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.15 40.33 8.67 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -104.81 113.37 26.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -40.39 126.3 2.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.679 HD21 HG12 ' A' ' 237' ' ' ILE . 15.4 mt -64.23 -175.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -137.31 -175.91 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 208' ' ' SER . 98.4 t -97.53 145.79 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.79 81.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.41 HE22 HD22 ' A' ' 246' ' ' LEU . 5.1 pt20 -82.86 148.01 27.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.436 ' HA ' HG22 ' A' ' 206' ' ' THR . 15.1 m-85 -80.95 128.66 33.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 12.5 tp -131.4 142.89 50.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -98.89 131.59 44.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.739 ' HB3' HD22 ' A' ' 268' ' ' LEU . 97.1 m -154.03 163.05 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.453 ' O ' HD23 ' A' ' 268' ' ' LEU . 70.0 mt -134.63 150.37 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.51 121.57 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.406 ' OE1' ' N ' ' A' ' 269' ' ' SER . 3.9 mp0 -104.75 -40.56 5.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -142.99 148.83 37.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.6 t -123.08 126.03 73.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -78.3 144.57 36.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.34 -65.52 3.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.525 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -86.71 37.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 46.98 36.39 8.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.04 -82.48 0.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.495 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.79 134.31 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 38.1 t -108.86 139.98 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 t -99.07 121.48 41.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 254' ' ' CYS . 11.5 mt -118.42 154.13 32.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.406 ' N ' ' OE1' ' A' ' 257' ' ' GLU . 36.4 t -154.05 152.41 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.84 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.968 HG22 ' HD2' ' A' ' 232' ' ' LYS . 20.2 m -80.09 139.99 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.8 92.12 0.48 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 273' ' ' SER . 11.1 m170 -38.88 -41.47 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.782 0.325 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 272' ' ' HIS . 85.2 p 35.5 41.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 273' ' ' SER . 48.4 tt0 -35.65 106.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLU . 88.6 t -35.93 -47.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 38.9 t -66.59 80.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 53.1 m -142.37 132.67 24.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.96 145.31 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 17.2 mm -77.87 136.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.92 -18.89 14.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 80.6 p -80.39 163.3 23.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.0 165.22 21.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -103.43 126.74 50.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -66.81 129.85 41.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.435 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 37.5 t -86.1 143.48 28.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.435 ' CG ' ' O ' ' A' ' 285' ' ' SER . 98.6 m95 -159.53 134.34 7.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -137.94 135.9 36.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.804 HD23 ' H ' ' A' ' 288' ' ' LEU . 2.6 pt? -101.3 163.75 12.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -85.63 170.66 12.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -142.45 130.2 21.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 39.7 tp -135.48 133.99 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.2 m -112.28 176.98 4.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 165.48 -159.71 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.539 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 129.75 18.08 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.247 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 27.5 m -139.72 158.35 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.1 t -135.94 136.05 40.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.507 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.1 t -91.83 108.48 19.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.38 . . . . 0.0 110.866 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 t -102.13 161.12 13.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.84 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -178.85 62.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.501 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.6 m -69.25 134.72 49.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 110.892 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 m -117.65 173.5 6.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.823 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -111.74 -151.48 11.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.29 142.21 28.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.807 0.337 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -78.53 175.36 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.7 t -91.29 -49.43 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -99.86 93.37 5.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 190' ' ' ARG . 0.3 OUTLIER -137.52 148.23 45.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.917 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 99.6 t -48.8 -44.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.472 ' C ' HD23 ' A' ' 192' ' ' LEU . 9.7 tt -39.95 111.23 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.9 t -155.42 164.03 39.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.502 ' O ' HG11 ' A' ' 259' ' ' VAL . . . -43.16 -24.7 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.46 -40.47 70.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.46 24.52 12.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.2 mt -110.53 172.41 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -134.39 151.48 76.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 121.2 7.89 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 2.256 . . . . 0.0 112.368 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.25 5.28 3.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.1 mtt -96.42 133.59 40.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.779 0.324 . . . . 0.0 110.857 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -85.43 116.28 23.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 202' ' ' LEU . 6.0 mp -120.92 130.22 53.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.3 m -97.99 126.15 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -138.46 -177.12 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.509 HG23 ' CE1' ' A' ' 251' ' ' TYR . 12.5 p -121.69 141.29 51.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.93 120.04 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.8 t -86.18 -39.29 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.1 m -157.02 156.01 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.844 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 246' ' ' LEU . 6.9 mp -108.53 122.9 48.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -111.08 156.96 20.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.579 ' O ' HD11 ' A' ' 230' ' ' LEU . 1.7 m-20 -75.35 -23.52 57.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -94.53 -22.17 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.5 -164.89 27.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.491 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 246' ' ' LEU . 75.0 m-85 -127.55 133.21 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.91 128.28 34.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 43.1 t -112.01 132.64 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.97 136.67 36.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 pt -127.4 -26.85 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.78 56.29 2.8 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.503 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 89.5 t -139.88 132.82 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.1 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -88.36 46.45 1.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 167.48 42.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.563 ' CG2' HG21 ' A' ' 266' ' ' VAL . 54.5 m -160.43 124.42 3.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -107.32 125.13 50.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.99 125.66 53.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 2.9 t80 -129.0 131.21 47.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.742 HD12 ' HD2' ' A' ' 229' ' ' PRO . 20.2 tp -104.3 132.06 21.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.742 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.3 Cg_endo -69.75 146.62 60.82 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.312 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 212' ' ' ASP . 23.7 mt -63.03 -26.58 68.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.41 -44.39 89.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 270' ' ' VAL . 26.9 mmtm -82.39 -41.89 19.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.76 -46.3 84.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -62.7 -38.82 91.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.916 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -65.44 -44.67 86.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.569 ' CD1' ' HG3' ' A' ' 240' ' ' LYS . 83.5 t80 -70.13 -38.66 75.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 241' ' ' ASN . 41.3 mt -69.21 -44.28 80.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 5.5 ptm180 -69.65 -37.44 76.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -81.52 -27.14 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.569 ' HG3' ' CD1' ' A' ' 236' ' ' TYR . 7.2 mmpt? -107.75 -64.91 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 237' ' ' ILE . 4.1 m120 -81.62 25.5 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ASN . 1.2 pmtp? 32.74 34.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 102.31 -45.27 1.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -34.42 120.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -53.61 152.7 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.609 HD22 ' NE2' ' A' ' 250' ' ' GLN . 17.7 mt -76.3 167.38 21.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.963 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -132.12 129.82 40.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 90.8 t -46.67 131.77 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 105.73 -30.22 10.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.609 ' NE2' HD22 ' A' ' 246' ' ' LEU . 10.2 pt20 -62.93 147.97 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.942 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.509 ' CE1' HG23 ' A' ' 206' ' ' THR . 10.6 m-85 -81.02 130.21 34.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.4 tp -123.93 145.06 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -94.28 129.05 41.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.964 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.782 ' HB3' HD22 ' A' ' 268' ' ' LEU . 63.7 m -148.43 151.99 36.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 201' ' ' MET . 38.5 mt -130.79 145.95 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.137 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 203' ' ' LEU . 6.2 t -70.29 122.58 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -105.5 -45.23 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -138.78 136.53 35.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 194' ' ' ALA . 36.1 t -122.67 125.74 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 261' ' ' GLY . 34.7 ttpt -90.14 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -37.25 -60.06 1.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -93.44 174.34 7.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -80.66 51.76 4.3 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -77.18 -80.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.97 133.89 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 111.133 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 224' ' ' THR . 22.1 t -106.34 139.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.1 t -101.43 125.72 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.782 HD22 ' HB3' ' A' ' 254' ' ' CYS . 45.6 mt -116.51 157.16 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 60.1 p -151.45 156.76 41.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 232' ' ' LYS . 41.7 t -78.19 131.85 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 255' ' ' ILE . . . -88.55 -111.01 1.13 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -134.98 -176.4 4.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.742 0.306 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 59.5 p -84.29 163.6 19.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.95 146.87 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 275' ' ' VAL . 45.1 t -85.46 31.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.9 t -82.36 40.58 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.808 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 8.9 t -105.43 143.52 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.132 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -52.11 147.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 21.1 mt -52.51 150.29 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -121.46 113.15 19.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 10.1 t -72.39 137.65 46.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -146.39 176.72 9.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -49.87 -49.55 49.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -107.89 103.07 12.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 64.2 m -131.76 173.78 10.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -89.84 174.78 7.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -136.55 173.03 12.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 15.1 tp 64.39 41.9 5.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -71.38 166.98 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -74.06 137.68 43.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -167.5 164.86 14.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 2.4 t -169.37 165.94 10.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 174.44 157.78 16.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -174.12 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.697 2.265 . . . . 0.0 112.33 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.6 t -133.79 -57.07 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.1 t -97.64 137.64 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.476 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 88.4 p -169.19 152.28 4.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.861 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -55.14 7.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.57 175.84 49.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 m -107.29 120.39 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.879 0.371 . . . . 0.0 110.897 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.4 t -146.15 115.22 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.22 -161.51 28.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.72 175.16 11.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.817 0.341 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -60.01 161.86 6.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 188' ' ' VAL . 10.9 t -52.91 -17.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 5.0 m120 37.84 51.79 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -69.58 132.51 46.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.538 ' O ' HG12 ' A' ' 191' ' ' VAL . 58.7 t -103.49 64.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.34 -48.1 3.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 15.5 p -172.77 157.92 3.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.93 -35.48 58.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.33 -38.6 85.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -70.1 -25.1 63.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.6 mt -60.85 -178.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -160.8 154.22 18.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 0.0 110.862 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 126.37 13.21 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.676 2.25 . . . . 0.0 112.377 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 127.74 0.84 6.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.8 mtt -90.05 128.7 36.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.36 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.6 mp -89.46 117.33 28.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 203' ' ' LEU . 3.9 mp -130.79 128.96 41.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 31.6 m -85.02 124.33 31.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.86 169.25 20.99 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 251' ' ' TYR . 2.7 p -119.24 138.12 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 0.0 111.098 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.83 121.99 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 42.8 t -86.49 -42.01 13.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.437 ' HA ' HG22 ' A' ' 248' ' ' VAL . 1.8 t -157.04 156.3 32.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.875 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -106.75 125.13 50.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -112.91 154.89 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.633 ' O ' HD11 ' A' ' 230' ' ' LEU . 10.1 p-10 -72.81 -18.99 61.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.849 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -97.52 -30.41 12.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.575 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -165.13 -165.6 22.72 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -127.94 131.74 49.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.78 125.9 33.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.1 t -112.22 132.87 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.128 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -79.96 131.79 35.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 pt -124.05 -18.77 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 67.78 40.06 89.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.95 138.04 51.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.23 127.93 34.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 73.14 36.82 56.06 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.477 ' CG2' HG21 ' A' ' 266' ' ' VAL . 56.4 m -149.97 123.87 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -109.37 130.73 55.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.575 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -131.72 140.25 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.738 HD12 ' HD2' ' A' ' 229' ' ' PRO . 22.6 tp -114.99 133.17 22.69 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.619 0.723 . . . . 0.0 110.889 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.738 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.76 145.24 56.59 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.3 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 212' ' ' ASP . 30.7 mt -63.38 -21.63 66.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.11 -44.7 68.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.824 ' HD2' HG22 ' A' ' 270' ' ' VAL . 17.5 tppt? -78.25 -30.69 48.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.87 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -77.01 -44.32 31.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -58.34 -33.4 69.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.58 -43.9 71.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 0.8 OUTLIER -72.89 -35.49 67.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.637 HG23 ' HB2' ' A' ' 241' ' ' ASN . 39.8 mt -70.64 -40.9 77.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.182 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.486 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 16.2 ptt85 -69.52 -37.44 77.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -80.76 -39.14 27.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 63.3 mmtt -94.05 -57.58 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.637 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -81.99 23.26 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.1 OUTLIER 34.09 32.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.79 45.4 7.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.476 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -122.92 112.29 17.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 111.13 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -34.19 132.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.2 mt -65.44 -176.56 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.91 141.89 27.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 209' ' ' SER . 92.3 t -57.68 151.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.29 -21.49 6.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.36 148.53 51.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.413 ' HA ' HG22 ' A' ' 206' ' ' THR . 11.3 m-85 -85.01 128.31 34.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.0 tp -126.08 135.73 52.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -92.75 131.49 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 82.6 m -152.74 162.98 40.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.6 mt -137.19 144.44 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 9.3 t -66.43 119.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -106.65 -46.91 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -132.26 136.02 46.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.15 132.84 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.4 ' CB ' ' H ' ' A' ' 265' ' ' VAL . 13.3 tptm -84.37 158.0 21.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -51.59 -94.57 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 263' ' ' GLY . 20.0 p-10 -73.67 64.13 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 36.57 42.78 0.7 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -66.47 -73.33 0.64 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.4 ' H ' ' CB ' ' A' ' 260' ' ' LYS . 75.5 t -133.87 133.44 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.364 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 224' ' ' THR . 19.0 t -105.15 137.8 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.755 ' C ' HD22 ' A' ' 268' ' ' LEU . 2.5 m -99.66 138.71 36.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.755 HD22 ' C ' ' A' ' 267' ' ' SER . 1.0 OUTLIER -121.05 148.35 44.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 28.3 p -151.75 141.87 22.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.824 HG22 ' HD2' ' A' ' 232' ' ' LYS . 33.7 m -79.45 141.82 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -157.95 -45.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -82.31 127.25 33.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.2 m -99.98 91.48 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.41 98.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.0 t -39.09 -42.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.3 t -40.58 -45.53 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 55.7 p 38.64 40.0 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.159 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -99.45 95.66 7.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 8.1 mt -103.32 152.36 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.083 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -81.55 14.96 2.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.045 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 22.1 p -126.16 135.55 51.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.142 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -149.65 162.03 41.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -164.01 118.33 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -61.66 157.56 17.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 10.8 t -69.18 109.6 4.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -150.68 143.52 24.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 43.5 44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 27.3 tp -110.3 94.02 4.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -144.91 171.45 14.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -79.18 142.5 36.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 292' ' ' SER . 6.5 tt -40.76 133.38 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.632 ' N ' HD23 ' A' ' 291' ' ' LEU . 89.6 p -157.65 114.65 2.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -165.44 141.39 6.99 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.52 9.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 14.9 t -104.91 109.54 21.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 51.9 p -88.16 97.46 11.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.84 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 t -60.86 98.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.914 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.4 t -114.99 41.75 2.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.03 -130.31 3.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.9 m -130.16 154.47 47.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.879 0.371 . . . . 0.0 110.878 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.8 p -102.93 144.0 31.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.57 156.48 27.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -120.94 166.24 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.0 115.79 8.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 28.1 m -83.5 -20.31 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.146 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -124.36 97.39 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -122.26 137.7 54.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 28.4 m -95.0 44.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 193' ' ' SER . 2.6 tt -118.19 -45.07 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.455 ' N ' HD23 ' A' ' 192' ' ' LEU . 2.8 m -75.49 146.84 40.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 197' ' ' LEU . . . -60.73 -9.99 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.117 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.81 -14.24 60.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -126.62 -9.05 6.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 194' ' ' ALA . 34.4 mt -63.97 161.4 15.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.53 ' N ' ' HE3' ' A' ' 201' ' ' MET . 49.7 mtmt -158.61 154.01 22.29 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.609 0.718 . . . . 0.0 110.84 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 107.26 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.722 2.282 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.69 7.01 3.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.558 ' HB3' HD11 ' A' ' 203' ' ' LEU . 8.6 mtt -92.8 132.66 36.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.41 112.22 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 201' ' ' MET . 2.1 mp -131.16 129.44 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.892 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.7 m -76.99 117.84 18.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -121.06 152.08 16.88 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -107.58 141.54 38.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.09 121.06 14.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.139 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.1 t -86.45 -46.13 10.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -157.07 156.42 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.23 126.9 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -115.21 156.41 25.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.659 ' O ' HD11 ' A' ' 230' ' ' LEU . 13.5 t70 -72.82 -24.04 60.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -87.96 -32.44 18.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -171.6 -159.55 18.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.626 ' CD2' HD12 ' A' ' 246' ' ' LEU . 96.3 m-85 -125.19 139.92 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.885 0.374 . . . . 0.0 110.917 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.32 130.83 44.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.97 146.07 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.55 129.68 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.506 HD11 ' CG2' ' A' ' 224' ' ' THR . 31.8 pt -121.76 -27.58 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.03 34.64 6.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.84 127.54 64.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.816 0.341 . . . . 0.0 111.143 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -99.33 94.55 6.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.37 -33.47 0.92 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.506 ' CG2' HD11 ' A' ' 219' ' ' ILE . 1.0 OUTLIER -92.66 151.04 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 111.163 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.78 121.09 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.14 127.62 54.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 6.2 t80 -132.09 137.03 47.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.49 HD23 ' HB2' ' A' ' 233' ' ' ALA . 11.1 tp -105.96 131.76 21.46 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 139.42 39.97 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.672 2.248 . . . . 0.0 112.321 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.659 HD11 ' O ' ' A' ' 212' ' ' ASP . 26.3 mt -63.11 -21.0 65.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 12.4 mt -70.79 -45.02 65.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.0 OUTLIER -81.87 -28.03 33.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.49 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -79.9 -49.13 12.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.098 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 33.3 tt0 -58.02 -44.38 87.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 236' ' ' TYR . 6.8 pt-20 -60.9 -40.43 93.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.652 ' CE1' HD11 ' A' ' 252' ' ' LEU . 1.2 t80 -73.12 -36.82 66.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 241' ' ' ASN . 31.1 mt -70.02 -40.95 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 4.8 ptm180 -69.1 -39.55 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -80.19 -19.93 45.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 236' ' ' TYR . 19.0 mmmt -105.88 -67.08 0.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.72 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.5 t-20 -84.11 29.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 14.0 pttm 37.44 28.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 84.41 50.46 4.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.72 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -125.58 122.27 36.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.111 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.67 138.44 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.626 HD12 ' CD2' ' A' ' 215' ' ' TYR . 18.4 mt -71.99 -174.95 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -127.79 -174.93 3.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.91 144.16 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.98 3.52 11.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 251' ' ' TYR . 0.8 OUTLIER -66.66 144.87 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.883 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.481 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 23.7 m-85 -80.8 126.66 31.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.652 HD11 ' CE1' ' A' ' 236' ' ' TYR . 6.0 tp -136.75 137.15 39.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.692 ' O ' HG12 ' A' ' 270' ' ' VAL . 21.5 t-20 -81.58 132.42 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 89.9 m -149.64 152.05 34.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.8 mt -137.08 146.44 28.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.4 t -74.24 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.33 -44.02 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -143.57 144.23 31.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.95 123.69 68.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -88.57 121.73 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 38.37 -143.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.468 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.26 63.98 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.92 0.391 . . . . 0.0 110.903 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 138.53 35.34 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -119.83 -109.65 2.28 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.2 t -113.14 148.23 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.128 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.6 t -118.16 139.32 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.8 m -98.95 120.73 39.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 25.7 mt -115.57 151.95 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 41.5 t -155.81 151.89 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 253' ' ' ASN . 20.9 m -89.26 128.79 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.122 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -108.3 -100.09 2.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -159.13 130.42 6.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -111.69 135.4 52.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -83.8 98.2 9.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.67 -53.46 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 5.2 m -55.61 176.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 43.5 p -137.38 162.51 33.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.73 167.75 15.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.723 ' H ' HD12 ' A' ' 279' ' ' ILE . 5.4 mp -53.49 143.51 5.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -62.74 100.46 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 14.7 t -158.91 140.45 13.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -116.07 151.21 36.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -51.41 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -39.55 101.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 32.8 t -131.87 143.23 50.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -74.85 94.97 2.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -63.99 128.28 35.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.6 tt -132.44 111.04 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -142.61 141.14 31.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -89.29 168.08 12.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -50.12 169.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 39.5 t -167.37 155.36 9.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -103.82 -158.07 24.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -13.85 35.15 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 0.0 112.311 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 3.2 m -42.67 -51.16 5.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 38.6 m -55.41 131.05 44.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.812 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.7 t 68.39 42.15 1.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 t -98.88 103.45 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 107.45 -133.1 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.453 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 16.3 m -55.0 156.62 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.838 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.3 t -118.17 101.19 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.17 3.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -62.48 161.99 10.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -74.58 102.35 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.3 m -76.94 -16.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.132 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 189' ' ' ASN . 7.2 t30 -128.76 96.0 4.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -161.89 160.5 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.6 m -85.52 51.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.177 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.92 114.48 15.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.948 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 196' ' ' ALA . 29.5 p -174.35 159.28 3.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -43.51 -27.86 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.071 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -102.48 -18.53 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' SER . . . -107.86 18.88 20.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.068 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -58.44 -177.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HG2' ' CE ' ' A' ' 201' ' ' MET . 14.1 ptmt -170.26 142.4 1.8 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 110.883 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 115.79 4.26 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.673 2.248 . . . . 0.0 112.325 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 129.6 9.78 3.12 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.476 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.465 ' CE ' ' HG2' ' A' ' 198' ' ' LYS . 64.5 mtm -98.1 135.73 39.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.693 ' C ' HD12 ' A' ' 203' ' ' LEU . 5.4 mp -93.16 119.94 32.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.936 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.693 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.7 mp -131.87 135.07 46.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.9 m -99.84 121.52 41.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.15 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -129.66 174.17 19.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.494 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' CE1' ' A' ' 251' ' ' TYR . 1.5 p -118.37 136.29 53.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.33 . . . . 0.0 111.193 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.57 127.83 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.176 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.7 t -92.27 -46.11 7.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.9 p -157.03 155.28 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.725 HD11 ' O ' ' A' ' 246' ' ' LEU . 7.4 mt -100.35 133.39 44.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.84 152.31 44.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -64.88 -23.02 67.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -88.66 -47.22 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -160.63 -165.07 16.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.499 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.643 ' CD1' HD22 ' A' ' 210' ' ' LEU . 45.0 m-85 -118.15 132.96 56.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -91.58 132.96 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.06 145.31 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -89.4 124.52 34.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 pt -121.88 -25.29 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.23 47.58 10.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.501 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.81 141.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -93.9 114.19 26.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 92.13 36.34 6.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.54 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 28.6 m -147.48 123.96 11.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -111.35 130.87 55.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -117.54 135.49 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 59.0 t80 -131.76 141.85 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.853 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -120.59 126.58 26.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.853 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.77 131.04 20.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 215' ' ' TYR . 21.4 mt -63.2 -21.64 66.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.91 -45.11 87.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.888 ' HD3' HG12 ' A' ' 270' ' ' VAL . 0.0 OUTLIER -70.45 -37.84 74.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.886 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.464 ' N ' ' HG3' ' A' ' 232' ' ' LYS . . . -75.34 -26.62 58.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -64.98 -31.67 73.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -74.11 -44.69 52.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 240' ' ' LYS . 1.4 t80 -73.05 -37.65 66.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.93 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.643 HG21 ' O ' ' A' ' 244' ' ' ALA . 51.7 mt -70.02 -41.87 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.473 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 13.2 ptm180 -67.12 -40.2 86.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 74.9 mm-40 -80.15 -19.95 46.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.513 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 64.9 mmtt -103.94 -68.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.85 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 11.7 t-20 -84.17 33.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 241' ' ' ASN . 74.3 mttt 34.48 32.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.94 69.16 1.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.447 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.85 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -137.55 -177.25 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -92.66 154.04 18.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.725 ' O ' HD11 ' A' ' 210' ' ' LEU . 19.1 mt -89.95 152.55 21.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -95.0 140.18 30.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.7 135.47 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.106 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 93.97 -18.34 56.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.475 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -63.06 148.07 48.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 0.0 110.89 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.458 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.2 m-85 -80.85 127.05 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.25 138.24 53.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.7 136.56 32.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 88.8 m -151.18 163.02 39.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 90.1 mt -136.17 145.5 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 5.9 t -68.02 122.31 18.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.22 -43.92 5.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -144.77 145.08 31.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.9 129.14 74.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -103.86 127.24 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 262' ' ' ASN . . . -43.74 167.06 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.501 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 263' ' ' GLY . 7.2 p-10 45.43 37.27 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 37.34 47.58 1.53 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.54 -85.11 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 48.9 t -121.94 136.84 57.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 111.149 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.2 137.76 38.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.504 ' C ' HD22 ' A' ' 268' ' ' LEU . 1.8 t -102.11 122.41 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.556 ' O ' HD22 ' A' ' 228' ' ' LEU . 0.3 OUTLIER -114.33 142.87 45.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 10.3 m -156.97 145.76 19.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.834 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.888 HG12 ' HD3' ' A' ' 232' ' ' LYS . 7.2 p -83.51 123.53 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -114.1 -97.81 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -110.93 -55.67 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 8.8 t 70.66 50.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.894 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -75.12 70.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.83 82.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.134 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.2 t -46.64 -41.63 15.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 81.4 p -129.77 121.93 27.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.137 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -102.44 100.09 10.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.553 ' H ' HD12 ' A' ' 279' ' ' ILE . 4.8 mp -69.1 145.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.167 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -123.16 95.51 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.1 t -70.88 142.3 51.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -93.65 167.36 11.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.54 143.12 46.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -98.82 171.8 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 33.7 t -61.13 164.93 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -78.41 163.67 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -115.83 -18.19 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 37.3 mt -87.31 36.86 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 66.2 t30 53.45 46.9 25.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -112.18 111.99 23.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 60.7 tp -126.12 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 37.2 m -154.82 172.05 18.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -110.49 146.06 17.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 296' ' ' SER . 53.4 Cg_endo -69.8 -43.32 2.69 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.715 2.277 . . . . 0.0 112.31 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 294' ' ' PRO . 2.0 t -34.61 95.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 294' ' ' PRO . 98.6 p -167.52 134.59 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.842 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 70.6 p -172.6 120.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 69.8 m -119.32 151.43 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.815 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 63.97 176.29 4.22 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.3 m -59.32 160.75 6.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 4.8 m -155.31 150.23 26.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 37.73 -144.59 0.17 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -119.6 156.44 30.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.335 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -40.18 127.45 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.867 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 66.9 t -57.99 -52.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.106 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 190' ' ' ARG . 7.7 m120 -164.01 140.4 6.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 189' ' ' ASN . 0.0 OUTLIER -34.68 149.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 193' ' ' SER . 30.9 m -89.45 -28.66 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.8 tp -42.08 -24.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 191' ' ' VAL . 11.3 p -45.17 159.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.94 -15.39 61.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -93.21 -19.19 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -126.19 31.41 5.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.638 ' C ' HG21 ' A' ' 259' ' ' VAL . 48.5 mt -45.81 161.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -123.49 145.16 46.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 136.28 32.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.649 2.233 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 121.59 -29.28 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.512 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 14.5 mtt -61.45 132.15 52.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.671 ' C ' HD22 ' A' ' 203' ' ' LEU . 4.3 mp -100.57 108.0 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.671 HD22 ' C ' ' A' ' 202' ' ' LEU . 2.1 mm? -121.55 132.76 54.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.4 m -89.0 120.01 30.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -115.95 166.22 12.28 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.471 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.36 56.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.146 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.18 121.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -89.23 -44.69 10.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.5 m -156.99 151.09 24.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.6 mp -96.72 123.51 40.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -112.0 158.6 19.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.81 -21.55 57.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -92.86 -20.11 21.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . 175.3 -171.64 44.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.488 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.666 ' CE1' HD12 ' A' ' 246' ' ' LEU . 89.0 m-85 -112.23 131.6 55.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.907 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.01 129.35 34.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -113.45 138.53 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -90.81 134.79 34.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.07 -21.14 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.22 54.87 3.41 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 24.1 t -148.38 138.53 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.22 125.66 36.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 102.87 -49.9 0.94 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.462 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 47.1 m -76.37 124.25 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 225' ' ' ARG . 4.3 ptp180 -116.53 127.99 55.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.01 128.75 56.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.559 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 8.0 t80 -124.75 136.35 53.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 229' ' ' PRO . 7.2 tp -105.74 130.83 22.4 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.826 ' HD2' HD12 ' A' ' 228' ' ' LEU . 53.6 Cg_endo -69.75 145.14 56.29 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.299 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 22.4 mt -63.03 -19.2 64.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -44.77 88.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -81.16 -28.91 34.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 215' ' ' TYR . . . -73.12 -47.17 46.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -62.89 -38.36 90.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.35 -44.54 87.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.661 ' HB2' HG21 ' A' ' 270' ' ' VAL . 11.3 t80 -72.04 -41.23 67.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 241' ' ' ASN . 40.9 mt -69.26 -41.03 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.491 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 21.8 ptt180 -70.05 -35.96 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -81.07 -36.17 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.468 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 27.4 mmtp -98.92 -58.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.656 ' HB2' HG23 ' A' ' 237' ' ' ILE . 4.4 m-20 -80.51 19.82 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm 38.25 26.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.53 44.36 5.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.509 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -102.7 -179.01 3.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -104.02 119.45 38.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.666 HD12 ' CE1' ' A' ' 215' ' ' TYR . 21.8 mt -62.14 -179.9 0.25 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -136.07 -175.53 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.87 149.43 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 67.16 14.98 64.7 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.467 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -87.52 148.06 25.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -81.05 128.54 33.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 236' ' ' TYR . 10.4 tp -133.07 145.13 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.62 136.08 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 75.5 m -153.99 163.02 40.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.3 mt -136.92 150.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 16.6 t -70.43 125.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -103.14 -46.73 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -145.42 146.61 31.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.638 HG21 ' C ' ' A' ' 197' ' ' LEU . 14.6 t -123.96 132.4 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 261' ' ' GLY . 3.1 tppp? -78.73 150.51 32.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 260' ' ' LYS . . . -35.96 -38.81 0.24 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.449 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -125.85 -176.54 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -76.07 48.21 2.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -80.31 -84.87 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.492 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.2 134.35 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 139.94 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.5 t -98.96 120.96 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 40.8 mt -111.71 154.46 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 23.2 p -152.68 141.97 21.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.852 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 236' ' ' TYR . 21.1 m -73.12 134.86 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -111.11 -75.31 0.78 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.502 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.01 151.19 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.831 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.7 t -125.81 166.53 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -70.21 79.73 0.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 86.6 t -113.32 -48.65 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 t -41.8 -42.69 2.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 83.2 m -54.61 109.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -36.3 113.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.067 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 281' ' ' THR . 5.8 mt -93.06 137.53 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.168 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -102.73 24.59 10.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 279' ' ' ILE . 11.7 m -91.42 122.37 33.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 283' ' ' GLN . 15.0 tp10 -67.72 153.4 43.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.41 ' N ' ' HG3' ' A' ' 282' ' ' GLU . 18.8 tp60 -161.77 136.47 7.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.95 113.81 23.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.3 m -57.02 138.47 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -88.54 146.05 25.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -45.44 119.31 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.26 147.18 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -167.92 163.6 13.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -93.38 117.32 29.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.87 132.1 40.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.8 p -85.91 131.71 34.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 163.79 -179.43 38.78 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 90.7 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.652 2.235 . . . . 0.0 112.376 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.3 p -87.62 107.11 18.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.4 p -101.51 -48.89 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.819 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.3 t 68.72 45.82 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.8 t -83.96 -44.95 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.894 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -155.43 74.79 0.23 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.6 p -102.61 42.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.921 0.391 . . . . 0.0 110.885 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.9 m -59.33 138.76 57.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 100.28 157.3 28.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.445 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.65 -63.4 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.804 0.335 . . . . 0.0 110.927 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -62.72 171.53 2.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.925 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 5.5 p -101.35 -19.39 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -127.32 43.84 3.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -50.66 153.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 191' ' ' VAL . 89.0 t -114.91 72.65 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.41 0.86 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 79.3 p -85.17 154.19 22.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 263' ' ' GLY . . . -75.27 -21.3 58.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.81 -21.93 43.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.85 54.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 mt -82.17 168.81 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -146.1 144.72 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 129.66 18.05 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 130.6 -1.34 5.6 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 15.6 mtm -88.75 140.5 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.427 HD13 HG11 ' A' ' 275' ' ' VAL . 4.6 mp -102.44 113.29 26.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.66 133.07 53.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -95.63 120.47 35.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -126.54 -169.93 12.85 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.0 p -131.96 137.91 48.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.354 . . . . 0.0 111.16 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.46 127.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.5 t -96.03 -40.59 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 11.6 m -154.93 156.02 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.8 mm? -100.33 110.22 22.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.32 139.1 31.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.506 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -63.06 -16.41 59.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -97.76 -36.74 10.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -159.58 -150.64 5.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 1.099 ' CE2' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.13 132.14 41.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.949 0.404 . . . . 0.0 110.911 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.9 131.4 37.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.3 t -115.82 145.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -92.52 128.97 38.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.56 -31.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.8 50.84 5.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.492 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.79 151.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.106 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 222' ' ' ASP . 3.1 t0 -92.65 110.64 22.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.73 55.59 2.65 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 87.7 m -156.03 122.97 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.339 . . . . 0.0 111.191 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 266' ' ' VAL . 68.8 mtt180 -116.13 129.47 56.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' A' ' 268' ' ' LEU . . . -119.77 128.98 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.131 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 16.0 t80 -131.97 135.01 46.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.832 HD13 ' N ' ' A' ' 229' ' ' PRO . 1.4 tm? -107.76 127.03 28.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.895 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.832 ' N ' HD13 ' A' ' 228' ' ' LEU . 53.5 Cg_endo -69.79 128.99 16.8 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.67 2.246 . . . . 0.0 112.346 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.656 HD23 ' HE1' ' A' ' 215' ' ' TYR . 18.4 mt -58.05 -22.05 48.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.6 mt -64.83 -45.03 87.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -83.44 -30.52 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.923 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 228' ' ' LEU . . . -68.07 -36.21 79.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -62.94 -39.29 94.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -62.41 -43.81 97.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.568 ' CE2' ' HE3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -73.14 -47.07 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.807 HG12 HD21 ' A' ' 246' ' ' LEU . 34.8 mt -61.15 -49.4 84.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.48 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.6 ptm180 -58.1 -43.17 86.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.479 ' N ' ' HG3' ' A' ' 238' ' ' ARG . 8.4 mm100 -80.36 -19.89 45.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.568 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 2.0 mmmp? -100.9 -75.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 243' ' ' GLY . 11.2 t-20 -80.66 41.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 241' ' ' ASN . 0.0 OUTLIER 33.28 34.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 75.45 54.16 5.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 245' ' ' LYS . . . -131.66 120.27 22.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 244' ' ' ALA . 0.0 OUTLIER -33.85 146.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 1.099 HD12 ' CE2' ' A' ' 215' ' ' TYR . 11.8 mt -78.14 179.63 6.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -123.33 171.05 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 75.3 t -92.54 139.83 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.33 -20.58 36.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -63.07 148.06 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.862 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -80.97 127.17 32.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.12 140.27 52.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -105.71 136.18 45.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 96.9 m -151.51 162.89 40.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.18 140.62 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.138 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.5 t -69.1 120.89 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.27 -39.7 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -144.81 141.64 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.1 t -120.66 130.93 74.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -82.25 145.7 29.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.33 -69.62 0.69 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.512 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -84.26 39.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.854 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 194' ' ' ALA . . . 38.58 34.77 0.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.517 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -67.11 -53.53 25.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.479 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.66 143.52 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 225' ' ' ARG . 43.2 t -126.95 140.07 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.862 ' C ' HD22 ' A' ' 268' ' ' LEU . 4.3 t -98.98 142.08 30.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.862 HD22 ' C ' ' A' ' 267' ' ' SER . 1.2 mm? -123.82 143.64 50.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.959 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 p -143.07 152.69 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 236' ' ' TYR . 58.6 t -79.16 141.51 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.078 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -179.25 118.66 0.61 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -106.76 73.21 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.349 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 275' ' ' VAL . 3.3 m -86.03 146.88 26.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.15 97.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 273' ' ' SER . 0.7 OUTLIER -115.67 -4.44 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.175 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.502 ' O ' ' C ' ' A' ' 277' ' ' THR . 23.6 m -91.87 143.19 26.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . 0.77 ' O ' HG23 ' A' ' 277' ' ' THR . 2.6 t 28.98 40.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 276' ' ' SER . . . -109.63 98.13 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 280' ' ' ALA . 49.5 mm -67.52 154.69 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.453 ' N ' HG22 ' A' ' 279' ' ' ILE . . . -85.27 28.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.0 t -88.88 152.6 21.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -167.73 135.59 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -73.1 141.6 47.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -50.27 128.71 20.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 28.7 t -114.94 96.25 5.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -92.04 125.92 36.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -139.09 105.85 5.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 288' ' ' LEU . 0.6 OUTLIER -87.75 151.69 22.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.921 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -118.48 130.17 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -93.88 87.95 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -50.12 173.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 27.1 t -155.55 138.26 15.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 155.38 -179.51 31.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.49 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -16.77 37.81 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.368 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.7 t -48.12 142.73 4.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 48.3 m -87.55 42.08 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.9 t 65.81 49.26 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.6 t -124.14 -43.61 2.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.09 173.41 23.31 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.502 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 t -69.18 146.35 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.848 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.7 m -59.05 -52.87 63.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -118.36 133.2 10.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -89.44 -51.49 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.344 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -115.08 122.86 47.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 13.7 m -54.78 -19.42 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -171.1 131.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -90.44 136.53 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.1 t -110.64 72.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 192' ' ' LEU . 1.6 pt? -112.36 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 t -46.56 172.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.57 -37.5 40.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.21 -33.21 72.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.421 ' HB3' ' C ' ' A' ' 192' ' ' LEU . . . -73.77 -28.98 61.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.41 149.75 16.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -119.59 149.24 47.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 0.0 110.895 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 256' ' ' VAL . 53.8 Cg_endo -69.78 116.87 4.76 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.721 2.281 . . . . 0.0 112.338 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.43 -9.83 3.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.719 ' O ' HG23 ' A' ' 255' ' ' ILE . 11.8 mtt -79.74 140.6 36.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.763 0.316 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.51 122.17 36.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.468 ' CD1' HG23 ' A' ' 256' ' ' VAL . 4.5 mp -131.25 125.23 32.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 m -92.51 119.09 31.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.63 16.54 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 p -118.23 139.8 50.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.484 HG11 HD21 ' A' ' 210' ' ' LEU . 61.9 t -60.99 134.59 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 45.9 t -109.91 -33.88 6.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.43 ' C ' HD23 ' A' ' 210' ' ' LEU . 1.8 t -157.03 156.12 32.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.83 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.56 HD22 ' HD1' ' A' ' 215' ' ' TYR . 10.0 mt -113.86 137.6 51.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -126.01 164.95 19.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.777 ' O ' HD11 ' A' ' 230' ' ' LEU . 6.1 p-10 -79.69 -26.49 40.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 213' ' ' HIS . 3.6 p80 -93.59 -17.7 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.476 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -177.75 -162.1 27.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.498 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.785 ' CE1' HD12 ' A' ' 246' ' ' LEU . 84.4 m-85 -133.94 139.93 46.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.926 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.85 130.5 34.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.32 131.59 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.59 134.69 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 16.2 pt -125.1 -21.4 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.64 47.92 7.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.36 135.7 61.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -88.68 107.24 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 97.92 36.93 4.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.478 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.5 m -153.01 125.31 8.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.103 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -114.08 131.75 56.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -118.22 134.89 54.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.099 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.476 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.3 t80 -127.17 140.4 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.897 HD12 ' HD2' ' A' ' 229' ' ' PRO . 24.9 tp -113.76 130.35 23.88 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.645 0.736 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.897 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.1 Cg_endo -69.68 146.59 61.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.268 . . . . 0.0 112.364 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 212' ' ' ASP . 31.3 mt -62.14 -19.9 63.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.77 -44.71 95.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -84.96 -41.47 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.452 ' HB2' HD23 ' A' ' 228' ' ' LEU . . . -65.11 -48.51 73.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.052 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 230' ' ' LEU . 12.4 tt0 -62.96 -37.73 88.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.91 -42.4 90.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.533 ' CD2' ' HD3' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -72.91 -38.92 66.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.961 HD11 HD11 ' A' ' 246' ' ' LEU . 66.0 mt -69.28 -40.5 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 14.3 ptm180 -70.23 -35.33 73.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -79.98 -40.43 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.533 ' HD3' ' CD2' ' A' ' 236' ' ' TYR . 0.0 OUTLIER -93.91 -55.39 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 237' ' ' ILE . 10.5 t-20 -81.43 19.12 1.03 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 241' ' ' ASN . 51.5 mttt 38.06 27.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 83.99 67.5 1.44 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 241' ' ' ASN . . . -146.35 151.47 37.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 111.152 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.47 154.91 2.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.961 HD11 HD11 ' A' ' 237' ' ' ILE . 66.8 mt -95.72 171.37 8.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.89 133.05 47.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.09 136.06 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.48 -23.19 34.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.586 ' NE2' HD22 ' A' ' 246' ' ' LEU . 6.7 pt20 -63.19 148.0 49.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.915 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -81.11 127.05 32.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 15.8 tp -127.61 137.1 52.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -84.42 131.58 34.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.585 ' HB3' HD22 ' A' ' 268' ' ' LEU . 32.3 m -145.99 153.54 40.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 201' ' ' MET . 15.2 mt -135.45 147.01 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 199' ' ' PRO . 40.0 t -66.93 124.52 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -105.65 -44.42 4.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -146.79 161.22 41.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.3 130.08 75.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -108.54 117.48 34.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -46.39 157.04 0.48 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.518 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 m120 58.87 25.46 13.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.912 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.47 45.75 4.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -74.57 -72.27 1.04 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.504 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.04 134.43 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.46 136.2 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.2 t -100.82 116.02 31.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.657 HD12 ' HB1' ' A' ' 226' ' ' ALA . 18.5 mt -115.69 156.68 25.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 255' ' ' ILE . 82.3 p -152.53 142.1 21.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 p -82.58 143.69 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 272' ' ' HIS . . . -136.62 106.27 0.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 271' ' ' GLY . 10.8 m80 -37.31 137.36 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 49.2 m -152.48 152.72 32.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 49.0 39.56 14.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 277' ' ' THR . 8.2 p -52.02 -40.26 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' THR . 28.2 m -40.29 -41.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 277' ' ' THR . 13.3 t 33.17 41.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -91.0 34.17 0.93 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.087 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 280' ' ' ALA . 4.6 mm -82.45 155.1 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.452 ' N ' HG22 ' A' ' 279' ' ' ILE . . . -102.86 101.76 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.9 p -139.42 169.73 17.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . 0.412 ' C ' ' CD ' ' A' ' 283' ' ' GLN . 12.9 pt-20 -170.35 140.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.412 ' CD ' ' C ' ' A' ' 282' ' ' GLU . 23.7 mp0 -148.65 140.46 23.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.462 ' C ' ' CD ' ' A' ' 284' ' ' GLN . 4.1 pp0? -87.57 151.95 22.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.1 p -129.59 116.64 19.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -44.11 150.52 0.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -59.23 148.43 31.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.7 tp -120.09 88.78 3.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 290' ' ' ASN . 4.9 m120 -161.65 131.39 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 289' ' ' ASN . 8.3 p30 -35.21 -45.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 6.6 tp -94.4 123.17 37.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 56.7 p -38.43 116.33 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -84.12 146.42 22.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.476 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -173.13 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.33 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 59.8 p -111.63 152.73 27.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -43.3 135.21 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.51 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 29.3 t -144.21 127.96 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.886 0.374 . . . . 0.0 110.896 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 m -155.07 173.0 17.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 51.2 77.23 0.14 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.9 p -120.79 -41.78 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 m -118.78 -69.51 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.871 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 186' ' ' LYS . . . -60.26 176.55 3.76 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.479 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 185' ' ' GLY . 14.1 ptpt 42.51 48.54 4.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.893 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -79.64 179.08 7.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 189' ' ' ASN . 63.9 t -128.54 75.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 188' ' ' VAL . 3.1 m-20 35.23 45.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 192' ' ' LEU . 12.4 ttm-85 -96.18 38.22 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.596 ' O ' HG12 ' A' ' 191' ' ' VAL . 16.0 t 39.67 27.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 190' ' ' ARG . 3.1 mp -141.96 123.17 14.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 47.4 m -163.06 -177.16 5.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.34 -26.63 3.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.73 -26.55 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -86.5 6.27 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.069 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.99 -176.47 2.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -158.88 152.4 19.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 132.83 24.09 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.701 2.268 . . . . 0.0 112.306 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 120.52 -10.7 10.54 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.483 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.4 mtt -73.94 127.58 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 203' ' ' LEU . 4.7 mp -88.74 113.52 24.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.404 HD23 ' O ' ' A' ' 202' ' ' LEU . 18.5 mt -129.69 134.92 47.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.94 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.46 117.03 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -120.12 154.85 16.33 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.515 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.9 p -104.85 132.86 50.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 111.125 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.03 120.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 33.2 t -86.0 -46.01 10.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.1 p -156.76 155.85 32.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.644 HD22 ' HD1' ' A' ' 215' ' ' TYR . 8.7 mt -102.92 139.0 39.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -125.1 161.65 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.485 ' O ' HD11 ' A' ' 230' ' ' LEU . 55.2 m-20 -72.54 -19.05 61.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -93.35 -39.51 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -166.39 -162.04 16.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.817 ' CE1' HD12 ' A' ' 246' ' ' LEU . 92.8 m-85 -120.58 130.34 54.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.929 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.42 133.94 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 49.2 t -115.95 139.81 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.147 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.16 129.88 34.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.92 -8.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.45 52.78 24.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.506 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.8 t -146.82 134.7 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 111.14 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -87.18 109.76 19.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 119.92 -49.17 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.607 ' CG2' HG21 ' A' ' 266' ' ' VAL . 48.6 m -68.21 124.1 22.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -111.3 131.17 55.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.22 134.79 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 36.7 t80 -131.81 143.41 50.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.915 HD12 ' HB2' ' A' ' 233' ' ' ALA . 0.3 OUTLIER -113.7 126.22 28.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.955 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.743 ' HD2' HD13 ' A' ' 228' ' ' LEU . 53.9 Cg_endo -69.73 129.13 17.09 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 212' ' ' ASP . 28.6 mt -62.94 -14.91 52.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 mt -73.79 -45.06 53.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -83.17 -36.84 24.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -64.78 -31.49 72.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -64.39 -41.19 96.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -63.64 -43.43 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 240' ' ' LYS . 18.3 t80 -72.1 -37.56 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 241' ' ' ASN . 76.5 mt -69.43 -45.82 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.173 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.468 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.2 ptp180 -61.47 -40.94 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -80.06 -21.17 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 236' ' ' TYR . 29.0 mmtm -99.44 -71.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 237' ' ' ILE . 17.2 t-20 -83.75 35.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' ASN . 25.5 mtpp 36.41 30.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.52 73.95 1.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -158.3 153.95 26.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.81 162.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.817 HD12 ' CE1' ' A' ' 215' ' ' TYR . 59.0 mt -95.31 -178.1 4.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.946 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 247' ' ' LYS . 3.4 mppt? -116.77 174.9 5.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 84.5 t -102.04 144.17 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.82 -6.09 20.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.79 147.94 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -80.99 127.24 32.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 14.7 tp -128.64 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -97.67 124.25 41.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 83.4 m -142.64 163.06 33.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 271' ' ' GLY . 91.6 mt -137.07 138.44 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.25 120.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -105.81 -33.5 7.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -144.0 133.45 23.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.98 132.08 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -87.41 157.64 19.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -68.1 -65.21 2.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.487 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.68 41.33 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 0.0 110.886 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 41.3 37.24 1.59 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -62.22 -74.74 0.37 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 35.6 t -132.77 135.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 111.167 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.607 HG21 ' CG2' ' A' ' 224' ' ' THR . 8.4 t -105.97 139.42 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.129 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.773 ' C ' HD22 ' A' ' 268' ' ' LEU . 7.5 m -100.39 139.54 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 267' ' ' SER . 1.1 mm? -121.19 153.0 38.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 255' ' ' ILE . 45.8 p -159.9 141.97 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.93 133.9 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.457 ' O ' HD11 ' A' ' 255' ' ' ILE . . . -160.19 103.38 0.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -78.28 62.72 3.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.791 0.329 . . . . 0.0 110.823 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 5.0 t -114.67 122.64 47.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -83.25 98.31 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.66 -59.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 m -130.18 125.05 34.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 43.4 p -42.57 143.39 0.68 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.14 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -98.61 -177.13 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.746 HG22 ' H ' ' A' ' 281' ' ' THR . 11.1 mt -86.5 142.22 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -97.21 20.89 10.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.746 ' H ' HG22 ' A' ' 279' ' ' ILE . 11.0 t -143.81 144.63 31.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -123.68 162.71 22.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.65 157.4 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -60.47 155.95 17.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 40.6 t -137.66 120.54 16.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 286' ' ' TRP . 5.0 t-105 -122.57 138.58 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -144.51 129.62 18.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 288' ' ' LEU . 1.6 pt? -82.15 174.43 11.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -151.44 111.8 4.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.898 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -64.63 -47.66 77.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.833 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -116.24 179.19 4.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.0 t -149.31 134.25 17.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -122.35 146.2 16.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.512 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -175.63 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.347 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.6 t -145.5 154.19 41.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 60.6 p -74.79 141.92 44.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.444 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.2 t -73.51 145.2 45.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 0.0 110.825 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 5.9 m -85.27 106.66 16.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -149.45 92.5 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.3 m -65.02 -61.81 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.853 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.3 t -46.09 165.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 153.95 -64.15 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -40.35 -60.04 1.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -161.5 106.67 1.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.71 145.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 190' ' ' ARG . 50.9 t-20 38.93 48.53 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 ttp180 -36.64 123.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 m -57.06 -18.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.23 109.74 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.4 m -82.68 174.43 11.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -44.41 -44.85 8.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -51.85 -54.1 32.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.5 -21.74 61.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 10.5 mt -67.25 -175.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -161.21 149.65 12.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.867 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 108.84 2.17 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 137.72 -5.82 3.45 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 255' ' ' ILE . 14.3 mtm -86.83 142.69 27.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.05 125.34 44.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 203' ' ' LEU . 4.5 mp -132.01 125.95 32.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -98.04 119.5 36.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -131.16 -165.18 11.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.1 p -129.92 138.75 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.02 128.54 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 47.1 t -87.8 -45.99 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 4.1 m -156.91 155.95 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.564 HD12 ' CE2' ' A' ' 215' ' ' TYR . 3.4 mm? -92.67 112.89 25.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -94.28 143.25 26.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.868 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.74 -19.13 65.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.49 -29.96 12.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 227' ' ' PHE . . . -166.64 -155.68 9.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.557 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.959 ' CE2' HD12 ' A' ' 246' ' ' LEU . 89.8 m-85 -125.49 125.85 43.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 110.897 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.39 133.94 33.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.01 141.56 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.79 131.44 34.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.1 pt -127.28 -29.42 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.44 41.09 21.56 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.443 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.4 t -121.78 144.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 111.074 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.75 108.09 20.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.35 33.79 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.475 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 95.8 m -143.6 123.13 13.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.341 . . . . 0.0 111.157 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -116.07 120.49 39.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD12 ' A' ' 268' ' ' LEU . . . -115.95 134.36 55.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.55 ' CZ ' ' HA3' ' A' ' 214' ' ' GLY . 24.8 t80 -132.0 144.0 50.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.855 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -113.67 126.9 27.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.643 0.735 . . . . 0.0 110.926 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.855 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.8 Cg_endo -69.79 136.15 32.21 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.499 HD23 ' HE1' ' A' ' 215' ' ' TYR . 31.9 mt -62.9 -24.35 67.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 29.2 mt -64.79 -42.24 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.57 -39.25 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 228' ' ' LEU . . . -61.0 -48.66 80.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.102 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -58.58 -37.97 76.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -64.25 -42.52 96.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.701 ' CD2' HG11 ' A' ' 270' ' ' VAL . 3.0 t80 -73.03 -40.02 65.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 241' ' ' ASN . 24.3 mt -68.1 -40.03 82.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.483 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.3 ptm180 -69.92 -37.98 76.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -81.38 -27.36 34.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 236' ' ' TYR . 66.9 mmtt -107.38 -63.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.726 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.4 m120 -81.37 24.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 241' ' ' ASN . 35.0 mtpt 34.77 31.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 82.79 44.54 7.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . -112.91 113.48 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -41.51 125.74 2.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.959 HD12 ' CE2' ' A' ' 215' ' ' TYR . 16.2 mt -58.94 -175.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -144.17 152.12 40.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 38.7 t -67.08 143.56 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.95 -21.06 16.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 252' ' ' LEU . 0.9 OUTLIER -65.49 148.32 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 110.954 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -80.97 133.04 35.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.444 ' HB2' ' NE2' ' A' ' 250' ' ' GLN . 24.2 tp -134.48 135.09 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -85.31 136.5 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.716 ' HB3' HD22 ' A' ' 268' ' ' LEU . 37.8 m -148.55 151.35 34.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 201' ' ' MET . 90.3 mt -131.52 138.69 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 17.2 t -62.73 123.71 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -106.82 -45.62 4.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -134.37 148.86 50.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 63.1 t -119.27 126.74 75.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -91.25 118.53 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -40.79 -56.88 2.98 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 263' ' ' GLY . 28.1 t30 -85.69 35.02 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.59 42.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.497 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -76.14 -74.21 0.95 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.6 130.99 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 111.152 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.19 139.95 27.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.1 t -99.38 120.75 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.801 HD12 ' HB1' ' A' ' 226' ' ' ALA . 27.9 mt -116.3 152.14 34.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 58.2 m -146.8 147.71 31.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.701 HG11 ' CD2' ' A' ' 236' ' ' TYR . 44.9 t -73.79 127.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -114.21 85.41 0.39 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -83.78 40.93 0.77 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 58.1 p -120.32 40.14 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -103.79 91.42 3.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.44 -10.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.187 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 7.7 t -113.27 127.75 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 81.4 p -109.23 130.4 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -120.31 104.15 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.113 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 78.0 mt -92.95 145.98 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -126.72 86.16 2.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 15.0 t -60.98 139.22 58.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -151.21 156.66 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -118.0 83.6 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -126.64 166.4 17.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 15.0 t -171.08 105.74 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.844 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -134.08 109.82 9.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.44 124.8 6.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 13.8 mt -152.59 -175.72 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -166.34 113.31 0.87 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -152.06 169.06 23.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.89 92.01 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.6 t -79.07 91.66 4.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -148.03 146.26 15.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -9.38 25.97 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.665 2.243 . . . . 0.0 112.371 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 97.4 p -97.07 134.84 39.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 29.6 m -76.72 -42.92 39.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.42 179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.0 t -129.9 -60.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.924 0.392 . . . . 0.0 110.863 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -138.1 163.52 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.97 -73.74 1.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.8 t -103.06 108.33 19.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 t -123.1 -42.99 2.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.19 -145.48 4.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -44.8 123.85 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 189' ' ' ASN . 0.1 OUTLIER -58.9 139.64 56.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.442 HG12 ' ND2' ' A' ' 187' ' ' ASN . 7.7 p -38.22 -29.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 187' ' ' ASN . 2.8 p-10 -142.72 124.51 15.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.0 ptt-85 -64.17 128.53 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 191' ' ' VAL . 20.4 t -93.43 37.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.081 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.78 81.16 1.41 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -164.01 154.92 15.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.83 96.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -66.1 -19.82 65.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.78 -32.89 58.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 76.3 mt -47.07 161.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.955 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -110.14 148.51 38.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.711 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 116.93 4.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 256' ' ' VAL . . . 126.84 -2.92 7.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.596 ' O ' HG23 ' A' ' 255' ' ' ILE . 34.3 mtt -68.07 141.24 56.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.651 ' C ' HD22 ' A' ' 203' ' ' LEU . 5.4 mp -87.23 111.04 20.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 202' ' ' LEU . 3.9 mm? -124.74 137.86 54.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 26.4 m -112.64 125.38 54.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -137.32 161.01 25.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.426 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.553 HG23 ' CE1' ' A' ' 251' ' ' TYR . 4.0 p -103.57 140.08 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 111.165 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.5 122.38 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.5 t -87.56 -43.36 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.1 m -156.81 155.77 32.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.8 mp -99.58 123.73 44.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.56 147.57 31.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -65.09 -27.42 68.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -90.6 -32.41 16.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -164.62 -159.19 10.9 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.534 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.929 ' CE1' HD12 ' A' ' 246' ' ' LEU . 94.6 m-85 -125.71 129.51 49.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.01 134.05 33.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 57.4 t -111.98 142.2 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.145 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -88.45 124.11 33.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -123.94 -27.39 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.03 40.69 10.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 64.9 t -128.59 142.14 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.127 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.51 126.63 38.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 98.99 -48.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 58.6 m -69.13 123.23 20.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -114.97 129.69 56.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -116.11 128.98 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.565 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 27.4 t80 -131.85 134.34 45.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.846 HD22 ' HD2' ' A' ' 229' ' ' PRO . 1.7 tm? -109.21 126.4 29.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.71 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.846 ' HD2' HD22 ' A' ' 228' ' ' LEU . 53.7 Cg_endo -69.74 133.77 26.42 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 215' ' ' TYR . 48.9 mt -61.2 -21.86 64.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 -44.99 85.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HD2' HG22 ' A' ' 270' ' ' VAL . 1.6 tmtp? -77.5 -31.54 53.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.9 -39.77 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -59.43 -33.87 71.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.33 -45.85 75.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.666 ' HB2' HG21 ' A' ' 270' ' ' VAL . 1.9 t80 -72.3 -38.04 68.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.623 HG23 ' HB2' ' A' ' 241' ' ' ASN . 51.6 mt -69.79 -42.45 80.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.119 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.478 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 17.9 ptt180 -69.77 -36.56 75.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -81.39 -34.74 31.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.551 ' HG3' ' CD2' ' A' ' 236' ' ' TYR . 1.2 mmmp? -99.66 -60.03 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 244' ' ' ALA . 8.6 m-20 -80.81 21.32 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 238' ' ' ARG . 8.8 mmmm 36.99 28.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 88.97 46.88 4.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.46 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 241' ' ' ASN . . . -106.25 177.56 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -100.12 137.59 38.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.929 HD12 ' CE1' ' A' ' 215' ' ' TYR . 23.5 mt -73.43 162.37 29.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -128.38 149.68 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.19 150.57 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.82 3.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.53 148.32 49.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.553 ' CE1' HG23 ' A' ' 206' ' ' THR . 11.8 m-85 -80.94 129.87 34.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 25.8 tp -122.85 140.77 52.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.518 ' O ' HG12 ' A' ' 270' ' ' VAL . 3.7 p30 -87.62 128.33 35.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.749 ' HB3' HD22 ' A' ' 268' ' ' LEU . 83.9 m -147.14 149.8 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 201' ' ' MET . 79.8 mt -134.54 139.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 200' ' ' GLY . 30.7 t -62.71 119.05 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -97.05 -40.04 9.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -153.62 152.94 31.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -123.22 127.96 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.41 178.01 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.69 -74.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 263' ' ' GLY . 1.4 m120 -80.12 45.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.908 0.385 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.72 37.98 0.18 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.97 5.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.481 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 146.37 32.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 0.0 111.118 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 27.8 t -113.33 139.33 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.9 t -99.3 118.57 36.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 254' ' ' CYS . 12.2 mt -120.88 146.98 46.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.929 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 5.6 p -147.09 145.47 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 236' ' ' TYR . 27.3 m -76.87 122.57 31.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.096 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -138.56 94.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -44.34 152.94 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 67.4 m -44.83 163.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -138.39 112.43 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.05 -58.95 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.15 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 60.3 m -75.24 85.36 2.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 12.8 t -101.42 147.74 25.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.167 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -89.82 100.85 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 57.9 mt -80.19 148.74 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -108.13 101.25 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 9.8 t -121.99 144.23 49.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.49 174.26 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -136.38 173.8 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -53.33 163.75 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.955 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 60.8 m -148.58 129.99 14.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.834 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -141.96 160.25 40.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.89 137.41 51.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 8.9 mp -104.78 119.37 38.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -40.3 148.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -85.13 99.19 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.33 89.89 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 86.0 p -139.03 127.35 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.91 153.05 2.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.5 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -17.02 37.66 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 65.7 m -52.24 96.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 42.9 m -74.35 166.26 23.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.814 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.479 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.5 t 43.25 42.22 3.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 18.9 m -111.3 85.38 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.832 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.48 156.75 28.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.8 m -118.0 -49.58 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.85 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 m -54.93 173.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.04 50.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -118.34 129.97 55.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.616 ' ND2' ' N ' ' A' ' 187' ' ' ASN . 0.0 OUTLIER -126.43 177.25 6.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.3 137.44 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 60.33 42.88 14.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.71 142.81 38.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.688 HG13 ' HB1' ' A' ' 196' ' ' ALA . 94.7 t -111.46 71.07 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.19 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.2 tp -130.29 41.18 3.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 196' ' ' ALA . 24.0 p -139.86 140.03 36.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -41.06 -36.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.94 -38.21 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.688 ' HB1' HG13 ' A' ' 191' ' ' VAL . . . -75.56 -29.9 59.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -58.88 164.12 3.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -140.05 151.47 65.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.2 20.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 113.29 -6.12 25.02 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.477 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.533 ' O ' HG23 ' A' ' 255' ' ' ILE . 43.7 mtt -67.85 138.83 56.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 110.865 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 202' ' ' LEU . 3.9 mp -94.44 110.13 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 202' ' ' LEU . 23.7 mt -131.13 141.65 50.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -111.56 124.63 52.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -127.24 -174.75 13.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.7 141.51 51.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.142 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.03 120.69 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.4 t -86.47 -41.87 14.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 56.4 p -156.4 156.0 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 248' ' ' VAL . 9.5 mp -105.01 124.46 49.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -115.34 145.21 42.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.932 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.771 ' O ' HD11 ' A' ' 230' ' ' LEU . 24.1 m-20 -67.48 -17.87 64.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -97.24 -20.05 18.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -177.95 -166.78 34.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 246' ' ' LEU . 85.0 m-85 -125.79 132.95 52.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.616 HD12 ' NH2' ' A' ' 225' ' ' ARG . 1.5 mm? -88.85 132.17 34.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.897 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.8 t -116.15 135.17 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.099 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -82.1 126.97 32.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 pt -119.01 -18.56 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.02 43.13 8.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.5 t -137.55 127.29 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.107 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.91 130.33 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 100.64 -43.41 1.76 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 78.8 m -73.92 132.0 42.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.787 0.327 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.616 ' NH2' HD12 ' A' ' 216' ' ' LEU . 6.9 tpm_? -109.33 123.18 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -114.96 126.92 55.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.1 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 9.0 t80 -132.01 139.21 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 229' ' ' PRO . 15.3 tp -112.73 133.41 21.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.622 0.725 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.0 Cg_endo -69.72 139.49 40.48 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.771 HD11 ' O ' ' A' ' 212' ' ' ASP . 84.1 mt -63.11 -25.08 68.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.9 mt -68.57 -45.05 73.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' CD ' ' O ' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -78.09 -33.14 50.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.15 63.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -58.45 -35.67 72.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -62.98 -42.92 99.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.56 ' C ' ' CD1' ' A' ' 236' ' ' TYR . 0.3 OUTLIER -72.47 -37.74 68.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.893 -179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 244' ' ' ALA . 32.7 mt -66.97 -39.11 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.129 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.477 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 8.5 ttt180 -69.2 -41.29 77.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -79.49 -20.3 47.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' A' ' 236' ' ' TYR . 47.1 mmtt -101.5 -69.78 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.681 ' CG ' ' HB3' ' A' ' 244' ' ' ALA . 15.7 t-20 -83.85 35.6 0.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 241' ' ' ASN . 38.9 mmtt 34.65 32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 80.37 68.49 1.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.5 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.681 ' HB3' ' CG ' ' A' ' 241' ' ' ASN . . . -143.76 169.24 18.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 111.057 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 146.98 50.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 215' ' ' TYR . 80.0 mt -87.67 178.25 6.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -132.95 153.14 51.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 210' ' ' LEU . 37.1 t -78.01 134.4 28.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.065 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 101.1 -22.36 39.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.449 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -64.54 148.04 51.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.05 128.47 33.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 252' ' ' LEU . 6.7 tp -123.09 142.9 50.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 270' ' ' VAL . 0.5 OUTLIER -92.43 130.51 38.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.681 ' HB3' HD22 ' A' ' 268' ' ' LEU . 95.1 m -154.91 153.0 30.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 201' ' ' MET . 96.6 mt -133.63 139.21 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.52 125.14 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -103.5 -45.82 4.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -142.51 158.37 43.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.0 t -123.25 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.45 136.57 36.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -44.7 -66.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.546 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 263' ' ' GLY . 19.1 t-20 -84.53 45.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 262' ' ' ASN . . . 35.24 36.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -68.76 -86.63 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.42 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.88 144.26 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.53 140.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.6 t -98.96 118.13 35.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 254' ' ' CYS . 13.2 mt -116.72 149.62 39.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 75.4 m -156.91 142.03 17.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 253' ' ' ASN . 17.4 t -71.89 142.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 272' ' ' HIS . . . -98.07 -37.01 4.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.529 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 271' ' ' GLY . 28.2 p80 42.55 28.47 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.9 t -148.38 148.01 29.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 69.12 41.77 1.35 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.27 -25.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 99.6 p -62.57 130.61 45.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 12.1 t -92.45 156.0 17.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -43.6 165.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 21.3 mt -50.4 150.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -101.53 101.15 11.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 18.0 p -104.53 119.97 40.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -85.88 -25.08 26.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.412 ' H ' ' CD ' ' A' ' 283' ' ' GLN . 4.0 pm0 -85.96 155.69 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -156.21 174.54 15.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 55.2 m -78.56 148.71 33.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.906 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -92.44 163.31 13.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -122.82 164.58 18.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.88 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 2.5 tp -138.88 123.01 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -87.5 173.2 9.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -172.8 172.13 4.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 15.4 mt 60.55 53.25 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 20.5 m -120.17 120.44 36.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -152.0 145.68 13.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.478 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -178.6 2.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.356 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 83.1 p -155.12 166.99 31.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 81.1 p -112.14 173.94 6.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.486 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.7 t -107.13 127.78 53.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -71.28 -49.87 38.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 116.37 -130.5 9.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.516 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -106.14 122.3 45.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.0 110.879 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -150.17 154.98 38.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -63.44 -161.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.444 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -94.53 -46.26 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -159.24 154.78 25.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.8 m -80.36 132.14 32.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.177 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 190' ' ' ARG . 20.9 t30 42.33 43.65 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 0.0 OUTLIER -36.34 147.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.38 -16.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.171 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 tt -59.53 107.72 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 56.0 m -146.27 171.63 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.97 -29.17 7.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.01 -32.36 71.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -73.66 -25.07 60.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.104 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 15.9 mt -57.83 152.28 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -129.95 148.93 71.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.528 0.68 . . . . 0.0 110.937 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 120.27 7.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 0.0 112.341 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 134.65 -12.02 4.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.576 ' O ' HG23 ' A' ' 255' ' ' ILE . 15.0 mtt -80.97 140.38 35.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.614 ' C ' HD12 ' A' ' 203' ' ' LEU . 4.9 mp -95.2 120.5 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 202' ' ' LEU . 5.1 mp -130.54 125.36 34.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 9.5 m -94.39 120.41 34.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -124.76 -174.43 14.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.492 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.3 p -123.55 142.38 51.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 111.116 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.09 120.4 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.3 t -85.16 -41.8 15.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.897 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -157.03 155.05 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.561 ' CD2' HG23 ' A' ' 248' ' ' VAL . 3.2 mm? -95.08 107.49 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.934 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -94.13 149.38 21.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.425 ' O ' HD11 ' A' ' 230' ' ' LEU . 26.7 t70 -72.55 -31.09 65.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -84.24 -28.75 27.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 227' ' ' PHE . . . -168.96 -158.75 13.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.662 ' CD1' HD12 ' A' ' 246' ' ' LEU . 97.0 m-85 -123.02 131.62 53.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.902 0.382 . . . . 0.0 110.922 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 226' ' ' ALA . 3.1 mm? -86.04 129.83 34.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.37 134.02 56.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.103 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.09 137.07 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 20.8 pt -126.27 -30.58 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.88 55.24 2.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 222' ' ' ASP . 25.2 t -140.18 155.99 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 221' ' ' VAL . 0.8 OUTLIER -101.23 119.11 38.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.36 44.19 6.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.534 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 90.0 m -144.18 131.5 20.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.811 0.338 . . . . 0.0 111.139 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -115.62 125.9 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 216' ' ' LEU . . . -121.9 122.19 38.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 214' ' ' GLY . 17.6 t80 -125.52 140.52 52.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 229' ' ' PRO . 12.2 tp -110.28 129.79 23.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.658 0.742 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 228' ' ' LEU . 54.3 Cg_endo -69.74 135.26 30.07 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.326 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 212' ' ' ASP . 39.0 mt -63.1 -23.82 67.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.77 -45.18 87.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.936 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' A' ' 270' ' ' VAL . 1.4 tppp? -85.12 -32.8 22.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.0 -44.43 80.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.114 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -58.65 -34.01 70.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -64.87 -43.79 91.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 240' ' ' LYS . 15.4 t80 -72.83 -42.17 64.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 241' ' ' ASN . 22.6 mt -68.13 -40.78 83.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.485 ' HA ' ' N ' ' A' ' 243' ' ' GLY . 11.8 ptm180 -70.11 -35.78 74.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -81.19 -34.59 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 236' ' ' TYR . 24.0 mmtp -100.75 -59.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.704 ' HB2' HG23 ' A' ' 237' ' ' ILE . 2.5 m120 -80.31 19.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.52 26.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 241' ' ' ASN . . . 87.1 46.68 4.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.78 116.33 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.109 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -38.21 133.13 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.662 HD12 ' CD1' ' A' ' 215' ' ' TYR . 49.6 mt -69.97 171.28 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -126.14 175.44 7.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 210' ' ' LEU . 42.7 t -92.15 132.59 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 102.19 -27.56 19.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.528 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -63.2 147.88 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -81.03 126.99 32.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 11.9 tp -120.72 138.3 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -85.63 135.12 33.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 65.2 m -156.33 154.58 30.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 201' ' ' MET . 43.2 mt -134.4 142.16 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.21 119.35 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -98.67 -46.4 5.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -150.15 158.39 44.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -120.54 129.38 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.32 156.54 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -70.09 159.58 53.42 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 48.21 34.97 4.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.35 . . . . 0.0 110.861 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 42.18 36.3 1.99 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -60.07 -81.05 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.498 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.61 146.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 53.7 t -113.44 138.8 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.6 t -100.78 117.76 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 15.7 mt -116.69 157.69 25.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.897 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 255' ' ' ILE . 73.0 p -154.72 142.0 19.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 232' ' ' LYS . 32.9 m -72.31 132.14 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -157.87 93.27 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -69.18 -51.93 33.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 90.8 p -53.74 173.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -137.64 126.58 24.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 276' ' ' SER . 27.7 m -99.79 -43.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.174 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.48 ' N ' HG23 ' A' ' 275' ' ' VAL . 30.2 t -49.32 151.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' THR . . . . . . . . . . . . . 34.7 p -82.08 164.63 21.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -86.73 155.59 20.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.894 HG22 ' H ' ' A' ' 281' ' ' THR . 66.9 mt -51.44 142.0 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.522 ' HB1' ' HG3' ' A' ' 282' ' ' GLU . . . -75.42 -20.11 59.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.894 ' H ' HG22 ' A' ' 279' ' ' ILE . 0.7 OUTLIER 45.79 28.6 0.59 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . 0.522 ' HG3' ' HB1' ' A' ' 280' ' ' ALA . 32.9 mt-10 -61.19 123.5 17.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.17 -43.27 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -42.79 114.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 68.3 m -111.31 126.65 55.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -55.34 -35.47 65.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -48.64 157.98 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.71 101.74 11.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -161.11 147.45 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -106.43 130.1 54.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.82 95.37 10.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 41.9 m -97.91 125.46 42.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.01 82.94 0.57 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 108.97 2.2 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.6 t -62.69 140.8 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.9 t -153.55 145.26 23.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.476 179.991 . . . . . . . . 0 0 . 1 stop_ save_